Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application.

[1]  A. Carlsson,et al.  3,4-Dihydroxyphenylalanine and 5-Hydroxytryptophan as Reserpine Antagonists , 1957, Nature.

[2]  J. H. Ward.  Hierarchical Grouping to Optimize an Objective Function , 1963 .

[3]  Jacques Monod,et al.  Chance and Necessity , 1970 .

[4]  Dr. Susumu Ohno.  Evolution by Gene Duplication , 1970, Springer Berlin Heidelberg.

[5]  C. Schuster,et al.  Fixed-interval schedule of cocaine reinforcement: effect of dose and infusion duration. , 1973, Journal of the experimental analysis of behavior.

[6]  C. Wilson,et al.  The effect of ovarian steroids on the accumulation of 3H-labelled monoamines by hypothalamic tissue in vitro. , 1974, Brain research.

[7]  A. Wirz-Justice,et al.  The effect of oestradiol dipropionate and progesterone on monoamioe uptake in rat brain 1 , 1974, Journal of neurochemistry.

[8]  D J Kupfer,et al.  REM latency: a psychobiologic marker for primary depressive disease. , 1976, Biological psychiatry.

[9]  R. Jensen.  Enzyme recruitment in evolution of new function. , 1976, Annual review of microbiology.

[10]  J. Blundell.  Is there a role for serotonin (5-hydroxytryptamine) in feeding? , 1977, International journal of obesity.

[11]  A. Coppen,et al.  Decreased cerebrospinal fluid concentration of free phenylacetic acid in depressive illness. , 1979, Clinica chimica acta; international journal of clinical chemistry.

[12]  G. Kovacs,et al.  Effect of oxytocin and vasopressin on memory consolidation: sites of action and catecholaminergic correlates after local microinjection into limbic-midbrain structures , 1979, Brain Research.

[13]  G. Vogel,et al.  Improvement of depression by REM sleep deprivation. New findings and a theory. , 1980, Archives of general psychiatry.

[14]  R. Mathew,et al.  Tricyclic side effects without tricyclics in depression. , 1980, Psychopharmacology bulletin.

[15]  S. Philips,et al.  Kinetic Measurements of the Turnover Rates of Phenylethylamine and Tryptamine In Vivo in the Rat Brain , 1980, Journal of neurochemistry.

[16]  R. S. Jones,et al.  Interactions between p-tyramine, m-tyramine, or beta-phenylethylamine and dopamine on single neurones in the cortex and caudate nucleus of the rat. , 1980, Canadian journal of physiology and pharmacology.

[17]  The discovery of phencyclidine [proceedings]. , 1980 .

[18]  P. Galton,et al.  A MORPHOMETRIC STUDY OF THE CRANIUM OF THE PACHYCEPHALOSAURID DINOSAUR STEGOCERAS , 1981 .

[19]  J. Gerlach,et al.  Bromocriptine and imipramine in endogenous depression. A double-blind controlled trial in out-patients. , 1981, Journal of affective disorders.

[20]  I. Blackburn,et al.  The Efficacy of Cognitive Therapy in Depression: A Treatment Trial Using Cognitive Therapy and Pharmacotherapy, each Alone and in Combination , 1981, British Journal of Psychiatry.

[21]  E. Albuquerque,et al.  Differentiation of the open and closed states of the ionic channels of nicotinic acetylcholine receptors by tricyclic antidepressants. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[22]  A. A. Chaikin,et al.  In: The new Solar System , 1981 .

[23]  D. Murphy,et al.  Functional subsensitivity of alpha 2-adrenoceptors accompanies reductions in yohimbine binding after clorgyline treatment. , 1982, European journal of pharmacology.

[24]  B. Katzung.  Basic and Clinical Pharmacology , 1982 .

[25]  F. Goodwin,et al.  Evidence that the pathophysiology of depression and the mechanism of action of antidepressant drugs both involve alterations in circadian rhythms. , 1982, Advances in biochemical psychopharmacology.

[26]  S. Gould,et al.  Exaptation—a Missing Term in the Science of Form , 1982, Paleobiology.

[27]  J J Hopfield,et al.  Neural networks and physical systems with emergent collective computational abilities. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[28]  D. Murphy,et al.  Effort and cognition in depression. , 1982, Archives of general psychiatry.

[29]  M. L. Berk,et al.  Efferent connections of the lateral hypothalamic area of the rat: An autoradiographic investigation , 1982, Brain Research Bulletin.

[30]  Y. Agid,et al.  Antiparkinsonian and antidepressant effects of high doses of bromocriptine. An independent comparison. , 1983, Journal of affective disorders.

[31]  Leo Breiman,et al.  Classification and Regression Trees , 1984 .

[32]  G. Oxenkrug,et al.  Clinical pharmacology of bupropion and imipramine in elderly depressives. , 1983, The Journal of clinical psychiatry.

[33]  P. Södersten,et al.  Vasopressin alters female sexual behaviour by acting on the brain independently of alterations in blood pressure , 1983, Nature.

[34]  J. Nurnberger,et al.  Reduced plasma and CSF gamma-aminobutyric acid in affective illness: effect of lithium carbonate. , 1983, Biological psychiatry.

[35]  N. Shorstein,et al.  Rapid down-regulation of serotonin2 receptor binding during combined administration of tricyclic antidepressant drugs and α 2 antagonists , 1983, Neuropharmacology.

[36]  F. Goodwin,et al.  Seasonal affective disorder. A description of the syndrome and preliminary findings with light therapy. , 1984, Archives of general psychiatry.

[37]  A. Simons,et al.  Cognitive therapy and pharmacotherapy. Singly and together in the treatment of depression. , 1984, Archives of general psychiatry.

[38]  Kay Cr.  The Royal College of General Practitioners' Oral Contraception Study: some recent observations. , 1984 .

[39]  S. Lal,et al.  Effect of apomorphine, a dopamine receptor agonist, on penile tumescence in normal subjects , 1984, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[40]  D. Kupfer,et al.  All-night spectral analysis of the sleep EEG in untreated depressives and normal controls , 1984, Psychiatry Research.

[41]  R. Mayeux,et al.  Altered serotonin metabolism in depressed patients with Parkinson's disease , 1984, Neurology.

[42]  John T. Clark,et al.  Evidence for the Modulation of Sexual Behavior by α-Adrenoceptors in Male Rats , 1985 .

[43]  R. Krishnan,et al.  Neurovegetative symptoms in chronic pain and depression. , 1985, Journal of affective disorders.

[44]  Electroconvulsive Therapy-Induced Cortisol Release: Changes with Depressive State. , 1985, Convulsive therapy.

[45]  M. E. Lewis,et al.  Combined autoradiographic-immunocytochemical analysis of opioid receptors and opioid peptide neuronal systems in brain , 1985, Peptides.

[46]  P. Linkowski,et al.  The 24-hour profile of adrenocorticotropin and cortisol in major depressive illness. , 1985, The Journal of clinical endocrinology and metabolism.

[47]  E. Giacobini,et al.  Pipecolic acid levels and transport in developing mouse brain. , 1985, Brain research.

[48]  A double‐blind group comparative study using the new anti‐depressant Org 3770, placebo and diazepam in patients with expected insomnia and anxiety before elective gynaecological surgery , 1985, Acta psychiatrica Scandinavica.

[49]  E. Smith,et al.  Differential interactions of "prosexual" drugs with 5-hydroxytryptamine1A and alpha 2-adrenergic receptors. , 1986, Behavioral neuroscience.

[50]  D. A. Edwards,et al.  Midbrain lesions, dopamine and male sexual behavior , 1986, Behavioural Brain Research.

[51]  M. Gastpar,et al.  Comparison of oral and intravenous treatment of depressive states: preliminary results of a WHO collaborative study. , 1986, Clinical neuropharmacology.

[52]  M. Menaker,et al.  Effects of diazepam on circadian phase advances and delays , 1986, Brain Research.

[53]  J. Hopfield,et al.  Computing with neural circuits: a model. , 1986, Science.

[54]  Goldberg Ma,et al.  Affective disorders and circadian rhythms. , 1986 .

[55]  D. Sirinathsinghji.  Regulation of lordosis behaviour in the female rat by corticotropin-releasing factor, β-endorphin/corticotropin and luteinizing hormone-releasing hormone neuronal systems in the medial preoptic area , 1986, Brain Research.

[56]  A. Coenen,et al.  Effects of REM sleep deprivation on central α1- and β-adrenoceptors in rat brain , 1986, Pharmacology Biochemistry and Behavior.

[57]  H. Weingartner.  Automatic and effort-demanding cognitive processes in depression. , 1986 .

[58]  M. Rubio,et al.  Time-related response of central serotonergic function to lithium administration. , 1986, General pharmacology.

[59]  S. Dilsaver.  Cholinergic mechanisms in depression , 1986, Brain Research Reviews.

[60]  S. Potkin,et al.  Melatonin in Depression , 1987 .

[61]  D. Kupfer,et al.  Prolactin secretion during sleep: A comparison between depressed patients and healthy control subjects , 1987, Biological Psychiatry.

[62]  A. D. Gordon.  A Review of Hierarchical Classification , 1987 .

[63]  G. Gessa,et al.  Apomorphine-induced penile erection and yawning: site of action in brain , 1987, Brain Research.

[64]  D. Sirinathsinghji.  Inhibitory influence of corticotropin releasing factor on components of sexual behaviour in the male rat , 1987, Brain Research.

[65]  R. Penney,et al.  Facilitation of lordosis by injection of substance P into the midbrain central gray. , 1987, Neuroendocrinology.

[66]  The regional distribution of p-tyramine and m-tyramine in the rat corpus striatum and the effect of monoamine oxidase inhibition , 1987, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[67]  P. Morselli,et al.  GABA and affective disorders. , 1987, Medical biology.

[68]  J. Gray,et al.  Increased GABAB receptor function in mouse frontal cortex after repeated administration of antidepressant drugs or electroconvulsive shocks , 1987, British journal of pharmacology.

[69]  C. Hiemke,et al.  Inhibition of synaptosomal high-affinity uptake of dopamine and serotonin by estrogen agonists and antagonists. , 1987, Biochemical pharmacology.

[70]  T. Yamamoto,et al.  The effect of agonists at the GABA-benzodiazepine receptor complex on the duration of immobility of mice in the forced swimming test. , 1987, European journal of pharmacology.

[71]  R. Tölle,et al.  Circadian rhythm of free urinary cortisol, temperature and heart rate in endogenous depressives and under antidepressant therapy. , 1987, Neuropsychobiology.

[72]  L. Wennogle,et al.  Allosteric Interaction Between the Site Labeled by [3H]Imipramine and the Serotonin Transporter in Human Platelets , 1987, Journal of neurochemistry.

[73]  G. Fava,et al.  Nocturnal prolactin and cortisol secretion and recovery from melancholia , 1987, Psychoneuroendocrinology.

[74]  H. Yoshimatsu,et al.  Blockade of the histamine H1-receptor in the rat ventromedial hypothalamus and feeding elicitation , 1988, Brain Research.

[75]  Brian Everitt,et al.  Principles of Multivariate Analysis , 2001 .

[76]  J. Kleinman,et al.  The neuropathology of schizophrenia. , 1988, Schizophrenia bulletin.

[77]  P. Micevych,et al.  Concentrations of cholecystokinin, substance P, and bombesin in discrete regions of male and female rat brain: Sex differences and estrogen effects , 1988, Experimental Neurology.

[78]  W. Lovenberg,et al.  Chronic MAO A and MAO B inhibition decreases the 5-HT1A receptor-mediated inhibition of forskolin-stimulated adenylate cyclase. , 1988, European journal of pharmacology.

[79]  ECT alters human monoamines in a different manner from that of antidepressant drugs. , 1988, Psychopharmacology bulletin.

[80]  C. Gambarana,et al.  Quantitative autoradiography of central beta adrenoceptor subtypes: comparison of the effects of chronic treatment with desipramine or centrally administered l-isoproterenol. , 1988, The Journal of pharmacology and experimental therapeutics.

[81]  G. Luscombe,et al.  The pharmacology of sibutramine hydrochloride (BTS 54 524), a new antidepressant which induces rapid noradrenergic down-regulation , 1988, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[82]  G. Chrousos,et al.  Interaction between GABAergic neurotransmission and rat hypothalamic corticotropin-releasing hormone secretion in vitro , 1988, Brain Research.

[83]  C. Wahlestedt,et al.  Antidepressant drugs increase the concentration of neuropeptide Y (NPY)-like immunoreactivity in the rat brain. , 1988, European journal of pharmacology.

[84]  Clifford M. Singer,et al.  Winter Depression and the Phase-Shift Hypothesis for Bright Light's Therapeutic Effects: History, Theory, and Experimental Evidence , 1988, Journal of biological rhythms.

[85]  J. Scuvée-Moreau,et al.  Electrophysiological effects of tianeptine on rat locus coeruleus, raphe dorsalis, and hippocampus activity. , 1988, Clinical neuropharmacology.

[86]  D. Kupfer,et al.  Social zeitgebers and biological rhythms. A unified approach to understanding the etiology of depression. , 1988, Archives of general psychiatry.

[87]  M. E. Lewis,et al.  Anatomy of CNS opioid receptors , 1988, Trends in Neurosciences.

[88]  C. Wahlestedt,et al.  Neuropeptide Y and peptide YY as possible cerebrospinal fluid markers for major depression and schizophrenia, respectively. , 1988, Journal of psychiatric research.

[89]  U. Trendelenburg.  The Extraneuronal Uptake and Metabolism of Catecholamines , 1988 .

[90]  N. Orthen-Gambill.  Antihistaminic drugs increase feeding, while histidine suppresses feeding in rats , 1988, Pharmacology Biochemistry and Behavior.

[91]  A. Meli,et al.  On the role of endogenous GABA in the forced swimming test in rats , 1988, Pharmacology Biochemistry and Behavior.

[92]  E. Biessen,et al.  Evidence for the existence of at least two different binding sites for 5HT-reuptake inhibitors within the 5HT-reuptake system from human platelets. , 1988, Biochemical pharmacology.

[93]  E. Hull,et al.  Pharmacological analysis of male rat sexual behavior , 1987, Neuroscience & Biobehavioral Reviews.

[94]  S. Markey,et al.  Antidepressants reduce whole-body norepinephrine turnover while enhancing 6-hydroxymelatonin output. , 1988, Archives of general psychiatry.

[95]  S. Checkley,et al.  A Comparison of Melatonin Secretion in Depressed Patients and Normal Subjects , 1988, British Journal of Psychiatry.

[96]  F. Bloom,et al.  Cellular and molecular mechanisms of drug dependence. , 1988, Science.

[97]  D. Ford,et al.  Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? , 1989, JAMA.

[98]  R. Wise,et al.  Brain dopamine and reward. , 1989, Annual review of psychology.

[99]  J. Hall,et al.  The role of the 5-HT2 receptor in the regulation of sexual performance of male rats. , 1989, Life sciences.

[100]  T. Robbins,et al.  Interactions between the amygdala and ventral striatum in stimulus-reward associations: Studies using a second-order schedule of sexual reinforcement , 1989, Neuroscience.

[101]  R. Wise.  Opiate reward: Sites and substrates , 1989, Neuroscience & Biobehavioral Reviews.

[102]  A. Fernández-Guasti,et al.  Inhibitory action of various 5-HT1B receptor agonists on rat masculine sexual behavior , 1989, Pharmacology Biochemistry and Behavior.

[103]  H. Akil,et al.  Chronic electroconvulsive shock treatment elicits up-regulation of CRF and AVP mRNA in select populations of neuroendocrine neurons , 1989, Brain Research.

[104]  N. Geyer,et al.  Rolipram in Major Depressive Disorder: Results of a Double-Blind Comparative Study with Imipramine , 1989, Pharmacopsychiatry.

[105]  M. Candito,et al.  Circadian rhythms in depression and recovery: Evidence for blunted amplitude as the main chronobiological abnormality , 1989, Psychiatry Research.

[106]  Direct effects of ovarian hormones on antidepressant binding sites , 1989, Brain Research Bulletin.

[107]  B. Scatton,et al.  The gabaergic hypothesis of depression , 1989, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[108]  J. Leysen,et al.  Melatonin modulates the sensitivity of 5-hydroxytryptamine-2 receptor-mediated sleep—wakefulness regulation in the rat , 1989, Neuroscience Letters.

[109]  P. Soubrié,et al.  Decreased GABA B receptors in helpless rats: reversal by tricyclic antidepressants. , 1989, Neuropsychobiology.

[110]  N. Motohashi,et al.  GABAB receptors are up-regulated by chronic treatment with lithium or carbamazepine. GABA hypothesis of affective disorders? , 1989, European journal of pharmacology.

[111]  C. Malsbury,et al.  Peptidergic control of male rat sexual behavior: The effects of intracerebral injections of substance P and cholecystokinin , 1989, Physiology & Behavior.

[112]  S. Sara,et al.  Idazoxan, an α-2 antagonist, facilitates memory retrieval in the rat , 1989 .

[113]  H. Robertson,et al.  Evidence that L-dopa-induced rotational behavior is dependent on both striatal and nigral mechanisms , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[114]  C. Malsbury,et al.  Neuropeptides and male sexual behavior , 1989, Neuroscience & Biobehavioral Reviews.

[115]  E. Theodorsson,et al.  Effect of repeated electroconvulsive treatment on regional concentrations of tachykinins, neurotensin, vasoactive intestinal polypeptide, neuropeptide Y, and galanin in rat brain , 1989, Journal of neuroscience research.

[116]  Potential antidepressant properties of subchronic GABA transaminase inhibitors in the forced swimming test in mice. , 1989, Neuropsychobiology.

[117]  A Cowan,et al.  Statistical analysis of drug-drug and site-site interactions with isobolograms. , 1989, Life sciences.

[118]  M. Kimura.  The neutral theory of molecular evolution and the world view of the neutralists. , 1989, Genome.

[119]  P. Wall,et al.  Textbook of pain , 1989 .

[120]  Treatment of a refractory depression with a combination of fluoxetine and d-amphetamine. , 1989, The American journal of psychiatry.

[121]  H. Meltzer,et al.  Serotonergic measures in the brains of suicide victims: 5-HT2 binding sites in the frontal cortex of suicide victims and control subjects. , 1989, The American journal of psychiatry.

[122]  D. Braida,et al.  Central effect of yohimbine on sexual behavior in the rat , 1990, Physiology & Behavior.

[123]  P. Zanoli,et al.  Effect of clenbuterol on sexual behavior in male rats , 1990, Physiology & Behavior.

[124]  W. Cahn,et al.  Effects of serotonin antagonists on m-chlorophenylpiperazine-mediated responses in normal subjects , 1990, Psychiatry Research.

[125]  B. Everitt.  Sexual motivation: A neural and behavioural analysis of the mechanisms underlying appetitive and copulatory responses of male rats , 1990, Neuroscience & Biobehavioral Reviews.

[126]  T. Ness,et al.  Visceral pain: a review of experimental studies , 1990, Pain.

[127]  Mark C. Jones.  PRINCIPLES AND PRACTICE OF SLEEP MEDICINE , 1990 .

[128]  C. Dourish,et al.  Cholecystokinin and anxiety. , 1990, Trends in pharmacological sciences.

[129]  M. Jouvet,et al.  Proopiomelanocortin (POMC)-derived peptides and sleep in the rat Part 1 — Hypnogenic properties of ACTH derivatives , 1990, Neuropeptides.

[130]  S. Patten.  Propranolol and Depression: Evidence from the Antihypertensive Trials , 1990, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[131]  D. Kupfer,et al.  Direction of weight change in recurrent depression. Consistency across episodes. , 1990, Archives of general psychiatry.

[132]  M. Hamon,et al.  Tianeptine stimulates uptake of 5-hydroxytryptamine in vivo in the rat brain , 1990, Neuropharmacology.

[133]  G. Chiara,et al.  Blockade of the Noradrenaline Carrier Increases Extracellular Dopamine Concentrations in the Prefrontal Cortex: Evidence that Dopamine Is Taken up In Vivo by Noradrenergic Terminals , 1990, Journal of neurochemistry.

[134]  B. Gorzalka,et al.  Sex differences in the effects of 1-(m-trifluoromethylphenyl) piperazine and 1-(m-chlorophenyl) piperazine on copulatory behavior in the rat , 1990, Neuropharmacology.

[135]  F. Rambert,et al.  Central alpha 1-adrenergic stimulation in relation to the behaviour stimulating effect of modafinil; studies with experimental animals. , 1990, European journal of pharmacology.

[136]  C. Fischette,et al.  Analysis of tandospirone (SM-3997) interactions with neurotransmitter receptor binding sites , 1990, Biological Psychiatry.

[137]  J. Blendy,et al.  Electroconvulsive shock differentially increases binding to alpha-1 adrenergic receptor subtypes in discrete regions of rat brain , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[138]  Napamezole, an alpha-2 adrenergic receptor antagonist and monoamine uptake inhibitor in vitro. , 1990, The Journal of pharmacology and experimental therapeutics.

[139]  L. Fabre,et al.  Clinical Effects of the 5‐HT1A Partial Agonists in Depression: A Composite Analysis of Buspirone in the Treatment of Depression , 1990, Journal of clinical psychopharmacology.

[140]  Y. Goshima,et al.  L-dopa facilitates the release of endogenous norepinephrine and dopamine via presynaptic beta 1- and beta 2-adrenoceptors under essentially complete inhibition of L-aromatic amino acid decarboxylase in rat hypothalamic slices. , 1990, Japanese journal of pharmacology.

[141]  L. Butcher,et al.  Cholinergic-dopaminergic interactions in cognitive performance. , 1990, Behavioral and neural biology.

[142]  A. Ontiveros,et al.  Lithium Carbonate Augmentation of Desipramine in Refractory Depression* , 1990, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[143]  M. Maj,et al.  GABA, depression and the mechanism of action of antidepressant drugs: a neuroendocrine approach. , 1990, Journal of affective disorders.

[144]  A. Puech,et al.  Antidepressant profile of bupropion and three metabolites in mice. , 1990, Pharmacopsychiatry.

[145]  W. Faustman,et al.  Distinguishing depression and negative symptoms in unmedicated patients with schizophrenia , 1990, Psychiatry Research.

[146]  D. Giuliani,et al.  NPY-induced inhibition of male copulatory activity is a direct behavioural effect , 1990, Neuropeptides.

[147]  D. Kupfer,et al.  Recurrent depression is associated with a persistent reduction in sleep-related growth hormone secretion. , 1990, Archives of general psychiatry.

[148]  A. Boulton.  Phenylethylaminergic modulation of catecholaminergic neurotransmission , 1991, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[149]  N. Barden,et al.  Antidepressant and other centrally acting drugs regulate glucocorticoid receptor messenger RNA levels in rat brain , 1991, Psychoneuroendocrinology.

[150]  S. Sara,et al.  Memory retrieval enhancement by locus coeruleus stimulation: evidence for mediation by β-receptors , 1991, Behavioural Brain Research.

[151]  C. Pollak,et al.  Sleep Problems and Institutionalization of the Elderly , 1991, Journal of geriatric psychiatry and neurology.

[152]  M. Herkenham,et al.  Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic implications. , 1991, The Journal of clinical investigation.

[153]  D. Overstreet,et al.  Clinical and biochemical aspects of depressive disorders: II. Transmitter/receptor theories , 1991, Synapse.

[154]  M. Le Moal,et al.  Mesocorticolimbic dopaminergic network: functional and regulatory roles. , 1991, Physiological reviews.

[155]  S. Woods,et al.  Effects of ritanserin on the behavioral, neuroendocrine, and cardiovascular responses to meta-chlorophenylpiperazine in healthy human subjects , 1991, Psychiatry Research.

[156]  Stuart A. Kauffman,et al.  The origins of order , 1993 .

[157]  G. M. Halliday,et al.  Distribution, morphology and number of monoamine-synthesizing and substance P-containing neurons in the human dorsal raphe nucleus , 1991, Neuroscience.

[158]  Scott Wetzler,et al.  m-Chlorophenylpiperazine as a probe of serotonin function , 1991, Biological Psychiatry.

[159]  E. Holsboer-trachsler,et al.  Repeated administration of the combined dexamethasone-human corticotropin releasing hormone stimulation test during treatment of depression , 1991, Psychiatry Research.

[160]  A. Kling,et al.  Clinical and biochemical aspects of depressive disorders: I. Introduction, classification, and research techniques , 1991, Synapse.

[161]  H. Anisman,et al.  Stressor-induced anhedonia in the mesocorticolimbic system , 1991, Neuroscience & Biobehavioral Reviews.

[162]  R. Post,et al.  Lack of beneficial effects of l-baclofen in affective disorder. , 1991, International clinical psychopharmacology.

[163]  B. Gorzalka,et al.  DOI-induced inhibition of copulatory behavior in male rats: Reversal by 5-HT2 antagonists , 1991, Pharmacology Biochemistry and Behavior.

[164]  J. Deakin.  Depression and 5HT , 1991, International clinical psychopharmacology.

[165]  P. Whitton,et al.  The effect of the novel antidepressant tianeptine on the concentration of 5-hydroxytryptamine in rat hippocampal dialysates in vivo , 1991, Neuropharmacology.

[166]  J. Blendy,et al.  Electroconvulsive Shock Increases α1b‐but Not α1a‐Adrenoceptor Binding Sites in Rat Cerebral Cortex , 1991 .

[167]  Trevor R. Norman,et al.  Behavioral studies of serotonin receptor agonists as antidepressant drugs. , 1991 .

[168]  T. Itoh,et al.  Clonidine inhibition of potassium-evoked release of glutamate and aspartate from rat cortical synaptosomes , 1991, Brain Research.

[169]  J. Hsiao,et al.  The mechanisms of action of lithium. I. Effects on serotoninergic and noradrenergic systems in normal subjects. , 1991, Archives of general psychiatry.

[170]  A. Loewy.  Chapter 12 Forebrain nuclei involved in autonomic control , 1991 .

[171]  G Chouvet,et al.  Afferent regulation of locus coeruleus neurons: anatomy, physiology and pharmacology. , 1991, Progress in brain research.

[172]  E. Pothos,et al.  Systemic morphine simultaneously decreases extracellular acetylcholine and increases dopamine in the nucleus accumbens of freely moving rats , 1991, Neuropharmacology.

[173]  C. Mazure,et al.  A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression. , 1991, Archives of general psychiatry.

[174]  G. Alexopoulos,et al.  Verbal memory and plasma drug concentrations in elderly depressives treated with nortriptyline. , 1991, Psychopharmacology bulletin.

[175]  J. Barrett,et al.  Anticonflict and discriminative stimulus effects of the 5‐HT1A compounds WY‐47,846 and WY‐48,723 and the mixed 5‐HT1A agonist/5‐HT2 antagonist WY‐50,324 in pigeons , 1991 .

[176]  E. Hull,et al.  D2 receptors in the paraventricular nucleus regulate genital responses and copulation in male rats , 1991, Pharmacology Biochemistry and Behavior.

[177]  Shigenori Watanabe,et al.  Effect of substance P on circadian rhythms of firing activity and the 2-deoxyglucose uptake in the rat suprachiasmatic nucleus in vitro , 1992, Brain Research.

[178]  A. Kamoun,et al.  Neurochemical and Pharmacological Properties of Tianeptine, A Novel Antidepressant , 1992, British Journal of Psychiatry.

[179]  J. Mendlewicz,et al.  Carbamazepine addition in tricyclic antidepressant-resistant unipolar depression , 1992, Biological Psychiatry.

[180]  A. Schatzberg,et al.  Psychotic (delusional) major depression: should it be included as a distinct syndrome in DSM-IV? , 1992, The American journal of psychiatry.

[181]  G. Kennett,et al.  The Effects of Tianeptine and other Antidepressants on a Rat Model of Depression , 1992, British Journal of Psychiatry.

[182]  S. Southmayd,et al.  Therapeutic sleep deprivation in a depressed patient: prolongation of response with concurrent thyroxine , 1992, Acta psychiatrica Scandinavica.

[183]  E. Hollander,et al.  Yohimbine treatment of sexual side effects induced by serotonin reuptake blockers. , 1992, The Journal of clinical psychiatry.

[184]  F. M. Jacobsen,et al.  Fluoxetine-induced sexual dysfunction and an open trial of yohimbine. , 1992, The Journal of clinical psychiatry.

[185]  J. Vaughan,et al.  The melanin‐concentrating hormone system of the rat brain: An immuno‐ and hybridization histochemical characterization , 1992, The Journal of comparative neurology.

[186]  K. Daimon,et al.  Circadian rhythm abnormalities of deep body temperature in depressive disorders. , 1992, Journal of affective disorders.

[187]  A. Puech,et al.  Animal Behavioural Studies in the Evaluation of Antidepressant Drugs , 1992, British Journal of Psychiatry.

[188]  S. Yamawaki,et al.  The effects of electroconvulsive shock or imipramine on subtypes of α1-adrenoceptors in the frontal cortex of the rat , 1992, Neuropharmacology.

[189]  P. Zee,et al.  Aging alters feedback effects of the activity-rest cycle on the circadian clock. , 1992, The American journal of physiology.

[190]  P. Cowen,et al.  Selective 5-HT1A and 5-HT2 receptor-mediated adrenocorticotropin release in the rat: effect of repeated antidepressant treatments. , 1992, European journal of pharmacology.

[191]  H. Lachman,et al.  Acute lithium treatment enhances neuropeptide Y gene expression in rat hippocampus. , 1992, Brain research. Molecular brain research.

[192]  R. Post,et al.  Endogenous biochemical abnormalities in affective illness: Therapeutic versus pathogenic , 1992, Biological Psychiatry.

[193]  J. Brosius,et al.  On "genomenclature": a comprehensive (and respectful) taxonomy for pseudogenes and other "junk DNA". , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[194]  J. van Ree,et al.  Dopamine and melatonin in the nucleus accumbens may be implicated in the mode of action of antidepressant drugs. , 1992, European journal of pharmacology.

[195]  F. Wollnik.  Effects of chronic administration and withdrawal of antidepressant agents on circadian activity rhythms in rats , 1992, Pharmacology Biochemistry and Behavior.

[196]  E. Maywood,et al.  Blockade of Glutamatergic Neurotransmission in the Suprachiasmatic Nucleus Prevents Cellular and Behavioural Responses of the Circadian System to Light , 1992, The European journal of neuroscience.

[197]  C. Colwell,et al.  NMDA as Well as Non-NMDA Receptor Antagonists Can Prevent the Phase-Shifting Effects of Light on the Circadian System of the Golden Hamster , 1992, Journal of biological rhythms.

[198]  R. Spanagel,et al.  Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[199]  L. Pozzi,et al.  Tianeptine increases the extracellular concentrations of dopamine in the nucleus accumbens by a serotonin-independent mechanism , 1992, Neuropharmacology.

[200]  J. Pratt,et al.  The neuroanatomical basis of anxiety. , 1992, Pharmacology & therapeutics.

[201]  P. Bech,et al.  Combined Treatment with Imipramine and Mianserin , 1992, Pharmacopsychiatry.

[202]  E. Heist,et al.  Neuroendocrine aspects of primary endogenous depression. XI. Serum melatonin measures in patients and matched control subjects. , 1992, Archives of general psychiatry.

[203]  T. Sharp,et al.  Evidence that 5‐HT2 receptor activation decreases noradrenaline release in rat hippocampus in vivo , 1992, British journal of pharmacology.

[204]  N. Orthen-Gambill,et al.  FMH-induced decrease in central histamine levels produces increased feeding and body weight in rats , 1992, Physiology & Behavior.

[205]  B. Gähwiler,et al.  Comparison of the actions of adenosine at pre‐ and postsynaptic receptors in the rat hippocampus in vitro. , 1992, The Journal of physiology.

[206]  R. Shank,et al.  Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic. , 1992, The Journal of pharmacology and experimental therapeutics.

[207]  D. Lesieur,et al.  Novel naphthalenic ligands with high affinity for the melatonin receptor. , 1992, Journal of medicinal chemistry.

[208]  V. Hillegaart,et al.  Stimulation of 5-HT1A and 5-HT1B receptors in brain regions and its effects on male rat sexual behaviour. , 1992, European journal of pharmacology.

[209]  G. Chrousos,et al.  The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. , 1992, JAMA.

[210]  G. Perrault,et al.  Activity of litoxetine and other serotonin uptake inhibitors in the tail suspension test in mice , 1992, Pharmacology Biochemistry and Behavior.

[211]  H. Fibiger,et al.  Neurochemical effects of electrically and chemically induced seizures: an in vivo microdialysis study in the rat hippocampus. , 1992, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[212]  R. Thisted,et al.  Sleep and Psychiatric Disorders: A Meta-analysis , 1992 .

[213]  R. Porsolt,et al.  Combined effects of diazepam and melatonin in two tests for anxiolytic activity in the mouse , 1992, Pharmacology Biochemistry and Behavior.

[214]  R. Clouse,et al.  Prevalence of Depression in Adults With Diabetes: An epidemiological evaluation , 1993, Diabetes Care.

[215]  C. Geula,et al.  Neuroglial cholinesterases in the normal brain and in Alzheimer's disease: Relationship to plaques, tangles, and patterns of selective vulnerability , 1993, Annals of neurology.

[216]  L. D. van de Kar,et al.  Neurons in the hypothalamic paraventricular nucleus mediate the serotonergic stimulation of prolactin secretion via 5-HT1c/2 receptors. , 1993, Endocrinology.

[217]  J. C. Winter,et al.  Antagonism of the stimulus effects of yohimbine and 8-hydroxydipropylaminotetralin , 1993, Pharmacology Biochemistry and Behavior.

[218]  M. Erlander,et al.  A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms , 1993, Neuron.

[219]  J. Redman,et al.  Successful use of S20098 and melatonin in an animal model of delayed sleep-phase syndrome (DSPS) , 1993, Pharmacology Biochemistry and Behavior.

[220]  C. Haag,et al.  Profiles of spontaneous 24-hour and stimulated growth hormone secretion in male patients with endogenous depression , 1993, Psychiatry Research.

[221]  S. Liggett,et al.  Structural basis for receptor subtype-specific regulation revealed by a chimeric beta 3/beta 2-adrenergic receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[222]  J. Wertz,et al.  5-HT1A and 5-HT1C/1D receptor agonists produce reciprocal effects on male sexual behavior of rhesus monkeys. , 1993, European journal of pharmacology.

[223]  W. Smeets,et al.  Immunocytochemistry and in situ hybridization of neuropeptide Y in the hypothalamus of Xenopus laevis in relation to background adaptation , 1993, Neuroscience.

[224]  Y Watanabe,et al.  Effects of glucocorticoids on hippocampal long‐term potentiation , 1993, Hippocampus.

[225]  D. Murphy,et al.  A comparison of the behavioral effects of oral versus intravenous mCPP administration in OCD patients and the effect of metergoline prior to IV mCPP , 1993, Biological Psychiatry.

[226]  R. Salomon,et al.  Monoamines and the mechanism of antidepressant action: effects of catecholamine depletion on mood of patients treated with antidepressants. , 1993, Psychopharmacology bulletin.

[227]  S. Nakanishi,et al.  Different binding epitopes on the NK1 receptor for substance P and a non-peptide antagonist , 1993, Nature.

[228]  J. Wess,et al.  Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular "cross-talk" between G-protein-linked receptors. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[229]  W. Haefely,et al.  Evidence for a role of 5-HT1C receptors in the antiserotonergic properties of some antidepressant drugs. , 1993, European journal of pharmacology.

[230]  W. Fantl,et al.  Signalling by receptor tyrosine kinases. , 1993, Annual review of biochemistry.

[231]  W. Danysz,et al.  Potential antidepressive properties of amantadine, memantine and bifemelane. , 1993, Pharmacology & toxicology.

[232]  S. Nakanishi,et al.  Two nonpeptide tachykinin antagonists act through epitopes on corresponding segments of the NK1 and NK2 receptors. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[233]  R. Nicoll,et al.  The opioid peptide dynorphin mediates heterosynaptic depression of hippocampal mossy fibre synapses and modulates long-term potentiation , 1993, Nature.

[234]  R. Duman,et al.  Chronic Electroconvulsive Seizures Increase the Expression of Serotonin2 Receptor mRNA in Rat Frontal Cortex , 1993, Journal of neurochemistry.

[235]  S. Garattini,et al.  Neurochemical mechanism of action of anorectic drugs. , 1993, Pharmacology & toxicology.

[236]  U. Knigge,et al.  Effect of selective serotonin receptor agonists on prolactin secretion in male rats. , 1993, Neuroendocrinology.

[237]  Misu Yoshimi,et al.  Is l-dopa an endogenous neurotransmitter? , 1993 .

[238]  B. Mallick,et al.  Effect of rapid eye movement sleep deprivation on rat brain monoamine oxidases , 1993, Neuroscience.

[239]  M. Tsuang.  Genotypes, Phenotypes, and the Brain , 1993, British Journal of Psychiatry.

[240]  N. Bowery,et al.  Repeated administration of desipramine and a GABAB receptor antagonist, CGP 36742, discretely up‐regulates GABAB receptor binding sites in rat frontal cortex , 1993, British journal of pharmacology.

[241]  F. Artigas.  5-HT and antidepressants: new views from microdialysis studies. , 1993, Trends in pharmacological sciences.

[242]  Y. Agid,et al.  Immunocytochemical Quantification of Tyrosine Hydroxylase at a Cellular Level in the Mesencephalon of Control Subjects and Patients with Parkinson's and Alzheimer's Disease , 1993, Journal of neurochemistry.

[243]  S. Hendry.  Organization of Neuropeptide Y Neurons in the Mammalian Central Nervous System , 1993 .

[244]  D. Lorrain,et al.  Nitric oxide increases dopamine and serotonin release in the medial preoptic area , 1993, Neuroreport.

[245]  R. Shank,et al.  Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol. , 1993, The Journal of pharmacology and experimental therapeutics.

[246]  J. D. McGaugh,et al.  Interaction of cholinergic-dopaminergic systems in the regulation of memory storage in aversively motivated learning tasks , 1993, Brain Research.

[247]  S. Foote,et al.  The Locus Coeruleus as a Site for Integrating Corticotropin‐Releasing Factor and Noradrenergic Mediation of Stress Responses a , 1993, Annals of the New York Academy of Sciences.

[248]  K. Datla,et al.  Behavioural and neurochemical evidence for the decrease of brain extracellular 5-HT by the antidepressant drug tianeptine , 1993, Neuropharmacology.

[249]  B. Budziszewska,et al.  The effect of repeated combined treatment with nifedipine and antidepressant drugs or electroconvulsive shock on the hippocampal corticosteroid receptors in rats , 1993, Neuropharmacology.

[250]  T. Cooper,et al.  Human brain fluoxetine concentrations. , 1993, The Journal of neuropsychiatry and clinical neurosciences.

[251]  R. Basaglia,et al.  Male sexual behaviour: further studies on the role of alpha 2-adrenoceptors. , 1993, Pharmacological research.

[252]  D. Filipini,et al.  Possible use of glucocorticoid receptor antagonists in the treatment of major depression: preliminary results using RU 486. , 1993, Journal of psychiatry & neuroscience : JPN.

[253]  I. Barraco.  Nucleus of the Solitary Tract , 1993 .

[254]  H. Schoemaker,et al.  Litoxetine: a selective 5-HT uptake inhibitor with concomitant 5-HT3 receptor antagonist and antiemetic properties. , 1993, European journal of pharmacology.

[255]  R. Moore,et al.  Intergeniculate leaflet: An anatomically and functionally distinct subdivision of the lateral geniculate complex , 1994, The Journal of comparative neurology.

[256]  M. Kuhar,et al.  Nitric oxide inhibits [3H]dopamine uptake , 1994, Brain Research.

[257]  D. Skene,et al.  Comparison of the effects of acute fluvoxamine and desipramine administration on melatonin and cortisol production in humans. , 1994, British journal of clinical pharmacology.

[258]  R. Campbell,et al.  Co-evolution of ligand-receptor pairs , 1994, Nature.

[259]  5-HT1A receptors and the tail-flick response. VI. Intrinsic alpha 1A-adrenoceptor antagonist properties can mask the actions of 5-HT1A receptor agonists in the spontaneous tail-flick paradigm. , 1994, The Journal of pharmacology and experimental therapeutics.

[260]  Steve Arnott,et al.  Successful Treatment of Fluvoxamine-Induced Anorgasmia by Cyproheptadine , 1994, British Journal of Psychiatry.

[261]  J. Nahon.  The melanin-concentrating hormone: from the peptide to the gene. , 1994, Critical reviews in neurobiology.

[262]  M. Volosin,et al.  Corticosterone influences forced swim-induced immobility , 1994, Pharmacology Biochemistry and Behavior.

[263]  A. Nierenberg,et al.  Trazodone for antidepressant-associated insomnia. , 1994, The American journal of psychiatry.

[264]  B. Hoffman,et al.  Adenosine A3 receptors regulate serotonin transport via nitric oxide and cGMP. , 1994, The Journal of biological chemistry.

[265]  C. Montigny,et al.  Current advances and trends in the treatment of depression. , 1994, Trends in pharmacological sciences.

[266]  P. Skolnick,et al.  Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments. , 1994, The Journal of pharmacology and experimental therapeutics.

[267]  Takashi Yamamoto,et al.  The medial preoptic area is involved in both sexual arousal and performance in male rats: re-evaluation of neuron activity in freely moving animals , 1994, Brain Research.

[268]  M. Liebowitz,et al.  The DSM-IV field trial for mixed anxiety-depression. , 1994, The American journal of psychiatry.

[269]  C. Wilson,et al.  Interactions between 5-hydroxytryptamine (5-HT) and testosterone in the control of sexual and nonsexual behaviour in male and female rats , 1994, Pharmacology Biochemistry and Behavior.

[270]  J. Hyttel.  Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs) , 1994, International clinical psychopharmacology.

[271]  R. Kessler,et al.  Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. , 1994, Archives of general psychiatry.

[272]  P. Rosenzweig,et al.  EEG profile of litoxetine after single and repeated administration in healthy volunteers. , 1994, British journal of clinical pharmacology.

[273]  Effects of FG 5893, a new compound with 5-HT1A receptor agonistic and 5-HT2 receptor antagonistic properties, on male rat sexual behavior. , 1994, European journal of pharmacology.

[274]  R. Post,et al.  Prefrontal cortex dysfunction in clinical depression , 1994 .

[275]  P. Cowen,et al.  Slow wave sleep in humans: Role of 5-HT2A and 5-HT2C receptors , 1994, Neuropharmacology.

[276]  M. Herkenham,et al.  Repeated electroconvulsive shock produces long-lasting increases in messenger RNA expression of corticotropin-releasing hormone and tyrosine hydroxylase in rat brain. Therapeutic implications. , 1994, The Journal of clinical investigation.

[277]  Kinzo Matsumoto,et al.  Monoamine depletion attenuates the REM sleep deprivation-induced increase in clonidine response in the forced swimming test , 1994, Pharmacology Biochemistry and Behavior.

[278]  Blockade of transmission at NMDA receptors facilitates the electrical and synthetic activity of ascending serotoninergic neurones , 1994, Brain Research.

[279]  T. Sharp,et al.  Biochemical evidence for the regulation of central noradrenergic activity by 5-HT1A and 5-HT2 receptors: Microdialysis studies in the awake and anaesthetized rat , 1994, Neuropharmacology.

[280]  M. J. Friedlander,et al.  Role of NO production in NMDA receptor-mediated neurotransmitter release in cerebral cortex. , 1994, Science.

[281]  P. Perruchet,et al.  The dissociation of explicit and implicit memory in depressed patients , 1994, Psychological Medicine.

[282]  P. D’Aquila,et al.  Antidepressant-like effect of selective dopamine D1 receptor agonists in the behavioural despair animal model of depression. , 1994, European journal of pharmacology.

[283]  J. O'Donnell,et al.  Involvement of beta-1 and beta-2 adrenergic receptors in the antidepressant-like effects of centrally administered isoproterenol. , 1994, The Journal of pharmacology and experimental therapeutics.

[284]  E. Palazidou,et al.  Involvement of the 5-HT2 receptor in the 5-HT receptor-mediated stimulation of prolactin release. , 1994, European journal of pharmacology.

[285]  C. Montigny.  Lithium addition in treatment-resistant depression. , 1994 .

[286]  A. Fernández-Guasti,et al.  Reversal of sexual exhaustion by serotonergic and noradrenergic agents , 1994, Behavioural Brain Research.

[287]  S. Preskorn.  Antidepressant drug selection: criteria and options. , 1994, The Journal of clinical psychiatry.

[288]  I. Lucki,et al.  Antidepressant-like behavioral effects of serotonin receptor agonists , 1994, Neuroscience & Biobehavioral Reviews.

[289]  C. Karson,et al.  In vivo 19F spin relaxation and localized spectroscopy of fluoxetine in human brain , 1994, Magnetic resonance in medicine.

[290]  B. Cooper,et al.  Evidence that the Acute Behavioral and Electrophysiological Effects of Bupropion (Wellbutrin®) Are Mediated by a Noradrenergic Mechanism , 1994, Neuropsychopharmacology.

[291]  M. Trimble,et al.  Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison. , 1994, The Journal of clinical psychiatry.

[292]  F. Montorsi,et al.  Effect of yohimbine-trazodone on psychogenic impotence: a randomized, double-blind, placebo-controlled study. , 1994, Urology.

[293]  B. Bogerts,et al.  The distribution of nitric oxide synthase immunoreactivity in the human brain , 1994, Neuroscience.

[294]  R. Schreiber,et al.  The potent activity of the 5-HT1A receptor agonists, S 14506 and S 14671, in the rat forced swim test is blocked by novel 5-HT1A receptor antagonists. , 1994, European journal of pharmacology.

[295]  S. Patten,et al.  Drug-Induced Depression , 1994, Drug safety.

[296]  D. Kripke,et al.  Antidepressant and depressogenic drugs lack consistent effects on hamster circadian rhythms , 1994, Psychiatry Research.

[297]  A. Schousboe,et al.  Role of GABAB receptors in intracellular Ca2+ homeostasis and possible interaction between GABAA and GABAB receptors in regulation of transmitter release in cerebellar granule neurons , 1994, Journal of neuroscience research.

[298]  The effects of administration of mCPP on psychological, cognitive, cardiovascular, hormonal and MHPG measurements in human volunteers , 1994, International clinical psychopharmacology.

[299]  Daniel J Buysse,et al.  Do electroencephalographic sleep studies predict recurrence in depressed patients successfully treated with psychotherapy , 1994 .

[300]  M. Millan,et al.  Clozapine inhibits serotoninergic transmission by an action at alpha 1-adrenoceptors not at 5-HT1A receptors. , 1994, European journal of pharmacology.

[301]  M. Norden.  Buspirone treatment of sexual dysfunction associated with selective serotonin re‐uptake inhibitors , 1994 .

[302]  Bruce A. Davis,et al.  The trace amines and their acidic metabolites in depression — an overview , 1994, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[303]  G. Andersson,et al.  Preclinical pharmacology of FG5893: a potential anxiolytic drug with high affinity for both 5-HT1A and 5-HT2A receptors. , 1994, European journal of pharmacology.

[304]  F. Holsboer,et al.  The neurosteroid tetrahydroprogesterone counteracts corticotropin-releasing hormone-induced anxiety and alters the release and gene expression of corticotropin-releasing hormone in the rat hypothalamus , 1994, Neuroscience.

[305]  J. Kelly,et al.  The effect of tianeptine and sertraline in three animal models of depression , 1994, Neuropharmacology.

[306]  P. Waldmeier,et al.  GABA and glutamate release affected by GABAB receptor antagonists with similar potency: no evidence for pharmacologically different presynaptic receptors , 1994, British journal of pharmacology.

[307]  P. Fan.  Effects of antidepressants on the inward current mediated by 5‐HT3 receptors in rat nodose ganglion neurones , 1994, British journal of pharmacology.

[308]  H. Fibiger,et al.  The potent and selective dopamine D1 receptor agonist A-77636 increases cortical and hippocampal acetylcholine release in the rat. , 1994, European journal of pharmacology.

[309]  J. Coull.  Pharmacological Manipulations of the α2-Noradrenergic System , 1994 .

[310]  S. Lightowler,et al.  Effect of chronic administration of selective 5-hydroxytryptamine and noradrenaline uptake inhibitors on a putative index of 5-HT 2C 2B receptor function , 1994, Neuropharmacology.

[311]  M. Pompeiano,et al.  Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors. , 1994, Brain research. Molecular brain research.

[312]  J. Pecknold.  Serotonin 5-HT1A Agonists , 1994 .

[313]  A. Wagner,et al.  Evolution of gene networks by gene duplications: a mathematical model and its implications on genome organization. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[314]  J. Halter,et al.  Sympathetic nervous system activity in major depression. Basal and desipramine-induced alterations in plasma norepinephrine kinetics. , 1994, Archives of general psychiatry.

[315]  J. A. Hooft,et al.  Interaction between enantiomers of mianserin and ORG3770 at 5-HT3 receptors in cultured mouse neuroblastoma cells , 1994, Neuropharmacology.

[316]  R. Shank,et al.  Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: structural determinants and role in antinociception. , 1995, The Journal of pharmacology and experimental therapeutics.

[317]  Antagonist properties of LY 165,163 at pre- and postsynaptic dopamine D2, D3 and D1 receptors: modulation of agonist actions at 5-HT1A receptors in vivo. , 1995, The Journal of pharmacology and experimental therapeutics.

[318]  Sabelli Hc,et al.  Phenylethylamine modulation of affect: therapeutic and diagnostic implications. , 1995, The Journal of neuropsychiatry and clinical neurosciences.

[319]  K. Jellinger,et al.  Therapeutic brain concentration of the NMDA receptor antagonist amantadine , 1995, Neuropharmacology.

[320]  C. Wichems,et al.  Novel 2-substituted cocaine analogs: uptake and ligand binding studies at dopamine, serotonin and norepinephrine transport sites in the rat brain. , 1995, The Journal of pharmacology and experimental therapeutics.

[321]  T. Kenakin,et al.  Agonist-receptor efficacy. I: Mechanisms of efficacy and receptor promiscuity. , 1995, Trends in pharmacological sciences.

[322]  R. Paredes,et al.  The GABAB antagonist CGP 35348 inhibits the effects of baclofen on sexual behavior and motor coordination , 1995, Brain Research Bulletin.

[323]  J. Kornhuber,et al.  Cerebrospinal fluid and serum concentrations of the N-methyl-d-aspartate (NMDA) receptor antagonist memantine in man , 1995, Neuroscience Letters.

[324]  F. Holsboer,et al.  V1 vasopressin receptor antisense oligodeoxynucleotide into septum reduces vasopressin binding, social discrimination abilities, and anxiety-related behavior in rats , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[325]  K. Rascati.  Drug utilization review of concomitant use of specific serotonin reuptake inhibitors or clomipramine with antianxiety/sleep medications. , 1995, Clinical therapeutics.

[326]  H. Kaplan,et al.  Psychostimulants apparently reverse sexual dysfunction secondary to selective serotonin re-uptake inhibitors. , 1995, Journal of sex & marital therapy.

[327]  M. Toru,et al.  Increased 5-HT2 receptor-mediated behavior 11 days after shock in learned helplessness rats. , 1995, European journal of pharmacology.

[328]  J. Cassel,et al.  Serotonergic modulation of cholinergic function in the central nervous system: Cognitive implications , 1995, Neuroscience.

[329]  J. Haggerty,et al.  Borderline hypothyroidism and depression. , 1995, Annual review of medicine.

[330]  D. Naritoku,et al.  Regional induction of fos immunoreactivity in the brain by anticonvulsant stimulation of the vagus nerve , 1995, Epilepsy Research.

[331]  Stanley J. Watson,et al.  Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications , 1995, Trends in Neurosciences.

[332]  M. Reith,et al.  Monoamine Interactions Measured by Microdialysis in the Ventral Tegmental Area of Rats Treated Systemically with (±)‐8‐Hydroxy‐2‐(Di‐n‐Propylamino)tetralin , 1995, Journal of neurochemistry.

[333]  I. Lucki,et al.  Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo. , 1995, The Journal of pharmacology and experimental therapeutics.

[334]  Abraham Weizman,et al.  Cyproheptadine treatment of sexual dysfunction induced by serotonin reuptake inhibitors. , 1995, Clinical neuropharmacology.

[335]  I. Hindmarch,et al.  The psychomotor and cognitive effects of litoxetine in young and middle aged volunteers. , 1995, British journal of clinical pharmacology.

[336]  David Julius,et al.  Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptors , 1995, Nature.

[337]  M. Bunsey,et al.  Specific effects of idazoxan in a distraction task: evidence that endogenous norepinephrine plays a role in selective attention in rats. , 1995, Behavioral neuroscience.

[338]  A. Sleight,et al.  Identification of 5-hydroxytryptamine7 receptor binding sites in rat hypothalamus: sensitivity to chronic antidepressant treatment. , 1995, Molecular pharmacology.

[339]  W. Harrison,et al.  Are patients who are intolerant to one serotonin selective reuptake inhibitor intolerant to another? , 1995, The Journal of clinical psychiatry.

[340]  Circadian rhythms and sleep regulation in seasonal affective disorder. , 1995, Acta neuropsychiatrica.

[341]  B. Yamamoto,et al.  Effect of Acute Stress on Hippocampal Glutamate Levels and Spectrin Proteolysis in Young and Aged Rats , 1995, Journal of neurochemistry.

[342]  C. Montigny,et al.  Noradrenergic modulation of central serotonergic neurotransmission: acute and long-term actions of mirtazapine , 1995, International clinical psychopharmacology.

[343]  B. Earley,et al.  Central nervous system pharmacology of neuropeptide Y. , 1995, Pharmacology & therapeutics.

[344]  A. Argiolas,et al.  Dopamine and sexual behavior , 1995, Neuroscience & Biobehavioral Reviews.

[345]  C. Priest,et al.  Temporal regulation by estrogen of beta-preprotachykinin mRNA expression in the rat ventromedial nucleus of the hypothalamus. , 1995, Brain research. Molecular brain research.

[346]  N. Taylor,et al.  Extra‐adrenal effects of metyrapone include inhibition of the 11‐oxoreductase activity of 11β‐hydroxysteroid dehydrogenase: a model for 11‐HSD I deficiency , 1995, Clinical endocrinology.

[347]  K. Fuxe,et al.  Modafinil and cortical γ-aminobutyric acid outflow. Modulation by 5-hydroxytryptamine neurotoxins , 1995 .

[348]  W. Nolen,et al.  Benzodiazepines for depression? A review of the literature. , 1995, International clinical psychopharmacology.

[349]  R Ramana,et al.  Residual symptoms after partial remission: an important outcome in depression , 1995, Psychological Medicine.

[350]  Facilitation of noradrenaline release from rat brain slices by beta-adrenoceptors. , 1995, Naunyn-Schmiedeberg's archives of pharmacology.

[351]  C. Dourish,et al.  Multiple serotonin receptors: opportunities for new treatments for obesity? , 1995, Obesity research.

[352]  W. Sieghart,et al.  Structure and pharmacology of gamma-aminobutyric acidA receptor subtypes. , 1995, Pharmacological reviews.

[353]  J. Richards,et al.  Cellular expression of mRNAs encoding monoamine oxidases A and B in the rat central nervous system , 1995, The Journal of comparative neurology.

[354]  G. Bagdy.  Role of the hypothalamic paraventricular nucleus in 5-HT1A , 5-HT2A and 5-HT2C receptor-mediated oxytocin, prolactin and ACTH/corticosterone responses , 1995, Behavioural Brain Research.

[355]  T. Kenakin,et al.  Agonist-receptor efficacy. II. Agonist trafficking of receptor signals. , 1995, Trends in pharmacological sciences.

[356]  J. Stamford,et al.  The effect of paroxetine on 5-HT efflux in the rat dorsal raphe nucleus is potentiated by both 5-HT1A and 5-HT 1B D receptor antagonists , 1995, Neuroscience Letters.

[357]  Daniel J Buysse,et al.  Circadian patterns of unintended sleep episodes during a constant routine in remitted depressed patients. , 1995, Journal of psychiatric research.

[358]  F. Colpaert,et al.  The alpha 2-adrenoceptor antagonist, (+)-efaroxan, enhances acetylcholine release in the rat cortex in vivo. , 1995, European journal of pharmacology.

[359]  A. Fernández-Guasti,et al.  Participation of the central noradrenergic system in the reestablishment of copulatory behavior of sexually exhausted rats by yohimbine, naloxone, and 8-OH-DPAT , 1995, Brain Research Bulletin.

[360]  T. Boer.  The effects of mirtazapine on central noradrenergic and serotonergic neurotransmission. , 1995 .

[361]  C. Maggi,et al.  The mammalian tachykinin receptors. , 1995, General pharmacology.

[362]  D. Jourdan,et al.  Involvement of bulbospinal pathways in the antinociceptive effect of clomipramine in the rat , 1995, Brain Research.

[363]  R. Duman,et al.  Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[364]  B. McEwen,et al.  Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: Involvement of glucocorticoid secretion and excitatory amino acid receptors , 1995, Neuroscience.

[365]  L. Steardo,et al.  New Insights into the Biology of Schizophrenia through the Mechanism of Action of Clozapine , 1995, Neuropsychopharmacology.

[366]  S. Snyder,et al.  Behavioural abnormalities in male mice lacking neuronal nitric oxide synthase , 1995, Nature.

[367]  D. Healy,et al.  The circadian system and the therapeutics of the affective disorders. , 1995, Pharmacology & therapeutics.

[368]  E. B. Souza.  Corticotropin-releasing factor receptors: Physiology, pharmacology, biochemistry and role in central nervous system and immune disorders , 1995, Psychoneuroendocrinology.

[369]  R. Quirion,et al.  Local modulation of hippocampal acetylcholine release by dopamine D1 receptors: a combined receptor autoradiography and in vivo dialysis study , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[370]  R. Porsolt,et al.  A‐80426, a potent and selective α2‐adrenoceptor antagonist with serotonin uptake‐blocking activity and putative antidepressant‐like effects: II. Pharmacology profile , 1995 .

[371]  J. Fritschy,et al.  GABAA‐receptor heterogeneity in the adult rat brain: Differential regional and cellular distribution of seven major subunits , 1995, The Journal of comparative neurology.

[372]  R. Arai,et al.  l-DOPA is converted to dopamine in serotonergic fibers of the striatum of the rat: a double-labeling immunofluorescence study , 1995, Neuroscience Letters.

[373]  R. Duvoisin,et al.  The metabotropic glutamate receptors: Structure and functions , 1995, Neuropharmacology.

[374]  S. Lukas,et al.  Buprenorphine treatment of refractory depression. , 1995, Journal of clinical psychopharmacology.

[375]  E. Hull.  Neurobiological Effects of Sex Steroid Hormones: Dopaminergic influences on male rat sexual behavior , 1995 .

[376]  S. Preskorn.  Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine, sertraline, and venlafaxine. , 1995, The Journal of clinical psychiatry.

[377]  J. Guelfi,et al.  Effectiveness of venlafaxine in patients hospitalized for major depression and melancholia. , 1995, The Journal of clinical psychiatry.

[378]  J. Stolzenburg,et al.  Further evidence that fluoxetine interacts with a 5-HT2C receptor in glial cells , 1995, Brain Research Bulletin.

[379]  A. Hamberger,et al.  Effects of vagus nerve stimulation on amino acids and other metabolites in the CSF of patients with partial seizures , 1995, Epilepsy Research.

[380]  D. Kerkman,et al.  Preclinical pharmacological actions of (+/-)-(1'R*,3R*)-3-phenyl-1- [1',2',3',4'-tetrahydro-5',6'-methylene-dioxy-1'-naphthalenyl) methyl] pyrrolidine methanesulfonate (ABT-200), a potential antidepressant agent that antagonizes alpha-2 adrenergic receptors and inhibits the neuronal uptake of norepi , 1995, The Journal of pharmacology and experimental therapeutics.

[381]  J. Feighner,et al.  Bupropion: a review of its mechanism of antidepressant activity. , 1995, The Journal of clinical psychiatry.

[382]  D. Overstreet,et al.  The role of acetylcholine mechanisms in mood disorders , 1995 .

[383]  E. Mylecharane.  Ventral tegmental area 5-HT receptors: mesolimbic dopamine release and behavioural studies , 1995, Behavioural Brain Research.

[384]  P. Jenner,et al.  The rationale for the use of dopamine agonists in Parkinson's disease , 1995, Neurology.

[385]  A. Galinowski,et al.  Effects of antidepressants on cognitive functions: A review , 1995, Neuroscience & Biobehavioral Reviews.

[386]  D. Bitrán,et al.  Anxiolytic Effect of Progesterone is Mediated by the Neurosteroid Allopregnanolone at Brain GABAA Receptors , 1995, Journal of neuroendocrinology.

[387]  U. Holzer‐Petsche.  Tachykinin receptors in gastrointestinal motility , 1995, Regulatory Peptides.

[388]  F. Bloom,et al.  Psychopharmacology: The Fourth Generation of Progress , 1995 .

[389]  K. Fuxe,et al.  Intercellular communication in the brain: Wiring versus volume transmission , 1995, Neuroscience.

[390]  P. Leff,et al.  The two-state model of receptor activation. , 1995, Trends in pharmacological sciences.

[391]  C. McDougle,et al.  Yohimbine augmentation of fluvoxamine in refractory depression: A single-blind study , 1995, Biological Psychiatry.

[392]  P. Benfield,et al.  Venlafaxine. A review of its pharmacology and therapeutic potential in depression. , 1995, Drugs.

[393]  H. Betz,et al.  Heterogeneity of antidepressant binding sites on the recombinant rat serotonin transporter SERT1. , 1995, Biochemistry.

[394]  B. Grant,et al.  Comorbidity between DSM-IV drug use disorders and major depression: results of a national survey of adults. , 1995, Journal of substance abuse.

[395]  B. Winblad,et al.  Prevalence and Correlates of Depression in a Population of Nonagenarians , 1995, British Journal of Psychiatry.

[396]  E. Esposito,et al.  Differential effects of acute and chronic fluoxetine administration on the spontaneous activity of dopaminergic neurones in the ventral tegmental area , 1995, British journal of pharmacology.

[397]  R. Morris,et al.  Glucocorticoids, hippocampal corticosteroid receptor gene expression and antidepressant treatment: relationship with spatial learning in young and aged rats , 1995, Neuroscience.

[398]  Y. Goshima,et al.  Neurotransmitter-like actions of L-DOPA. , 1995, Advances in pharmacology.

[399]  R. Uitti,et al.  Comparative Review of Dopamine Receptor Agonists in Parkinson’s Disease , 1996, CNS drugs.

[400]  S. Stanford,et al.  Increased noradrenaline efflux induced by local infusion of fluoxetine in the rat frontal cortex. , 1996, European journal of pharmacology.

[401]  S. Yamawaki,et al.  Chronic antidepressant exposure enhances 5-hydroxytryptamine7 receptor-mediated cyclic adenosine monophosphate accumulation in rat frontocortical astrocytes. , 1996, The Journal of pharmacology and experimental therapeutics.

[402]  M. Tsuji,et al.  Involvement of GABAB receptor systems in action of antidepressants. II: Baclofen attenuates the effect of desipramine whereas muscimol has no effect in learned helplessness paradigm in rats , 1996, Brain Research.

[403]  Y. Minabe,et al.  Interactions of selective serotonin reuptake inhibitors with subtypes of sigma receptors in rat brain. , 1996, European journal of pharmacology.

[404]  John T. Clark,et al.  Central propranolol and pindolol, but not atenolol nor metoprolol, inhibit sexual behavior in male rats , 1996, Physiology & Behavior.

[405]  C. Wilcox,et al.  A double-blind trial of low- and high-dose ranges of gepirone-ER compared with placebo in the treatment of depressed outpatients. , 1996, Psychopharmacology bulletin.

[406]  Michael Wu,et al.  Subpallidal outputs to the nucleus accumbens and the ventral tegmental area: anatomical and electrophysiological studies , 1996, Brain Research.

[407]  Zhiyuan Ma,et al.  Differential regulation of 5‐hydroxytryptamine release by GABAA and GABAB receptors in midbrain raphe nuclei and forebrain of rats , 1996, British journal of pharmacology.

[408]  F. Ebling.  The role of glutamate in the photic regulation of the suprachiasmatic nucleus , 1996, Progress in Neurobiology.

[409]  R. Salomon,et al.  Clinical and biochemical effects of catecholamine depletion on antidepressant-induced remission of depression. , 1996, Archives of general psychiatry.

[410]  K. Kristensson,et al.  Melatonin and its new agonist S-20098 restore synchronized sleep fragmented by experimental trypanosome infection in the rat , 1996, Brain Research Bulletin.

[411]  S. Korte,et al.  Antisense to the glucocorticoid receptor in hippocampal dentate gyrus reduces immobility in forced swim test. , 1996, European journal of pharmacology.

[412]  H. Sackeim,et al.  Resistance to antidepressant medications and short-term clinical response to ECT. , 1996, The American journal of psychiatry.

[413]  J. Stewart,et al.  Imipramine treatment of alcoholics with primary depression: A placebo-controlled clinical trial. , 1996, Archives of general psychiatry.

[414]  M. Bös,et al.  5HT2C receptor agonists exhibit antidepressant-like properties in the anhedonia model of depression in rats , 1996, European Neuropsychopharmacology.

[415]  C. Szabó.  Physiological and pathophysiological roles of nitric oxide in the central nervous system , 1996, Brain Research Bulletin.

[416]  R. Nonno,et al.  The melatonin receptor in the human brain: cloning experiments and distribution studies. , 1996, Brain research. Molecular brain research.

[417]  H. Westenberg,et al.  Cholecystokinin in anxiety , 1996, European Neuropsychopharmacology.

[418]  E. Mufson,et al.  Retrograde transport of brain‐derived neurotrophic factor (BDNF) following infusion in neo‐and limbic cortex in rat: Relationship to BDNF mRNA expressing neurons , 1996, The Journal of comparative neurology.

[419]  M. Tsuji,et al.  Involvement of GABAB receptor systems in experimental depression: baclofen but not bicuculline exacerbates helplessness in rats , 1996, Brain Research.

[420]  P. Baumann,et al.  A double-blind, placebo-controlled study of citalopram with and without lithium in the treatment of therapy-resistant depressive patients: a clinical, pharmacokinetic, and pharmacogenetic investigation. , 1996, Journal of clinical psychopharmacology.

[421]  G. E. Pickard,et al.  5HT1B Receptor Agonists Inhibit Light-Induced Phase Shifts of Behavioral Circadian Rhythms and Expression of the Immediate–Early Gene c-fos in the Suprachiasmatic Nucleus , 1996, The Journal of Neuroscience.

[422]  Sabelli Hc,et al.  Sustained antidepressant effect of PEA replacement. , 1996, The Journal of neuropsychiatry and clinical neurosciences.

[423]  J. Neumaier,et al.  Chronic Fluoxetine Reduces Serotonin Transporter mRNA and 5-HT1B mRNA in a Sequential Manner in the Rat Dorsal Raphe Nucleus , 1996, Neuropsychopharmacology.

[424]  Influence of antidepressant drugs on learning and memory paradigms in mice. , 1996, Indian journal of experimental biology.

[425]  R. Duman,et al.  Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[426]  D. Neckelmann,et al.  Sleep and EEG power spectrum effects of the 5-HT1A antagonist NAN-190 alone and in combination with citalopram , 1996, Behavioural Brain Research.

[427]  R. Shrivastava,et al.  Nefazodone versus sertraline in outpatients with major depression: focus on efficacy, tolerability, and effects on sexual function and satisfaction. , 1996, The Journal of clinical psychiatry.

[428]  J. D. McGaugh,et al.  Dose-dependent suppression of adrenocortical activity with metyrapone: Effects on emotion and memory , 1996, Psychoneuroendocrinology.

[429]  T. Reisine.  Opioid analgesics and antagonists , 1996 .

[430]  H. Steiner,et al.  Pain responses, anxiety and aggression in mice deficient in pre-proenkephalin , 1996, Nature.

[431]  C. Nemeroff.  Augmentation strategies in patients with refractory depression , 1996, Depression and anxiety.

[432]  B. Sahakian,et al.  Cognitive performance in tests sensitive to frontal lobe dysfunction in the elderly depressed , 1996, Psychological Medicine.

[433]  H. Mallick,et al.  β-Adrenergic modulation of male sexual behavior elicited from the medial preoptic area in rats , 1996, Behavioural Brain Research.

[434]  S. Reppert,et al.  Melatonin receptors step into the light: cloning and classification of subtypes. , 1996, Trends in pharmacological sciences.

[435]  M. Hamon,et al.  Sleep deprivation reduces the citalopram –induced inhibition of serotoninergic neuronal firing in the nucleus raphe dorsalis of the rat , 1996, Journal of sleep research.

[436]  C. C. Duncan,et al.  Circadian profiles of cortisol, prolactin, and thyrotropin in seasonal affective disorder , 1996, Biological Psychiatry.

[437]  R. Salín-Pascual,et al.  Antidepressant effect of transdermal nicotine patches in nonsmoking patients with major depression. , 1996, The Journal of clinical psychiatry.

[438]  G. Chrousos,et al.  Bone mineral density in women with depression. , 1996, The New England journal of medicine.

[439]  F. Bloom,et al.  Learning impairment in transgenic mice with central overexpression of corticotropin-releasing factor , 1996, Neuroscience.

[440]  H. Okamura,et al.  NEUROBIOLOGY OF l-DOPAergic SYSTEMS , 1996, Progress in Neurobiology.

[441]  M. Weissman,et al.  Cross-national epidemiology of major depression and bipolar disorder. , 1996, JAMA.

[442]  R. Kessler,et al.  Comorbidity of DSM–III–R Major Depressive Disorder in the General Population: Results from the US National Comorbidity Survey , 1996, British Journal of Psychiatry.

[443]  S. Checkley,et al.  The relationship between the effects of metyrapone treatment on depressed mood and urinary steroid profiles , 1996, Psychoneuroendocrinology.

[444]  Gavin Kilpatrick,et al.  GR205171: A novel antagonist with high affinity for the tachykinin NK1 receptor, and potent broad-spectrum anti-emetic activity , 1996, Regulatory Peptides.

[445]  R. Davis,et al.  Mirtazapine , 1996, CNS drugs.

[446]  J. Pujol,et al.  Tyrosine hydroxylase expression within Balb/C and C57Black/6 mouse locus coeruleus. I. Topological organization and phenotypic plasticity of the enzyme-containing cell population , 1996, Brain Research.

[447]  R. Dufresne.  Issues in polypharmacotherapy: focus on major depression. , 1996, Psychopharmacology bulletin.

[448]  N Sartorius,et al.  Depression Comorbid with Anxiety: Results from the WHO Study on Psychological Disorders in Primary Health Care , 1996, British Journal of Psychiatry.

[449]  Takeshi Inoue,et al.  Bromocriptine treatment of tricyclic and heterocyclic antidepressant-resistant depression , 1996, Biological Psychiatry.

[450]  A. Cupello,et al.  NITRIC OXIDE AND GABAA RECEPTOR FUNCTION THE RAT CEREBRAL CORTEX AND CEREBELLAR GRANULE CELLS , 1996, Neuroscience.

[451]  Y. Nakagawa,et al.  Involvement of GABAB receptor systems in action of antidepressants: baclofen but not bicuculline attenuates the effects of antidepressants on the forced swim test in rats , 1996, Brain Research.

[452]  M. Millan,et al.  Down-regulation of rat β-adrenoceptors by clenbuterol or desipramine does not require chronic treatment: [3H]CGP-12177 binding reveals rapid (24 hour) modulation , 1996, Brain Research Bulletin.

[453]  A. Rush,et al.  The dexamethasone suppression test in patients with mood disorders. , 1996, The Journal of clinical psychiatry.

[454]  K. Hidaka,et al.  Biochemical profile of YM992, a novel selective serotonin reuptake inhibitor with 5-HT2A receptor antagonistic activity , 1996, Neuropharmacology.

[455]  R. Sapolsky,et al.  Stress, Glucocorticoids, and Damage to the Nervous System: The Current State of Confusion. , 1996, Stress.

[456]  G. Muirhead,et al.  Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. , 1996, International journal of impotence research.

[457]  J. Mendlewicz,et al.  A double-blind comparison of tianeptine, imipramine and placebo in the treatment of major depressive episodes , 1996, European Psychiatry.

[458]  Tetsuya Kobayashi,et al.  σ1 Receptor subtype is involved in the relief of behavioral despair in the mouse forced swimming test , 1996 .

[459]  J. Akiyoshi,et al.  Effects of antidepressants on intracellular Ca2+ mobilization in CHO cells transfected with the human 5-HT2C receptors , 1996, Biological Psychiatry.

[460]  P. Renard,et al.  Melatonin analogues as agonists and antagonists in the circadian system and other brain areas. , 1996, European journal of pharmacology.

[461]  P. Skolnick,et al.  Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression. , 1996, Pharmacopsychiatry.

[462]  Andrés G. Fernández,et al.  GR 127935 blocks the locomotor and antidepressant-like effects of RU 24969 and the action of antidepressants in the mouse tail suspension test , 1996, Pharmacology Biochemistry and Behavior.

[463]  J. M. Koolhaas,et al.  Long-term changes in open field behaviour following a single social defeat in rats can be reversed by sleep deprivation , 1996, Physiology & Behavior.

[464]  M. Spedding,et al.  Modulation of sexual behaviour in the rat by a potent and selective α2‐adrenoceptor antagonist, delequamine (RS‐15385‐197) , 1996, British journal of pharmacology.

[465]  D. Vetrie,et al.  A novel X–linked gene, DDP, shows mutations in families with deafness (DFN–1), dystonia, mental deficiency and blindness , 1996, Nature Genetics.

[466]  J. Seckl,et al.  11 beta-Hydroxysteroid dehydrogenase in cultured hippocampal cells reactivates inert 11-dehydrocorticosterone, potentiating neurotoxicity , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[467]  K. Fuxe,et al.  The vigilance promoting drug modafinil decreases GABA release in the medial preoptic area and in the posterior hypothalamus of the awake rat: possible involvement of the serotonergic 5-HT3 receptor , 1996, Neuroscience Letters.

[468]  W. Koek,et al.  (−)-Pindolol and (±)-Tertatolol Affect Rat Hippocampal 5-HT Levels Through Mechanisms Involving Not Only 5-HT1A, But Also 5-HT1B Receptors , 1996, Neuropharmacology.

[469]  B. Pollock,et al.  Paroxetine is a novel nitric oxide synthase inhibitor. , 1996, Psychopharmacology bulletin.

[470]  S. Cabib,et al.  Dopamine-N-methyl-D-aspartate interactions in the modulation of locomotor activity and memory consolidation in mice. , 1996, European journal of pharmacology.

[471]  R. D. Hunt,et al.  The Contribution of α2-Noradrenergic Mechanisms to Prefrontal Cortical Cognitive Function: Potential Significance for Attention-Deficit Hyperactivity Disorder , 1996 .

[472]  Kiyohisa Takahashi,et al.  Reduction of substance P after chronic antidepressants treatment in the striatum, substantia nigra and amygdala of the rat , 1996, Brain Research.

[473]  M. Jouvet,et al.  Effects of tianeptine, sertraline and clomipramine on brain serotonin metabolism: a voltammetric approach in the rat , 1996, Brain Research.

[474]  U. Frenz,et al.  Changes in energy metabolism and metabolite patterns of obese rats after application of dexfenfluramine , 1996, Pharmacology Biochemistry and Behavior.

[475]  M. I. Gonzalez,et al.  Behavioral effects of α-MSH and MCH after central administration in the female rat , 1996, Peptides.

[476]  S. Honma,et al.  Substance P receptor regulates the photic induction of Fos-like protein in the suprachiasmatic nucleus of Syrian hamsters , 1996, Brain Research.

[477]  P. Pauwels,et al.  Serotonin dimers: application of the bivalent ligand approach to the design of new potent and selective 5-HT(1B/1D) agonists. , 1996, Journal of medicinal chemistry.

[478]  H. Lachman,et al.  Modulation of learned helplessness by 5-hydroxytryptamine2A receptor antisense oligodeoxynucleotides , 1996, Psychiatry Research.

[479]  D. Faulds,et al.  Dexfenfluramine , 2013, Drugs.

[480]  E. Schömig,et al.  The Extraneuronal Transporter for Monoamine Transmitters Exists in Cells Derived from Human Central Nervous System Glia , 1996, The European journal of neuroscience.

[481]  CGP 36 742, an orally active GABAB receptor antagonist, facilitates memory in a social recognition test in rats , 1996, Behavioural Brain Research.

[482]  E P Sloan,et al.  Circadian Rhythms and Psychiatric Disorders in the Elderly , 1996, Journal of geriatric psychiatry and neurology.

[483]  W. Duncan,et al.  Circadian rhythms and the pharmacology of affective illness. , 1996, Pharmacology & therapeutics.

[484]  M. Toussaint,et al.  A double-blind, placebo-controlled evaluation of the effects of orally administered venlafaxine on sleep in inpatients with major depression. , 1996, Psychopharmacology bulletin.

[485]  A. Steiger,et al.  Neuropeptides and human sleep. , 1997, Sleep.

[486]  B. Gidal,et al.  Melatonin: Therapeutic Use in Sleep Disorders , 1997, The Annals of pharmacotherapy.

[487]  H. Jackson,et al.  Comparison of the effects of sibutramine and other monoamine reuptake inhibitors on food intake in the rat , 1997, British journal of pharmacology.

[488]  T. L. Krukoff,et al.  Stress‐induced activation of nitric oxide‐producing neurons in the rat brain , 1997, The Journal of comparative neurology.

[489]  A. Harvey,et al.  Novel tacrine analogues for potential use against Alzheimer's disease: potent and selective acetylcholinesterase inhibitors and 5-HT uptake inhibitors. , 1997, Journal of medicinal chemistry.

[490]  G. Aghajanian,et al.  5-HT2A Receptor-Mediated Regulation of Brain-Derived Neurotrophic Factor mRNA in the Hippocampus and the Neocortex , 1997, The Journal of Neuroscience.

[491]  B. Murphy.  Antiglucocorticoid therapies in major depression: A review , 1997, Psychoneuroendocrinology.

[492]  R. Kessler,et al.  Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. , 1997, Archives of general psychiatry.

[493]  R. Hamer,et al.  Serotonin reuptake inhibitor-induced sexual dysfunction and its treatment: a large-scale retrospective study of 596 psychiatric outpatients. , 1997, Journal of sex & marital therapy.

[494]  P. Mitchell,et al.  Potentiation of the time-dependent, antidepressant-induced changes in the agonistic behaviour of resident rats by the 5-HT1A receptor antagonist, WAY-100635 , 1997, Behavioural pharmacology.

[495]  J. O'Donnell.  Pharmacological Characterization of the Discriminative Stimulus Effects of Clenbuterol in Rats , 1997, Pharmacology Biochemistry and Behavior.

[496]  E. Sigel,et al.  The benzodiazepine binding site of GABAA receptors. , 1997, Trends in pharmacological sciences.

[497]  H. Westenberg,et al.  Effects of trazodone and fluoxetine in the treatment of major depression: therapeutic pharmacokinetic and pharmacodynamic interactions through formation of meta-chlorophenylpiperazine. , 1997, Journal of clinical psychopharmacology.

[498]  M. Mesulam,et al.  Butyrylcholinesterase in the life cycle of amyloid plaques , 1997, Annals of neurology.

[499]  Antiepileptic drug augmentation for treatment-resistant depression. , 1997, The Journal of clinical psychiatry.

[500]  D. Lorrain,et al.  Extracellular Serotonin in the Lateral Hypothalamic Area Is Increased during the Postejaculatory Interval and Impairs Copulation in Male Rats , 1997, The Journal of Neuroscience.

[501]  B. Bettler,et al.  Expression cloning of GABAB receptors uncovers similarity to metabotropic glutamate receptors , 1997, Nature.

[502]  M. Millan,et al.  5-HT2C receptors mediate penile erections in rats: actions of novel and selective agonists and antagonists. , 1997, European journal of pharmacology.

[503]  A. Saiardi,et al.  Dopamine D2 receptors in signal transduction and behavior. , 1997, Critical reviews in neurobiology.

[504]  D J Kupfer,et al.  Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy combinations. , 1997, Archives of general psychiatry.

[505]  G. Bernardi,et al.  Monoamine Oxidase Inhibition Causes a Long-Term Prolongation of the Dopamine-Induced Responses in Rat Midbrain Dopaminergic Cells , 1997, The Journal of Neuroscience.

[506]  M. Millan,et al.  Buspirone Enhances Duloxetine‐ and Fluoxetine‐Induced Increases in Dialysate Levels of Dopamine and Noradrenaline, but Not Serotonin, in the Frontal Cortex of Freely Moving Rats , 1997, Journal of neurochemistry.

[507]  M. Thase,et al.  The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. , 1997, JAMA.

[508]  J. Stamford,et al.  Actions of tramadol, its enantiomers and principal metabolite, O-desmethyltramadol, on serotonin (5-HT) efflux and uptake in the rat dorsal raphe nucleus. , 1997, British journal of anaesthesia.

[509]  S. Reppert.  Melatonin Receptors: Molecular Biology of a New Family of G Protein-Coupled Receptors , 1997, Journal of biological rhythms.

[510]  D. Hammond.  Inhibitory Neurotransmitters and Nociception: Role of GABA and Glycine , 1997 .

[511]  Sertraline-induced anorgasmia treated with intermittent nefazodone. , 1997 .

[512]  A. Brown,et al.  SB 242084, a Selective and Brain Penetrant 5-HT2C Receptor Antagonist , 1997, Neuropharmacology.

[513]  C. McKittrick,et al.  Chronic Social Stress Alters Levels of Corticotropin-Releasing Factor and Arginine Vasopressin mRNA in Rat Brain , 1997, The Journal of Neuroscience.

[514]  P. Skolnick.  Antidepressants : new pharmacological strategies , 1997 .

[515]  R. Hen,et al.  Regulation of Serotonin Release in the Frontal Cortex and Ventral Hippocampus of Homozygous Mice Lacking 5‐HT1B Receptors: In Vivo Microdialysis Studies , 1997, Journal of neurochemistry.

[516]  Inhibition by nitric oxide of the uptake of [3H]serotonin into rat brain synaptosomes. , 1997, Japanese journal of pharmacology.

[517]  B. Moghaddam,et al.  Temporal dynamics of glutamate efflux in the prefrontal cortex and in the hippocampus following repeated stress: effects of pretreatment with saline or diazepam , 1997, Neuroscience.

[518]  H. Christensen,et al.  A quantitative review of cognitive deficits in depression and Alzheimer-type dementia , 1997, Journal of the International Neuropsychological Society.

[519]  Dehydroepiandrosterone (DHEA) treatment of depression , 1997, Biological Psychiatry.

[520]  R. Blakely,et al.  Pharmacological profile of antidepressants and related compounds at human monoamine transporters. , 1997, European journal of pharmacology.

[521]  R. Baldessarini,et al.  Combining serotonin reuptake inhibitors and bupropion in partial responders to antidepressant monotherapy. , 1997, The Journal of clinical psychiatry.

[522]  R. Sonoda,et al.  Pharmacological studies on YM992, a novel antidepressant with selective serotonin re-uptake inhibitory and 5-HT2A receptor antagonistic activity. , 1997, European journal of pharmacology.

[523]  I. Hindmarch.  The effects of antidepressants on psychomotor function with particular reference to reboxetine , 1997, European Neuropsychopharmacology.

[524]  A. Gobert,et al.  α2‐Adrenergic Receptor Blockade Markedly Potentiates Duloxetine‐ and Fluoxetine‐Induced Increases in Noradrenaline, Dopamine, and Serotonin Levels in the Frontal Cortex of Freely Moving Rats , 1997 .

[525]  H. Müller-Gärtner,et al.  In VivoEvidence for the Involvement of Dopamine-D2Receptors in Striatum and Anterior Cingulate Gyrus in Major Depression , 1997, NeuroImage.

[526]  S. Wonnacott,et al.  Presynaptic nicotinic ACh receptors , 1997, Trends in Neurosciences.

[527]  H. Jackson,et al.  Investigation of the mechanisms underlying the hypophagic effects of the 5‐HT and noradrenaline reuptake inhibitor, sibutramine, in the rat , 1997, British journal of pharmacology.

[528]  A. Ågmo,et al.  GABAergic drugs and sexual motivation, receptivity and exploratory behaviors in the female rat , 1997, Psychopharmacology.

[529]  P. Spano,et al.  Opposite effects of dopamine D2 and D3 receptors on learning and memory in the rat. , 1997, European journal of pharmacology.

[530]  P. Fox,et al.  Cingulate function in depression: a potential predictor of treatment response , 1997, Neuroreport.

[531]  S. Wonnacott,et al.  Presynaptic Nicotinic Modulation of Dopamine Release in the Three Ascending Pathways Studied by In Vivo Microdialysis: Comparison of Naive and Chronic Nicotine‐Treated Rats , 1997, Journal of neurochemistry.

[532]  E. Gibson,et al.  Curzon et al. reply , 1997 .

[533]  Abraham Weizman,et al.  Mianserin, a 5-HT2a/2c and alpha 2 antagonist, in the treatment of sexual dysfunction induced by serotonin reuptake inhibitors. , 1997, Clinical neuropharmacology.

[534]  A. Dickenson,et al.  The Pharmacology of Pain , 1997, Handbook of Experimental Pharmacology.

[535]  J. Davis,et al.  DST studies in psychotic depression: a meta-analysis. , 1997, The American journal of psychiatry.

[536]  J. Seckl.  11β-Hydroxysteroid Dehydrogenase in the Brain: A Novel Regulator of Glucocorticoid Action? , 1997, Frontiers in Neuroendocrinology.

[537]  S. Montgomery,et al.  Milnacipran, a new serotonin and noradrenaline reuptake inhibitor: an overview of its antidepressant activity and clinical tolerability , 1997, International clinical psychopharmacology.

[538]  M. Millan,et al.  Agonist and Inverse Agonist Efficacy at Human Recombinant Serotonin 5-HT1A Receptors as a Function of Receptor:G-protein Stoichiometry , 1997, Neuropharmacology.

[539]  A. M. Etgen,et al.  Estradiol reduction of α 2-adrenoceptor binding in female rat cortex is correlated with decreases in α 2A/D-adrenoceptor messenger RNA , 1997, Neuroscience.

[540]  R. Davis,et al.  Nefazodone. A review of its pharmacology and clinical efficacy in the management of major depression. , 1997, Drugs.

[541]  M. Millan,et al.  Noradrenaline and adrenaline are high affinity agonists at dopamine D4 receptors. , 1997, European journal of pharmacology.

[542]  O. Blin,et al.  Serotonin and human information processing: fluvoxamine can improve reaction time performance , 1997, Neuroscience Letters.

[543]  K. Fuxe,et al.  Modafinil: An antinarcoleptic drug with a different neurochemical profile to d-amphetamine and dopamine uptake blockers , 1997, Biological Psychiatry.

[544]  G. Goodwin.  Neuropsychological and neuroimaging evidence for the involvement of the frontal lobes in depression , 1997, Journal of psychopharmacology.

[545]  F. Lang,et al.  Cloning and characterization of two human polyspecific organic cation transporters. , 1997, DNA and cell biology.

[546]  A. Wirz-Justice,et al.  Melatonin and S-20098 increase REM sleep and wake-up propensity without modifying NREM sleep homeostasis. , 1997, The American journal of physiology.

[547]  B. Pollock,et al.  Plasma levels of citalopram enantiomers and metabolites in elderly patients. , 1997, Psychopharmacology bulletin.

[548]  K. Jeffery,et al.  Modifiable neuronal connections: an overview for psychiatrists. , 1997, The American journal of psychiatry.

[549]  P. Cowen,et al.  SSRI treatment decreases prolactin and hyperthermic responses to mCPP , 1997, Psychopharmacology.

[550]  I. Lucki,et al.  Chronic administration of the 5‐HT1A receptor agonist 8‐OH‐DPAT differentially desensitizes 5‐HT1A autoreceptors of the dorsal and median raphe nuclei , 1997, Synapse.

[551]  U. Halbreich.  Hormonal interventions with psychopharmacological potential: an overview. , 1997, Psychopharmacology bulletin.

[552]  M. Stock,et al.  Sibutramine: a review of the pharmacology of a novel anti-obesity agent. , 1997, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[553]  M. A. Benedito,et al.  Activities of Monoamine Oxidase (MAO) A and B in Discrete Regions of Rat Brain After Rapid Eye Movement (REM) Sleep Deprivation , 1997, Pharmacology Biochemistry and Behavior.

[554]  A. Arnsten,et al.  Catecholamine regulation of the prefrontal cortex , 1997, Journal of psychopharmacology.

[555]  R. Miledi,et al.  Blockage of 5HT2C serotonin receptors by fluoxetine (Prozac). , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[556]  E. Sibille,et al.  Antisense inhibition of 5-hydroxytryptamine2a receptor induces an antidepressant-like effect in mice. , 1997, Molecular pharmacology.

[557]  E. Sigel,et al.  ReviewThe benzodiazepine binding site of GABAA receptors , 1997 .

[558]  K. Fuxe,et al.  The antinarcoleptic drug modafinil increases glutamate release in thalamic areas and hippocampus , 1997, Neuroreport.

[559]  M. Uchiyama,et al.  Sleep and mood disorders. , 1997, Sleep medicine reviews.

[560]  C. Nemeroff,et al.  Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites. , 1997, The Journal of pharmacology and experimental therapeutics.

[561]  H. Berendsen,et al.  Indirect in vivo 5-HT1A-agonistic effects of the new antidepressant mirtazapine , 1997, Psychopharmacology.

[562]  P. Moore,et al.  Selective inhibitors of neuronal nitric oxide synthase--is no NOS really good NOS for the nervous system? , 1997, Trends in pharmacological sciences.

[563]  M. I. González,et al.  Stimulatory effect of melanin-concentrating hormone on luteinising hormone release. , 1997, Neuroendocrinology.

[564]  R. Miledi,et al.  Blockage of muscle and neuronal nicotinic acetylcholine receptors by fluoxetine (Prozac). , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[565]  S. Heinrichs,et al.  Anti-sexual and anxiogenic behavioral consequences of corticotropin-releasing factor overexpression are centrally mediated , 1997, Psychoneuroendocrinology.

[566]  E. Gibson,et al.  Appetite suppression by commonly used drugs depends on 5-HT receptors but not on 5-HT availability. , 1997, TIPS - Trends in Pharmacological Sciences.

[567]  Evidence that the enhancement of dopamine function by repeated electroconvulsive shock requires concomitant activation of D1-like and D2-like dopamine receptors , 1997, Psychopharmacology.

[568]  Antagonism of selective serotonin reuptake inhibitor-induced nausea by mirtazapine. , 1997, International clinical psychopharmacology.

[569]  H. Moldofsky,et al.  Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy , 1997, Neurology.

[570]  G. Aguilera,et al.  Regulation of pituitary V1b vasopressin receptor messenger ribonucleic acid by adrenalectomy and glucocorticoid administration. , 1997, Endocrinology.

[571]  David Taylor,et al.  The adverse effects of antidepressants , 1997 .

[572]  G. Chrousos,et al.  The longitudinal course of psychopathology in Cushing's syndrome after correction of hypercortisolism. , 1997, The Journal of clinical endocrinology and metabolism.

[573]  T. Egawa,et al.  Rolipram and its optical isomers, phosphodiesterase 4 inhibitors, attenuated the scopolamine-induced impairments of learning and memory in rats. , 1997, Japanese journal of pharmacology.

[574]  S. J. Gatley,et al.  Relationship between subjective effects of cocaine and dopamine transporter occupancy , 1997, Nature.

[575]  R. Blakely,et al.  Protein Kinase C Activation Regulates Human Serotonin Transporters in HEK-293 Cells via Altered Cell Surface Expression , 1997, The Journal of Neuroscience.

[576]  Maya Frankfurt,et al.  Prevention of stress-induced morphological and cognitive consequences , 1997, European Neuropsychopharmacology.

[577]  P. Plenge,et al.  An affinity-modulating site on neuronal monoamine transport proteins. , 1997, Pharmacology & toxicology.

[578]  S. Wiviott,et al.  S-nitrosothiols inhibit neuronal norepinephrine transport. , 1997, The American journal of physiology.

[579]  E. Vizi,et al.  Nicotinic acetylcholine receptor antagonist effect of fluoxetine in rat hippocampal slices , 1997, Brain Research.

[580]  B. Gorzalka,et al.  Inhibition of Subjective and Physiological Sexual Arousal in Women by Clonidine , 1997, Psychosomatic medicine.

[581]  A. Rush,et al.  When at first you don't succeed: sequential strategies for antidepressant nonresponders. , 1997, The Journal of clinical psychiatry.

[582]  Richard C. Strohman,et al.  The coming Kuhnian revolution in biology , 1997, Nature Biotechnology.

[583]  R. Idzerda,et al.  PKA isoforms, neural pathways, and behaviour: making the connection , 1997, Current Opinion in Neurobiology.

[584]  P. Willner.  The mesolimbic dopamine system as a target for rapid antidepressant action , 1997, International clinical psychopharmacology.

[585]  D. Stein,et al.  Buspirone is an effective augmenting agent of serotonin selective re-uptake inhibitors in severe treatment-refractory depression. , 1997, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[586]  G. Bartoszyk,et al.  EMD 68843, a serotonin reuptake inhibitor with selective presynaptic 5-HT1A receptor agonistic properties. , 1997, European journal of pharmacology.

[587]  D. Hodges,et al.  D1 Agonist Dihydrexidine Releases Acetylcholine and Improves Cognitive Performance in Rats , 1997, Pharmacology Biochemistry and Behavior.

[588]  R. Rupprecht.  The neuropsychopharmacological potential of neuroactive steroids. , 1997, Journal of psychiatric research.

[589]  T. Robbins,et al.  Central cholinergic systems and cognition. , 1997, Annual review of psychology.

[590]  E. Seifritz,et al.  Effect of sleep deprivation on neuroendocrine response to a serotonergic probe in healthy male subjects. , 1997, Journal of psychiatric research.

[591]  Joffe Rt.  Refractory depression: treatment strategies, with particular reference to the thyroid axis. , 1997 .

[592]  W. Gaebel,et al.  Pramipexole, a Dopamine Agonist, in Major Depression: Antidepressant Effects and Tolerability in an Open‐Label Study with Multiple Doses , 1997 .

[593]  Takeshi Kumazawa,et al.  Increased stress response and β–phenylethylamine in MAOB–deficient mice , 1997, Nature Genetics.

[594]  N. Volkow,et al.  Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. , 1998, The American journal of psychiatry.

[595]  D. Murphy,et al.  The Influence of Ondansetron and m-Chlorophenylpiperazine on Scopolamine-Induced Cognitive, Behavioral, and Physiological Responses in Young Healthy Controls , 1998, Biological Psychiatry.

[596]  P. Goodnick,et al.  Selective serotonin reuptake inhibitors in affective disorders — I. Basic pharmacology , 1998, Journal of psychopharmacology.

[597]  M. Bauer,et al.  Treatment of Refractory Depression with High-Dose Thyroxine , 1998, Neuropsychopharmacology.

[598]  T. Sharp,et al.  Effect of antidepressant drugs on dopamine D1 and D2 receptor expression and dopamine release in the nucleus accumbens of the rat , 1998, Psychopharmacology.

[599]  R. Lane.  SSRI-Induced extrapyramidal side-effects and akathisia: implications for treatment , 1998, Journal of psychopharmacology.

[600]  Stephen P. Hunt,et al.  Altered nociception, analgesia and aggression in mice lacking the receptor for substance P , 1998, Nature.

[601]  S. Stahl.  Augmentation of antidepressants by estrogen. , 1998, Psychopharmacology bulletin.

[602]  Langford Rm,et al.  Tramadol hydrochloride: an overview of current use. , 1998 .

[603]  P. Pauwels,et al.  Design and synthesis of new potent, silent 5-HT1A antagonists by covalent coupling of aminopropanol derivatives with selective serotonin reuptake inhibitors. , 1998, Bioorganic & medicinal chemistry letters.

[604]  R. Gannon,et al.  Local Administration of Serotonin Agonists Blocks Light-Induced Phase Advances of the Circadian Activity Rhythm in the Hamster , 1998, Journal of biological rhythms.

[605]  W. Spooren,et al.  Patterns of c-fos expression induced by fluvoxamine are different after acute vs. chronic oral administration , 1998, European Neuropsychopharmacology.

[606]  R. Lam,et al.  A Canadian multicenter study of three fixed doses of controlled-release ipsapirone in outpatients with moderate to severe major depression. , 1998, Journal of clinical psychopharmacology.

[607]  J. Nelson.  Treatment of antidepressant nonresponders: augmentation or switch? , 1998, The Journal of clinical psychiatry.

[608]  John R. Searle,et al.  How to study consciousness scientifically 1 Published on the World Wide Web on 24 November 1998. 1 , 1998, Brain Research Reviews.

[609]  M. Weissman,et al.  Uncomplicated and Comorbid Obsessive-Compulsive Disorder in an Epidemiologic Sample , 1998, CNS Spectrums.

[610]  O. Puciłowski,et al.  Effects of melatonin receptor ligands on swim test immobility , 1998, Neuroreport.

[611]  K. Goa,et al.  Sibutramine. A review of its contribution to the management of obesity. , 1998, Drugs.

[612]  M. Millan,et al.  Actions of α2 adrenoceptor ligands at α2A and 5-HT1A receptors: the antagonist, atipamezole, and the agonist, dexmedetomidine, are highly selective for α2A adrenoceptors , 1998, Naunyn-Schmiedeberg's Archives of Pharmacology.

[613]  M. Berger,et al.  Neurobiological similarities in antidepressant sleep deprivation and psychostimulant use: a psychostimulant theory of antidepressant sleep deprivation , 1998, Psychopharmacology.

[614]  D. Greenblatt,et al.  Nefazodone in major depression: adjunctive benzodiazepine therapy and tolerability. , 1998, Journal of clinical psychopharmacology.

[615]  P. Contreras,et al.  Differential patterns of regional c-Fos induction in the rat brain by amphetamine and the novel wakefulness-promoting agent modafinil , 1998, Neuroscience Letters.

[616]  F. Lang,et al.  Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine. , 1998, Molecular pharmacology.

[617]  N. Obermüller,et al.  Transport of Monoamine Transmitters by the Organic Cation Transporter Type 2, OCT2* , 1998, The Journal of Biological Chemistry.

[618]  A. Glassman,et al.  Cigarette smoking and major depression. , 1998, Journal of addictive diseases.

[619]  H. Sackeim,et al.  Effects of electroconvulsive therapy on plasma vasopressin and oxytocin , 1998, Biological Psychiatry.

[620]  H. Betz,et al.  Distinct Effects of Imipramine on 5‐Hydroxytryptamine Uptake Mediated by the Recombinant Rat Serotonin Transporter SERT1 , 1998, Journal of neurochemistry.

[621]  G. Holstege,et al.  Premature ejaculation and serotonergic antidepressants-induced delayed ejaculation: the involvement of the serotonergic system , 1998, Behavioural Brain Research.

[622]  C. Woolf,et al.  Null Mutations Lacking Substance: Elucidating Pain Mechanisms by Genetic Pharmacology , 1998, Neuron.

[623]  P. Pauwels,et al.  Dimers of 5HT1 ligands preferentially bind to 5HT1B/1D receptor subtypes. , 1998, Bioorganic & medicinal chemistry letters.

[624]  N. Breslau,et al.  Major depression and stages of smoking. A longitudinal investigation. , 1998, Archives of general psychiatry.

[625]  S. Stahl,et al.  Effectiveness of ipsapirone, a 5-HT-1A partial agonist, in major depressive disorder: support for the role of 5-HT-1A receptors in the mechanism of action of serotonergic antidepressants. , 1998, The international journal of neuropsychopharmacology.

[626]  I. Anderson.  SSRIs versus tricyclic antidepressants in depressed inpatients: A meta‐analysis of efficacy and tolerability , 1998, Depression and anxiety.

[627]  E. Smeraldi,et al.  Faster onset of action of fluvoxamine in combination with pindolol in the treatment of delusional depression: a controlled study. , 1998, Journal of clinical psychopharmacology.

[628]  D. Gründemann,et al.  Catecholamine transport by the organic cation transporter type 1 (OCT1) , 1998, British journal of pharmacology.

[629]  E. Dimitriou,et al.  Buspirone augmentation of antidepressant therapy. , 1998, Journal of clinical psychopharmacology.

[630]  J F O'Hanlon,et al.  Venlafaxine's effects on healthy volunteers' driving, psychomotor, and vigilance performance during 15-day fixed and incremental dosing regimens. , 1998, Journal of clinical psychopharmacology.

[631]  S. Caccia,et al.  Citalopram‐induced hypophagia is enhanced by blockade of 5‐HT1A receptors: role of 5‐HT2C receptors , 1998, British journal of pharmacology.

[632]  M. Kaste,et al.  Frequency and clinical determinants of poststroke depression. , 1998, Stroke.

[633]  B. Westerink,et al.  The pharmacology of mesocortical dopamine neurons: a dual-probe microdialysis study in the ventral tegmental area and prefrontal cortex of the rat brain. , 1998, The Journal of pharmacology and experimental therapeutics.

[634]  D. Kennaway,et al.  Serotonin 5-HT2c agonists mimic the effect of light pulses on circadian rhythms , 1998, Brain Research.

[635]  M. Alreja,et al.  Excitatory effects of muscarine on septohippocampal neurons: involvement of M3 receptors , 1998, Brain Research.

[636]  C. Woolley.  Estrogen-Mediated Structural and Functional Synaptic Plasticity in the Female Rat Hippocampus , 1998, Hormones and Behavior.

[637]  Neuroactive steroid concentrations following metyrapone administration in depressed patients and healthy volunteers , 1998, Biological Psychiatry.

[638]  G. Lynch,et al.  Facilitative Effects of the Ampakine CX516 on Short-Term Memory in Rats: Correlations with Hippocampal Neuronal Activity , 1998, The Journal of Neuroscience.

[639]  S. Montgomery,et al.  Mirtazapine versus amitriptyline in the long‐term treatment of depression: a double‐blind placebo‐controlled study , 1998, International clinical psychopharmacology.

[640]  S. Ballard,et al.  Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes. , 1998, The Journal of urology.

[641]  Relationships between Thyroid Hormone and Antidepressant Responses to Total Sleep Deprivation in Mood Disorder Patients , 1998, Biological Psychiatry.

[642]  G. Rappold,et al.  Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter , 1998, Nature Neuroscience.

[643]  R. Gur,et al.  Depression in schizophrenia: I. association with neuropsychological deficits , 1998, Biological Psychiatry.

[644]  A. Glassman.  Cardiovascular effects of antidepressant drugs: updated , 1998, The Journal of clinical psychiatry.

[645]  H. Jackson,et al.  Sibutramine: a novel anti-obesity drug. A review of the pharmacological evidence to differentiate it from d-amphetamine and d-fenfluramine. , 1998, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[646]  Araceli M. Huerta,et al.  From specific gene regulation to genomic networks: a global analysis of transcriptional regulation in Escherichia coli. , 1998, BioEssays : news and reviews in molecular, cellular and developmental biology.

[647]  J. Pratt,et al.  GR205171 blocks apomorphine and amphetamine-induced conditioned taste aversions. , 1998, European journal of pharmacology.

[648]  John A. Rice,et al.  Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse. , 1998, Journal of affective disorders.

[649]  J. Pancrazio,et al.  Inhibition of neuronal Na+ channels by antidepressant drugs. , 1998, The Journal of pharmacology and experimental therapeutics.

[650]  P. Goodnick,et al.  Selective serotonin reuptake inhibitors in the treatment of affective disorders—III. Tolerability, safety and pharmacoeconomics , 1998, Journal of psychopharmacology.

[651]  M. Palkovits,et al.  Localization and Dynamic Regulation of Biogenic Amine Transporters in the Mammalian Central Nervous System , 1998, Frontiers in Neuroendocrinology.

[652]  P. Leff,et al.  Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus. , 1998, Molecular pharmacology.

[653]  B. Leonard,et al.  Depression, stress and immunological activation: the role of cytokines in depressive disorders. , 1998, Life sciences.

[654]  M. Dziedzicka-Wasylewska,et al.  Effect of antidepressant drugs administered repeatedly on the dopamine D3 receptors in the rat brain. , 1998, European journal of pharmacology.

[655]  L. Tecott,et al.  Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene , 1998, Nature Medicine.

[656]  J. Metzger,et al.  An NK1 receptor antagonist affects the circadian regulation of locomotor activity in golden hamsters , 1998, Brain Research.

[657]  M. Dubocovich,et al.  Melatonin receptor subtype expression in human cerebellum. , 1998, Neuroreport.

[658]  T. Wehr,et al.  Decreased Sensitivity to Light of the Photic Entrainment Pathway during Chronic Clorgyline and Lithium Treatments , 1998, Journal of biological rhythms.

[659]  R. Miledi,et al.  Effects of fluoxetine on wild and mutant neuronal α7 nicotinic receptors , 1998, Molecular Psychiatry.

[660]  P. Bech,et al.  Morning Fluoxetine plus Evening Mianserin Versus Morning Fluoxetine plus Evening Placebo in the Acute Treatment of Major Depression , 1998, Pharmacopsychiatry.

[661]  M. Hongo,et al.  Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome , 1998, Gut.

[662]  N. Canteras,et al.  Nitric oxide synthase activity in the dorsal periaqueductal gray of rats expressing innate fear responses , 1998, Neuroreport.

[663]  J. Micó,et al.  Tramadol induces antidepressant-type effects in mice. , 1998, Life sciences.

[664]  K. Rickels,et al.  Buspirone and imipramine for the treatment of major depression in the elderly. , 1998, The Journal of clinical psychiatry.

[665]  T. Hijzen,et al.  Discriminative stimulus properties of mCPP: evidence for a 5-HT2C receptor mode of action , 1998, Psychopharmacology.

[666]  Trevor R. Norman,et al.  Combining pindolol and paroxetine in an animal model of chronic antidepressant action--can early onset of action be detected? , 1998, European journal of pharmacology.

[667]  R. Rosen,et al.  Bupropion as an antidote for serotonin reuptake inhibitor-induced sexual dysfunction. , 1998, The Journal of clinical psychiatry.

[668]  S. Leibowitz,et al.  Hypothalamic serotonin in control of eating behavior, meal size, and body weight , 1998, Biological Psychiatry.

[669]  C. Heyser,et al.  Substance dependence as a compulsive behavior , 1998, Journal of psychopharmacology.

[670]  E. Rolls.  The Brain and Emotion , 2000 .

[671]  D. Lorrain,et al.  8-OH-DPAT influences extracellular levels of serotonin and dopamine in the medial preoptic area of male rats , 1998, Brain Research.

[672]  B. Yamamoto,et al.  Regulation of Extracellular Dopamine by the Norepinephrine Transporter , 1998, Journal of neurochemistry.

[673]  R. Duman,et al.  Molecular and Cellular Actions of Chronic Electroconvulsive Seizures , 1998, The journal of ECT.

[674]  M. Millan,et al.  WAY 100,635 enhances both the 'antidepressant' actions of duloxetine and its influence on dialysate levels of serotonin in frontal cortex. , 1998, European journal of pharmacology.

[675]  K. Fuxe,et al.  Alterations in neuropeptide Y and Y1 receptor mRNA expression in brains from an animal model of depression: region specific adaptation after fluoxetine treatment. , 1998, Brain research. Molecular brain research.

[676]  J. Redman,et al.  Entrainment of Rat Circadian Rhythms by the Melatonin Agonist S-20098 Requires Intact Suprachiasmatic Nuclei But Not the Pineal , 1998, Journal of biological rhythms.

[677]  R. Blakely,et al.  Phosphorylation and Regulation of Antidepressant-sensitive Serotonin Transporters* , 1998, The Journal of Biological Chemistry.

[678]  K. Blennow,et al.  Decreased monoamine metabolites in frontotemporal dementia and Alzheimer’s disease , 1998, Neurobiology of Aging.

[679]  M. Bourin,et al.  Dose-dependent noradrenergic and serotonergic properties of venlafaxine in animal models indicative of antidepressant activity , 1998, Psychopharmacology.

[680]  M. Rubinstein,et al.  Opposite roles of D1 and D5 dopamine receptors in locomotion revealed by selective antisense oligonucleotides , 1998, Neuroreport.

[681]  V. Ganapathy,et al.  Identity of the Organic Cation Transporter OCT3 as the Extraneuronal Monoamine Transporter (uptake2) and Evidence for the Expression of the Transporter in the Brain* , 1998, The Journal of Biological Chemistry.

[682]  H. Sitte,et al.  Carrier‐Mediated Release, Transport Rates, and Charge Transfer Induced by Amphetamine, Tyramine, and Dopamine in Mammalian Cells Transfected with the Human Dopamine Transporter , 1998, Journal of neurochemistry.

[683]  F. Alford,et al.  1 Growth hormone deficiency and cardiovascular risk , 1998 .

[684]  M. Bös,et al.  The role of 5-HT2C receptors in affective disorders. , 1998, Expert opinion on investigational drugs.

[685]  S. Kasper,et al.  Effects of tryptophan depletion vs catecholamine depletion in patients with seasonal affective disorder in remission with light therapy. , 1998, Archives of general psychiatry.

[686]  R G Hill,et al.  Distinct mechanism for antidepressant activity by blockade of central substance P receptors. , 1998, Science.

[687]  A. Lewy,et al.  Use of melatonin for sleep and circadian rhythm disorders. , 1998, Annals of medicine.

[688]  S. Endo,et al.  Effects of trazodone hydrochloride and imipramine on polysomnography in healthy subjects , 1998, Psychiatry and clinical neurosciences.

[689]  Y. Ichitani,et al.  Intrahippocampal d-cycloserine improves MK-801-induced memory deficits: radial-arm maze performance in rats , 1998, Brain Research.

[690]  S. Kasper,et al.  Effects of tryptophan depletion in drug-free depressed patients who responded to total sleep deprivation. , 1998, Archives of general psychiatry.

[691]  M. Briley,et al.  Milnacipran, a new specific serotonin and noradrenaline reuptake inhibitor. , 1998, Drugs of today.

[692]  C. McDougle,et al.  Lithium and desipramine versus desipramine alone in the treatment of severe major depression: a preliminary study , 1998, International clinical psychopharmacology.

[693]  L. Hokin,et al.  Lithium acutely inhibits and chronically up-regulates and stabilizes glutamate uptake by presynaptic nerve endings in mouse cerebral cortex. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[694]  S. Kollins,et al.  Discriminative-stimulus and participant-rated effects of methylphenidate, bupropion, and triazolam in d-amphetamine-trained humans. , 1998, Experimental and clinical psychopharmacology.

[695]  A. Lewy,et al.  Morning vs evening light treatment of patients with winter depression. , 1998, Archives of general psychiatry.

[696]  C. T. Wotjak,et al.  Dissociated central and peripheral release of vasopressin, but not oxytocin, in response to repeated swim stress: New insights into the secretory capacities of peptidergic neurons , 1998, Neuroscience.

[697]  F. Holsboer,et al.  Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1 , 1998, Nature Genetics.

[698]  C. McDougle,et al.  Tryptophan Depletion During Continuous CSF Sampling in Healthy Human Subjects , 1998, Neuropsychopharmacology.

[699]  A. Sleight,et al.  5-HT2C receptor agonists: pharmacological characteristics and therapeutic potential. , 1998, The Journal of pharmacology and experimental therapeutics.

[700]  K. Larsson,et al.  Subchronic Administration of Fluoxetine Impairs Estrous Behavior in Intact Female Rats , 1998, Neuropsychopharmacology.

[701]  R. Joffe.  The use of thyroid supplements to augment antidepressant medication. , 1998, The Journal of clinical psychiatry.

[702]  Klaus P. Ebmeier,et al.  Cortical grey matter reductions associated with treatment-resistant chronic unipolar depression , 1998, British Journal of Psychiatry.

[703]  Kenneth A. Jones,et al.  GABAB receptors function as a heteromeric assembly of the subunits GABABR1 and GABABR2 , 1998, Nature.

[704]  T. Zetterström,et al.  Repeated electroconvulsive shock extends the duration of enhanced gene expression for BDNF in rat brain compared with a single administration. , 1998, Brain research. Molecular brain research.

[705]  G. Edelman,et al.  Consciousness and Complexity , 1998 .

[706]  C. Parsons,et al.  Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications. , 1998, Pharmacological reviews.

[707]  J. Amsterdam,et al.  A double-blind study of paroxetine, fluoxetine, and placebo in outpatients with major depression. , 1998, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

[708]  K. Lesch.  Review : Serotonin Transporter and Psychiatric Disorders: Listening to the Gene , 1998 .

[709]  M. Landén,et al.  A randomized, double-blind, placebo-controlled trial of buspirone in combination with an SSRI in patients with treatment-refractory depression. , 1998, The Journal of clinical psychiatry.

[710]  M. Millan,et al.  Agonist and Antagonist Actions of (-)Pindolol at Recombinant, Human Serotonin1A (5-HT1A) Receptors , 1998, Neuropsychopharmacology.

[711]  J. Daunais,et al.  Long-acting blockade of biogenic amine transporters in rat brain by administration of the potent novel tropane 2beta-propanoyl-3beta-(2-Naphthyl)-tropane. , 1998, The Journal of pharmacology and experimental therapeutics.

[712]  A. Guidotti,et al.  Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[713]  D. Helmeste,et al.  The role of calcium in the etiology of the affective disorders. , 1998, Japanese journal of pharmacology.

[714]  P. Rosenzweig,et al.  Clinical pharmacology of befloxatone: a brief review. , 1998, Journal of affective disorders.

[715]  S. Kulkarni,et al.  Sigma (σ1) receptor mediated antidepressant‐like effects of neurosteroids in the Porsolt forced swim test , 1998 .

[716]  F. Turek,et al.  Resynchronisation of a diurnal rodent circadian clock accelerated by a melatonin agonist , 1998, Neuroreport.

[717]  R. Shigemoto,et al.  GABAB-receptor subtypes assemble into functional heteromeric complexes , 1998, Nature.

[718]  J. Drews.  Biotechnology's metamorphosis into a drug discovery industry , 1998, Nature Biotechnology.

[719]  C. de Montigny,et al.  Long-Term Antidepressant Treatments Result in a Tonic Activation of Forebrain 5-HT1A Receptors , 1998, The Journal of Neuroscience.

[720]  P. Pauwels,et al.  Dimerization of sumatriptan as an efficient way to design a potent, centrally and orally active 5-HT1B agonist. , 1998, Bioorganic & medicinal chemistry letters.

[721]  M. Joëls,et al.  Brain corticosteroid receptor balance in health and disease. , 1998, Endocrine reviews.

[722]  E. Kandel,et al.  Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation and improves memory. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[723]  R. Lammintausta,et al.  Facilitation of cognitive functions by a specific alpha2-adrenoceptor antagonist, atipamezole. , 1998, European journal of pharmacology.

[724]  S. Mir,et al.  Pindolol augmentation of antidepressant therapy , 1998, British Journal of Psychiatry.

[725]  P. Haddad.  The SSRI discontinuation syndrome , 1998, Journal of psychopharmacology.

[726]  R. Hagan,et al.  Cellular and Molecular Actions of Lamotrigine: Possible Mechanisms of Efficacy in Bipolar Disorder , 1998, Neuropsychobiology.

[727]  A. Ghadirian,et al.  Neuroendocrine Responses to Inhibitors of Steroid Biosynthesis in Patients with Major Depression Resistant to Antidepressant Therapy , 1998, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[728]  D. Pauly,et al.  Fishing down marine food webs , 1998, Science.

[729]  B. Westerink,et al.  GABA receptors and benzodiazepine binding sites modulate hippocampal acetylcholine release in vivo. , 1998, European journal of pharmacology.

[730]  L. Kar.  METHODS in NEUROENDOCRINOLOGY , 1998 .

[731]  C. Vargas,et al.  Dissimilar effects of lithium and valproic acid on GABA and glutamine concentrations in rat cerebrospinal fluid. , 1998, General pharmacology.

[732]  L. Leach,et al.  On the nature and pattern of neurocognitive function in major depressive disorder. , 1998, Neuropsychiatry, neuropsychology, and behavioral neurology.

[733]  P. Pauwels,et al.  Dimerization of 8-OH-DPAT increases activity at serotonin 5-HT1A receptors , 1998, Naunyn-Schmiedeberg's Archives of Pharmacology.

[734]  M. Thase,et al.  Depression, sleep, and antidepressants. , 1998, The Journal of clinical psychiatry.

[735]  R. McCarley,et al.  REM sleep deprivation increases the levels of tyrosine hydroxylase and norepinephrine transporter mRNA in the locus coeruleus. , 1998, Brain research. Molecular brain research.

[736]  Duncan J. Watts,et al.  Collective dynamics of ‘small-world’ networks , 1998, Nature.

[737]  G. Debonnel,et al.  Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters. , 1998, European journal of pharmacology.

[738]  Marcus E. Raichle,et al.  Suppression of Regional Cerebral Blood during Emotional versus Higher Cognitive Implications for Interactions between Emotion and Cognition , 1998 .

[739]  B Olivier,et al.  Serotonin, serotonergic receptors, selective serotonin reuptake inhibitors and sexual behaviour , 1998, International clinical psychopharmacology.

[740]  Y. Imanishi,et al.  Simultaneous activation of two different receptor systems by enkephalin/neurotensin conjugates having spacer chains of various lengths. , 1998, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[741]  J. Salamone,et al.  Sexual Behavior in Male Rats After Radiofrequency or Dopamine-Depleting Lesions in Nucleus Accumbens , 1998, Pharmacology Biochemistry and Behavior.

[742]  G. Koob,et al.  Corticotropin Releasing Factor Receptor 1–Deficient Mice Display Decreased Anxiety, Impaired Stress Response, and Aberrant Neuroendocrine Development , 1998, Neuron.

[743]  H. Silver,et al.  Adding risperidone to selective serotonin reuptake inhibitor improves chronic depression. , 1998, Journal of clinical psychopharmacology.

[744]  B. Gorzalka,et al.  Chronic Stress Effects on Sexual Behavior in Male and Female Rats Mediation by 5-HT2A Receptors , 1998, Pharmacology Biochemistry and Behavior.

[745]  G. Koob,et al.  Neurobiological Similarities in Depression and Drug Dependence: A Self-Medication Hypothesis , 1998, Neuropsychopharmacology.

[746]  M. Scheinin,et al.  Alpha2C-adrenoceptor-overexpressing mice are impaired in executing nonspatial and spatial escape strategies. , 1998, Molecular pharmacology.

[747]  M. Bourin,et al.  Pindolol does not act only on 5-HT1A receptors in augmenting antidepressant activity in the mouse forced swimming test , 1998, Psychopharmacology.

[748]  C. Montigny,et al.  Acute and long-term actions of the antidepressant drug mirtazapine on central 5-HT neurotransmission. , 1998, Journal of affective disorders.

[749]  T. Chase,et al.  Levodopa therapy , 1998, Neurology.

[750]  J. Velázquez-Moctezuma,et al.  Pharmacological Features of Masculine Sexual Behavior in an Animal Model of Depression , 1998, Pharmacology Biochemistry and Behavior.

[751]  K. Larsson,et al.  Evidence for an involvement of 5-HT1B receptors in the inhibition of male rat ejaculatory behavior produced by 5-HTP , 1998, Psychopharmacology.

[752]  V. Hillegaart,et al.  Facilitation and inhibition of male rat ejaculatory behaviour by the respective 5‐HT1A and 5‐HT1B receptor agonists 8‐OH‐DPAT and anpirtoline, as evidenced by use of the corresponding new and selective receptor antagonists NAD‐299 and NAS‐181 , 1998, British journal of pharmacology.

[753]  E. Levin,et al.  Nicotinic acetylcholine involvement in cognitive function in animals , 1998, Psychopharmacology.

[754]  E. Theodorsson,et al.  Neuropeptide Y, neurokinin A and neurotensin in brain regions of Fawn Hooded “depressed”, wistar, and Sprague dawley rats. Effects of electroconvulsive stimuli , 1998, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[755]  D. Nakahara,et al.  Characterization of beta-phenylethylamine-induced monoamine release in rat nucleus accumbens: a microdialysis study. , 1998, European journal of pharmacology.

[756]  S. Kasper,et al.  Weak antidepressant response after buspirone augmentation of serotonin reuptake inhibitors in refractory severe depression , 1998, International clinical psychopharmacology.

[757]  I. Lucki,et al.  Antidepressant behavioral effects by dual inhibition of monoamine reuptake in the rat forced swimming test , 1998, Psychopharmacology.

[758]  D. Pfaff,et al.  Estrogen alters behavior and forebrain c-fos expression in ovariectomized rats subjected to the forced swim test. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[759]  S. Watson,et al.  Regulation of Serotonin1A, Glucocorticoid, and Mineralocorticoid Receptor in Rat and Human Hippocampus: Implications for the Neurobiology of Depression , 1998, Biological Psychiatry.

[760]  C. Montigny,et al.  Possible serotonergic mechanisms underlying the antidepressant and anti-obsessive–compulsive disorder responses , 1998, Biological Psychiatry.

[761]  A. Schatzberg,et al.  Serotonergic synergism: the risks and benefits of combining the selective serotonin reuptake inhibitors with other serotonergic drugs , 1998, Biological Psychiatry.

[762]  H. Chugani.  Biological basis of emotions: brain systems and brain development. , 1998, Pediatrics.

[763]  G. Eble.  On the dual nature of chance in evolutionary biology and paleobiology , 1998, Paleobiology.

[764]  Y. Hishikawa,et al.  Single and repeated electroconvulsive shocks activate dopaminergic and 5-hydroxytryptaminergic neurotransmission in the frontal cortex of rats , 1998, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[765]  D. Bertrand,et al.  Open-Channel Blockers at the Human α4β2 Neuronal Nicotinic Acetylcholine Receptor , 1998 .

[766]  R. Drucker-Colín,et al.  Effects of nicotine and mecamylamine on rat dorsal raphe neurons. , 1998, European journal of pharmacology.

[767]  M. Reith,et al.  Carbamazepine‐Induced Release of Serotonin from Rat Hippocampus In Vitro , 1998, Epilepsia.

[768]  L. Uphouse,et al.  Attenuation of the lordosis-inhibiting effects of 8-OH-DPAT by TFMPP and quipazine , 1998, Brain Research.

[769]  P. Skolnick,et al.  Adaptation of cortical NMDA receptors by chronic treatment with specific serotonin reuptake inhibitors. , 1998, European journal of pharmacology.

[770]  E. Esposito,et al.  Involvement of serotonin and dopamine in the mechanism of action of novel antidepressant drugs: a review. , 1998, Journal of clinical psychopharmacology.

[771]  S. Krahl,et al.  Locus Coeruleus Lesions Suppress the Seizure‐Attenuating Effects of Vagus Nerve Stimulation , 1998, Epilepsia.

[772]  B. Sahakian,et al.  Idazoxan potentiates rather than antagonizes some of the cognitive effects of clonidine , 1999, Psychopharmacology.

[773]  Trevor Sharp,et al.  A review of central 5-HT receptors and their function , 1999, Neuropharmacology.

[774]  T. Chase,et al.  Tolerance to a suprathreshold dose of L-Dopa in MPTP mice: effects of glutamate antagonists , 1999, Journal of Neural Transmission.

[775]  R. Blakely,et al.  Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants. , 1999, Science.

[776]  S. Marder,et al.  Novel antipsychotics: comparison of weight gain liabilities. , 1999, The Journal of clinical psychiatry.

[777]  M. Frye,et al.  Pramipexole in refractory bipolar depression. , 1999, The American journal of psychiatry.

[778]  A. Christopoulos,et al.  The generation of nitric oxide by G protein-coupled receptors. , 1998, Life sciences.

[779]  B. Jacobs,et al.  Electrical Stimulation of Rat Medial Prefrontal Cortex Enhances Forebrain Serotonin Output: Implications for Electroconvulsive Therapy and Transcranial Magnetic Stimulation in Depression , 1999, Neuropsychopharmacology.

[780]  P. Lewinsohn,et al.  Natural course of adolescent major depressive disorder: I. Continuity into young adulthood. , 1999, Journal of the American Academy of Child and Adolescent Psychiatry.

[781]  R. A. Murphy,et al.  Activity-dependent activation of TrkB neurotrophin receptors in the adult CNS. , 1999, Learning & memory.

[782]  Y. Lecrubier,et al.  The prescribing of psychotropic drugs by primary care physicians: an international collaborative study. , 1999, Journal of clinical psychopharmacology.

[783]  M. Rettori,et al.  The effects of melatonin on the behavioural disturbances induced by chronic mild stress in C3H/He mice. , 1999, Behavioural pharmacology.

[784]  T. Robbins,et al.  The effects of chronic administration of hydrocortisone on cognitive function in normal male volunteers , 1999, Psychopharmacology.

[785]  S. Snyder,et al.  The pineal gland and melatonin: molecular and pharmacologic regulation. , 1999, Annual review of pharmacology and toxicology.

[786]  O. Rampin,et al.  5-Hydroxytryptamine2C receptors on spinal neurons controlling penile erection in the rat , 1999, Neuroscience.

[787]  G. Griebel,et al.  Is there a future for neuropeptide receptor ligands in the treatment of anxiety disorders? , 1999, Pharmacology & therapeutics.

[788]  J. Amsterdam,et al.  Fluoxetine efficacy in menopausal women with and without estrogen replacement. , 1999, Journal of affective disorders.

[789]  P. Boyer,et al.  Venlafaxine and paroxetine in treatment-resistant depression , 1999, British Journal of Psychiatry.

[790]  G. Wilcock,et al.  The cholinergic hypothesis of Alzheimer’s disease: a review of progress , 1999, Journal of neurology, neurosurgery, and psychiatry.

[791]  M. Loreau,et al.  Biodiversity and ecosystem productivity in a fluctuating environment: the insurance hypothesis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[792]  B. Pollock,et al.  Cognitive effects of paroxetine in older depressed patients. , 1999, The Journal of clinical psychiatry.

[793]  ROBALZOTAN TARTRATE HYDRATE , 1999 .

[794]  Neural plasticity to stress and antidepressant treatment , 1999, Biological Psychiatry.

[795]  M. Geyer,et al.  Increased Exploratory Activity and Altered Response to LSD in Mice Lacking the 5-HT5A Receptor , 1999, Neuron.

[796]  K. Morita,et al.  Dominant Negative Isoform of Rat Norepinephrine Transporter Produced by Alternative RNA Splicing* , 1999, The Journal of Biological Chemistry.

[797]  H. Herzog,et al.  Regional distribution of Y‐receptor subtype mRNAs in rat brain , 1999, The European journal of neuroscience.

[798]  A. Phillips,et al.  Facilitation of Sexual Behavior and Enhanced Dopamine Efflux in the Nucleus Accumbens of Male Rats afterd-Amphetamine-Induced Behavioral Sensitization , 1999, The Journal of Neuroscience.

[799]  E. Berlow,et al.  Strong effects of weak interactions in ecological communities , 1999, Nature.

[800]  P. Cowen,et al.  Effects of (−)‐tertatolol, (−)‐penbutolol and (±)‐pindolol in combination with paroxetine on presynaptic 5‐HT function: an in vivo microdialysis and electrophysiological study , 1999, British journal of pharmacology.

[801]  T. Insel,et al.  Autoradiographic and in situ hybridization localization of corticotropin‐releasing factor 1 and 2 receptors in nonhuman primate brain , 1999, The Journal of comparative neurology.

[802]  K. Fuxe,et al.  Alterations in neuropeptide Y levels and Y1 binding sites in the Flinders Sensitive Line rats, a genetic animal model of depression , 1999, Neuroscience Letters.

[803]  F. Chaouloff,et al.  Serotonin and Stress , 1999, Neuropsychopharmacology.

[804]  Expression of 5-HT receptors and the 5-HT transporter in rat brain after electroconvulsive shock , 1999, Neuroscience Letters.

[805]  M S Buchsbaum,et al.  Prediction of antidepressant effects of sleep deprivation by metabolic rates in the ventral anterior cingulate and medial prefrontal cortex. , 1999, The American journal of psychiatry.

[806]  Elizabeth Gould,et al.  Serotonin and Hippocampal Neurogenesis , 1999, Neuropsychopharmacology.

[807]  K. Miczek,et al.  Interactions between social stress and morphine in the periaqueductal gray: effects on affective vocal and reflexive pain responses in rats , 1999, Psychopharmacology.

[808]  M. Millan,et al.  Human dopamine D(3) receptors mediate mitogen-activated protein kinase activation via a phosphatidylinositol 3-kinase and an atypical protein kinase C-dependent mechanism. , 1999, Molecular pharmacology.

[809]  M. Fava,et al.  Residual symptoms in depressed patients who respond acutely to fluoxetine. , 1999, The Journal of clinical psychiatry.

[810]  J. Calabrese,et al.  A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. , 1999, The Journal of clinical psychiatry.

[811]  M. Millan,et al.  5-HT2C receptors are involved in the discriminative stimulus effects of citalopram in rats , 1999, Psychopharmacology.

[812]  B. O'dowd,et al.  Serotonin 5‐HT1B and 5‐HT1D receptors form homodimers when expressed alone and heterodimers when co‐expressed , 1999, FEBS letters.

[813]  M. Dratman,et al.  Evidence that 3,3′,5-triiodothyronine is concentrated in and delivered from the locus coeruleus to its noradrenergic targets via anterograde axonal transport , 1999, Neuroscience.

[814]  S. Kennedy,et al.  Sexual dysfunction before antidepressant therapy in major depression. , 1999, Journal of affective disorders.

[815]  M. Thase,et al.  Prefrontal cortical dysfunction in depression determined by Wisconsin Card Sorting Test performance. , 1999, The American journal of psychiatry.

[816]  J. Markowitz,et al.  Age of onset in chronic major depression: relation to demographic and clinical variables, family history, and treatment response. , 1999, Journal of affective disorders.

[817]  L. Tecott,et al.  Reduced satiating effect of d-fenfluramine in serotonin 5-HT2C receptor mutant mice , 1999, Psychopharmacology.

[818]  A. Kastin,et al.  Differential distribution of endomorphin 1‐ and endomorphin 2‐like immunoreactivities in the CNS of the rodent , 1999 .

[819]  Colleen M. Niswender,et al.  RNA Editing of the Human Serotonin 5-Hydroxytryptamine 2C Receptor Silences Constitutive Activity* , 1999, The Journal of Biological Chemistry.

[820]  R. Hen,et al.  Key Role of 5-HT1B Receptors in the Regulation of Paradoxical Sleep as Evidenced in 5-HT1B Knock-Out Mice , 1999, The Journal of Neuroscience.

[821]  T. Suda,et al.  Role of serotonergic neurons in L-DOPA-derived extracellular dopamine in the striatum of 6-OHDA-lesioned rats. , 1999, Neuroreport.

[822]  O. Rampin.  Pharmacology of α-Adrenoceptors in Male Sexual Function , 1999, European Urology.

[823]  C. Boast,et al.  5HT Antagonists Attenuate MK801-Impaired Radial Arm Maze Performance in Rats , 1999, Neurobiology of Learning and Memory.

[824]  S. Satake,et al.  GABAB receptor-mediated presynaptic inhibition of glutamatergic and GABAergic transmission in the basolateral amygdala , 1999, Neuropharmacology.

[825]  F. Holsboer,et al.  Corticotropin-releasing hormone receptor subtypes and emotion , 1999, Biological Psychiatry.

[826]  M M Weissman,et al.  Depressed adolescents grown up. , 1999, JAMA.

[827]  S. Simmens,et al.  Pharmacotherapy response and diagnostic validity in atypical depression. , 1999, Journal of affective disorders.

[828]  A. Cupello,et al.  GABAB receptor activation protects GABAA receptor from cyclic AMP-dependent down-regulation in rat cerebellar granule cells , 1999, Neuroscience.

[829]  R. Wise,et al.  Dopamine Fluctuations in the Nucleus Accumbens during Maintenance, Extinction, and Reinstatement of Intravenous d-Amphetamine Self-Administration , 1999, The Journal of Neuroscience.

[830]  A. Stoltzfus.  On the Possibility of Constructive Neutral Evolution , 1999, Journal of Molecular Evolution.

[831]  M. Millan,et al.  Buspirone modulates basal and fluoxetine-stimulated dialysate levels of dopamine, noradrenaline and serotonin in the frontal cortex of freely moving rats: activation of serotonin1A receptors and blockade of α2-adrenergic receptors underlie its actions , 1999, Neuroscience.

[832]  R. McIntyre,et al.  Do depressed subjects who have failed both fluoxetine and a tricyclic antidepressant respond to the combination? , 1999, The Journal of clinical psychiatry.

[833]  U. Spampinato,et al.  Selective blockade of serotonin-2C/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: a combined in vivo electrophysiological and microdialysis study , 1999, Neuroscience.

[834]  T. Svensson,et al.  The antipsychotic drug risperidone interacts with auto- and hetero-receptors regulating serotonin output in the rat frontal cortex , 1999, Neuropharmacology.

[835]  J. Uslaner,et al.  Association of depressive symptoms during abstinence with the subjective high produced by cocaine. , 1999, The American journal of psychiatry.

[836]  M. Bauer,et al.  Lithium augmentation in treatment-resistant depression: meta-analysis of placebo-controlled studies. , 1999, Journal of clinical psychopharmacology.

[837]  C. Sherbourne,et al.  Functioning and utility for current health of patients with depression or chronic medical conditions in managed, primary care practices. , 1999, Archives of general psychiatry.

[838]  C. Altar.  Neurotrophins and depression. , 1999, Trends in pharmacological sciences.

[839]  J. Davidson,et al.  Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder. , 1999, The Journal of clinical psychiatry.

[840]  D. Overstreet,et al.  Antidepressant effects of nicotine in an animal model of depression , 1999, Psychopharmacology.

[841]  S. Childers,et al.  Self-administration of cocaine analogs by rats , 1999, Psychopharmacology.

[842]  J. Rybakowski,et al.  The dexamethasone/corticotropin-releasing hormone test in depression in bipolar and unipolar affective illness. , 1999, Journal of psychiatric research.

[843]  C. Niswender,et al.  Serotonin 5‐HT2C Receptor RNA Editing Alters Receptor Basal Activity , 1999, Journal of neurochemistry.

[844]  G. Szénási,et al.  Differential EEG effects of the anxiolytic drugs, deramciclane (EGIS-3886), ritanserin and chlordiazepoxide in rats , 1999, Psychopharmacology.

[845]  R. Duman,et al.  Role of 5-HT2A receptors in the stress-induced down-regulation of brain-derived neurotrophic factor expression in rat hippocampus , 1999, Neuroscience Letters.

[846]  K. Fuxe,et al.  The Vigilance Promoting Drug Modafinil Increases Extracellular Glutamate Levels in the Medial Preoptic Area and the Posterior Hypothalamus of the Conscious Rat: Prevention by Local GABAA Receptor Blockade , 1999, Neuropsychopharmacology.

[847]  E. Klein,et al.  Chronic repetitive transcranial magnetic stimulation alters β-adrenergic and 5-HT2 receptor characteristics in rat brain , 1999, Brain Research.

[848]  R. Donahue,et al.  A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline. , 1999, Clinical therapeutics.

[849]  G. Koob,et al.  Reduced anxiety-like and cognitive performance in mice lacking the corticotropin-releasing factor receptor 1 1 Published on the World Wide Web on 27 November 1998. 1 , 1999, Brain Research.

[850]  Obituary: Charles M. Steinberg (1932–99) , 1999, Nature.

[851]  E Gould,et al.  Estrogen Stimulates a Transient Increase in the Number of New Neurons in the Dentate Gyrus of the Adult Female Rat , 1999, The Journal of Neuroscience.

[852]  J. Raymond,et al.  The recombinant 5‐HT1A receptor: G protein coupling and signalling pathways , 1999, British journal of pharmacology.

[853]  Care of the sexually active depressed patient. , 1999, The Journal of clinical psychiatry.

[854]  J. Sirviö,et al.  Central alpha1-adrenoceptors: their role in the modulation of attention and memory formation. , 1999, Pharmacology & therapeutics.

[855]  R. Dingledine,et al.  The glutamate receptor ion channels. , 1999, Pharmacological reviews.

[856]  C. Bountra,et al.  Review article: the therapeutic potential of 5‐HT3 receptor antagonists in the treatment of irritable bowel syndrome , 1999, Alimentary pharmacology & therapeutics.

[857]  T. Winkler,et al.  Psychomotor retardation and anhedonia in depression , 1999, Acta psychiatrica Scandinavica.

[858]  D. Nebert,et al.  Pharmacogenetics and pharmacogenomics: why is this relevant to the clinical geneticist? , 1999, Clinical genetics.

[859]  H. Meltzer,et al.  Pindolol and mianserin augment the antidepressant activity of fluoxetine in hospitalized major depressed patients, including those with treatment resistance. , 1999, Journal of clinical psychopharmacology.

[860]  J. Warnock,et al.  Treatment Augmentation With Opiates in Severe and Refractory Major Depression , 1999, American Journal of Psychiatry.

[861]  M. Spedding,et al.  Changes in EEG spectral power in the prefrontal cortex of conscious rats elicited by drugs interacting with dopaminergic and noradrenergic transmission , 1999, British journal of pharmacology.

[862]  Bao-Ming Li,et al.  Alpha-2 Adrenergic Modulation of Prefrontal Cortical Neuronal Activity Related to Spatial Working Memory in Monkeys , 1999, Neuropsychopharmacology.

[863]  R. Salomon,et al.  Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action , 1999, Biological Psychiatry.

[864]  C. Calhau,et al.  Comparison between uptake2 and rOCT1: effects of catecholamines, metanephrines and corticosterone , 1999, Naunyn-Schmiedeberg's Archives of Pharmacology.

[865]  A. Beekman,et al.  Review of community prevalence of depression in later life , 1999, British Journal of Psychiatry.

[866]  M. Bünemann,et al.  G‐protein coupled receptor kinases as modulators of G‐protein signalling , 1999, The Journal of physiology.

[867]  Yasuo Hishikawa,et al.  Melatonin secretion rhythm disorders in patients with senile dementia of Alzheimer’s type with disturbed sleep–waking , 1999, Biological Psychiatry.

[868]  Yumiko Saito,et al.  Molecular characterization of the melanin-concentrating-hormone receptor , 1999, Nature.

[869]  A. Eison,et al.  Effects of Antidepressants on 5-HT7 Receptor Regulation in the Rat Hypothalamus , 1999, Neuropsychopharmacology.

[870]  R. Hauger,et al.  Working memory is more sensitive than declarative memory to the acute effects of corticosteroids: a dose-response study in humans. , 1999, Behavioral neuroscience.

[871]  L. P. Morin,et al.  Serotonin and the regulation of mammalian circadian rhythmicity. , 1999, Annals of medicine.

[872]  R. Carney,et al.  Major depression, heart rate, and plasma norepinephrine in patients with coronary heart disease , 1999, Biological Psychiatry.

[873]  G. McGaughey,et al.  Synthesis and SAR of adatanserin: novel adamantyl aryl- and heteroarylpiperazines with dual serotonin 5-HT(1A) and 5-HT(2) activity as potential anxiolytic and antidepressant agents. , 1999, Journal of medicinal chemistry.

[874]  Anna Wirz-Justice,et al.  Sleep deprivation in depression: what do we know, where do we go? , 1999, Biological Psychiatry.

[875]  O. Hermanson,et al.  Distribution of preprovasopressin mRNA in the rat central nervous system , 1999, The Journal of comparative neurology.

[876]  M. Millan,et al.  The induction of pain: an integrative review , 1999, Progress in Neurobiology.

[877]  J. Rybakowski,et al.  Potentiation of Antidepressants with Lithium or Carbamazepine in Treatment-Resistant Depression , 1999, Neuropsychobiology.

[878]  R. Hirschfeld,et al.  Sexual functioning in depressed outpatients taking mirtazapine , 1999, Depression and anxiety.

[879]  J. Gorman,et al.  Low levels of transthyretin in the CSF of depressed patients. , 1999, The American journal of psychiatry.

[880]  H. Meltzer,et al.  The effect of ipsapirone and S(−)-pindolol on dopamine release in rat striatum and nucleus accumbens , 1999, Brain Research.

[881]  M. Millan,et al.  Modulation of Dialysate Levels of Dopamine, Noradrenaline, and Serotonin (5-HT) in the Frontal Cortex of Freely-Moving Rats by (-)-Pindolol Alone and in Association with 5-HT Reuptake Inhibitors: Comparative Roles of β-Adrenergic, 5-HT1A, and 5-HT1B Receptors , 1999, Neuropsychopharmacology.

[882]  R. Wightman,et al.  Paracrine neurotransmission in the CNS: involvement of 5-HT , 1999, Trends in Neurosciences.

[883]  S. Esteban,et al.  Activation and desensitization by cyclic antidepressant drugs of α2-autoreceptors, α2-heteroreceptors and 5-HT1A-autoreceptors regulating monoamine synthesis in the rat brain in vivo , 1999, Naunyn-Schmiedeberg's Archives of Pharmacology.

[884]  F. Dudek,et al.  5-HT1B Receptor–Mediated Presynaptic Inhibition of Retinal Input to the Suprachiasmatic Nucleus , 1999, The Journal of Neuroscience.

[885]  M. Scheinin,et al.  Overexpression of Alpha2C-adrenoceptors impairs water maze navigation , 1999, Neuroscience.

[886]  I. Hindmarch,et al.  A double-blind, placebo-controlled investigation of the effects of fexofenadine, loratadine and promethazine on cognitive and psychomotor function. , 1999, British journal of clinical pharmacology.

[887]  Andrzej Pilc,et al.  Potential anti-anxiety, anti-addictive effects of LY 354740, a selective group II glutamate metabotropic receptors agonist in animal models , 1999, Neuropharmacology.

[888]  D. Lorrain,et al.  Partial antagonism of 8-OH-DPAT'S effects on male rat sexual behavior with a D2, but not a 5-HT1A, antagonist , 1999, Brain Research.

[889]  D. Nouaud,et al.  Molecular domestication — more than a sporadic episode in evolution , 1999 .

[890]  Isaac Meilijson,et al.  Neuronal Regulation: A Mechanism for Synaptic Pruning During Brain Maturation , 1999, Neural Computation.

[891]  P. Schuster,et al.  Comorbidity in primary care: presentation and consequences. , 1999, The Journal of clinical psychiatry.

[892]  M. Landén,et al.  Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors. , 1999, Journal of clinical psychopharmacology.

[893]  Lakshmi A. Devi,et al.  G-protein-coupled receptor heterodimerization modulates receptor function , 1999, Nature.

[894]  Nicolas Singewald,et al.  Nitric oxide modulates the release of serotonin in the rat hypothalamus , 1999, Brain Research.

[895]  R. Rosen,et al.  Effects of SSRIs on sexual function: a critical review. , 1999, Journal of clinical psychopharmacology.

[896]  E. Przegaliński,et al.  Tolerance to Anxiolytic- and Antidepressant-Like Effects of a Partial Agonist of GlycineB Receptors , 1999, Pharmacology Biochemistry and Behavior.

[897]  Karl J. Friston,et al.  Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [(18)F]dopa-PET study. , 1999, Brain : a journal of neurology.

[898]  A. S. Chang,et al.  Nongenomic steroidal modulation of high-affinity serotonin transport. , 1999, Biochimica et biophysica acta.

[899]  O. Wolkowitz,et al.  Double-blind treatment of major depression with dehydroepiandrosterone. , 1999, The American journal of psychiatry.

[900]  L. Pozzi,et al.  Fluoxetine Increases Extracellular Dopamine in the Prefrontal Cortex by a Mechanism Not Dependent on Serotonin , 1999, Journal of neurochemistry.

[901]  I. Izquierdo,et al.  Melanin-concentrating hormone (MCH) modifies memory retention in rats ☆ , 1999, Peptides.

[902]  A. Gobert,et al.  Inverse Agonists and Serotonergic Transmission: From Recombinant, Human Serotonin (5-HT)1B Receptors to G-Protein Coupling and Function in Corticolimbic Structures in vivo , 1999, Neuropsychopharmacology.

[903]  E. Bullmore,et al.  Functional magnetic resonance imaging neuroactivation studies in normal subjects and subjects with the narcoleptic syndrome. Actions of modafinil , 1999, Journal of sleep research.

[904]  W. Frishman,et al.  Neuropsychiatric manifestations of cardiovascular drug therapy. , 1999, Heart disease.

[905]  J. Nelson.  A review of the efficacy of serotonergic and noradrenergic reuptake inhibitors for treatment of major depression , 1999, Biological Psychiatry.

[906]  G. Christ,et al.  Modification of sexual behavior of Long–Evans male rats by drugs acting on the 5-HT1A receptor , 1999, Brain Research.

[907]  J. Calixto,et al.  Tachykinin NK3receptor involvement in anxiety , 1999, Neuropeptides.

[908]  A. Shaywitz,et al.  CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. , 1999, Annual review of biochemistry.

[909]  T. Hökfelt,et al.  Serotonin and substance P co-exist in dorsal raphe neurons of the human brain. , 1999, Neuroreport.

[910]  P. Fitzpatrick,et al.  Tetrahydropterin-dependent amino acid hydroxylases. , 1999, Annual review of biochemistry.

[911]  J. Lissauer.  How common are habitable planets? , 1999, Nature.

[912]  M. Starr,et al.  Microdialysis study of the effects of the antiparkinsonian drug budipine on L‐DOPA‐induced release of dopamine and 5‐hydroxytryptamine by rat substantia nigra and corpus striatum , 1999, Synapse.

[913]  A. Meneses,et al.  5-HT system and cognition , 1999, Neuroscience & Biobehavioral Reviews.

[914]  G. Koob.  Stress, Corticotropin‐releasing Factor, and Drug Addiction , 1999, Annals of the New York Academy of Sciences.

[915]  R. Hirschfeld.  Efficacy of SSRIs and newer antidepressants in severe depression: comparison with TCAs. , 1999, The Journal of clinical psychiatry.

[916]  E. Vizi,et al.  Nicotinic Acetylcholine Receptor Antagonistic Activity of Monoamine Uptake Blockers in Rat Hippocampal Slices , 1999, Journal of neurochemistry.

[917]  M. Spedding,et al.  Contrasting EEG profiles elicited by antipsychotic agents in the prefrontal cortex of the conscious rat: antagonism of the effects of clozapine by modafinil , 1999, British journal of pharmacology.

[918]  Harold F. Levison,et al.  The formation of Uranus and Neptune in the Jupiter–Saturn region of the Solar System , 1999, Nature.

[919]  A. G. Smith,et al.  The Dopamine D3/D2 Receptor Agonist 7-OH-DPAT Induces Cognitive Impairment in the Marmoset , 1999, Pharmacology Biochemistry and Behavior.

[920]  B. McEwen,et al.  Effects of antidepressants and benzodiazepine treatments on the dendritic structure of CA3 pyramidal neurons after chronic stress. , 1999, European journal of pharmacology.

[921]  B. Borowsky,et al.  An in situ hybridization study of the distribution of the GABA(B2) protein mRNA in the rat CNS. , 1999, Brain research. Molecular brain research.

[922]  J. Kelly,et al.  Metyrapone displays antidepressant-like properties in preclinical paradigms , 1999, Psychopharmacology.

[923]  The serotonin antagonist mianserin for treatment of serotonin reuptake inhibitor-induced sexual dysfunction in women: an open-label add-on study. , 1999, Clinical neuropharmacology.

[924]  L. Price,et al.  Mirtazapine Augmentation in the Treatment of Refractory Depression , 1999 .

[925]  J. Sawynok.  Novel aspects of pain management : opioids and beyond , 1999 .

[926]  R. Emeson,et al.  Serotonin-2C Receptor Pre-mRNA Editing in Rat Brain andin Vitro by Splice Site Variants of the Interferon-inducible Double-stranded RNA-specific Adenosine Deaminase ADAR1* , 1999, The Journal of Biological Chemistry.

[927]  I. Paul,et al.  Nitric oxide synthase inhibitors have antidepressant-like properties in mice: 2. Chronic treatment results in downregulation of cortical β-adrenoceptors , 1999 .

[928]  J. Newcomer,et al.  Decreased memory performance in healthy humans induced by stress-level cortisol treatment. , 1999, Archives of general psychiatry.

[929]  A. Berghöfer,et al.  Amantadine Revisited: An Open Trial of Amantadinesulfate Treatment in Chronically Depressed Patients with Borna Disease Virus Infection , 1999, Pharmacopsychiatry.

[930]  A. Farah.  Relief of SSRI-induced sexual dysfunction with mirtazapine treatment. , 1999, The Journal of clinical psychiatry.

[931]  A. Krystal,et al.  Zolpidem for persistent insomnia in SSRI-treated depressed patients. , 1999, The Journal of clinical psychiatry.

[932]  R. Dantzer,et al.  Cytokines and depression: fortuitous or causative association? , 1999, Molecular Psychiatry.

[933]  T. Patterson,et al.  Depressive symptoms in schizophrenia. , 1999, The American journal of psychiatry.

[934]  O. Wolkowitz,et al.  Antiglucocorticoid treatment of depression: double-blind ketoconazole , 1999, Biological Psychiatry.

[935]  J. Born,et al.  Beneficial treatment of age-related sleep disturbances with prolonged intranasal vasopressin. , 1999, Journal of clinical psychopharmacology.

[936]  R. Krueger.  The structure of common mental disorders. , 1999, Archives of general psychiatry.

[937]  D. Lorrain,et al.  Lateral Hypothalamic Serotonin Inhibits Nucleus Accumbens Dopamine: Implications for Sexual Satiety , 1999, The Journal of Neuroscience.

[938]  B. Roth,et al.  Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression∗ ∗ See accompanying Editorial, in this issue. , 1999, Biological Psychiatry.

[939]  W. Paulus,et al.  Changes in 5-HT1A and NMDA binding sites by a single rapid transcranial magnetic stimulation procedure in rats , 1999, Brain Research.

[940]  Alan Frazer,et al.  5-HT1B antagonists modulate clearance of extracellular serotonin in rat hippocampus , 1999, Neuroscience Letters.

[941]  M S Kramer,et al.  Discovery of the antidepressant and anti-emetic efficacy of substance P receptor (NK1) antagonists. , 1999, Trends in pharmacological sciences.

[942]  M. Trivedi,et al.  Double-blind, placebo-substitution study of nefazodone in the prevention of relapse during continuation treatment of outpatients with major depression. , 1999, International clinical psychopharmacology.

[943]  D J Sanger,et al.  5-HT1A receptor antagonists neither potentiate nor inhibit the effects of fluoxetine and befloxatone in the forced swim test in rats. , 1999, European journal of pharmacology.

[944]  D. Gründemann,et al.  Selective substrates for non-neuronal monoamine transporters. , 1999, Molecular pharmacology.

[945]  R. Lukas,et al.  Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and ibogaine. , 1999, The Journal of pharmacology and experimental therapeutics.

[946]  R. Roth,et al.  Dopamine D4 receptor antagonist reversal of subchronic phencyclidine-induced object retrieval/detour deficits in monkeys , 1999, Psychopharmacology.

[947]  M. Haney,et al.  Fluoxetine-Maintained Obese Humans Effect on Food Intake and Body Weight , 1999, Physiology & Behavior.

[948]  J. Nelson,et al.  Risperidone augmentation of selective serotonin reuptake inhibitors in major depression. , 1999, The Journal of clinical psychiatry.

[949]  D. Greenblatt,et al.  Human cytochromes and some newer antidepressants: kinetics, metabolism, and drug interactions. , 1999, Journal of clinical psychopharmacology.

[950]  J. Bockaert,et al.  Molecular tinkering of G protein‐coupled receptors: an evolutionary success , 1999, The EMBO journal.

[951]  C. Pavlides,et al.  Effects of mineralocorticoid and glucocorticoid receptors on long-term potentiation in the CA3 hippocampal field , 1999, Brain Research.

[952]  M. Millan,et al.  Serotonin (5-HT)2A receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rats , 1999, Neuropharmacology.

[953]  Dean K. Naritoku,et al.  Enhanced recognition memory following vagus nerve stimulation in human subjects , 1999, Nature Neuroscience.

[954]  J. Changeux,et al.  Use of knock-out mice to determine the molecular basis for the actions of nicotine. , 1999, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[955]  C Koch,et al.  Complexity and the nervous system. , 1999, Science.

[956]  M. Thase,et al.  Is psychotherapy an effective treatment for melancholia and other severe depressive states? , 1999, Journal of affective disorders.

[957]  K. Looper,et al.  Precision and comparability of adverse event rates of newer antidepressants. , 1999, Journal of clinical psychopharmacology.

[958]  J. Stamford,et al.  Effects of tramadol stereoisomers on norepinephrine efflux and uptake in the rat locus coeruleus measured by real time voltammetry. , 1999, British journal of anaesthesia.

[959]  L. Parsons,et al.  Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. , 1999, The American journal of psychiatry.

[960]  J. Shih,et al.  MAO-A and -B gene knock-out mice exhibit distinctly different behavior. , 1999, Neurobiology.

[961]  E. Stein,et al.  Baclofen inhibits heroin self-administration behavior and mesolimbic dopamine release. , 1999, The Journal of pharmacology and experimental therapeutics.

[962]  K. Maubach,et al.  Novel strategies for pharmacotherapy of depression. , 1999, Current opinion in chemical biology.

[963]  S. Woods,et al.  Effect of catecholamine depletion on lithium-induced long-term remission of bipolar disorder , 1999, Biological Psychiatry.

[964]  H. Nurnberg,et al.  Antidepressant medication change in a clinical treatment setting: a comparison of the effectiveness of selective serotonin reuptake inhibitors. , 1999, The Journal of clinical psychiatry.

[965]  P. Pauwels,et al.  Magnitude of 5-HT1B and 5-HT1A receptor activation in guinea-pig and rat brain: evidence from sumatriptan dimer-mediated [35S]GTPgammaS binding responses. , 1999, Brain research. Molecular brain research.

[966]  Y. Nakagawa,et al.  The GABA(B) receptor antagonist CGP36742 improves learned helplessness in rats. , 1999, European journal of pharmacology.

[967]  K. Larsson,et al.  Synergistic actions of the 5-HT1A receptor antagonist WAY-100635 and citalopram on male rat ejaculatory behavior. , 1999, European journal of pharmacology.

[968]  S. Mellon,et al.  Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[969]  G. Rodríguez-Manzo.  Yohimbine interacts with the dopaminergic system to reverse sexual satiation: further evidence for a role of sexual motivation in sexual exhaustion. , 1999, European journal of pharmacology.

[970]  E. Sellers,et al.  Attenuation of the euphoric effects of cocaine by the dopamine D1/D5 antagonist ecopipam (SCH 39166) , 1999, Archives of general psychiatry.

[971]  B. Westerink,et al.  Tonic regulation of the activity of noradrenergic neurons in the locus coeruleus of the conscious rat studied by dual-probe microdialysis , 1999, Brain Research.

[972]  Wolfgang Gaebel,et al.  Dopamine D2 receptor binding before and after treatment of major depression measured by [123I]IBZM SPECT , 1999, Psychiatry Research: Neuroimaging.

[973]  A. Saria,et al.  The tachykinin NK1 receptor in the brain: pharmacology and putative functions. , 1999, European journal of pharmacology.

[974]  L. Uphouse,et al.  5-HT2C receptor involvement in female rat lordosis behavior , 1999, Brain Research.

[975]  I. Paul,et al.  Nitric oxide synthase inhibitors have antidepressant-like properties in mice. 1. Acute treatments are active in the forced swim test. , 1999, European journal of pharmacology.

[976]  Albert,et al.  Emergence of scaling in random networks , 1999, Science.

[977]  P. Hartig,et al.  Messenger RNA Editing of the Human Serotonin 5-HT2C Receptor , 1999, Neuropsychopharmacology.

[978]  A. Schatzberg.  Antidepressant effectiveness in severe depression and melancholia. , 1999, The Journal of clinical psychiatry.

[979]  K. Neve,et al.  Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type. , 1999, The Journal of pharmacology and experimental therapeutics.

[980]  J. Hopfield,et al.  From molecular to modular cell biology , 1999, Nature.

[981]  U. Bhalla,et al.  Complexity in biological signaling systems. , 1999, Science.

[982]  J. Gulcher,et al.  Ethics of population genomics research , 1999, Nature.

[983]  S. Stanford,et al.  Comparison of changes in the extracellular concentration of noradrenaline in rat frontal cortex induced by sibutramine or d‐amphetamine: modulation by α2‐adrenoceptors , 1999, British journal of pharmacology.

[984]  M. Scheinin,et al.  Genetic alteration of the α2-adrenoceptor subtype c in mice affects the development of behavioral despair and stress-induced increases in plasma corticosterone levels , 1999, Molecular Psychiatry.

[985]  A. Mathé.  Neuropeptides and electroconvulsive treatment. , 1999, The journal of ECT.

[986]  M. Picciotto.  Knock-out mouse models used to study neurobiological systems. , 1999, Critical reviews in neurobiology.

[987]  E. Vizi,et al.  Modulatory role of presynaptic nicotinic receptors in synaptic and non-synaptic chemical communication in the central nervous system , 1999, Brain Research Reviews.

[988]  R. Anwyl.  Metabotropic glutamate receptors: electrophysiological properties and role in plasticity , 1999, Brain Research Reviews.

[989]  T. Svensson,et al.  Locus coeruleus neuronal activity and noradrenaline availability in the frontal cortex of rats chronically treated with imipramine: effect of α2-adrenoceptor blockade , 1999, Biological Psychiatry.

[990]  A. Chicz–DeMet,et al.  Sleep deprivation therapy in depressive illness and parkinson's disease , 1999, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[991]  D. E. Clark.  Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 1. Prediction of intestinal absorption. , 1999, Journal of pharmaceutical sciences.

[992]  J. Wernicke,et al.  A noradrenergic and serotonergic hypothesis of the linkage between epilepsy and affective disorders. , 1999, Critical reviews in neurobiology.

[993]  R. Lukas,et al.  Antidepressants Noncompetitively Inhibit Nicotinic Acetylcholine Receptor Function , 1999, Journal of neurochemistry.

[994]  D. Kupfer,et al.  Accelerating Antidepressant Response in Geriatric Depression: A Post Hoc Comparison of Combined Sleep Deprivation and Paroxetine versus Monotherapy with Paroxetine, Nortriptyline, or Placebo , 1999, Journal of geriatric psychiatry and neurology.

[995]  M. Reith,et al.  Effect of alterations in extracellular norepinephrine on adrenoceptors: a microdialysis study in freely moving rats. , 1999, European journal of pharmacology.

[996]  G. Spalletta,et al.  Concentrations of 3α-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery , 1999, Biological Psychiatry.

[997]  G. Simon,et al.  An international study of the relation between somatic symptoms and depression. , 1999, The New England journal of medicine.

[998]  R Hen,et al.  5-HT1B Receptor Knock-Out Mice Exhibit Increased Exploratory Activity and Enhanced Spatial Memory Performance in the Morris Water Maze , 1999, The Journal of Neuroscience.

[999]  Richard F. Thompson,et al.  17β-Estradiol Enhances NMDA Receptor-Mediated EPSPs and Long-Term Potentiation , 1999 .

[1000]  M. Ingelman-Sundberg,et al.  Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment. , 1999, Trends in pharmacological sciences.

[1001]  J. Sirviö,et al.  Comparison of the effects of acute and subchronic administration of atipamezole on reaction to novelty and active avoidance learning in rats , 1999, Naunyn-Schmiedeberg's Archives of Pharmacology.

[1002]  C. Parsons,et al.  Memantine is a clinically well tolerated N-methyl-d-aspartate (NMDA) receptor antagonist—a review of preclinical data , 1999, Neuropharmacology.

[1003]  S. Heinrichs,et al.  The role of corticotropin-releasing factor and urocortin in the modulation of ingestive behavior , 1999, Neuropeptides.

[1004]  G. Chrousos,et al.  The endocrinology of melancholic and atypical depression: relation to neurocircuitry and somatic consequences. , 1999, Proceedings of the Association of American Physicians.

[1005]  A. Argiolas,et al.  Neuropeptides and sexual behaviour , 1999, Neuroscience & Biobehavioral Reviews.

[1006]  J. Peuskens,et al.  The evolving definition of treatment resistance. , 1999, The Journal of clinical psychiatry.

[1007]  D. Lesieur,et al.  Antagonistic Effects of S 22153, a New mt1 and MT2 Receptor Ligand, on the Neophobia-Reducing Properties of Melatonin in BALB/c Mice , 1999, Pharmacology Biochemistry and Behavior.

[1008]  G. Koob,et al.  Neuropeptide Y blocks anxiogenic-like behavioral action of corticotropin-releasing factor in an operant conflict test and elevated plus maze , 2000, Peptides.

[1009]  B. Lerer,et al.  Pharmacological mechanisms of T3 augmentation of antidepressant action. , 2000, The international journal of neuropsychopharmacology.

[1010]  R. Silberstein,et al.  Serotonin, noradrenaline and cognitive function: a preliminary investigation of the acute pharmacodynamic effects of a serotonin versus a serotonin and noradrenaline reuptake inhibitor , 2000, Behavioural pharmacology.

[1011]  S. Siris.  Depression in schizophrenia: perspective in the era of "Atypical" antipsychotic agents. , 2000, The American journal of psychiatry.

[1012]  R. Porsolt.  Animal Models of Depression: Utility for Transgenic Research , 2000, Reviews in the neurosciences.

[1013]  M. Frye,et al.  The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study. , 2000, The Journal of clinical psychiatry.

[1014]  T. Zetterström,et al.  Repeated electroconvulsive shock promotes the sprouting of serotonergic axons in the lesioned rat hippocampus , 2000, Neuroscience.

[1015]  A. Mooradian,et al.  Effect of amitriptyline on the messenger RNA of thyroid hormone-responsive genes in rat cerebral tissue , 2000, Experimental Brain Research.

[1016]  D. Wong,et al.  Synergistic Effects of Olanzapine and Other Antipsychotic Agents in Combination with Fluoxetine on Norepinephrine and Dopamine Release in Rat Prefrontal Cortex , 2000, Neuropsychopharmacology.

[1017]  Susan G. Amara,et al.  Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor , 2000, Biological Psychiatry.

[1018]  M. Buhot,et al.  Role of serotonin in memory impairment , 2000, Annals of medicine.

[1019]  C. Stewart,et al.  Repeated ECS and fluoxetine administration have equivalent effects on hippocampal synaptic plasticity , 2000, Psychopharmacology.

[1020]  Efficacy, safety and tolerability of combined administration of lithium and selective serotonin reuptake inhibitors: a review of the current evidence. Hertfordshire Neuroscience Research Group. , 2000, International clinical psychopharmacology.

[1021]  M. Millan,et al.  Agonist and antagonist actions of yohimbine as compared to fluparoxan at α2‐adrenergic receptors (AR)s, serotonin (5‐HT)1A, 5‐HT1B, 5‐HT1D and dopamine D2 and D3 receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states , 2000, Synapse.

[1022]  D. O'connor,et al.  Evidence for accelerated desensitisation of 5-HT2C receptors following combined treatment with fluoxetine and the 5-HT1A receptor antagonist, WAY 100,635, in the rat , 2000, Neuropharmacology.

[1023]  Reidun Ursin,et al.  Serotonin and the sleep/wake cycle: special emphasis on microdialysis studies , 2000, Progress in Neurobiology.

[1024]  D. Pines,et al.  The theory of everything. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[1025]  E. Levin,et al.  Ventral hippocampal α4β2 nicotinic receptors and chronic nicotine effects on memory , 2000, Neuropharmacology.

[1026]  M Briley,et al.  The possible role of 5-HT(1B/D) receptors in psychiatric disorders and their potential as a target for therapy. , 2000, European journal of pharmacology.

[1027]  Johan Bengzon,et al.  Increased neurogenesis in a model of electroconvulsive therapy , 2000, Biological Psychiatry.

[1028]  A. Bannon,et al.  Behavioral characterization of neuropeptide Y knockout mice , 2000, Brain Research.

[1029]  H. Ågren,et al.  Reduced brain norepinephrine and dopamine release in treatment-refractory depressive illness: evidence in support of the catecholamine hypothesis of mood disorders. , 2000, Archives of general psychiatry.

[1030]  O. Rampin,et al.  Central noradrenergic control of penile erection , 2000, International Journal of Impotence Research.

[1031]  J. R. Painter,et al.  Short-term cotherapy with clonazepam and fluoxetine: anxiety, sleep disturbance and core symptoms of depression. , 2000, Journal of affective disorders.

[1032]  Tobias Meyer,et al.  Translocation and Reversible Localization of Signaling Proteins A Dynamic Future for Signal Transduction , 2000, Cell.

[1033]  I. Goodyer,et al.  First-episode major depression in adolescents. Affective, cognitive and endocrine characteristics of risk status and predictors of onset. , 2000, The British journal of psychiatry : the journal of mental science.

[1034]  M. Popoli,et al.  Second Messenger‐Regulated Protein Kinases in the Brain , 2000, Journal of neurochemistry.

[1035]  A. Monge,et al.  Design, synthesis and biological evaluation of new 3-[(4-aryl)piperazin-1-yl]-1-arylpropane derivatives as potential antidepressants with a dual mode of action: serotonin reuptake inhibition and 5-HT1A receptor antagonism. , 2000, Farmaco.

[1036]  R. Sapolsky,et al.  Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. , 2000, Archives of general psychiatry.

[1037]  Takeshi Inoue,et al.  Preliminary communication Open pergolide treatment of tricyclic and heterocyclic antidepressant-resistant depression , 2000 .

[1038]  D. Price.  Psychological and neural mechanisms of the affective dimension of pain. , 2000, Science.

[1039]  L. Pelosi,et al.  Working memory dysfunction in major depression: an event-related potential study , 2000, Clinical Neurophysiology.

[1040]  A. Gelenberg,et al.  Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial. , 2000, JAMA.

[1041]  D. Bylund,et al.  Inverse agonism at α2-adrenoceptors in native tissue , 2000 .

[1042]  J. Vetulani,et al.  Antidepressants: past, present and future. , 2000, European journal of pharmacology.

[1043]  I. Guillemain,et al.  Immunocytochemical localization of the sigma1 receptor in the adult rat central nervous system , 2000, Neuroscience.

[1044]  M. Millan,et al.  S18616, a highly potent spiroimidazoline agonist at alpha(2)-adrenoceptors: II. Influence on monoaminergic transmission, motor function, and anxiety in comparison with dexmedetomidine and clonidine. , 2000, The Journal of pharmacology and experimental therapeutics.

[1045]  C. Lipinski.  Drug-like properties and the causes of poor solubility and poor permeability. , 2000, Journal of pharmacological and toxicological methods.

[1046]  V. Ganapathy,et al.  Structure, function, and regional distribution of the organic cation transporter OCT3 in the kidney. , 2000, American journal of physiology. Renal physiology.

[1047]  L. Prézeau,et al.  Mapping the Agonist-binding Site of GABAB Type 1 Subunit Sheds Light on the Activation Process of GABABReceptors* , 2000, The Journal of Biological Chemistry.

[1048]  K. Merikangas,et al.  The comorbidity of depression and substance use disorders. , 2000, Clinical psychology review.

[1049]  G. Aguilera,et al.  Regulation of vasopressin V1b receptors in the anterior pituitary gland of the rat , 2000, Experimental physiology.

[1050]  B. Hawes,et al.  The melanin-concentrating hormone receptor couples to multiple G proteins to activate diverse intracellular signaling pathways. , 2000, Endocrinology.

[1051]  L. Price,et al.  Efficacy of continuation ECT and antidepressant drugs compared to long-term antidepressants alone in depressed patients. , 2000, The American journal of psychiatry.

[1052]  A. C. Collins,et al.  Mice Lacking PKCγ Exhibit Decreased Anxiety , 2000 .

[1053]  B. Harvey,et al.  Neuropharmacology of Paradoxic Weight Gain with Selective Serotonin Reuptake Inhibitors , 2000, Clinical neuropharmacology.

[1054]  K. Fuxe,et al.  Amplification of cortical serotonin release: a further neurochemical action of the vigilance-promoting drug modafinil , 2000, Neuropharmacology.

[1055]  R. Dantzer,et al.  Chronic treatment with the atypical antidepressant tianeptine attenuates sickness behavior induced by peripheral but not central lipopolysaccharide and interleukin-1β in the rat , 2001, Psychopharmacology.

[1056]  T. Branchek,et al.  5-ht6 receptors as emerging targets for drug discovery. , 2000, Annual review of pharmacology and toxicology.

[1057]  W. Spooren,et al.  Anxiolytic-like effects of the prototypical metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine in rodents. , 2000, The Journal of pharmacology and experimental therapeutics.

[1058]  Oligomerization of serotonin transporter and its functional consequences. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[1059]  K. Mckenna.  Some proposals regarding the organization of the central nervous system control of penile erection , 2000, Neuroscience & Biobehavioral Reviews.

[1060]  S. M. Walton.  Advances in use of the 5-HT3 receptor antagonists , 2000, Expert opinion on pharmacotherapy.

[1061]  K. Nakamura,et al.  Serotonergic mechanisms involved in the attentional and vigilance task performance of rats and the palliative action of aniracetam , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.

[1062]  J. Riley,et al.  Negative affect, self-report of depressive symptoms, and clinical depression: relation to the experience of chronic pain. , 2000, The Clinical journal of pain.

[1063]  R. Bottlender,et al.  Prevalence and background factorsof depression in first admittedschizophrenic patients , 2000, Acta psychiatrica Scandinavica.

[1064]  S Kasper,et al.  Social phobia: diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment. , 2000, Journal of affective disorders.

[1065]  D. Cardinali,et al.  The human body circadian: How the biologic clock influences sleep and emotion. , 2000, Neuro endocrinology letters.

[1066]  D. Henze,et al.  Dopamine increases excitability of pyramidal neurons in primate prefrontal cortex. , 2000, Journal of neurophysiology.

[1067]  C. Chopde,et al.  Antidepressant-like effect of the neurosteroid 3α-hydroxy-5α-pregnan-20-one in mice forced swim test , 2000, Pharmacology Biochemistry and Behavior.

[1068]  M. Esler,et al.  Nitric oxide mediated modulation of norepinephrine transport: identification of a potential target for S‐nitrosylation , 2000, British journal of pharmacology.

[1069]  D. Overstreet,et al.  Neuropeptide Y in male and female brains of Flinders Sensitive Line, a rat model of depression. Effects of electroconvulsive stimuli. , 2000, Journal of psychiatric research.

[1070]  P. Whitton,et al.  Nitric oxide modulates N-methyl-d-aspartate-evoked serotonin release in the raphe nuclei and frontal cortex of the freely moving rat , 2000, Neuroscience Letters.

[1071]  R. Borski.  Nongenomic Membrane Actions of Glucocorticoids in Vertebrates , 2000, Trends in Endocrinology & Metabolism.

[1072]  A. Steiger,et al.  Neuropeptide Y promotes sleep and inhibits ACTH and cortisol release in young men , 2000, Neuropharmacology.

[1073]  T. Yamaguchi,et al.  Effect of acute treatment with YM992 on extracellular norepinephrine levels in the rat frontal cortex. , 2000, European journal of pharmacology.

[1074]  K. Nishikura,et al.  Altered G Protein‐Coupling Functions of RNA Editing Isoform and Splicing Variant Serotonin2C Receptors , 2000, Journal of neurochemistry.

[1075]  F. Ciruela,et al.  The GABAB receptor interacts directly with the related transcription factors CREB2 and ATFx. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[1076]  Decreased glucocorticoid receptor mRNA levels in individuals with depression, bipolar disorder and schizophrenia , 2000, Schizophrenia Research.

[1077]  J. Heaton.  Central neuropharmacological agents and mechanisms in erectile dysfunction: the role of dopamine , 2000, Neuroscience & Biobehavioral Reviews.

[1078]  M. Young,et al.  Computational analysis of functional connectivity between areas of primate cerebral cortex. , 2000, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[1079]  M. Brownfield,et al.  Localization of serotonin5A receptors in discrete regions of the circadian timing system in the Syrian hamster , 2000, Brain Research.

[1080]  J F Pujol,et al.  Singular subsets of locus coeruleus neurons may recover tyrosine hydroxylase phenotype transiently expressed during development. , 2000, Brain research. Molecular brain research.

[1081]  Peter G. Clifton,et al.  Similarities in the action of Ro 60-0175, a 5-HT2C receptor agonist, and d-fenfluramine on feeding patterns in the rat , 2000, Psychopharmacology.

[1082]  M. Raiteri,et al.  GABAB receptor antagonists elevate both mRNA and protein levels of the neurotrophins nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) but not neurotrophin-3 (NT-3) in brain and spinal cord of rats , 2000, Neuropharmacology.

[1083]  H. Bengtsson,et al.  Serotonin autoreceptor function and antidepressant drug action , 2000, Journal of psychopharmacology.

[1084]  G. Aghajanian,et al.  Dual control of dorsal raphe serotonergic neurons by GABAB receptors. Electrophysiological and microdialysis studies , 2000, Synapse.

[1085]  H. Baumgarten,et al.  Anatomy of central serotoninergic projection systems , 2000 .

[1086]  D. Schoepp,et al.  Regulation of Neurotransmitter Release by Metabotropic Glutamate Receptors , 2000, Journal of neurochemistry.

[1087]  F. Turek,et al.  A melatonin agonist facilitates circadian resynchronization in old hamsters after abrupt shifts in the light–dark cycle , 2000, Brain Research.

[1088]  A. Gelenberg,et al.  Mirtazapine substitution in SSRI-induced sexual dysfunction. , 2000, The Journal of clinical psychiatry.

[1089]  R. Joffe,et al.  Thyroid hormone levels and recurrence of major depression. , 2000, The American journal of psychiatry.

[1090]  P. Sokoloff,et al.  Selective increase of dopamine D3 receptor gene expression as a common effect of chronic antidepressant treatments , 2000, Molecular Psychiatry.

[1091]  J. Buccafusco,et al.  Multiple central nervous system targets for eliciting beneficial effects on memory and cognition. , 2000, The Journal of pharmacology and experimental therapeutics.

[1092]  J. Bancroft.  Effects of alpha-2 blockade on sexual response: experimental studies with Delequamine (RS15385) , 2000, International Journal of Impotence Research.

[1093]  L. Swanson.  Cerebral hemisphere regulation of motivated behavior 1 1 Published on the World Wide Web on 2 November 2000. , 2000, Brain Research.

[1094]  M. Giovannini,et al.  Local GABAergic modulation of acetylcholine release from the cortex of freely moving rats , 2000, The European journal of neuroscience.

[1095]  D. Nelson,et al.  LY367265, an inhibitor of the 5-hydroxytryptamine transporter and 5-hydroxytryptamine(2A) receptor antagonist: a comparison with the antidepressant, nefazodone. , 2000, European journal of pharmacology.

[1096]  J. Vry,et al.  Effects of selected serotonin 5-HT1 and 5-HT2 receptor agonists on feeding behavior: possible mechanisms of action , 2000, Neuroscience & Biobehavioral Reviews.

[1097]  R. Quirion,et al.  Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[1098]  S H Lisanby,et al.  Animal models of the mechanisms of action of repetitive transcranial magnetic stimulation (RTMS): Comparisons with electroconvulsive shock (ECS) , 2000, Depression and anxiety.

[1099]  B. Leonard,et al.  A review of the role of serotonin receptors in psychiatric disorders , 2000, Human psychopharmacology.

[1100]  M. Arkle,et al.  Ipsapirone suppresses food intake in food-deprived rats by an action at 5-HT(1A) receptors. , 2000, European journal of pharmacology.

[1101]  M. Neal,et al.  Evidence for a Complex Influence of Nicotinic Acetylcholine Receptors on Hippocampal Serotonin Release , 2000, Journal of neurochemistry.

[1102]  L. Villanueva.  Is there a gap between preclinical and clinical studies of analgesia? , 2000, Trends in pharmacological sciences.

[1103]  S. Huang,et al.  Shape-dependent control of cell growth, differentiation, and apoptosis: switching between attractors in cell regulatory networks. , 2000, Experimental cell research.

[1104]  S. Salvadori,et al.  Pharmacology of nociceptin and its receptor: a novel therapeutic target , 2000, British journal of pharmacology.

[1105]  L. Kiessling,et al.  Chapter 29. Principles for multivalent ligand design , 2000 .

[1106]  J. Markowitz,et al.  A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. , 2000, The New England journal of medicine.

[1107]  J. Bancroft,et al.  Female sexual dysfunction associated with antidepressant administration: a randomized, placebo-controlled study of pharmacologic intervention. , 2000, American Journal of Psychiatry.

[1108]  B. Olivier,et al.  5-HT3 receptor antagonists and anxiety; a preclinical and clinical review , 2000, European Neuropsychopharmacology.

[1109]  G. Chrousos,et al.  Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[1110]  Anne W. Schmidt,et al.  5-HT1A receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex , 2000, Biological Psychiatry.

[1111]  S. Nakanishi,et al.  Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor , 2000, Nature.

[1112]  Alessandro Usiello,et al.  Distinct functions of the two isoforms of dopamine D2 receptors , 2000, Nature.

[1113]  Y. Michotte,et al.  MK801 influences L-DOPA-induced dopamine release in intact and hemi-parkinson rats. , 2000, European journal of pharmacology.

[1114]  M. Stock,et al.  The Effect of Leptin on Luteinizing Hormone Release Is Exerted in the Zona Incerta and Mediated by Melanin‐Concentrating Hormone , 2000, Journal of neuroendocrinology.

[1115]  B. Gorzalka,et al.  Sex differences in forced-swim and open-field test behaviours after chronic administration of melatonin. , 2000, European journal of pharmacology.

[1116]  F. Artigas,et al.  Role of uptake inhibition and autoreceptor activation in the control of 5‐HT release in the frontal cortex and dorsal hippocampus of the rat , 2000, British journal of pharmacology.

[1117]  M. Rettori,et al.  Anxiolytic-like properties of melatonin receptor agonists in mice: involvement of mt1 and/or MT2 receptors in the regulation of emotional responsiveness , 2000, Neuropharmacology.

[1118]  A. Arnsten,et al.  The Selective Dopamine D4 Receptor Antagonist, PNU-101387G, Prevents Stress-Induced Cognitive Deficits in Monkeys , 2000, Neuropsychopharmacology.

[1119]  Combined treatment with venlafaxine and tricyclic antidepressants in depressed patients who had partial response to clomipramine or imipramine: initial findings. , 2000 .

[1120]  F. Drago,et al.  Acute low doses of melatonin restore full sexual activity in impotent male rats , 2000, Brain Research.

[1121]  W. McIntyre Burnham,et al.  Neurogenesis in the Dentate Gyrus of the Rat Following Electroconvulsive Shock Seizures , 2000, Experimental Neurology.

[1122]  M. Caligiuri,et al.  Motor and cognitive aspects of motor retardation in depression. , 2000, Journal of affective disorders.

[1123]  G. Ulak,et al.  Anxiolytic-Like Effects of 7-Nitroindazole in the Rat Plus-Maze Test , 2000, Pharmacology Biochemistry and Behavior.

[1124]  M. Millan,et al.  Citalopram reduces social interaction in rats by activation of serotonin (5-HT)2C receptors , 2000, Neuropharmacology.

[1125]  F. Deák,et al.  Inhibition of voltage-gated calcium channels by fluoxetine in rat hippocampal pyramidal cells , 2000, Neuropharmacology.

[1126]  B. Olivier,et al.  Serotonin, dopamine and norepinephrine transporters in the central nervous system and their inhibitors. , 2000, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.

[1127]  M. Millan,et al.  Serotonin2C receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: A combined dialysis and electrophysiological analysis in the rat , 2000, Synapse.

[1128]  M. Petroni,et al.  Glucocorticoids and neuroendocrine function , 2000, International Journal of Obesity.

[1129]  C. Chopde,et al.  Serotonergic agents modulate antidepressant-like effect of the neurosteroid 3α-hydroxy-5α-pregnan-20-one in mice 1 1 Published on the World Wide Web on 20 April 2000. , 2000, Brain Research.

[1130]  C. Shapiro,et al.  Preliminary randomized double-blind placebo-controlled trial of tryptophan combined with fluoxetine to treat major depressive disorder: antidepressant and hypnotic effects. , 2000, Journal of psychiatry & neuroscience : JPN.

[1131]  F. Lejeune,et al.  Pindolol excites dopaminergic and adrenergic neurons, and inhibits serotonergic neurons, by activation of 5‐HT1A receptors , 2000, The European journal of neuroscience.

[1132]  R Hill,et al.  NK1 (substance P) receptor antagonists--why are they not analgesic in humans? , 2000, Trends in pharmacological sciences.

[1133]  H. Allain,et al.  Depression in Parkinson's disease , 2000, BMJ : British Medical Journal.

[1134]  E. Eriksson.  Antidepressant drugs: does it matter if they inhibit the reuptake of noradrenaline or serotonin? , 2000, Acta psychiatrica Scandinavica. Supplementum.

[1135]  G. Wegener,et al.  Endogenous nitric oxide decreases hippocampal levels of serotonin and dopamine in vivo , 2000, British journal of pharmacology.

[1136]  W. Bunney,et al.  Molecular Clock Genes in Man and Lower Animals: Possible Implications for Circadian Abnormalities in Depression , 2000, Neuropsychopharmacology.

[1137]  Mario Engelmann,et al.  Acute transcranial magnetic stimulation of frontal brain regions selectively modulates the release of vasopressin, biogenic amines and amino acids in the rat brain , 2000, The European journal of neuroscience.

[1138]  R Levenson,et al.  The dopamine D3 receptor interacts with itself and the truncated D3 splice variant d3nf: D3-D3nf interaction causes mislocalization of D3 receptors. , 2000, Molecular pharmacology.

[1139]  A. Greenshaw,et al.  Neurochemical and metabolic aspects of antidepressants: an overview. , 2000, Journal of psychiatry & neuroscience : JPN.

[1140]  I. Hindmarch,et al.  Safety and tolerability considerations: tricyclic antidepressants vs. selective serotonin reuptake inhibitors , 2000, Acta psychiatrica Scandinavica. Supplementum.

[1141]  G. Rogers,et al.  Positive modulators of the AMPA receptor , 2000 .

[1142]  Susumu Tonegawa,et al.  Dopamine D2 Long Receptor-Deficient Mice Display Alterations in Striatum-Dependent Functions , 2000, The Journal of Neuroscience.

[1143]  R. Ye,et al.  Nitric Oxide Activation of p38 Mitogen-activated Protein Kinase in 293T Fibroblasts Requires cGMP-dependent Protein Kinase* , 2000, The Journal of Biological Chemistry.

[1144]  M. Millan,et al.  Reciprocal Autoreceptor and Heteroreceptor Control of Serotonergic, Dopaminergic and Noradrenergic on Behalf Of: British Association for Psychopharmacology , 2022 .

[1145]  A. Schatzberg,et al.  Acute antidepressant effects of intravenous hydrocortisone and CRH in depressed patients: a double-blind, placebo-controlled study. , 2000, The American journal of psychiatry.

[1146]  J. Kiss.  Role of nitric oxide in the regulation of monoaminergic neurotransmission , 2000, Brain Research Bulletin.

[1147]  J. Kent.  SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression , 2000, The Lancet.

[1148]  P. Bech,et al.  Meta-analysis of randomised controlled trials of fluoxetine v. placebo and tricyclic antidepressants in the short-term treatment of major depression , 2000, British Journal of Psychiatry.

[1149]  D. Schluter,et al.  Analysis of an evolutionary species–area relationship , 2000, Nature.

[1150]  R. Iyengar,et al.  Signaling Networks The Origins of Cellular Multitasking , 2000, Cell.

[1151]  A Frazer,et al.  5‐HT1B Receptor‐Mediated Regulation of Serotonin Clearance in Rat Hippocampus In Vivo , 2000, Journal of neurochemistry.

[1152]  M. Höfler,et al.  Why do people with anxiety disorders become depressed? A prospective‐longitudinal community study , 2000, Acta psychiatrica Scandinavica. Supplementum.

[1153]  Onset of action of mirtazapine on anxiety symptoms related to depression , 2000, European Neuropsychopharmacology.

[1154]  I. Anderson,et al.  Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. , 2000, Journal of affective disorders.

[1155]  C. Meston,et al.  The neurobiology of sexual function. , 2000, Archives of general psychiatry.

[1156]  M. Brandão,et al.  Place aversion induced by blockade of mu or activation of kappa opioid receptors in the dorsal periaqueductal gray matter. , 2000, Behavioural pharmacology.

[1157]  Lack of sertraline efficacy probably due to an interaction with carbamazepine. , 2000, The Journal of clinical psychiatry.

[1158]  Eric J. Nestler,et al.  Chronic Antidepressant Treatment Increases Neurogenesis in Adult Rat Hippocampus , 2000, The Journal of Neuroscience.

[1159]  C. Saper,et al.  Hypothalamic Arousal Regions Are Activated during Modafinil-Induced Wakefulness , 2000, The Journal of Neuroscience.

[1160]  A. Baumgartner.  Thyroxine and the treatment of affective disorders: an overview of the results of basic and clinical research. , 2000, The international journal of neuropsychopharmacology.

[1161]  M. Millan,et al.  S18327 (1-{2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperid-1-yl]ethyl}3-phenyl imidazolin-2-one), a Novel, Potential Antipsychotic Displaying Marked Antagonist Properties at α1- and α2-Adrenergic Receptors: II. Functional Profile and a Multiparametric Comparison with Haloperidol, Clozapine, and 11 Othe , 2000 .

[1162]  Jae K. Lee,et al.  Mining and Visualizing Large Anticancer Drug Discovery Databases , 2000, J. Chem. Inf. Comput. Sci..

[1163]  M. Damaj,et al.  Bupropion is a nicotinic antagonist. , 2000, The Journal of pharmacology and experimental therapeutics.

[1164]  H. Loh,et al.  Molecular mechanisms and regulation of opioid receptor signaling. , 2000, Annual review of pharmacology and toxicology.

[1165]  L. Dawson,et al.  In vivo effects of the 5‐HT6 antagonist SB‐271046 on striatal and frontal cortex extracellular concentrations of noradrenaline, dopamine, 5‐HT, glutamate and aspartate , 2000, British journal of pharmacology.

[1166]  E. Vreugdenhil,et al.  Corticosterone Effects on BDNF Expression in the Hippocampus Implications for Memory Formation , 2000, Stress.

[1167]  P. D’Aquila,et al.  The role of dopamine in the mechanism of action of antidepressant drugs. , 2000, European journal of pharmacology.

[1168]  P. Krogsgaard‐Larsen,et al.  Ligands for glutamate receptors: design and therapeutic prospects. , 2000, Journal of medicinal chemistry.

[1169]  C. Montigny,et al.  Effects of the co-administration of mirtazapine and paroxetine on serotonergic neurotransmission in the rat brain , 2000, European Neuropsychopharmacology.

[1170]  Joseph E LeDoux.  Emotion Circuits in the Brain , 2000 .

[1171]  A. Roses.  Pharmacogenetics and the practice of medicine , 2000, Nature.

[1172]  W. Drevets.  Neuroimaging studies of mood disorders , 2000, Biological Psychiatry.

[1173]  N. Toschi,et al.  Long-Term Repetitive Transcranial Magnetic Stimulation Increases the Expression of Brain-Derived Neurotrophic Factor and Cholecystokinin mRNA, but not Neuropeptide Tyrosine mRNA in Specific Areas of Rat Brain , 2000, Neuropsychopharmacology.

[1174]  I. Lucki,et al.  5-HT4 receptors do not mediate the antidepressant-like behavioral effects of fluoxetine in a modified forced swim test. , 2000, European journal of pharmacology.

[1175]  J. Hagan,et al.  Anxiolytic profile of ropinirole in the rat, mouse and common marmoset , 2000, Psychopharmacology.

[1176]  P. Goldman-Rakic,et al.  Reversal of antipsychotic-induced working memory deficits by short-term dopamine D1 receptor stimulation. , 2000, Science.

[1177]  B. Budziszewska,et al.  Antidepressant drugs inhibit glucocorticoid receptor‐mediated gene transcription – a possible mechanism , 2000, British journal of pharmacology.

[1178]  C. Folke,et al.  Coral reef disturbance and resilience in a human-dominated environment. , 2000, Trends in ecology & evolution.

[1179]  B. Jacobs,et al.  Adult brain neurogenesis and psychiatry: a novel theory of depression , 2000, Molecular Psychiatry.

[1180]  O. Rampin,et al.  Central neural regulation of penile erection , 2000, Neuroscience & Biobehavioral Reviews.

[1181]  M. Picciotto,et al.  Nicotinic Receptors in the Brain: Links between Molecular Biology and Behavior , 2000, Neuropsychopharmacology.

[1182]  S. Hjorth,et al.  Interaction of the antidepressant mirtazapine with α2-adrenoceptors modulating the release of 5-HT in different rat brain regions in vivo , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.

[1183]  Albert-László Barabási,et al.  Error and attack tolerance of complex networks , 2000, Nature.

[1184]  T. Soderling,et al.  Postsynaptic protein phosphorylation and LTP , 2000, Trends in Neurosciences.

[1185]  L. Marangell.  Augmentation of standard depression therapy. , 2000, Clinical therapeutics.

[1186]  Trevor W. Robbins,et al.  Enhanced and Impaired Attentional Performance After Infusion of D1 Dopaminergic Receptor Agents into Rat Prefrontal Cortex , 2000, The Journal of Neuroscience.

[1187]  T. Bonner,et al.  Distribution of the GABAB receptor subunit gb2 in rat CNS , 2000, Brain Research.

[1188]  R. Schwarting,et al.  Substance P and its role in neural mechanisms governing learning, anxiety and functional recovery , 2000, Neuropeptides.

[1189]  G Lynch,et al.  Positive Modulation of AMPA Receptors Increases Neurotrophin Expression by Hippocampal and Cortical Neurons , 2000, The Journal of Neuroscience.

[1190]  A. Berghöfer,et al.  Double-blind, placebo-controlled trial of the use of lithium to augment antidepressant medication in continuation treatment of unipolar major depression. , 2000, The American journal of psychiatry.

[1191]  J. O'reardon,et al.  Physiological effects of electroconvulsive therapy and transcranial magnetic stimulation in major depression , 2000, Depression and anxiety.

[1192]  M. Fava,et al.  Pramipexole Augmentation in the Treatment of Unipolar and Bipolar Depression: A Retrospective Chart Review , 2000, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

[1193]  M. Thase.  Treatment issues related to sleep and depression. , 2000, The Journal of clinical psychiatry.

[1194]  D. Jasinski.  An evaluation of the abuse potential of modafinil using methylphenidate as a reference , 2000, Journal of psychopharmacology.

[1195]  A. Dierich,et al.  Mice deficient for δ- and μ-opioid receptors exhibit opposing alterations of emotional responses , 2000, Nature Genetics.

[1196]  R. Blakely,et al.  Biogenic amine transporters: regulation in flux , 2000, Current Opinion in Neurobiology.

[1197]  J. Kable,et al.  In Vivo Gene Modification Elucidates Subtype-Specific Functions of a 2-Adrenergic Receptors 1 , 2000 .

[1198]  S. Ferguson,et al.  Antidepressant-like effects of the subtype-selective nicotinic acetylcholine receptor agonist, SIB-1508Y, in the learned helplessness rat model of depression , 2000, Psychopharmacology.

[1199]  D. Sheehan,et al.  Efficacy of extended-release venlafaxine in nondepressed outpatients with generalized anxiety disorder. , 2000, The American journal of psychiatry.

[1200]  R. Lipton,et al.  Headache and major depression , 2000, Neurology.

[1201]  A. Serretti,et al.  Venlafaxine versus fluvoxamine in the treatment of delusional depression: a pilot double-blind controlled study. , 2000, The Journal of clinical psychiatry.

[1202]  K. Fujishige,et al.  Immunohistochemical Localization of cGMP-binding cGMP-specific Phosphodiesterase (PDE5) in Rat Tissues , 2000, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[1203]  J. Neumaier,et al.  Antidepressant‐induced regulation of 5‐HT1b mRNA in rat dorsal raphe nucleus reverses rapidly after drug discontinuation , 2000, Journal of neuroscience research.

[1204]  A. M. Kinsey,et al.  Localization of 5-ht5A receptor-like immunoreactivity in the rat brain , 2000, Brain Research.

[1205]  John H Krystal,et al.  Antidepressant effects of ketamine in depressed patients , 2000, Biological Psychiatry.

[1206]  L. Doncarlos,et al.  Estrogen desensitizes 5-HT1A receptors and reduces levels of Gz, Gi1 and Gi3 proteins in the hypothalamus , 2000, Neuropharmacology.

[1207]  T. Blackburn,et al.  Immunohistochemical localisation of the 5-HT2C receptor protein in the rat CNS , 2000, Neuropharmacology.

[1208]  B. O'dowd,et al.  Oligomerization of Dopamine and Serotonin Receptors , 2000, Neuropsychopharmacology.

[1209]  J. Blundell,et al.  Separate systems for serotonin and leptin in appetite control , 2000, Annals of medicine.

[1210]  R. Angus Silver,et al.  GABA Spillover from Single Inhibitory Axons Suppresses Low-Frequency Excitatory Transmission at the Cerebellar Glomerulus , 2000, The Journal of Neuroscience.

[1211]  M. Millan,et al.  Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of α2‐adrenergic and serotonin2C receptors: a comparison with citalopram , 2000, The European journal of neuroscience.

[1212]  D B Boivin,et al.  Influence of sleep-wake and circadian rhythm disturbances in psychiatric disorders. , 2000, Journal of psychiatry & neuroscience : JPN.

[1213]  A. Shekhar,et al.  LY354740, a potent group II metabotropic glutamate receptor agonist prevents lactate-induced panic-like response in panic-prone rats , 2000, Neuropharmacology.

[1214]  A. Young,et al.  Future therapeutic targets in mood disorders: the glucocorticoid receptor , 2000, British Journal of Psychiatry.

[1215]  P. Delgado.  Depression: the case for a monoamine deficiency. , 2000, The Journal of clinical psychiatry.

[1216]  B. Pollock,et al.  Comorbid anxiety disorders in depressed elderly patients. , 2000, The American journal of psychiatry.

[1217]  C. Seyfried,et al.  5-HT reuptake inhibitors with 5-HT(1B/1D) antagonistic activity: a new approach toward efficient antidepressants. , 2000, Journal of medicinal chemistry.

[1218]  R. Mistlberger,et al.  Sleep deprivation stimulates serotonin release in the suprachiasmatic nucleus , 2000, Neuroreport.

[1219]  E. Dere,et al.  Superior Water Maze Performance and Increase in Fear-Related Behavior in the Endothelial Nitric Oxide Synthase-Deficient Mouse Together with Monoamine Changes in Cerebellum and Ventral Striatum , 2000, The Journal of Neuroscience.

[1220]  J. Drews.  Drug discovery: a historical perspective. , 2000, Science.

[1221]  B. Roozendaal,et al.  Acute cortisone administration impairs retrieval of long-term declarative memory in humans , 2000, Nature Neuroscience.

[1222]  M. Higuchi,et al.  Functional neuroimaging of cognition impaired by a classical antihistamine, d‐chlorpheniramine , 2000, British journal of pharmacology.

[1223]  F. Holsboer,et al.  Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated. , 2000, Journal of psychiatric research.

[1224]  A. Basbaum,et al.  Pain genes?: natural variation and transgenic mutants. , 2000, Annual review of neuroscience.

[1225]  H. Dringenberg,et al.  Alzheimer's disease: more than a ‘cholinergic disorder' — evidence that cholinergic–monoaminergic interactions contribute to EEG slowing and dementia , 2000, Behavioural Brain Research.

[1226]  A. Thorburn,et al.  Novel anti-obesity drugs , 2000, Expert Opinion on Investigational Drugs.

[1227]  G. Ulak,et al.  Antidepressant-like effect of 7-nitroindazole in the forced swimming test in rats , 2000, Psychopharmacology.

[1228]  M. Fava,et al.  Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment. , 2000, The Journal of clinical psychiatry.

[1229]  Christian Broberger,et al.  Neuropeptides — an overview , 2000, Neuropharmacology.

[1230]  P. Maycox,et al.  The distribution of the mRNA and protein products of the melanin‐concentrating hormone (MCH) receptor gene, slc‐1, in the central nervous system of the rat , 2000, The European journal of neuroscience.

[1231]  J. Chan,et al.  Hippocampal noradrenergic neurotransmission in concurrent EEG desynchronization and inhibition of penile erection induced by cocaine in the rat , 2000, British journal of pharmacology.

[1232]  T. Robbins,et al.  Chemical neuromodulation of frontal-executive functions in humans and other animals , 2000, Experimental Brain Research.

[1233]  J. O'Donnell,et al.  Effects of rolipram on scopolamine-induced impairment of working and reference memory in the radial-arm maze tests in rats , 2000, Psychopharmacology.

[1234]  A. Schatzberg,et al.  Pramipexole augmentation of a selective serotonin reuptake inhibitor in the treatment of depression. , 2000, Journal of clinical psychopharmacology.

[1235]  R. Albert,et al.  The large-scale organization of metabolic networks , 2000, Nature.

[1236]  Does mirtazapine enhance serotonergic neurotransmission in depressed patients? , 2000, Psychopharmacology.

[1237]  A. Mørk,et al.  Involvement of hippocampal neuropeptide Y in mediating the chronic actions of lithium, electroconvulsive stimulation and citalopram , 2000, Neuropharmacology.

[1238]  K. Kaufman,et al.  Modafinil augmentation of antidepressant treatment in depression. , 2000, The Journal of clinical psychiatry.

[1239]  A. Gobert,et al.  The ability of WAY100,635 to potentiate the neurochemical and functional actions of fluoxetine is enhanced by co-administration of SB224,289, but not BRL15572 , 2000, Neuropharmacology.

[1240]  C. Voigt,et al.  Rational evolutionary design: the theory of in vitro protein evolution. , 2000, Advances in protein chemistry.

[1241]  R. Quirion,et al.  Dopamine D-5 receptor modulates hippocampal acetylcholine release. , 2000, Brain research. Molecular brain research.

[1242]  F. Zhang,et al.  A primitive enantiornithine bird and the origin of feathers. , 2000, Science.

[1243]  J. Carlson,et al.  Enantioselective behavioral effects of sibutramine metabolites. , 2000, European journal of pharmacology.

[1244]  S. Lightowler,et al.  Measurement of Anxiety in Transgenic Mice , 2000, Reviews in the neurosciences.

[1245]  C. Meston,et al.  Evidence that serotonin affects female sexual functioning via peripheral mechanisms , 2000, Physiology & Behavior.

[1246]  T. Hökfelt,et al.  Neuroanatomical localisation of Substance P in the CNS and sensory neurons , 2000, Neuropeptides.

[1247]  C. Spencer.  The efficacy of intramuscular tramadol as a rapid-onset antidepressant. , 2000, The Australian and New Zealand journal of psychiatry.

[1248]  Dwight L. Evans,et al.  Comparison of pramipexole, fluoxetine, and placebo in patients with major depression , 2000, Depression and anxiety.

[1249]  B. O'dowd,et al.  Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties. , 2000, The Journal of biological chemistry.

[1250]  L. Judd,et al.  Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness? , 2000, The American journal of psychiatry.

[1251]  H. V. Van Tol,et al.  The dopamine D(4) receptor: one decade of research. , 2000, European journal of pharmacology.

[1252]  P. Holmes,et al.  Neuropeptide-Y exerts antidepressant-like effects in the forced swim test in rats. , 2000, European journal of pharmacology.

[1253]  PREPULSE INHIBITION DEFICITS IN SCHIZOPHRENIA: ARE THEY REVERSIBLE? , 2000 .

[1254]  Robinson,et al.  Menopause and depression: a review of psychologic function and sex steroid neurobiology during the menopause(1). , 2000, Primary care update for Ob/Gyns.

[1255]  Elizabeth Gould,et al.  Regulation of hippocampal neurogenesis in adulthood , 2000, Biological Psychiatry.

[1256]  Florian Holsboer,et al.  The Corticosteroid Receptor Hypothesis of Depression , 2000, Neuropsychopharmacology.

[1257]  P. Escribá,et al.  Chronic clorgyline induces selective down-regulation of alpha2-adrenoceptor agonist binding sites in rat brain. , 2000, Pharmacology & toxicology.

[1258]  R. Blakely,et al.  Cocaine and Antidepressant-Sensitive Biogenic Amine Transporters Exist in Regulated Complexes with Protein Phosphatase 2A , 2000, The Journal of Neuroscience.

[1259]  E. Hoencamp,et al.  Lithium augmentation of venlafaxine: an open-label trial. , 2000, Journal of clinical psychopharmacology.

[1260]  Hill,et al.  A randomized trial of the long-term, continued efficacy and safety of modafinil in narcolepsy. , 2000, Sleep medicine.

[1261]  M. Terashima,et al.  Electrophysiologic Analysis of Antidepressant Drug Effects on the GABAA Receptor Complex Based upon Antagonist-Induced Encephalographic Power Spectrum Changes , 2000, Neuropsychobiology.

[1262]  A. Gardier,et al.  Effects of acute and chronic tianeptine administration on serotonin outflow in rats: comparison with paroxetine by using in vivo microdialysis. , 2000, European journal of pharmacology.

[1263]  I. Lucki,et al.  Antidepressant-like behavioral effects mediated by 5-Hydroxytryptamine(2C) receptors. , 2000, The Journal of pharmacology and experimental therapeutics.

[1264]  E. Fliers,et al.  Interaction of prefrontal cortical and hypothalamic systems in the pathogenesis of depression. , 2000, Progress in brain research.

[1265]  A. L. Mize,et al.  Acute and long-term effects of 17β-estradiol on Gi/o coupled neurotransmitter receptor function in the female rat brain as assessed by agonist-stimulated [ 35 S ]GTPγS binding , 2000, Brain Research.

[1266]  Guang Chen,et al.  Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2’s neurotrophic effects? , 2000, Biological Psychiatry.

[1267]  A. Force,et al.  The probability of duplicate gene preservation by subfunctionalization. , 2000, Genetics.

[1268]  Holger Stark,et al.  High constitutive activity of native H3 receptors regulates histamine neurons in brain , 2000, Nature.

[1269]  L. Uphouse.  Female gonadal hormones, serotonin, and sexual receptivity , 2000, Brain Research Reviews.

[1270]  D. Nutt.  Treatment of depression and concomitant anxiety , 2000, European Neuropsychopharmacology.

[1271]  G. Maina,et al.  Multicentre, double‐blind, comparison of fluvoxamine and clomipramine in the treatment of obsessive‐compulsive disorder , 2000, International clinical psychopharmacology.

[1272]  F. Fazio,et al.  Effects of Fluvoxamine Treatment on the in Vivo Binding of [F-18]FESP in Drug Naive Depressed Patients: A Pet Study , 2000, NeuroImage.

[1273]  K. McCann.  The diversity–stability debate , 2000, Nature.

[1274]  Agneta Nordberg,et al.  Neuronal nicotinic receptors in the human brain , 2000, Progress in Neurobiology.

[1275]  J. Glennon,et al.  Differential effects of acute and short‐term lithium administration on dialysate glutamate and GABA levels in the frontal cortex of the conscious rat , 2000, Synapse.

[1276]  D. Schoepp.  Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system. , 2001, The Journal of pharmacology and experimental therapeutics.

[1277]  G. Goodwin,et al.  Cognitive deficits in depression: Possible implications for functional neuropathology , 2001, British Journal of Psychiatry.

[1278]  D. Perrett,et al.  Administration of the beta-adrenoceptor blocker propranolol impairs the processing of facial expressions of sadness , 2001, Psychopharmacology.

[1279]  J. Gutkind,et al.  G-protein-coupled receptors and signaling networks: emerging paradigms. , 2001, Trends in pharmacological sciences.

[1280]  G. Bovasso.  Cannabis abuse as a risk factor for depressive symptoms. , 2001, The American journal of psychiatry.

[1281]  A. Clayton,et al.  Substitution of an SSRI with bupropion sustained release following SSRI-induced sexual dysfunction. , 2001, The Journal of clinical psychiatry.

[1282]  M. Millan,et al.  Pindolol antagonises G-protein activation at both pre- and postsynaptic serotonin 5-HT1A receptors: a [35S]GTPγS autoradiography study , 2001, Naunyn-Schmiedeberg's Archives of Pharmacology.

[1283]  Daniel J Buysse,et al.  Treatment of Insomnia in Hospitalized Patients , 2001, The Annals of pharmacotherapy.

[1284]  P. Masand,et al.  Sustained-release bupropion for selective serotonin reuptake inhibitor-induced sexual dysfunction: a randomized, double-blind, placebo-controlled, parallel-group study. , 2001, The American journal of psychiatry.

[1285]  M. Popoli,et al.  Serine/threonine kinases as molecular targets of antidepressants: implications for pharmacological treatment and pathophysiology of affective disorders. , 2001, Pharmacology & therapeutics.

[1286]  D. Middlemiss,et al.  SB-243213; a selective 5-HT2C receptor inverse agonist with improved anxiolytic profile: lack of tolerance and withdrawal anxiety , 2001, Neuropharmacology.

[1287]  Joshua A. Bueller,et al.  Regional Mu Opioid Receptor Regulation of Sensory and Affective Dimensions of Pain , 2001, Science.

[1288]  E. Joyce,et al.  Antipsychotic drug treatment: recent advances , 2001 .

[1289]  B. Bjorvatn,et al.  Sleep and waking following microdialysis perfusion of the selective 5-HT1A receptor antagonist p-MPPI into the dorsal raphe nucleus in the freely moving rat , 2001, Brain Research.

[1290]  J. Qiu,et al.  Possible genomic consequence of nongenomic action of glucocorticoids in neural cells. , 2001, News in physiological sciences : an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society.

[1291]  M. Millan,et al.  Selective blockade of neurokinin (NK)1 receptors facilitates the activity of adrenergic pathways projecting to frontal cortex and dorsal hippocampus in rats , 2001, Journal of neurochemistry.

[1292]  P. Blier,et al.  Effects of the Selective Norepinephrine Reuptake Inhibitor Reboxetine on Norepinephrine and Serotonin Transmission in the Rat Hippocampus , 2001, Neuropsychopharmacology.

[1293]  Bryan L Roth,et al.  Paradoxical trafficking and regulation of 5-HT2A receptors by agonists and antagonists , 2001, Brain Research Bulletin.

[1294]  B. McEwen,et al.  Tracking the estrogen receptor in neurons: Implications for estrogen-induced synapse formation , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[1295]  F. Nicoletti,et al.  Molecular determinants of metabotropic glutamate receptor signaling. , 2001, Trends in pharmacological sciences.

[1296]  D. Tulshian,et al.  SCH-202676: An allosteric modulator of both agonist and antagonist binding to G protein-coupled receptors. , 2001, Molecular pharmacology.

[1297]  J. Weiss,et al.  Effects of chronic antidepressant drug administration and electroconvulsive shock on locus coeruleus electrophysiologic activity , 2001, Biological Psychiatry.

[1298]  F. Leslie,et al.  Expression of the melanin‐concentrating hormone (MCH) receptor mRNA in the rat brain , 2001, The Journal of comparative neurology.

[1299]  F. Turek,et al.  Melatonin or a melatonin agonist corrects age-related changes in circadian response to environmental stimulus. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

[1300]  O. Steward,et al.  Selective Targeting of Newly Synthesized Arc mRNA to Active Synapses Requires NMDA Receptor Activation , 2001, Neuron.

[1301]  R. Gannon.  5HT7 Receptors in the Rodent Suprachiasmatic Nucleus , 2001, Journal of biological rhythms.

[1302]  A. Urani,et al.  The interaction between neuroactive steroids and the σ1 receptor function: behavioral consequences and therapeutic opportunities , 2001, Brain Research Reviews.

[1303]  C. Montigny,et al.  Assessment of the Serotonin and Norepinephrine Reuptake Blocking Properties of Duloxetine in Healthy Subjects , 2001, Neuropsychopharmacology.

[1304]  O. Wolkowitz,et al.  Antiglucocorticoid drugs in the treatment of depression , 2001, Expert opinion on investigational drugs.

[1305]  Tudor I. Oprea,et al.  Is There a Difference between Leads and Drugs? A Historical Perspective , 2001, J. Chem. Inf. Comput. Sci..

[1306]  M. Millan,et al.  S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine. , 2001, The Journal of pharmacology and experimental therapeutics.

[1307]  F. Turek,et al.  The selective neurokinin 1 receptor antagonist R116301 modulates photic responses of the hamster circadian system , 2001, Neuropharmacology.

[1308]  D. Pfaff,et al.  Female preproenkephalin-knockout mice display altered emotional responses. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[1309]  W. McCall,et al.  Electroconvulsive therapy in the era of modern psychopharmacology. , 2001, The international journal of neuropsychopharmacology.

[1310]  B. Graveley.  Alternative splicing: increasing diversity in the proteomic world. , 2001, Trends in genetics : TIG.

[1311]  O. Hurko.  Genetics and genomics in neuropsychopharmacology: the impact on drug discovery and development , 2001, European Neuropsychopharmacology.

[1312]  T. Salt,et al.  Metabotropic glutamate (mGlu) receptors and nociceptive processing , 2001 .

[1313]  C. Altar,et al.  Antidepressant-like responses to the combined sigma and 5-HT1A receptor agonist OPC-14523 , 2001, Neuropharmacology.

[1314]  D. Wong,et al.  Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex , 2002, Psychopharmacology.

[1315]  D. Streiner,et al.  Is antidepressant-benzodiazepine combination therapy clinically more useful? A meta-analytic study. , 2001, Journal of affective disorders.

[1316]  B. Appelberg,et al.  Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study. , 2001, The Journal of clinical psychiatry.

[1317]  C. Dowrick,et al.  Depressive disorders in Europe: prevalence figures from the ODIN study , 2001, British Journal of Psychiatry.

[1318]  T. Paus,et al.  Repetitive Transcranial Magnetic Stimulation of the Human Prefrontal Cortex Induces Dopamine Release in the Caudate Nucleus , 2001, The Journal of Neuroscience.

[1319]  L. Parsons,et al.  Compulsive Drug‐Seeking Behavior and Relapse , 2001 .

[1320]  M. Fava,et al.  Tryptophan depletion in SSRI-recovered depressed outpatients , 2001, Psychopharmacology.

[1321]  M. Thase,et al.  Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo. , 2001, The Journal of clinical psychiatry.

[1322]  H. Dyke,et al.  Chapter 5. Phosphodiesterase 4 inhibitors , 2001 .

[1323]  J. Haller,et al.  Non-genomic effects of glucocorticoids in the neural system Evidence, mechanisms and implications , 2001, Progress in Neurobiology.

[1324]  A. Nobre,et al.  The noradrenergic alpha2 agonist clonidine modulates behavioural and neuroanatomical correlates of human attentional orienting and alerting. , 2001, Cerebral cortex.

[1325]  E Nevo,et al.  Evolution of genome–phenome diversity under environmental stress , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[1326]  I. Lucki,et al.  Regional patterns of compensation following genetic deletion of either 5-hydroxytryptamine(1A) or 5-hydroxytryptamine(1B) receptor in the mouse. , 2001, The Journal of pharmacology and experimental therapeutics.

[1327]  D. Dlaboga,et al.  Effect of repeated treatment with tianeptine and fluoxetine on the central α1-adrenergic system , 2001, Neuropharmacology.

[1328]  K. Lesch,et al.  Plasticity in serotonin uptake in primary neuronal cultures of serotonin transporter knockout mice. , 2001, Brain research. Developmental brain research.

[1329]  M. Crawley,et al.  Scale dependence in plant biodiversity. , 2001, Science.

[1330]  R. Mailman,et al.  Dinapsoline: characterization of a D1 dopamine receptor agonist in a rat model of Parkinson's disease. , 2001, The Journal of pharmacology and experimental therapeutics.

[1331]  Y. Jan,et al.  Ligand-induced signal transduction within heterodimeric GABAB receptor , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[1332]  Andrzej Pilc,et al.  The antianxiety-like effects of antagonists of group I and agonists of group II and III metabotropic glutamate receptors after intrahippocampal administration , 2001, Psychopharmacology.

[1333]  S. Kaur,et al.  Interactions between cholinergic and GABAergic neurotransmitters in and around the locus coeruleus for the induction and maintenance of rapid eye movement sleep in rats , 2001, Neuroscience.

[1334]  D. Smith,et al.  Studies towards the next generation of antidepressants. Part 1: Indolylcyclohexylamines as potent serotonin reuptake inhibitors. , 2001, Bioorganic & medicinal chemistry letters.

[1335]  M. P. McDonald,et al.  The α2A-Adrenergic Receptor Plays a Protective Role in Mouse Behavioral Models of Depression and Anxiety , 2001, The Journal of Neuroscience.

[1336]  M. Banasr,et al.  Serotonin mediates oestrogen stimulation of cell proliferation in the adult dentate gyrus , 2001, The European journal of neuroscience.

[1337]  M. Szuba,et al.  Depression, sleep physiology, and antidepressant drugs , 2001, Depression and anxiety.

[1338]  M. Millan,et al.  Dopamine D2 receptor-mediated G-protein activation in rat striatum: functional autoradiography and influence of unilateral 6-hydroxydopamine lesions of the substantia nigra , 2001, Brain Research.

[1339]  L. Stinus,et al.  Idazoxan and 8-OH-DPAT Modify the Behavioral Effects Induced by Either NA, or 5-HT, or Dual NA/5-HT Reuptake Inhibition in the Rat Forced Swimming Test , 2001, Neuropsychopharmacology.

[1340]  M. Rowley,et al.  Current and novel approaches to the drug treatment of schizophrenia. , 2001, Journal of medicinal chemistry.

[1341]  Koen Van Laere,et al.  The Mechanism of Action of Vagus Nerve Stimulation for Refractory Epilepsy: The Current Status , 2001, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

[1342]  D. Nelson,et al.  m-CPP hypolocomotion is selectively antagonized by compounds with high affinity for 5-HT2C receptors but not 5-HT2A or 5-HT2B receptors , 2001, Behavioural pharmacology.

[1343]  M. Ritchie,et al.  [Letters to nature] , 1975, Nature.

[1344]  Anne W. Schmidt,et al.  Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile. , 2001, European journal of pharmacology.

[1345]  P. Portoghese,et al.  From models to molecules: opioid receptor dimers, bivalent ligands, and selective opioid receptor probes. , 2001, Journal of medicinal chemistry.

[1346]  S. Grant,et al.  Proteomics of multiprotein complexes: answering fundamental questions in neuroscience. , 2001, Trends in biotechnology.

[1347]  H. Wiesinger.  Arginine metabolism and the synthesis of nitric oxide in the nervous system , 2001, Progress in Neurobiology.

[1348]  C. Oxnard,et al.  Evolutionary radiations and convergences in the structural organization of mammalian brains , 2001, Nature.

[1349]  H. Yoshimatsu,et al.  Targeted disruption of histamine H1-receptor attenuates regulatory effects of leptin on feeding, adiposity, and UCP family in mice. , 2001, Diabetes.

[1350]  R. Hen,et al.  5‐HT1B Autoreceptors limit the effects of selective serotonin re‐uptake inhibitors in mouse hippocampus and frontal cortex , 2001, Journal of neurochemistry.

[1351]  N. Shapira,et al.  Treatment of refractory major depression with tramadol monotherapy. , 2001, The Journal of clinical psychiatry.

[1352]  J. Seckl,et al.  Lack of tissue glucocorticoid reactivation in 11β-hydroxysteroid dehydrogenase type 1 knockout mice ameliorates age-related learning impairments , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[1353]  J. Koolhaas,et al.  S20098 AFFECTS THE FREE-RUNNING RHYTHMS OF BODY TEMPERATURE AND ACTIVITY AND DECREASES LIGHT-INDUCED PHASE DELAYS OF CIRCADIAN RHYTHMS OF THE RAT , 2001, Chronobiology international.

[1354]  Aaron M. Beedle,et al.  Molecular determinants of opioid analgesia: Modulation of presynaptic calcium channels , 2001 .

[1355]  H. Yoshimatsu,et al.  Central infusion of histamine reduces fat accumulation and upregulates UCP family in leptin-resistant obese mice. , 2001, Diabetes.

[1356]  M. Frye,et al.  Does thyroid supplementation accelerate tricyclic antidepressant response? A review and meta-analysis of the literature. , 2001, The American journal of psychiatry.

[1357]  A. Gelenberg,et al.  Efficacy of sildenafil citrate for the treatment of erectile dysfunction in men taking serotonin reuptake inhibitors. , 2001, The American journal of psychiatry.

[1358]  A Carlsson,et al.  Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. , 2001, Annual review of pharmacology and toxicology.

[1359]  J. D. McGaugh,et al.  Experience-Dependent Gene Expression in the Rat Hippocampus after Spatial Learning: A Comparison of the Immediate-Early GenesArc, c-fos, and zif268 , 2001, The Journal of Neuroscience.

[1360]  M. Massi,et al.  Antidepressant-type effect of the NK3 tachykinin receptor agonist aminosenktide in mouse lines differing in endogenous opioid system activity , 2001, Peptides.

[1361]  M. Preisig,et al.  Lithium augmentation in venlafaxine-refractory depression. , 2001, Journal of clinical psychopharmacology.

[1362]  J. Joyce.  Dopamine D3 receptor as a therapeutic target for antipsychotic and antiparkinsonian drugs. , 2001, Pharmacology & therapeutics.

[1363]  M. Sasa,et al.  Potentiation of 5-HT3 receptor functions in the hippocampal CA1 region of rats following repeated electroconvulsive shock treatments , 2001, Neuroscience Letters.

[1364]  Michele Zoli,et al.  Molecular and Physiological Diversity of Nicotinic Acetylcholine Receptors in the Midbrain Dopaminergic Nuclei , 2001, The Journal of Neuroscience.

[1365]  J. Becker,et al.  The Role of Dopamine in the Nucleus Accumbens and Striatum during Sexual Behavior in the Female Rat , 2001, The Journal of Neuroscience.

[1366]  P. Nathan,et al.  Inspection time: a neuropsychophysiological test for measuring the functional integrity of the cholinergic system. , 2001, Medical hypotheses.

[1367]  Jyrki P. Kukkonen,et al.  Agonist trafficking of Gi/o‐mediated α2A‐adrenoceptor responses in HEL 92.1.7 cells , 2001 .

[1368]  T. Kenakin,et al.  Inverse, protean, and ligand‐selective agonism: matters of receptor conformation , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[1369]  P. Cuevas,et al.  Differential effects of serotonin reuptake inhibitors on erectile responses, NO‐production, and neuronal NO synthase expression in rat corpus cavernosum tissue , 2001, British journal of pharmacology.

[1370]  Michel Bouvier,et al.  Oligomerization of G-protein-coupled transmitter receptors , 2001, Nature Reviews Neuroscience.

[1371]  W Tatton,et al.  The Anti‐Parkinson Drug Rasagiline and Its Cholinesterase Inhibitor Derivatives Exert Neuroprotection Unrelated to MAO Inhibition in Cell Culture and in Vivo , 2001, Annals of the New York Academy of Sciences.

[1372]  E. Leinonen,et al.  A review of the pharmacological and clinical profile of mirtazapine. , 2006, CNS drug reviews.

[1373]  A. Montejo,et al.  Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. , 2001, The Journal of clinical psychiatry.

[1374]  G. Perrault,et al.  Effects of SR48968, a selective non-peptide NK2 receptor antagonist on emotional processes in rodents , 2001, Psychopharmacology.

[1375]  Martin Bobrow,et al.  Patents in a genetic age , 2001, Nature.

[1376]  E V Koonin,et al.  Origin of alternative splicing by tandem exon duplication. , 2001, Human molecular genetics.

[1377]  M. Bourin,et al.  Involvement of 5-HT2C receptors in the anti-immobility effects of antidepressants in the forced swimming test in mice , 2001, European Neuropsychopharmacology.

[1378]  L. Doncarlos,et al.  Neuroprotection by estradiol , 2001, Progress in Neurobiology.

[1379]  C. Lüscher,et al.  Epilepsy, Hyperalgesia, Impaired Memory, and Loss of Pre- and Postsynaptic GABAB Responses in Mice Lacking GABAB(1) , 2001, Neuron.

[1380]  A. Sleight,et al.  A role for 5-ht6 receptors in retention of spatial learning in the Morris water maze , 2001, Neuropharmacology.

[1381]  J. Soares,et al.  Perspectives on the use of anticonvulsants in the treatment of bipolar disorder. , 2001, The international journal of neuropsychopharmacology.

[1382]  C. Parsons,et al.  NMDA receptors as targets for drug action in neuropathic pain. , 2001, European journal of pharmacology.

[1383]  P. Skolnick,et al.  Antidepressant-like actions of an AMPA receptor potentiator (LY392098) , 2001, Neuropharmacology.

[1384]  R. Gainetdinov,et al.  Following the trace of elusive amines , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[1385]  M. Matsunaga,et al.  Activation of 5‐HT1A but not 5‐HT1B receptors attenuates an increase in extracellular dopamine derived from exogenously administered l‐DOPA in the striatum with nigrostriatal denervation , 2001, Journal of neurochemistry.

[1386]  L. Kahn,et al.  Role of Estrogen in the Aetiology and Treatment of Mood Disorders , 2001, CNS drugs.

[1387]  G. Gessa,et al.  γ-Hydroxybutyric acid and baclofen decrease extracellular acetylcholine levels in the hippocampus via GABAB receptors☆ , 2001 .

[1388]  G. Walker,et al.  Discovery and SAR of org 24598-a selective glycine uptake inhibitor. , 2001, Bioorganic & medicinal chemistry letters.

[1389]  W. Drevets.  Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders , 2001, Current Opinion in Neurobiology.

[1390]  S. Mani.  Ligand-Independent Activation of Progestin Receptors in Sexual Receptivity , 2001, Hormones and Behavior.

[1391]  M. Hotopf,et al.  Amitriptyline v. the rest: still the leading antidepressant after 40 years of randomised controlled trials , 2001, British Journal of Psychiatry.

[1392]  Molecular-dynamics and NMR investigation of the property space of the zwitterionic antihistamine cetirizine , 2001 .

[1393]  Nancy Knowlton.  Coral Reef Biodiversity--Habitat Size Matters , 2001, Science.

[1394]  C. Stewart,et al.  Repeated electroconvulsive stimulation, but not antidepressant drugs, induces mossy fibre sprouting in the rat hippocampus , 2001, Brain Research.

[1395]  S. Kanba,et al.  Elevated plasma nitrate levels in depressive states. , 2001, Journal of affective disorders.

[1396]  D. Wong,et al.  Comparative Affinity of Duloxetine and Venlafaxine for Serotonin and Norepinephrine Transporters in vitro and in vivo, Human Serotonin Receptor Subtypes, and Other Neuronal Receptors , 2001, Neuropsychopharmacology.

[1397]  P. Worley,et al.  Agonist-independent activation of metabotropic glutamate receptors by the intracellular protein Homer , 2001, Nature.

[1398]  M. Nakane,et al.  The biochemical and neurologic basis for the treatment of male erectile dysfunction. , 2001, The Journal of pharmacology and experimental therapeutics.

[1399]  Gro Harlem Brundtland,et al.  Mental Health: New Understanding, New Hope , 2001 .

[1400]  D. Murphy,et al.  In vivo assessment of the effects of estrogen on human brain , 2001, Trends in Endocrinology & Metabolism.

[1401]  H. López-Valdés,et al.  Antagonism of nicotinic acetylcholine receptors by inhibitors of monoamine uptake , 2001, Molecular Psychiatry.

[1402]  P. Björntorp,et al.  Do stress reactions cause abdominal obesity and comorbidities? , 2001, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[1403]  Paul J. Harrison,et al.  Electroconvulsive shock increases tachykinin NK(1) receptors, but not the encoding mRNA, in rat cortex. , 2001, European journal of pharmacology.

[1404]  I. Sora,et al.  Dopaminergic Role in Stimulant-Induced Wakefulness , 2001, The Journal of Neuroscience.

[1405]  J. Kukkonen,et al.  Modelling of promiscuous receptor-Gi/Gs-protein coupling and effector response. , 2001, Trends in pharmacological sciences.

[1406]  S. Kõks,et al.  Strain and gender differences in the behavior of mouse lines commonly used in transgenic studies , 2001, Physiology & Behavior.

[1407]  M. Millan,et al.  Anxiolytic Properties of the Selective, Non-peptidergic CRF1 Antagonists, CP154,526 and DMP695: A Comparison to Other Classes of Anxiolytic Agent , 2001, Neuropsychopharmacology.

[1408]  F. Gasparini,et al.  Potential anxiolytic‐ and antidepressant‐like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist , 2001, British journal of pharmacology.

[1409]  Tohru Yoshioka,et al.  GABAB receptor activation enhances mGluR-mediated responses at cerebellar excitatory synapses , 2001, Nature Neuroscience.

[1410]  R. Kerwin,et al.  Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. , 2001, Archives of general psychiatry.

[1411]  P. Carvey,et al.  Neuroprotective effects of D3 dopamine receptor agonists. , 2001, Parkinsonism & related disorders.

[1412]  F. Holsboer,et al.  Hyperactivity of CRH neuronal circuits as a target for therapeutic interventions in affective disorders , 2001, Peptides.

[1413]  B. Spruijt,et al.  Chronic imipramine treatment partially reverses the long-term changes of hippocampal synaptic plasticity in socially stressed rats , 2001, Neuroscience Letters.

[1414]  G. Nowak,et al.  Antidepressant-like properties of zinc in rodent forced swim test , 2001, Brain Research Bulletin.

[1415]  Ricard V. Solé,et al.  Complexity and fragility in ecological networks , 2000, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[1416]  M. Wong,et al.  Research and treatment approaches to depression , 2001, Nature Reviews Neuroscience.

[1417]  D. Murphy,et al.  Maintenance of Serotonin in the Intestinal Mucosa and Ganglia of Mice that Lack the High-Affinity Serotonin Transporter: Abnormal Intestinal Motility and the Expression of Cation Transporters , 2001, The Journal of Neuroscience.

[1418]  Mathias Berger,et al.  Sleep and depression — results from psychobiological studies: an overview , 2001, Biological Psychology.

[1419]  H. Rezazadeh,et al.  Effect of chronic and acute administration of fluoxetine and its additive effect with morphine on the behavioural response in the formalin test in rats , 2001, The Journal of pharmacy and pharmacology.

[1420]  D. Fell,et al.  The small world inside large metabolic networks , 2000, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[1421]  A. Meneses.  Could the 5-HT1B receptor inverse agonism affect learning consolidation? , 2001, Neuroscience & Biobehavioral Reviews.

[1422]  P. Cowen,et al.  Pindolol augmentation of selective serotonin reuptake inhibitors: PET evidence that the dose used in clinical trials is too low. , 2001, The American journal of psychiatry.

[1423]  M. Papp,et al.  S33005, a novel ligand at both serotonin and norepinephrine transporters: II. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine. , 2001, The Journal of pharmacology and experimental therapeutics.

[1424]  Jens Frahm,et al.  Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[1425]  G. Kennett,et al.  Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptors , 2001, Neuropharmacology.

[1426]  S. Korte.  Corticosteroids in relation to fear, anxiety and psychopathology , 2001, Neuroscience & Biobehavioral Reviews.

[1427]  D. Brunzell,et al.  Neuronal nicotinic acetylcholine receptor subunit knockout mice: physiological and behavioral phenotypes and possible clinical implications. , 2001, Pharmacology & therapeutics.

[1428]  M. Siepmann,et al.  The effects of reboxetine on autonomic and cognitive functions in healthy volunteers , 2001, Psychopharmacology.

[1429]  M. Opp,et al.  Corticotropin-releasing hormone (CRH) as a regulator of waking , 2001, Neuroscience & Biobehavioral Reviews.

[1430]  G. Griebel,et al.  Selective blockade of neurokinin-2 receptors produces antidepressant-like effects associated with reduced corticotropin-releasing factor function. , 2001, The Journal of pharmacology and experimental therapeutics.

[1431]  George P Chrousos,et al.  Depression: a major, unrecognized risk factor for osteoporosis? , 2001, Trends in Endocrinology & Metabolism.

[1432]  F. Holsboer.  Antidepressant Drug Discovery in the Postgenomic Era , 2001, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[1433]  C. Stief,et al.  Oral α adrenoceptor blockade as a treatment of erectile dysfunction , 2001, World Journal of Urology.

[1434]  H. Wikström,et al.  Electrooxidation potential as a tool in the early screening for new safer clozapine-like analogues. , 2001, Journal of medicinal chemistry.

[1435]  Switching versus augmentation: a prospective, naturalistic comparison in depressed, treatment-resistant patients. , 2001, The Journal of clinical psychiatry.

[1436]  M. Matsunaga,et al.  Fluoxetine reduces l-DOPA-derived extracellular DA in the 6-OHDA-lesioned rat striatum , 2001, Neuroreport.

[1437]  G. Eisenhofer.  The role of neuronal and extraneuronal plasma membrane transporters in the inactivation of peripheral catecholamines. , 2001, Pharmacology & therapeutics.

[1438]  T. J. Nickola,et al.  Antidepressant Drug-Induced Alterations in Neuron-Localized Tumor Necrosis Factor-α mRNA and α2-Adrenergic Receptor Sensitivity , 2001 .

[1439]  Carmine M Pariante,et al.  Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment , 2001, Biological Psychiatry.

[1440]  A. Monge,et al.  New 3-[4-(aryl)piperazin-1-yl]-1-(benzo[b]thiophen-3-yl)propane derivatives with dual action at 5-HT1A serotonin receptors and serotonin transporter as a new class of antidepressants. , 2001, European journal of medicinal chemistry.

[1441]  C. Williams,et al.  Regulation of the serotonin transporter by interacting proteins. , 2001, Biochemical Society transactions.

[1442]  G. Bagdy,et al.  Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635. , 2001, The international journal of neuropsychopharmacology.

[1443]  M. Buchsbaum,et al.  Clinical Neurochemical Implications of Sleep Deprivation's Effects on the Anterior Cingulate of Depressed Responders , 2001, Neuropsychopharmacology.

[1444]  H. Haas,et al.  The physiology of brain histamine , 2001, Progress in Neurobiology.

[1445]  Beth Borowsky,et al.  Trace amines: Identification of a family of mammalian G protein-coupled receptors , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[1446]  D. Cutler,et al.  Distribution of substance P and neurokinin‐1 receptor immunoreactivity in the suprachiasmatic nuclei and intergeniculate leaflet of hamster, mouse, and rat , 2001, The Journal of comparative neurology.

[1447]  T. Münte,et al.  Central effects of sildenafil (Viagra) on auditory selective attention and verbal recognition memory in humans: a study with event-related brain potentials , 2001, World Journal of Urology.

[1448]  Gregory G. Brown,et al.  The Effects of Total Sleep Deprivation on Cerebral Responses to Cognitive Performance , 2001, Neuropsychopharmacology.

[1449]  E. Billett,et al.  Phenylethylamine, a possible link to the antidepressant effects of exercise? , 2001, British journal of sports medicine.

[1450]  L. Schneider,et al.  Estrogen replacement therapy and antidepressant response to sertraline in older depressed women. , 2001, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[1451]  R Jouvent,et al.  Decreased presynaptic dopamine function in the left caudate of depressed patients with affective flattening and psychomotor retardation. , 2001, The American journal of psychiatry.

[1452]  A. Schatzberg,et al.  Cortisol activity and cognitive changes in psychotic major depression. , 2001, The American journal of psychiatry.

[1453]  R. Shaw,et al.  Range shifts and adaptive responses to Quaternary climate change. , 2001, Science.

[1454]  Repeated treatment with imipramine, fluvoxamine and tranylcypromine decreases the number of escape failures by activating dopaminergic systems in a rat learned helplessness test. , 2001, Life sciences.

[1455]  M. Hamon,et al.  Extracellular dopamine in the rat prefrontal cortex during reward-, punishment- and novelty-associated behaviour. Effects of diazepam , 2001, Pharmacology Biochemistry and Behavior.

[1456]  B. McEwen.  Invited review: Estrogens effects on the brain: multiple sites and molecular mechanisms. , 2001, Journal of applied physiology.

[1457]  K. Walsh,et al.  Parkinson's disease and anxiety , 2001, Postgraduate medical journal.

[1458]  M. Thase,et al.  Cognitive disturbance in outpatient depressed younger adults: evidence of modest impairment , 2001, Biological Psychiatry.

[1459]  D. Swaab,et al.  Alterations in arginine vasopressin neurons in the suprachiasmatic nucleus in depression. , 2001, Archives of general psychiatry.

[1460]  P. Dominiak,et al.  Biological significance of agmatine, an endogenous ligand at imidazoline binding sites , 2001, British journal of pharmacology.

[1461]  L. Devi,et al.  Oligomerization of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[1462]  S. Mitchell,et al.  LY393558, a 5-hydroxytryptamine reuptake inhibitor and 5-HT(1B/1D) receptor antagonist: effects on extracellular levels of 5-hydroxytryptamine in the guinea pig and rat. , 2001, European journal of pharmacology.

[1463]  A. Pekary,et al.  Antidepressant effects of thyrotropin-releasing hormone analogues using a rodent model of depression , 2001, Pharmacology Biochemistry and Behavior.

[1464]  Timothy B. Stockwell,et al.  The Sequence of the Human Genome , 2001, Science.

[1465]  I. Lucki,et al.  Genetic regulation of extracellular serotonin by 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) autoreceptors in different brain regions of the mouse. , 2001, The Journal of pharmacology and experimental therapeutics.

[1466]  Willem Soudijn,et al.  Allosteric modulation of G-protein-coupled receptors , 2001 .

[1467]  K. Wilson,et al.  Alternative diagnostic criteria for major depressive disorder in patients with chronic pain , 2001, Pain.

[1468]  H. Randeva,et al.  Rat cerebral cortex corticotropin‐releasing hormone receptors: evidence for receptor coupling to multiple G‐proteins , 2001, Journal of neurochemistry.

[1469]  A. McKee,et al.  Differential circadian rhythm disturbances in men with Alzheimer disease and frontotemporal degeneration. , 2001, Archives of general psychiatry.

[1470]  M. Yoshioka,et al.  Evidence for involvement of central 5-HT(4) receptors in cholinergic function associated with cognitive processes: behavioral, electrophysiological, and neurochemical studies. , 2001, The Journal of pharmacology and experimental therapeutics.

[1471]  J. Martinerie,et al.  The brainweb: Phase synchronization and large-scale integration , 2001, Nature Reviews Neuroscience.

[1472]  J. Chan,et al.  Involvement of noradrenergic innervation from locus coeruleus to hippocampal formation in negative feedback regulation of penile erection in the rat , 2001, Hippocampus.

[1473]  Takeshi Inoue,et al.  Effect of subchronic lithium treatment on citalopram‐induced increases in extracellular concentrations of serotonin in the medial prefrontal cortex , 2001, Journal of neurochemistry.

[1474]  S. Hunt,et al.  Comparison of the phenotype of NK1R−/− mice with pharmacological blockade of the substance P (NK 1 ) receptor in assays for antidepressant and anxiolytic drugs , 2001, Behavioural pharmacology.

[1475]  K. Semba,et al.  Inhibition of synaptically evoked cortical acetylcholine release by intracortical glutamate: involvement of GABAergic neurons , 2001, The European journal of neuroscience.

[1476]  M. Höfler,et al.  Social anxiety disorder and the risk of depression: a prospective community study of adolescents and young adults. , 2001, Archives of general psychiatry.

[1477]  F. Quitkin,et al.  Does mirtazapine have a more rapid onset than SSRIs? , 2001, The Journal of clinical psychiatry.

[1478]  H. Volz,et al.  Opipramol for the Treatment of Generalized Anxiety Disorder: A Placebo-Controlled Trial Including an Alprazolam-Treated Group , 2001, Journal of clinical psychopharmacology.

[1479]  A. Puech,et al.  Benefits from mianserin augmentation of fluoxetine in patients with major depression non‐responders to fluoxetine alone , 2001, Acta psychiatrica Scandinavica.

[1480]  P. Fossati,et al.  Problem-solving abilities in unipolar depressed patients: comparison of performance on the modified version of the Wisconsin and the California sorting tests , 2001, Psychiatry Research.

[1481]  J. Flippen-Anderson,et al.  Pharmacological and behavioral analysis of the effects of some bivalent ligand-based monoamine reuptake inhibitors. , 2001, Journal of medicinal chemistry.

[1482]  M. Millan,et al.  Agonist properties of pindolol at h5-HT1A receptors coupled to mitogen-activated protein kinase. , 2001, European journal of pharmacology.

[1483]  S. Strogatz.  Exploring complex networks , 2001, Nature.

[1484]  D. Jane,et al.  Glutamate release inhibiting properties of the novel mGlu5 receptor antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP): complementary in vitro and in vivo evidence , 2001, Neuropharmacology.

[1485]  Partha P. Mitra,et al.  Scalable architecture in mammalian brains , 2001, Nature.

[1486]  J. Boot,et al.  In vitro activity of LY393558, an inhibitor of the 5-hydroxytryptamine transporter with 5-HT(1B/1D/2) receptor antagonist properties. , 2001, European journal of pharmacology.

[1487]  H. Prast,et al.  The nitric oxide system modulates the in vivo release of acetylcholine in the nucleus accumbens induced by stimulation of the hippocampal fornix/fimbria‐projection , 2001, The European journal of neuroscience.

[1488]  D. Bellwood,et al.  Regional-Scale Assembly Rules and Biodiversity of Coral Reefs , 2001, Science.

[1489]  Alan F. Schatzberg,et al.  Rapid Reversal of Psychotic Depression Using Mifepristone , 2001, Journal of clinical psychopharmacology.

[1490]  K. Minneman,et al.  Splice variants of G protein-coupled receptors. , 2001, Molecular interventions.

[1491]  S. Huang,et al.  Genomics, complexity and drug discovery: insights from Boolean network models of cellular regulation. , 2001, Pharmacogenomics.

[1492]  M. Scheinin,et al.  Evaluation of the alpha2C-adrenoceptor as a neuropsychiatric drug target studies in transgenic mouse models. , 2001, Life sciences.

[1493]  A. Szymańska,et al.  Diurnal profile of melatonin concentrations in patients with major depression: relationship to the clinical manifestation and antidepressant treatment. , 2001, Neuro endocrinology letters.

[1494]  G. Gebhart,et al.  Combinations of neurokinin receptor antagonists reduce visceral hyperalgesia. , 2001, The Journal of pharmacology and experimental therapeutics.

[1495]  Klaus P. Ebmeier,et al.  The effects of noradrenergic re-uptake inhibition on memory encoding in man , 2001, Psychopharmacology.

[1496]  R. Rosen,et al.  Treatment of erectile dysfunction in men with depressive symptoms: results of a placebo-controlled trial with sildenafil citrate. , 2001, The American journal of psychiatry.

[1497]  Osama Mawlawi,et al.  Differential Occupancy of Somatodendritic and Postsynaptic 5HT1A Receptors by Pindolol: A Dose-Occupancy Study with [11C]WAY 100635 and Positron Emission Tomography in Humans , 2001, Neuropsychopharmacology.

[1498]  M. Müller,et al.  Depressive factors and their relationships with other symptom domains in schizophrenia, schizoaffective disorder, and psychotic depression. , 2001, Schizophrenia bulletin.

[1499]  S. Nicolaidis,et al.  Variations in extracellular monoamines in the prefrontal cortex and medial hypothalamus after modafinil administration: a microdialysis study in rats , 2001, Neuroreport.

[1500]  G. Mason,et al.  Noradrenergic Function and Clinical Outcome in Antidepressant Pharmacotherapy , 2001, Neuropsychopharmacology.

[1501]  C. Nemeroff,et al.  Effects of Sodium Valproate on Corticotropin-Releasing Factor Systems in Rat Brain , 2001, Neuropsychopharmacology.

[1502]  I. Lucki,et al.  Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice , 2001, Psychopharmacology.

[1503]  M. Rugg,et al.  Effects of repeated cortisol administration on brain potential correlates of episodic memory retrieval , 2002, Psychopharmacology.

[1504]  F. Bymaster,et al.  Current perspectives on the development of non-biogenic amine-based antidepressants. , 2001, Pharmacological research.

[1505]  D. Baldwin,et al.  A randomized, double-blind controlled comparison of nefazodone and paroxetine in the treatment of depression: safety, tolerability and efficacy in continuation phase treatment , 2001, Journal of psychopharmacology.

[1506]  S. Hunt,et al.  5-Hydroxytryptamine (5-HT)1A Autoreceptor Adaptive Changes in Substance P (Neurokinin 1) Receptor Knock-Out Mice Mimic Antidepressant-Induced Desensitization , 2001, The Journal of Neuroscience.

[1507]  G P Hess,et al.  Inhibition of the serotonin 5-HT3 receptor by nicotine, cocaine, and fluoxetine investigated by rapid chemical kinetic techniques. , 2001, Biochemistry.

[1508]  R. Morris,et al.  Tianeptine and its enantiomers: effects on spatial memory in rats with medial septum lesions , 2001, Neuropharmacology.

[1509]  M. Quick,et al.  PICKing on transporters , 2001, Trends in Neurosciences.

[1510]  D. Zullino,et al.  Lithium Augmentation in Depressive Patients Not Responding to Selective Serotonin Reuptake Inhibitors1 , 2001, Pharmacopsychiatry.

[1511]  M. Millan,et al.  Potential antidepressants displayed combined alpha(2)-adrenoceptor antagonist and monoamine uptake inhibitor properties. , 2001, Journal of medicinal chemistry.

[1512]  C. Wermuth,et al.  Design, synthesis, and structure-activity relationships of a series of 3-[2-(1-benzylpiperidin-4-yl)ethylamino]pyridazine derivatives as acetylcholinesterase inhibitors. , 2001, Journal of medicinal chemistry.

[1513]  A. Basbaum,et al.  Molecular mechanisms of nociception , 2001, Nature.

[1514]  R. Jeanningros,et al.  Chronic Effects of Triiodothyronine in Combination with Imipramine on 5-HT Transporter, 5-HT1A and 5-HT2A Receptors in Adult Rat Brain , 2001, Neuropsychopharmacology.

[1515]  S. Dursun,et al.  Reboxetine plus citalopram for refractory depression not responding to venlafaxine: possible mechanisms , 2001, Psychopharmacology.

[1516]  K. Zuideveld,et al.  Active efflux of the 5-HT(1A) receptor agonist flesinoxan via P-glycoprotein at the blood-brain barrier. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[1517]  Y. Sugimoto,et al.  Effects of 5-HT(2) receptor antagonists on the anti-immobility effects of imipramine in the forced swimming test with mice. , 2001, European journal of pharmacology.

[1518]  R. Hen,et al.  Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[1519]  G. Pasternak,et al.  The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor family. , 2001, Pharmacological reviews.

[1520]  Jacques Bradwejn, Diana Koszycki.  Cholecystokinin and panic disorder: Past and future clinical research strategies , 2001, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[1521]  H. Tanila,et al.  Spatial working memory improvement by an α2-adrenoceptor agonist dexmedetomidine is not mediated through α2C-adrenoceptor , 2001, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[1522]  E. Nestler,et al.  Altered Responsiveness to Cocaine and Increased Immobility in the Forced Swim Test Associated with Elevated cAMP Response Element-Binding Protein Expression in Nucleus Accumbens , 2001, The Journal of Neuroscience.

[1523]  J. Stamford,et al.  Multiple 5-HT1 autoreceptor subtypes govern serotonin release in dorsal and median raphé nuclei , 2001, Neuropharmacology.

[1524]  G. Biggio,et al.  GABAA-receptor plasticity during long-term exposure to and withdrawal from progesterone. , 2001, International review of neurobiology.

[1525]  J. Vente,et al.  The effects of phosphodiesterase inhibition on cyclic GMP and cyclic AMP accumulation in the hippocampus of the rat , 2001, Brain Research.

[1526]  T. Su,et al.  The antidepressant-like effect induced by sigma(1)-receptor agonists and neuroactive steroids in mice submitted to the forced swimming test. , 2001, The Journal of pharmacology and experimental therapeutics.

[1527]  L. Marangell.  Switching antidepressants for treatment-resistant major depression. , 2001, The Journal of clinical psychiatry.

[1528]  NS-2330 (Neurosearch). , 2001, Current opinion in investigational drugs.

[1529]  I. Lucki,et al.  Antidepressant-like behavioral effects in 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) receptor mutant mice. , 2001, The Journal of pharmacology and experimental therapeutics.

[1530]  F. Dudek,et al.  Serotonergic Modulation of Retinal Input to the Mouse Suprachiasmatic Nucleus Mediated by 5-HT1B and 5-HT7 Receptors , 2001, Journal of biological rhythms.

[1531]  S. Zorn,et al.  The pharmacology of weight gain with antipsychotics. , 2001, The Journal of clinical psychiatry.

[1532]  F. Nava,et al.  Melatonin reduces anxiety induced by lipopolysaccharide in the rat , 2001, Neuroscience Letters.

[1533]  A. Wagner.  The yeast protein interaction network evolves rapidly and contains few redundant duplicate genes. , 2001, Molecular biology and evolution.

[1534]  A. Chipman.  Developmental exaptation and evolutionary change , 2001, Evolution & development.

[1535]  M. Farrell,et al.  Antidepressants for cocaine dependence. , 2003, The Cochrane database of systematic reviews.

[1536]  M. Webster,et al.  Multivariate analysis of prefrontal cortical data from the Stanley Foundation Neuropathology Consortium , 2001, Brain Research Bulletin.

[1537]  Discovery of novel, orally active dual NK1/NK2 antagonists. , 2001, Bioorganic & medicinal chemistry letters.

[1538]  T. Balkin,et al.  Maintaining alertness and performance during sleep deprivation: modafinil versus caffeine , 2001, Psychopharmacology.

[1539]  M. Bennett,et al.  Activation of Metabotropic Glutamate Receptor 1 Accelerates NMDA Receptor Trafficking , 2001, The Journal of Neuroscience.

[1540]  A. Zwinderman,et al.  Antidepressants and Ejaculation: A Double-Blind, Randomized, Placebo-Controlled, Fixed-Dose Study With Paroxetine, Sertraline, and Nefazodone , 2001, Journal of clinical psychopharmacology.

[1541]  L. Takahashi,et al.  Antagonism of CRF2 receptors produces anxiolytic behavior in animal models of anxiety , 2001, Brain Research.

[1542]  I. Hickie,et al.  Late-onset depression: genetic, vascular and clinical contributions , 2001, Psychological Medicine.

[1543]  H. Sackeim,et al.  The definition and meaning of treatment-resistant depression. , 2001, The Journal of clinical psychiatry.

[1544]  D. Doak,et al.  Physical stress and diversity-productivity relationships: The role of positive interactions , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[1545]  Wei Zhang,et al.  A novel augmentation strategy for treating resistant major depression. , 2001, The American journal of psychiatry.

[1546]  J. A. Boer,et al.  Is the beneficial antidepressant effect of coadministration of pindolol really due to somatodendritic autoreceptor antagonism? , 2001, Biological Psychiatry.

[1547]  J. Neumaier,et al.  Localization of 5-HT7 receptors in rat brain by immunocytochemistry, in situ hybridization, and agonist stimulated cFos expression , 2001, Journal of Chemical Neuroanatomy.

[1548]  W. Tse,et al.  Difference in serotonergic and noradrenergic regulation of human social behaviours , 2001, Psychopharmacology.

[1549]  L. Szirovicza,et al.  Similarities in the pattern of regional brain dysfunction in negative schizophrenia and unipolar depression: a single photon emission-computed tomography and auditory evoked potentials study , 2001, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[1550]  I. Bitter,et al.  Tianeptine and paroxetine in major depressive disorder, with a special focus on the anxious component in depression: an international, 6‐week double‐blind study † , 2001, Human psychopharmacology.

[1551]  H. Akunne,et al.  Neuropharmacological profile of a selective sigma ligand, igmesine: a potential antidepressant , 2001, Neuropharmacology.

[1552]  W. Im,et al.  Allosteric modulation of the human 5-HT(7A) receptor by lipidic amphipathic compounds. , 2001, Molecular pharmacology.

[1553]  C. Soares,et al.  Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. , 2001, Archives of general psychiatry.

[1554]  A. V. D. Does,et al.  The effects of tryptophan depletion on mood and psychiatric symptoms. , 2001 .

[1555]  R. Heavens,et al.  Distribution of 5-ht(5A), 5-ht(5B), 5-ht(6) and 5-HT(7) receptor mRNAs in the rat brain. , 2001, Brain research. Molecular brain research.

[1556]  P. Reich,et al.  Diversity and Productivity in a Long-Term Grassland Experiment , 2001, Science.

[1557]  S. Tam,et al.  Yohimbine: a clinical review. , 2001, Pharmacology & therapeutics.

[1558]  K. Andersson.  Pharmacology of penile erection. , 2001, Pharmacological reviews.

[1559]  M. Mintun,et al.  Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study , 2001, Biological Psychiatry.

[1560]  J. Assreuy,et al.  Nitric oxide involvement in the anxiogenic-like effect of substance P , 2001, Behavioural Brain Research.

[1561]  G. E. Pickard,et al.  Subcellular distribution of 5‐HT1b and 5‐HT7 receptors in the mouse suprachiasmatic nucleus , 2001, The Journal of comparative neurology.

[1562]  C. Spencer,et al.  Tianeptine , 2001, CNS Drugs.

[1563]  R. Shelton,et al.  Serum thyrotropin concentrations and bioactivity during sleep deprivation in depression. , 2001, Archives of general psychiatry.

[1564]  R. Howard,et al.  Depression in older people with mild stroke, carotid stenosis and peripheral vascular disease: a comparison with healthy controls , 2001, International journal of geriatric psychiatry.

[1565]  F. Giuliano,et al.  Oral drug therapy for erectile dysfunction. , 2001, The Urologic clinics of North America.

[1566]  N. Landrø,et al.  Neuropsychological function in nonpsychotic unipolar major depression. , 2001, Neuropsychiatry, neuropsychology, and behavioral neurology.

[1567]  J. Burbach,et al.  Immunohistochemical localization of the vasopressin V1b receptor in the rat brain and pituitary gland: anatomical support for its involvement in the central effects of vasopressin. , 2001, Endocrinology.

[1568]  Sarah H Lisanby,et al.  Therapeutic application of repetitive transcranial magnetic stimulation: a review , 2001, Clinical Neurophysiology.

[1569]  B. Hoebel,et al.  Nucleus accumbens muscarinic receptors in the control of behavioral depression: antidepressant-like effects of local M1 antagonist in the Porsolt swim test , 2001, Neuroscience.

[1570]  Erwan Bezard,et al.  Pathophysiology of levodopa-induced dyskinesia: Potential for new therapies , 2001, Nature Reviews Neuroscience.

[1571]  H A Pincus,et al.  The societal costs of chronic major depression. , 2001, The Journal of clinical psychiatry.

[1572]  C. Sherbourne,et al.  The quality of care for depressive and anxiety disorders in the United States. , 2001, Archives of general psychiatry.

[1573]  P. Celada,et al.  How does pindolol improve antidepressant action? , 2001, Trends in pharmacological sciences.

[1574]  M. Thase,et al.  Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors , 2001, British Journal of Psychiatry.

[1575]  R. Neubig,et al.  Inverse Agonist Activity at the α2A-Adrenergic Receptor , 2001 .

[1576]  B. Roth,et al.  Control of Serotonergic Function in Medial Prefrontal Cortex by Serotonin-2A Receptors through a Glutamate-Dependent Mechanism , 2001, The Journal of Neuroscience.

[1577]  S. Carlton,et al.  Metabotropic glutamate 1α receptors on peripheral primary afferent fibers: their role in nociception , 2001, Brain Research.

[1578]  O. V. Mortensen,et al.  Species‐scanning mutagenesis of the serotonin transporter reveals residues essential in selective, high‐affinity recognition of antidepressants , 2001, Journal of neurochemistry.

[1579]  F. Schenk,et al.  A Behavioral Study of Alpha-1b Adrenergic Receptor Knockout Mice: Increased Reaction to Novelty and Selectively Reduced Learning Capacities , 2001, Neurobiology of Learning and Memory.

[1580]  D. Puigdemont,et al.  Augmentation of Fluoxetine's Antidepressant Action by Pindolol: Analysis of Clinical, Pharmacokinetic, and Methodologic Factors , 2001, Journal of clinical psychopharmacology.

[1581]  W. Riedel,et al.  Non-serotonergic pharmacological profiles and associated cognitive effects of serotonin reuptake inhibitors , 2001, Journal of psychopharmacology.

[1582]  Sylvain Houle,et al.  Lower dopamine transporter binding potential in striatum during depression , 2001, Neuroreport.

[1583]  P. Hansson.  Neuropathic pain : pathophysiology and treatment , 2001 .

[1584]  D. Wirtshafter,et al.  Localization of GABAB receptors in midbrain monoamine containing neurons in the rat , 2001, Brain Research Bulletin.

[1585]  M. Bauer,et al.  Thyroid Hormone, Neural Tissue and Mood Modulation , 2001, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[1586]  Corrigendum to “Potentiation of 5-HT3 receptor functions in the hippocampal CA1 region of rats following repeated electroconvulsive shock treatments” [Neurosci. Lett. 307 (2001) 37–40] , 2001, Neuroscience Letters.

[1587]  D. Kennaway,et al.  Serotonin, excitatory amino acids and the photic control of melatonin rhythms and SCN c-FOS in the rat , 2001, Brain Research.

[1588]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.

[1589]  E. Chesler,et al.  Transgenic studies of pain and analgesia: mutation or background genotype? , 2001, The Journal of pharmacology and experimental therapeutics.

[1590]  F. Battaini.  Protein kinase C isoforms as therapeutic targets in nervous system disease states. , 2001, Pharmacological research.

[1591]  D. Grandy,et al.  Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. , 2001, Molecular pharmacology.

[1592]  Ene I. Ette,et al.  The Process of Knowledge Discovery from Large Pharmacokinetic Data Sets , 2001, Journal of clinical pharmacology.

[1593]  A. L. Mize,et al.  Estrogens Act in Rat Hippocampus and Frontal Cortex to Produce Rapid, Receptor-Mediated Decreases in Serotonin 5-HT1A Receptor Function , 2001, Neuroendocrinology.

[1594]  M. Gurrath.  Peptide-binding G protein-coupled receptors: new opportunities for drug design. , 2001, Current medicinal chemistry.

[1595]  F. Artigas.  Limitations to enhancing the speed of onset of antidepressants — are rapid action antidepressants possible? , 2001, Human psychopharmacology.

[1596]  C. Decker,et al.  Prediction of pharmacokinetic properties using experimental approaches during early drug discovery. , 2001, Current opinion in chemical biology.

[1597]  C. Parsons,et al.  The N-methyl-d-aspartate receptor channel blockers memantine, MRZ 2/579 and other amino-alkyl-cyclohexanes antagonise 5-HT3 receptor currents in cultured HEK-293 and N1E-115 cell systems in a non-competitive manner , 2001, Neuroscience Letters.

[1598]  H. Silver.  Fluvoxamine as an adjunctive agent in schizophrenia. , 2006, CNS drug reviews.

[1599]  Zhen Yan,et al.  Serotonin Receptors Modulate GABAA Receptor Channels through Activation of Anchored Protein Kinase C in Prefrontal Cortical Neurons , 2001, The Journal of Neuroscience.

[1600]  M. Segal,et al.  Estradiol Induces Formation of Dendritic Spines in Hippocampal Neurons: Functional Correlates , 2001, Hormones and Behavior.

[1601]  J Norberg,et al.  Phenotypic diversity and ecosystem functioning in changing environments: A theoretical framework , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[1602]  E. Huang,et al.  Neurotrophins: roles in neuronal development and function. , 2001, Annual review of neuroscience.

[1603]  J. P. Grime,et al.  Biodiversity and Ecosystem Functioning: Current Knowledge and Future Challenges , 2001, Science.

[1604]  S. Carpenter,et al.  Catastrophic shifts in ecosystems , 2001, Nature.

[1605]  R. Clayton,et al.  Coronary risk in growth hormone deficient hypopituitary adults: increased predicted risk is due largely to lipid profile abnormalities , 2001, Clinical endocrinology.

[1606]  J. Shih,et al.  Biochemical, behavioral, physiologic, and neurodevelopmental changes in mice deficient in monoamine oxidase A or B , 2001, Brain Research Bulletin.

[1607]  C M Rutter,et al.  Treatment process and outcomes for managed care patients receiving new antidepressant prescriptions from psychiatrists and primary care physicians. , 2001, Archives of general psychiatry.

[1608]  F. Zitman,et al.  Psychomotor slowing, neuroendocrine responses, and behavioral changes after oral administration of meta-chlorophenylpiperazine in normal volunteers , 2001, Psychiatry Research.

[1609]  C. Møldrup.  Ethical, Social and Legal Implications of Pharmacogenomics: A Critical Review , 2002, Public Health Genomics.

[1610]  P. Stewart,et al.  Growth Hormone, Insulin-Like Growth Factor-I and the Cortisol-Cortisone Shuttle , 2001, Hormone Research in Paediatrics.

[1611]  L. Dwoskin,et al.  Bupropion Inhibits Nicotine-Evoked [3H]Overflow from Rat Striatal Slices Preloaded with [3H]Dopamine and from Rat Hippocampal Slices Preloaded with [3H]Norepinephrine , 2002, Journal of Pharmacology and Experimental Therapeutics.

[1612]  F. Holsboer,et al.  Vasopressin Mediates the Response of the Combined Dexamethasone/CRH Test in Hyper-anxious Rats: Implications for Pathogenesis of Affective Disorders , 2002, Neuropsychopharmacology.

[1613]  J. Micó,et al.  Antidepressant-like effects of tramadol and other central analgesics with activity on monoamines reuptake, in helpless rats. , 2002, Life sciences.

[1614]  K. Andersson,et al.  New directions for erectile dysfunction therapies , 2002, International Journal of Impotence Research.

[1615]  C. Chopde,et al.  Behavioral action of ethanol in Porsolt’s forced swim test: modulation by 3alpha-hydroxy-5alpha-pregnan-20-one , 2002, Neuropharmacology.

[1616]  K. Itoh,et al.  A variable number of tandem repeats in the serotonin transporter gene does not affect the antidepressant response to fluvoxamine , 2002, Psychiatry Research.

[1617]  P. Strange,et al.  Mechanisms of ligand binding and efficacy at the human D2(short) dopamine receptor , 2002, Journal of neurochemistry.

[1618]  Eric J. Nestler,et al.  Inhibition of cAMP Response Element-Binding Protein or Dynorphin in the Nucleus Accumbens Produces an Antidepressant-Like Effect , 2002, The Journal of Neuroscience.

[1619]  P. Gold,et al.  Multiple feedback mechanisms activating corticotropin-releasing hormone system in the brain during stress , 2002, Pharmacology Biochemistry and Behavior.

[1620]  J. Harro,et al.  The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y , 2002, Neuroscience & Biobehavioral Reviews.

[1621]  T. Ohta.  Near-neutrality in evolution of genes and gene regulation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[1622]  B. Giros,et al.  A Third Vesicular Glutamate Transporter Expressed by Cholinergic and Serotoninergic Neurons , 2002, The Journal of Neuroscience.

[1623]  S. Iyengar,et al.  Group II mGluR receptor agonists are effective in persistent and neuropathic pain models in rats , 2002, Pharmacology Biochemistry and Behavior.

[1624]  Alan A. Wilson,et al.  Bupropion occupancy of the dopamine transporter is low during clinical treatment , 2002, Psychopharmacology.

[1625]  M. Millan.  Descending control of pain , 2002, Progress in Neurobiology.

[1626]  C. Schmauss,et al.  Modulation of Serotonin 2C Receptor Editing by Sustained Changes in Serotonergic Neurotransmission , 2002, The Journal of Neuroscience.

[1627]  H. Meltzer.  Suicidality in schizophrenia: A review of the evidence for risk factors and treatment options , 2002, Current psychiatry reports.

[1628]  M. Gitlin,et al.  Bupropion-Sustained Release as a Treatment for SSRI-Induced Sexual Side Effects , 2002, Journal of sex & marital therapy.

[1629]  H. Westenberg,et al.  The effects of selective serotonin reuptake inhibitors on extracellular 5-HT in the hippocampus of 5-HT 1 B receptor knockout mice , 2002 .

[1630]  L. Davidson,et al.  The relationship between anxiety and substance use disorders among individuals with severe affective disorders. , 2002, Comprehensive psychiatry.

[1631]  T. Kitami,et al.  Biochemical networking contributes more to genetic buffering in human and mouse metabolic pathways than does gene duplication , 2002, Nature Genetics.

[1632]  Susan R. George,et al.  G-Protein-coupled receptor oligomerization and its potential for drug discovery , 2002, Nature Reviews Drug Discovery.

[1633]  P. Joyce,et al.  A common P-glycoprotein polymorphism is associated with nortriptyline-induced postural hypotension in patients treated for major depression , 2002, The Pharmacogenomics Journal.

[1634]  B. Griffond,et al.  Cell and molecular cell biology of melanin-concentrating hormone. , 2002, International review of cytology.

[1635]  S. Schulz,et al.  Clinical use of quetiapine in disease states other than schizophrenia. , 2002, The Journal of clinical psychiatry.

[1636]  N. Sousa,et al.  Corticosteroids: Sculptors of the Hippocampal Formation , 2002, Reviews in the neurosciences.

[1637]  P. Andrews,et al.  Adaptationism – how to carry out an exaptationist program , 2002, Behavioral and Brain Sciences.

[1638]  J. Fritschy,et al.  A new benzodiazepine pharmacology. , 2002, The Journal of pharmacology and experimental therapeutics.

[1639]  M. Bidlingmaier,et al.  Endocrinological effects of mirtazapine in healthy volunteers , 2002, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[1640]  C. Normann,et al.  Lamotrigine as adjunct to paroxetine in acute depression: a placebo-controlled, double-blind study. , 2002, The Journal of clinical psychiatry.

[1641]  F. Leslie,et al.  Expression of neuronal nicotinic acetylcholine receptor subunit mRNAs within midbrain dopamine neurons , 2002, The Journal of comparative neurology.

[1642]  Allen D. Roses,et al.  Genome-based pharmacogenetics and the pharmaceutical industry , 2002, Nature Reviews Drug Discovery.

[1643]  Marianne B. Müller,et al.  Repetitive transcranial magnetic stimulation increases the release of dopamine in the mesolimbic and mesostriatal system , 2002, Neuropharmacology.

[1644]  J. Kelsey.  Treatment strategies in achieving remission in major depressive disorder , 2002, Acta psychiatrica Scandinavica. Supplementum.

[1645]  E. Fuchs,et al.  The antidepressant tianeptine persistently modulates glutamate receptor currents of the hippocampal CA3 commissural associational synapse in chronically stressed rats , 2002, The European journal of neuroscience.

[1646]  U. Alon,et al.  Negative autoregulation speeds the response times of transcription networks. , 2002, Journal of molecular biology.

[1647]  R. Bitner,et al.  Alpha-7 nicotinic receptor expression by two distinct cell types in the dorsal raphe nucleus and locus coeruleus of rat , 2002, Brain Research.

[1648]  G. Baker,et al.  Stereochemistry and drug efficacy and development: relevance of chirality to antidepressant and antipsychotic drugs , 2002, Annals of medicine.

[1649]  F. Kuenzi,et al.  Enhanced Learning and Memory and Altered GABAergic Synaptic Transmission in Mice Lacking the α5 Subunit of the GABAAReceptor , 2002, The Journal of Neuroscience.

[1650]  D. Dlaboga,et al.  Effect of repeated treatment with mirtazapine on the central alpha1-adrenergic receptors. , 2002, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[1651]  H. Giedke,et al.  Therapeutic use of sleep deprivation in depression. , 2002, Sleep medicine reviews.

[1652]  Wei Huang,et al.  Novel dual inhibitors of AChE and MAO derived from hydroxy aminoindan and phenethylamine as potential treatment for Alzheimer's disease. , 2002, Journal of medicinal chemistry.

[1653]  H. Berthoud,et al.  Multiple neural systems controlling food intake and body weight , 2002, Neuroscience & Biobehavioral Reviews.

[1654]  James G Barbee,et al.  Lamotrigine as an augmentation agent in treatment-resistant depression. , 2002, The Journal of clinical psychiatry.

[1655]  S. Smith,et al.  Progesterone withdrawal increases the α4 subunit of the GABAA receptor in male rats in association with anxiety and altered pharmacology — a comparison with female rats , 2002, Neuropharmacology.

[1656]  A. Leuchter,et al.  Changes in brain function of depressed subjects during treatment with placebo. , 2002, The American journal of psychiatry.

[1657]  G. Chrousos,et al.  Divergent endocrine abnormalities in melancholic and atypical depression: clinical and pathophysiologic implications. , 2002, Endocrinology and metabolism clinics of North America.

[1658]  Joseph E LeDoux,et al.  The Group I Metabotropic Glutamate Receptor mGluR5 Is Required for Fear Memory Formation and Long-Term Potentiation in the Lateral Amygdala , 2002, The Journal of Neuroscience.

[1659]  M. Shin,et al.  Modulation of tianeptine on ion currents induced by inhibitory neurotransmitters in acutely dissociated dorsal raphe neurons of Sprague–Dawley rats , 2002, European Neuropsychopharmacology.

[1660]  M. Hamon,et al.  Altered regulation of the 5‐HT system in the brain of MAO‐A knock‐out mice , 2002, The European journal of neuroscience.

[1661]  D. Copenhagen,et al.  The identification of vesicular glutamate transporter 3 suggests novel modes of signaling by glutamate , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[1662]  A. Mykletun,et al.  An association between depression, anxiety and thyroid function – a clinical fact or an artefact? , 2002, Acta psychiatrica Scandinavica.

[1663]  M. Gerstein,et al.  A question of size: the eukaryotic proteome and the problems in defining it. , 2002, Nucleic acids research.

[1664]  A. Pałucha,et al.  On the role of metabotropic glutamate receptors in the mechanisms of action of antidepressants. , 2002, Polish journal of pharmacology.

[1665]  J. O'Brien,et al.  A Comprehensive Review of Proton Magnetic Resonance Spectroscopy Studies in Dementia and Parkinson’s Disease , 2002, Dementia and Geriatric Cognitive Disorders.

[1666]  T. Kenakin,et al.  G Protein-Coupled Receptor Allosterism and Complexing , 2002, Pharmacological Reviews.

[1667]  A. Heinz,et al.  Thyroid hormones, serotonin and mood: of synergy and significance in the adult brain , 2002, Molecular Psychiatry.

[1668]  M. Faith,et al.  Obesity-depression associations in the population. , 2002, Journal of psychosomatic research.

[1669]  T. Steckler,et al.  The fallacy of behavioral phenotyping without standardisation , 2002, Genes, brain, and behavior.

[1670]  H. Lôo,et al.  Determination of the dose of agomelatine, a melatoninergic agonist and selective 5-HT2C antagonist, in the treatment of major depressive disorder: a placebo-controlled dose range study , 2002, International clinical psychopharmacology.

[1671]  Sui Huang.  Rational drug discovery: what can we learn from regulatory networks? , 2002, Drug discovery today.

[1672]  Dennis S. Charney,et al.  Neuropsychopharmacology : The Fifth Generation of Progress , 2002 .

[1673]  B. Feige,et al.  Fluoxetine and Sleep EEG: Effects of a Single Dose, Subchronic Treatment, and Discontinuation in Healthy Subjects , 2002, Neuropsychopharmacology.

[1674]  D. Talmage,et al.  Nicotinic receptor-mediated effects on appetite and food intake. , 2002, Journal of neurobiology.

[1675]  L. Dwoskin,et al.  Reboxetine: attenuation of intravenous nicotine self-administration in rats. , 2002, The Journal of pharmacology and experimental therapeutics.

[1676]  H. Manji,et al.  PKC, MAP kinases and the bcl-2 family of proteins as long-term targets for mood stabilizers , 2002, Molecular Psychiatry.

[1677]  R. Knapp,et al.  Antidepressant activity of memory-enhancing drugs in the reduction of submissive behavior model. , 2002, European journal of pharmacology.

[1678]  G. Alexopoulos.  Frontostriatal and limbic dysfunction in late-life depression. , 2002, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[1679]  W. Danysz,et al.  Synergistic effect of uncompetitive NMDA receptor antagonists and antidepressant drugs in the forced swimming test in rats , 2002, Neuropharmacology.

[1680]  E. Esposito,et al.  Role of serotonin2C receptors in the control of brain dopaminergic function , 2002, Pharmacology Biochemistry and Behavior.

[1681]  M. Thase.  Comparing the methods used to compare antidepressants. , 2002, Psychopharmacology bulletin.

[1682]  M. Millan,et al.  Differential Actions of Antiparkinson Agents at Multiple Classes of Monoaminergic Receptor. II. Agonist and Antagonist Properties at Subtypes of Dopamine D2-Like Receptor and α1/α2-Adrenoceptor , 2002, Journal of Pharmacology and Experimental Therapeutics.

[1683]  L. Tamam,et al.  Selective serotonin reuptake inhibitor discontinuation syndrome: A review , 2002, Advances in therapy.

[1684]  M E J Newman,et al.  Community structure in social and biological networks , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[1685]  M. Thase,et al.  Citalopram treatment of paroxetine‐intolerant depressed patients , 2002, Depression and anxiety.

[1686]  P. Celada,et al.  Origin and functional role of the extracellular serotonin in the midbrain raphe nuclei , 2002, Brain Research Reviews.

[1687]  W. Kostowski,et al.  Effects of D1 receptor agonist SKF 38393 on male rat sexual behavior and postcopulatory departure in the goal compartment–runway paradigm , 2002, Physiology & Behavior.

[1688]  P. Gilligan,et al.  The CRF1 receptor antagonist DMP696 produces anxiolytic effects and inhibits the stress-induced hypothalamic-pituitary-adrenal axis activation without sedation or ataxia in rats , 2002, Psychopharmacology.

[1689]  R. Dantzer,et al.  Cytokine-induced sickness behaviour: mechanisms and implications , 2002, Trends in Neurosciences.

[1690]  P. Goldman-Rakic,et al.  The Physiological Role of 5-HT2A Receptors in Working Memory , 2002, The Journal of Neuroscience.

[1691]  H. Eisenberg,et al.  The nicotinic allosteric potentiating ligand galantamine facilitates synaptic transmission in the mammalian central nervous system. , 2002, Molecular pharmacology.

[1692]  Brian K. Kobilka,et al.  Mutation of the α2A-Adrenoceptor Impairs Working Memory Performance and Annuls Cognitive Enhancement by Guanfacine , 2002, The Journal of Neuroscience.

[1693]  C. Rao,et al.  Control, exploitation and tolerance of intracellular noise , 2002, Nature.

[1694]  S. Gould.  The Structure of Evolutionary Theory , 2002 .

[1695]  S. File,et al.  Nicotinic–serotonergic interactions in brain and behaviour , 2002, Pharmacology Biochemistry and Behavior.

[1696]  H. Sackeim,et al.  Vagus nerve stimulation (VNS) for major depressive episodes: one year outcomes , 2002, Biological Psychiatry.

[1697]  Terry Kenakin,et al.  Drug efficacy at G protein-coupled receptors. , 2002, Annual review of pharmacology and toxicology.

[1698]  S. Shen-Orr,et al.  Network motifs in the transcriptional regulation network of Escherichia coli , 2002, Nature Genetics.

[1699]  I. Lucki,et al.  Evidence for corticotropin-releasing factor regulation of serotonin in the lateral septum during acute swim stress: adaptation produced by repeated swimming , 2002, Psychopharmacology.

[1700]  Y. Sugimoto,et al.  Differential effects of the 5-HT2 receptor antagonist on the anti-immobility effects of noradrenaline and serotonin reuptake inhibitors in the forced swimming test , 2002, Brain Research.

[1701]  A. Nordberg,et al.  Sustained cholinesterase inhibition in AD patients receiving rivastigmine for 12 months , 2002, Neurology.

[1702]  A Frazer,et al.  Delayed pharmacological effects of antidepressants , 2002, Molecular Psychiatry.

[1703]  F. Borsini,et al.  Pharmacology of flibanserin. , 2006, CNS drug reviews.

[1704]  A. Garcı́a-Sacristán,et al.  Penile Arteries and Erection , 2002, Journal of Vascular Research.

[1705]  R. Duman,et al.  Brain-Derived Neurotrophic Factor Produces Antidepressant Effects in Behavioral Models of Depression , 2002, The Journal of Neuroscience.

[1706]  A. Rush,et al.  The impact of treatment-resistant depression on health care utilization and costs. , 2002, The Journal of clinical psychiatry.

[1707]  P. Willner,et al.  The validity of animal models of predisposition to depression. , 2002, Behavioural pharmacology.

[1708]  S. Hill,et al.  Mechanisms of Cross-Talk between G-Protein-Coupled Receptors , 2002, Neurosignals.

[1709]  M. Behrens,et al.  Metabotropic Glutamate Receptor 1-Induced Upregulation of NMDA Receptor Current: Mediation through the Pyk2/Src-Family Kinase Pathway in Cortical Neurons , 2002, The Journal of Neuroscience.

[1710]  M. Sanak,et al.  Repeated imipramine and electroconvulsive shock increase alpha 1A-adrenoceptor mRNA level in rat prefrontal cortex. , 2002, European journal of pharmacology.

[1711]  G. Nowak,et al.  Interaction of zinc with antidepressants in the forced swimming test in mice. , 2002, Polish journal of pharmacology.

[1712]  Multidimensional analysis of the concentrations of 17 substances in the CSF of schizophrenics and controls , 2002, Journal of Neural Transmission.

[1713]  J. Lisman,et al.  The molecular basis of CaMKII function in synaptic and behavioural memory , 2002, Nature Reviews Neuroscience.

[1714]  R. Duman,et al.  Antidepressants and neuroplasticity. , 2002, Bipolar disorders.

[1715]  M. Millan,et al.  Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake A pharmacological characterization of diverse classes of antidepressant agents , 2002, Pharmacology Biochemistry and Behavior.

[1716]  C. Freund,et al.  Emerging Ethical Issues in Pharmacogenomics , 2002, American journal of pharmacogenomics : genomics-related research in drug development and clinical practice.

[1717]  N. Canteras,et al.  The role of lateral septal NK1 receptors in mediating anxiogenic effects induced by intracerebroventricular injection of substance P , 2002, Behavioural Brain Research.

[1718]  C. Wotjak,et al.  Forced swimming triggers vasopressin release within the amygdala to modulate stress‐coping strategies in rats , 2002, The European journal of neuroscience.

[1719]  K. Maubach,et al.  Chronic substance P (NK1) receptor antagonist and conventional antidepressant treatment increases burst firing of monoamine neurones in the locus coeruleus , 2002, Neuroscience.

[1720]  D. Middlemiss,et al.  Serotonergic targets in depression. , 2002, Current opinion in pharmacology.

[1721]  E. Levin.  Nicotinic receptor subtypes and cognitive function. , 2002, Journal of neurobiology.

[1722]  G. Gambaro.  Strategies to safely interfere with prostanoid activity while avoiding adverse renal effects: could COX-2 and COX-LOX dual inhibition be the answer? , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[1723]  Andreas Wagner,et al.  Selection and gene duplication: a view from the genome , 2002, Genome Biology.

[1724]  Dennis L. Murphy,et al.  Serotonin uptake into dopamine neurons via dopamine transporters: a compensatory alternative , 2002, Brain Research.

[1725]  C. Davies,et al.  GABAB Receptors: From Monogamy to Promiscuity , 2002, Neurosignals.

[1726]  O. Kretz,et al.  Corticosteroid receptors in the brain: gene targeting studies , 2002, Brain Research Bulletin.

[1727]  R. Quirion,et al.  Neuropeptide Y (NPY) and depression: from animal studies to the human condition. , 2002, Life sciences.

[1728]  A. Schatzberg,et al.  An open label trial of C-1073 (mifepristone) for psychotic major depression* , 2002, Biological Psychiatry.

[1729]  F. Guimarães,et al.  Effects of single or repeated restraint stress on GluR1 and GluR2 flip and flop mRNA expression in the hippocampal formation , 2002, Brain Research Bulletin.

[1730]  M. Millan,et al.  The selective neurokinin (NK)1 antagonist, GR205,171, stereospecifically enhances mesocortical dopaminergic transmission in the rat: a combined dialysis and electrophysiological study , 2002, Brain Research.

[1731]  D. Nutt,et al.  Generalized anxiety disorder: comorbidity, comparative biology and treatment. , 2002, The international journal of neuropsychopharmacology.

[1732]  R. Krishnan,et al.  Clinical experience with substance P receptor (NK1) antagonists in depression. , 2002, The Journal of clinical psychiatry.

[1733]  F. Holsboer,et al.  Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression. , 2002, Current opinion in pharmacology.

[1734]  A. Roses.  SNPs—where's the beef? , 2002, The Pharmacogenomics Journal.

[1735]  Philippe Chemineau,et al.  Changes in the 5-HT2A receptor system in the pre-mammillary hypothalamus of the ewe are related to regulation of LH pulsatile secretion by an endogenous circannual rhythm , 2003, BMC Neuroscience.

[1736]  A. Schatzberg.  Pharmacological principles of antidepressant efficacy , 2002, Human psychopharmacology.

[1737]  B. Mcewen,et al.  Structural plasticity and tianeptine: cellular and molecular targets , 2002, European Psychiatry.

[1738]  D. Gurwitz,et al.  Inhibition of glycogen synthase kinase-3beta by bivalent zinc ions: insight into the insulin-mimetic action of zinc. , 2002, Biochemical and biophysical research communications.

[1739]  P. Reiner,et al.  Substance P in the descending cholinergic projection to REM sleep‐induction regions of the rat pontine reticular formation: anatomical and electrophysiological analyses , 2002, The European journal of neuroscience.

[1740]  Jack M Gorman,et al.  Efficacy Comparison of Escitalopram and Citalopram in the Treatment of Major Depressive Disorder: Pooled Analysis of Placebo-Controlled Trials , 2002, CNS Spectrums.

[1741]  Y. Hishikawa,et al.  Effect of serotonin 1A agonist tandospirone on depression symptoms in senile patients with dementia , 2002, Human psychopharmacology.

[1742]  M. Millan,et al.  Stimulation by antipsychotic agents of mitogen-activated protein kinase (MAPK) coupled to cloned, human (h)serotonin (5-HT)1A receptors , 2002, Psychopharmacology.

[1743]  A. Monge,et al.  Antidepressant-like activity of VN2222, a serotonin reuptake inhibitor with high affinity at 5-HT1A receptors. , 2002, European journal of pharmacology.

[1744]  David J. Galas,et al.  A duplication growth model of gene expression networks , 2002, Bioinform..

[1745]  Anje-Margriet Neutel,et al.  Stability in Real Food Webs: Weak Links in Long Loops , 2002, Science.

[1746]  J. Palha,et al.  Thyroid hormone distribution in the mouse brain: the role of transthyretin 1 1 Presented in part in the abstract form to the Society for Neuroscience meeting in San Diego, CA, USA, November 2001. , 2002, Neuroscience.

[1747]  Francis S. Collins,et al.  Genomic medicine--a primer. , 2002, The New England journal of medicine.

[1748]  A. Hughes,et al.  Adaptive evolution after gene duplication. , 2002, Trends in genetics : TIG.

[1749]  C. Belzung,et al.  Genetic basis of anxiety-like behaviour: a critical review , 2002, Brain Research Bulletin.

[1750]  P. Sarkar.  In quest of thyroid hormone function in mature mammalian brain. , 2002, Indian journal of experimental biology.

[1751]  K. Gołembiowska,et al.  Inhibition of amino acid release by 5-HT1B receptor agonist in the rat prefrontal cortex. , 2002, Polish journal of pharmacology.

[1752]  R. Hill,et al.  The Suprachiasmatic Nucleus Exhibits Diurnal Variations in Spontaneous Excitatory Postsynaptic Activity , 2002, Journal of biological rhythms.

[1753]  G. Koob,et al.  Lack of reward and locomotor stimulation induced by heroin in mu-opioid receptor-deficient mice. , 2002, European journal of pharmacology.

[1754]  Lukas Rj,et al.  Regulation of nicotinic acetylcholine receptor numbers and function by chronic nicotine exposure. , 2002 .

[1755]  M. Reith,et al.  Is Na+ required for the binding of dopamine, amphetamine, tyramine, and octopamine to the human dopamine transporter? , 2002, Naunyn-Schmiedeberg's Archives of Pharmacology.

[1756]  Elucidating the antidepressant actions of substance P (NK1 receptor) antagonists. , 2002, Current opinion in investigational drugs.

[1757]  E. Nunes,et al.  Bupropion Treatment for Cocaine Abuse and Adult Attention-Deficit/Hyperactivity Disorder , 2002, Journal of addictive diseases.

[1758]  H. Prast,et al.  Involvement of nitric oxide, cyclic GMP and phosphodiesterase 5 in excitatory amino acid and GABA release in the nucleus accumbens evoked by activation of the hippocampal fimbria , 2002, Neuroscience.

[1759]  A. Herbison,et al.  Sex differences in the regulation of tyrosine hydroxylase gene transcription by estrogen in the locus coeruleus of TH9-LacZ transgenic mice. , 2002, Brain research. Molecular brain research.

[1760]  T. Lundstedt,et al.  Proteochemometrics modeling of the interaction of amine G-protein coupled receptors with a diverse set of ligands. , 2002, Molecular pharmacology.

[1761]  S. Montgomery,et al.  Antidepressant medications: a review of the evidence for drug-induced sexual dysfunction. , 2002, Journal of affective disorders.

[1762]  R. Hauger,et al.  The CRF peptide family and their receptors: yet more partners discovered. , 2002, Trends in pharmacological sciences.

[1763]  P. Marin,et al.  Synaptic multiprotein complexes associated with 5‐HT2C receptors: a proteomic approach , 2002, The EMBO journal.

[1764]  L. Naudon,et al.  Differential effects of chronic antidepressant treatments on μ- and δ-opioid receptors in rat brain , 2002 .

[1765]  I. Izquierdo,et al.  Bupropion and sertraline enhance retrieval of recent and remote long-term memory in rats , 2002, Behavioural pharmacology.

[1766]  M. Inazu,et al.  Astroglial dopamine transport is mediated by norepinephrine transporter , 2002, Naunyn-Schmiedeberg's Archives of Pharmacology.

[1767]  R. Paine.  Trophic Control of Production in a Rocky Intertidal Community , 2002, Science.

[1768]  J. Macher,et al.  Efficacy and safety of hydroxyzine in the treatment of generalized anxiety disorder: a 3-month double-blind study. , 2002, The Journal of clinical psychiatry.

[1769]  R. Sysko,et al.  Placebo response in studies of major depression: variable, substantial, and growing. , 2002, JAMA.

[1770]  J. Belknap,et al.  Complex-trait genetics: emergence of multivariate strategies , 2002, Nature Reviews Neuroscience.

[1771]  L. Coolen,et al.  Identification of a Potential Ejaculation Generator in the Spinal Cord , 2002, Science.

[1772]  U. Hacksell,et al.  Discovery of an ectopic activation site on the M(1) muscarinic receptor. , 2002, Molecular pharmacology.

[1773]  Kevin J. Gaston,et al.  Functional diversity (FD), species richness and community composition , 2002 .

[1774]  J. Mundt,et al.  Factors contributing to failed trials of new agents: can technology prevent some problems? , 2002, The Journal of clinical psychiatry.

[1775]  J. Waller,et al.  Atypical neuroleptics stimulate neurogenesis in adult rat brain , 2002, Journal of neuroscience research.

[1776]  J. Markowitz,et al.  Differential effects of nefazodone and cognitive behavioral analysis system of psychotherapy on insomnia associated with chronic forms of major depression. , 2002, The Journal of clinical psychiatry.

[1777]  P. Fossier,et al.  Monitoring of Ligand-independent Dimerization and Ligand-induced Conformational Changes of Melatonin Receptors in Living Cells by Bioluminescence Resonance Energy Transfer* 210 , 2002, The Journal of Biological Chemistry.

[1778]  M. Raiteri,et al.  International Union of Pharmacology. XXXIII. Mammalian γ-Aminobutyric AcidB Receptors: Structure and Function , 2002, Pharmacological Reviews.

[1779]  R. Baker,et al.  Acute behavioral and physiological effects of modafinil in drug abusers , 2002, Behavioural pharmacology.

[1780]  A. Hopkins,et al.  The druggable genome , 2002, Nature Reviews Drug Discovery.

[1781]  T. Maurice.  Improving Alzheimer's Disease-Related Cognitive Deficits with sigma1 Receptor Agonists. , 2002, Drug news & perspectives.

[1782]  S. Aslan,et al.  The effects of mirtazapine on sleep: a placebo controlled, double-blind study in young healthy volunteers. , 2002, Sleep.

[1783]  A. Bilkei-Gorzo,et al.  Diminished Anxiety- and Depression-Related Behaviors in Mice with Selective Deletion of the Tac1 Gene , 2002, The Journal of Neuroscience.

[1784]  Thomas Ryckmans,et al.  First dual NK(1) antagonists-serotonin reuptake inhibitors: synthesis and SAR of a new class of potential antidepressants. , 2002, Bioorganic & Medicinal Chemistry Letters.

[1785]  T. J. Sajdyk,et al.  Role of norepinephrine in the dorsomedial hypothalamic panic response An in vivo microdialysis study , 2002, Pharmacology Biochemistry and Behavior.

[1786]  Nicola J. Rinaldi,et al.  Transcriptional Regulatory Networks in Saccharomyces cerevisiae , 2002, Science.

[1787]  E. Nisenbaum,et al.  LY404187: a novel positive allosteric modulator of AMPA receptors. , 2006, CNS drug reviews.

[1788]  M. Webster,et al.  Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders , 2002, Molecular Psychiatry.

[1789]  N. Castanon,et al.  Effects of antidepressants on cytokine production and actions , 2002, Brain, Behavior, and Immunity.

[1790]  H. Meltzer,et al.  5-HT2A receptor antagonism potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and inhibits that in the nucleus accumbens in a dose-dependent manner , 2002, Brain Research.

[1791]  M. Pérez,et al.  Melanin concentrating hormone increase hippocampal synaptic transmission in the rat , 2002, Peptides.

[1792]  Neo D. Martinez,et al.  Two degrees of separation in complex food webs , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[1793]  T. Amit,et al.  The involvement of mitogen‐activated protein (MAP) kinase in the regulation of amyloid precursor protein processing by novel cholinesterase inhibitors derived from rasagiline , 2002 .

[1794]  B. Feige,et al.  Effects of the Neuropeptide Substance P on Sleep, Mood, and Neuroendocrine Measures in Healthy Young Men , 2002, Neuropsychopharmacology.

[1795]  M. Trivedi,et al.  Sexual function and satisfaction in the treatment of chronic major depression with nefazodone, psychotherapy, and their combination. , 2002, The Journal of clinical psychiatry.

[1796]  M. Millan,et al.  Characterization of phospholipase C activity at h5-HT2C compared with h5-HT2B receptors: influence of novel ligands upon membrane-bound levels of [3H]phosphatidylinositols , 2002, Naunyn-Schmiedeberg's Archives of Pharmacology.

[1797]  G. Fava,et al.  Residual symptoms in depression An emerging therapeutic concept , 2002, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[1798]  T. Kenakin,et al.  The ligand paradox between affinity and efficacy: can you be there and not make a difference? , 2002, Trends in pharmacological sciences.

[1799]  A. Nehra,et al.  Combination therapy for erectile dysfunction: Where we are and what’s in the future , 2002, Current urology reports.

[1800]  G. Nowak,et al.  Multiple MPEP administrations evoke anxiolytic- and antidepressant-like effects in rats , 2002, Neuropharmacology.

[1801]  S. Kennedy,et al.  Combining bupropion SR with venlafaxine, paroxetine, or fluoxetine: a preliminary report on pharmacokinetic, therapeutic, and sexual dysfunction effects. , 2002, The Journal of clinical psychiatry.

[1802]  M. Heilig,et al.  Diverse functions of neuropeptide Y revealed using genetically modified animals , 2002, Neuropeptides.

[1803]  T. Paparrigopoulos.  Melatonin response to atenolol administration in depression: indication of β‐adrenoceptor dysfunction in a subtype of depression , 2002, Acta psychiatrica Scandinavica.

[1804]  Combination spinal analgesic chemotherapy: a systematic review. , 2002 .

[1805]  T. Hijzen,et al.  Overexpression of corticotropin‐releasing hormone in transgenic mice and chronic stress‐like autonomic and physiological alterations , 2002, The European journal of neuroscience.

[1806]  M. Trabucchi,et al.  Paroxetine and fluoxetine effects on mood and cognitive functions in depressed nondemented elderly patients. , 2002, The Journal of clinical psychiatry.

[1807]  M. Youdim,et al.  Effect of TV3326, a novel monoamine-oxidase cholinesterase inhibitor, in rat models of anxiety and depression , 2002, Psychopharmacology.

[1808]  Richard Entsuah,et al.  Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression , 2002, Biological Psychiatry.

[1809]  A. Gelenberg,et al.  Sequential catecholamine and serotonin depletion in mirtazapine-treated depressed patients. , 2002, The international journal of neuropsychopharmacology.

[1810]  R. Palmiter,et al.  The neuropeptide Y Y1 receptor regulates leptin‐mediated control of energy homeostasis and reproductive functions , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[1811]  J. Krystal,et al.  Ritanserin antagonism of m-chlorophenylpiperazine effects in neuroleptic-free schizophrenics patients: support for serotonin-2 receptor modulation of schizophrenia symptoms , 2002, Psychopharmacology.

[1812]  H. Eldar-Finkelman,et al.  Glycogen synthase kinase 3: an emerging therapeutic target. , 2002, Trends in molecular medicine.

[1813]  A. Blokland,et al.  Effects of two selective phosphodiesterase type 5 inhibitors, sildenafil and vardenafil, on object recognition memory and hippocampal cyclic GMP levels in the rat , 2002, Neuroscience.

[1814]  H. Mallick,et al.  Role of the lateral septal noradrenergic system in the elaboration of male sexual behavior in rats , 2002, Pharmacology Biochemistry and Behavior.

[1815]  Raymond W Lam,et al.  Combining antidepressants for treatment-resistant depression: a review. , 2002, The Journal of clinical psychiatry.

[1816]  C. R. Cloninger,et al.  The discovery of susceptibility genes for mental disorders , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[1817]  W. Riedel,et al.  Additional dopamine reuptake inhibition attenuates vigilance impairment induced by serotonin reuptake inhibition in man , 2002, Journal of psychopharmacology.

[1818]  J. Doyle,et al.  Reverse Engineering of Biological Complexity , 2002, Science.

[1819]  Dean R. Madden,et al.  Ion channel structure: The structure and function of glutamate receptor ion channels , 2002, Nature Reviews Neuroscience.

[1820]  G. Sagnella.  Review: Vasopeptidase inhibitors , 2002 .

[1821]  Carsten Schwarz,et al.  Genomewide comparison of DNA sequences between humans and chimpanzees. , 2002, American journal of human genetics.

[1822]  C. Beasley,et al.  An investigation of the Wnt-signalling pathway in the prefrontal cortex in schizophrenia, bipolar disorder and major depressive disorder , 2002, Schizophrenia Research.

[1823]  R. Quirion,et al.  Alzheimer’s disease and the basal forebrain cholinergic system: relations to β-amyloid peptides, cognition, and treatment strategies , 2002, Progress in Neurobiology.

[1824]  S. Kanba,et al.  Antipsychotic, antidepressant, anxiolytic, and anticonvulsant drugs induce type II nitric oxide synthase mRNA in rat brain , 2002, Neuroscience Letters.

[1825]  R. Grimée,et al.  Dual NK(1) antagonists--serotonin reuptake inhibitors as potential antidepressants. Part 2: SAR and activity of benzyloxyphenethyl piperazine derivatives. , 2002, Bioorganic & medicinal chemistry letters.

[1826]  B. Lebowitz,et al.  Enhancing the Technology of Clinical Trials and the Trials Model to Evaluate Newly Developed, Targeted Antidepressants , 2002, Neuropsychopharmacology.

[1827]  F. Bymaster,et al.  Muscarinic receptors as a target for drugs treating schizophrenia. , 2002, Current drug targets. CNS and neurological disorders.

[1828]  R. Lester,et al.  Desensitization of neuronal nicotinic receptors. , 2002, Journal of neurobiology.

[1829]  I. Lucki,et al.  cAMP Response Element-Binding Protein Is Essential for the Upregulation of Brain-Derived Neurotrophic Factor Transcription, But Not the Behavioral or Endocrine Responses to Antidepressant Drugs , 2002, The Journal of Neuroscience.

[1830]  J. O'Donnell,et al.  Antidepressant-like Profile and Reduced Sensitivity to Rolipram in Mice Deficient in the PDE4D Phosphodiesterase Enzyme , 2002, Neuropsychopharmacology.

[1831]  G. Chrousos,et al.  Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states , 2002, Molecular Psychiatry.

[1832]  K. Nisijima,et al.  Tandospirone potentiates the fluoxetine-induced increases in extracellular dopamine via 5-HT1A receptors in the rat medial frontal cortex , 2002, Neurochemistry International.

[1833]  H. Arai,et al.  Differential cognitive effects of ebastine and (+)-chlorpheniramine in healthy subjects: correlation between cognitive impairment and plasma drug concentration. , 2002, British journal of clinical pharmacology.

[1834]  L. Limbird,et al.  G protein-coupled receptor interacting proteins: emerging roles in localization and signal transduction. , 2002, Cellular signalling.

[1835]  Danielle C. Turner,et al.  Cognitive enhancing effects of modafinil in healthy volunteers , 2002, Psychopharmacology.

[1836]  W. Brown,et al.  Are placebo controls necessary to test new antidepressants and anxiolytics? , 2002, The international journal of neuropsychopharmacology.

[1837]  Stephen R. Johnson,et al.  Molecular properties that influence the oral bioavailability of drug candidates. , 2002, Journal of medicinal chemistry.

[1838]  T. Tabira,et al.  Dopamine-receptor stimulation in the prefrontal cortex ameliorates stress-induced rotarod impairment , 2002, Pharmacology Biochemistry and Behavior.

[1839]  M. Scheinin,et al.  Behavioral and neurochemical characterization of α2A-adrenergic receptor knockout mice , 2002, Neuroscience.

[1840]  J. Herbert,et al.  Dehydroepiandrosterone (DHEA) stimulates neurogenesis in the hippocampus of the rat, promotes survival of newly formed neurons and prevents corticosterone‐induced suppression , 2002, The European journal of neuroscience.

[1841]  L. de Angelis.  5-HT2A antagonists in psychiatric disorders. , 2002, Current opinion in investigational drugs.

[1842]  S. Shen-Orr,et al.  Network motifs: simple building blocks of complex networks. , 2002, Science.

[1843]  B. Roth,et al.  Localization of 5-HT2A receptors on dopamine cells in subnuclei of the midbrain A10 cell group , 2002, Neuroscience.

[1844]  Hiroaki Kitano,et al.  Looking beyond the details: a rise in system-oriented approaches in genetics and molecular biology , 2002, Current Genetics.

[1845]  Eduardo Sontag,et al.  Untangling the wires: A strategy to trace functional interactions in signaling and gene networks , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[1846]  D. Nutt,et al.  Randomised controlled study of sleep after nefazodone or paroxetine treatment in out-patients with depression. , 2002, The British journal of psychiatry : the journal of mental science.

[1847]  J. Javitch,et al.  Peroxynitrite Inactivates the Human Dopamine Transporter by Modification of Cysteine 342: Potential Mechanism of Neurotoxicity in Dopamine Neurons , 2002, The Journal of Neuroscience.

[1848]  E. Portales-Casamar,et al.  The antidepressant-like effect induced by the sigma1 (σ1) receptor agonist igmesine involves modulation of intracellular calcium mobilization , 2002, Psychopharmacology.

[1849]  K. Luan Phan,et al.  Functional Neuroanatomy of Emotion: A Meta-Analysis of Emotion Activation Studies in PET and fMRI , 2002, NeuroImage.

[1850]  R. Lefkowitz,et al.  Arresting developments in heptahelical receptor signaling and regulation. , 2002, Trends in cell biology.

[1851]  M. Thase.  The next step forward: a move toward evidence, and away from fear of the industry. , 2002, Psychopharmacology bulletin.

[1852]  J. O'Donnell,et al.  Effects of Antidepressants in Rats Trained to Discriminate Centrally Administered Isoproterenol , 2002, Journal of Pharmacology and Experimental Therapeutics.

[1853]  J. Rybakowski,et al.  Reboxetine, a New Noradrenaline Selective Antidepressant, Is at Least as Effective as Fluoxetine in the Treatment of Depression , 2002, Journal of clinical psychopharmacology.

[1854]  R. Hoerr,et al.  Ensaculin (KA-672 HCl): a multitransmitter approach to dementia treatment. , 2006, CNS drug reviews.

[1855]  E. Jutkiewicz,et al.  Behavioral effects of δ-opioid receptor agonists: Potential antidepressants? , 2002 .

[1856]  D. Dlaboga,et al.  Effect of repeated treatment with tianeptine and fluoxetine on central dopamine D2/D3 receptors , 2002, Behavioural pharmacology.

[1857]  V. Novotny,et al.  Tianeptine and fluoxetine in major depression: a 6‐week randomised double‐blind study , 2002, Human psychopharmacology.

[1858]  B. Lerer,et al.  Effects of triiodothyronine and imipramine on basal 5-HT levels and 5-HT(1) autoreceptor activity in rat cortex. , 2002, European journal of pharmacology.

[1859]  Y. Goshima,et al.  Is DOPA a neurotransmitter? , 2002, Trends in pharmacological sciences.

[1860]  D. Dlaboga,et al.  Effect of repeated treatment with mirtazapine on the central dopaminergic D2/D3 receptors. , 2002, Polish journal of pharmacology.

[1861]  A. E. Hirsh,et al.  Evolutionary Rate in the Protein Interaction Network , 2002, Science.

[1862]  P. Hurn,et al.  Selective estrogen receptor modulators: tissue actions and potential for CNS protection. , 2006, CNS drug reviews.

[1863]  G F Mason,et al.  Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments , 2002, Molecular Psychiatry.

[1864]  Julie Perroy,et al.  A Single Subunit (GB2) Is Required for G-protein Activation by the Heterodimeric GABAB Receptor* , 2002, The Journal of Biological Chemistry.

[1865]  Andreas Wagner,et al.  Estimating coarse gene network structure from large-scale gene perturbation data. , 2002, Genome research.

[1866]  P. Mantyh.  Neurobiology of substance P and the NK1 receptor. , 2002, The Journal of clinical psychiatry.

[1867]  A. Zangen,et al.  Impaired release of β-endorphin in response to serotonin in a rat model of depression , 2002, Neuroscience.

[1868]  Y. Kiuchi,et al.  An Investigation of Monoamine Receptors Involved in Antinociceptive Effects of Antidepressants , 2002, Anesthesia and analgesia.

[1869]  E. Rastetter,et al.  Resource-based niches provide a basis for plant species diversity and dominance in arctic tundra , 2002, Nature.

[1870]  Israel Liberzon,et al.  μ-Opioid receptors and limbic responses to aversive emotional stimuli , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[1871]  Beth Borowsky,et al.  Antidepressant, anxiolytic and anorectic effects of a melanin-concentrating hormone-1 receptor antagonist , 2002, Nature Medicine.

[1872]  J. R. Painter,et al.  Is extended clonazepam cotherapy of fluoxetine effective for outpatients with major depression? , 2002, Journal of affective disorders.

[1873]  G. Kennett,et al.  5-HT1B receptors modulate components of satiety in the rat: behavioural and pharmacological analyses of the selective serotonin1B agonist CP-94,253 , 2002, Psychopharmacology.

[1874]  B. O'dowd,et al.  Oligomerization of opioid receptors: generation of novel signaling units. , 2002, Current opinion in pharmacology.

[1875]  D. Brunzell,et al.  Effect of nicotine and nicotinic receptors on anxiety and depression , 2002, Neuroreport.

[1876]  M. Śmiałowska,et al.  Effect of chronic imipramine or electroconvulsive shock on the expression of mGluR1a and mGluR5a immunoreactivity in rat brain hippocampus , 2002, Neuropharmacology.

[1877]  J. Kiss,et al.  The non-competitive AMPA receptor antagonist (GYKI 52466) blocks quisqualate-induced acetylcholine release from the rat hippocampus and striatum: an in vivo microdialysis study , 2002, Neurochemistry International.

[1878]  H. Sackeim,et al.  Neuropsychiatric applications of transcranial magnetic stimulation: a meta analysis. , 2002, The international journal of neuropsychopharmacology.

[1879]  T. Fenton,et al.  Oligomerization of G-protein-coupled Receptors Shown by Selective Co-immunoprecipitation* , 2002, The Journal of Biological Chemistry.

[1880]  D. Quartermain,et al.  Role of brain α1B‐adrenoceptors in modafinil‐induced behavioral activity , 2002, Synapse.

[1881]  T. Myhrer,et al.  Effects of scopolamine and d-cycloserine on non-spatial reference memory in rats , 2002, Behavioural Brain Research.

[1882]  David Bleakman,et al.  An AMPA receptor potentiator modulates hippocampal expression of BDNF: an in vivo study , 2002, Neuropharmacology.

[1883]  Steven C Schachter,et al.  Vagus nerve stimulation therapy summary: Five years after FDA approval , 2002, Neurology.

[1884]  I. Lucki,et al.  Behavioral and Neurochemical Effects of 5-{4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl}-benzofuran-2-carboxamide (EMD 68843): A Combined Selective Inhibitor of Serotonin Reuptake and 5-Hydroxytryptamine1A Receptor Partial Agonist , 2002, Journal of Pharmacology and Experimental Therapeutics.

[1885]  J. Clack.  Patterns and processes in the early evolution of the tetrapod ear. , 2002, Journal of neurobiology.

[1886]  O. Rampin,et al.  α2a and α2c adrenoceptors on spinal neurons controlling penile erection , 2002, Neuroscience.

[1887]  A. Barabasi,et al.  Hierarchical Organization of Modularity in Metabolic Networks , 2002, Science.

[1888]  B. Szewczyk,et al.  Anxiolytic- and antidepressant-like effects of group III metabotropic glutamate agonist (1S,3R,4S)-1-aminocyclopentane-1,3,4-tricarboxylic acid (ACPT-I) in rats. , 2002, Polish journal of pharmacology.

[1889]  R. Elliott,et al.  5-HT2C receptor activation by m-chlorophenylpiperazine detected in humans with fMRI , 2002, Neuroreport.

[1890]  N. Simon,et al.  Ropinirole for antidepressant-induced sexual dysfunction , 2002, International clinical psychopharmacology.

[1891]  R. Anwyl,et al.  Overcoming the Effects of Stress on Synaptic Plasticity in the Intact Hippocampus: Rapid Actions of Serotonergic and Antidepressant Agents , 2002, The Journal of Neuroscience.

[1892]  Craig Mallinckrodt,et al.  Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial. , 2002, The Journal of clinical psychiatry.

[1893]  G. Nomikos,et al.  Effects of Typical and Atypical Antipsychotics and Receptor Selective Compounds on Acetylcholine Efflux in the Hippocampus of the Rat , 2002, Neuropsychopharmacology.

[1894]  J. Bernal.  Action of thyroid hormone in brain , 2002, Journal of endocrinological investigation.

[1895]  Tudor I. Oprea.  Current trends in lead discovery: Are we looking for the appropriate properties? , 2002, J. Comput. Aided Mol. Des..

[1896]  B. Langguth,et al.  Sleep deprivation in depression stabilizing antidepressant effects by repetitive transcranial magnetic stimulation. , 2002, Life sciences.

[1897]  P. Hurskainen,et al.  Novel detection strategies for drug discovery. , 2002, Drug discovery today.

[1898]  N. K. Popova,et al.  5-HT2A and 5-HT2C Serotonin Receptors Differentially Modulate Mouse Sexual Arousal and the Hypothalamo-Pituitary-Testicular Response to the Presence of a Female , 2002, Neuroendocrinology.

[1899]  M. Namiki,et al.  A causative factor of copulatory disorder in rats following social stress. , 2002, The Journal of urology.

[1900]  L. Price,et al.  A double-blind, placebo-controlled study of antidepressant augementation with mirtazapine , 2002, Biological Psychiatry.

[1901]  M. Stein,et al.  A randomized, double-blind, fixed-dose comparison of paroxetine and placebo in the treatment of generalized social anxiety disorder. , 2002, The Journal of clinical psychiatry.

[1902]  Y. Gomita,et al.  Neuronal nicotinic receptor and psychiatric disorders: functional and behavioral effects of nicotine. , 2002, Japanese journal of pharmacology.

[1903]  H. Möller,et al.  Repetitive Transcranial Magnetic Stimulation (rTMS) in Major Depression: Relation between Efficacy and Stimulation Intensity , 2002, Neuropsychopharmacology.

[1904]  G. Higgins,et al.  Influence of the 5-HT2C receptor antagonist, SB-242084, in tests of anxiety , 2002, Pharmacology Biochemistry and Behavior.

[1905]  D. Robinson.  Monoamine oxidase inhibitors: a new generation. , 2002, Psychopharmacology bulletin.

[1906]  A. Kudoh,et al.  Small-Dose Ketamine Improves the Postoperative State of Depressed Patients , 2002, Anesthesia and analgesia.

[1907]  Benno Roozendaal,et al.  Stress and Memory: Opposing Effects of Glucocorticoids on Memory Consolidation and Memory Retrieval , 2002, Neurobiology of Learning and Memory.

[1908]  M. Fava,et al.  Double-Blind Study of High-Dose Fluoxetine Versus Lithium or Desipramine Augmentation of Fluoxetine in Partial Responders and Nonresponders to Fluoxetine , 2002, Journal of clinical psychopharmacology.

[1909]  R. Quirion,et al.  The Neuropeptide Y (NPY) Y1 Receptor Subtype Mediates NPY-induced Antidepressant-like Activity in the Mouse Forced Swimming Test , 2002, Neuropsychopharmacology.

[1910]  E. Wong,et al.  Reboxetine: functional inhibition of monoamine transporters and nicotinic acetylcholine receptors. , 2002, The Journal of pharmacology and experimental therapeutics.

[1911]  M. Marinelli,et al.  Interaction between glucocorticoid hormones, stress and psychostimulant drugs * , 2002, The European journal of neuroscience.

[1912]  E. Lehr.  Potential antidepressant properties of pramipexole detected in locomotor and operant behavioral investigations in mice , 2002, Psychopharmacology.

[1913]  Neurobiology of Depression , 2002, Neuron.

[1914]  L. Schechter,et al.  The potential utility of 5-HT1A receptor antagonists in the treatment of cognitive dysfunction associated with Alzheimer s disease. , 2002, Current pharmaceutical design.

[1915]  Fridolin Sulser,et al.  The role of CREB and other transcription factors in the pharmacotherapy and etiology of depression , 2002, Annals of medicine.

[1916]  G. Griebel,et al.  Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[1917]  B. Rothbaum,et al.  Symptomatic and syndromal anxiety in chronic forms of major depression: effect of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination. , 2002, The Journal of clinical psychiatry.

[1918]  R. Hen,et al.  Participation of 5‐HT1B receptors in the inhibitory actions of serotonin on masculine sexual behaviour of mice: pharmacological analysis in 5‐HT1B receptor knockout mice , 2002 .

[1919]  M. I. Smith,et al.  Effect of SB-243213, a selective 5-HT2C receptor antagonist, on the rat sleep profile A comparison to paroxetine , 2002, Pharmacology Biochemistry and Behavior.

[1920]  M. Rigby,et al.  Substance P (Neurokinin 1) Receptor Antagonists Enhance Dorsal Raphe Neuronal Activity , 2002, The Journal of Neuroscience.

[1921]  Athina Markou,et al.  Assessing antidepressant activity in rodents: recent developments and future needs. , 2002, Trends in pharmacological sciences.

[1922]  M. Millan,et al.  Differential Actions of Antiparkinson Agents at Multiple Classes of Monoaminergic Receptor. I. A Multivariate Analysis of the Binding Profiles of 14 Drugs at 21 Native and Cloned Human Receptor Subtypes , 2002, Journal of Pharmacology and Experimental Therapeutics.

[1923]  Xiaohua Li,et al.  BDNF‐mediated signal transduction is modulated by GSK3β and mood stabilizing agents , 2002, Journal of neurochemistry.

[1924]  Rebeca Martínez-Turrillas,et al.  Chronic antidepressant treatment increases the membrane expression of AMPA receptors in rat hippocampus , 2002, Neuropharmacology.

[1925]  K. Fuxe,et al.  Differential enhancement of dialysate serotonin levels in distinct brain regions of the awake rat by modafinil: Possible relevance for wakefulness and depression , 2002, Journal of neuroscience research.

[1926]  C. Eap,et al.  Carbamazepine augmentation in depressive patients non-responding to citalopram: a pharmacokinetic and clinical pilot study , 2002, European Neuropsychopharmacology.

[1927]  M. Biondi,et al.  Psychopathological dimensions of depression: a factor study of the 17-item Hamilton depression rating scale in unipolar depressed outpatients. , 2002, Journal of affective disorders.

[1928]  G. Nowak,et al.  A role for glutamate in the treatment of anxiety and depression: Focus on group I metabotropic glutamate (mGlu) receptors , 2002 .

[1929]  Christopher J. Lee,et al.  A genomic view of alternative splicing , 2002, Nature Genetics.

[1930]  C. Gaveriaux-Ruff,et al.  Exploring the opioid system by gene knockout , 2002, Progress in Neurobiology.

[1931]  René Garcia.  Stress, metaplasticity, and antidepressants. , 2002, Current molecular medicine.

[1932]  Kelly A Berg,et al.  Rapid desensitization of the serotonin(2C) receptor system: effector pathway and agonist dependence. , 2002, The Journal of pharmacology and experimental therapeutics.

[1933]  R. Gannon,et al.  Delta opioid inhibition of light-induced phase advances in hamster circadian activity rhythms , 2002, Brain Research.

[1934]  H. Kitano.  Systems Biology: A Brief Overview , 2002, Science.

[1935]  C Stough,et al.  Evidence of an early information processing speed deficit in unipolar major depression , 2002, Psychological Medicine.

[1936]  I. Lucki,et al.  Noradrenergic lesions differentially alter the antidepressant-like effects of reboxetine in a modified forced swim test. , 2002, European journal of pharmacology.

[1937]  T. Kelly,et al.  Discriminative-stimulus effects of modafinil in cocaine-trained humans. , 2002, Drug and alcohol dependence.

[1938]  J. Raber,et al.  Decreased anxiety-like behavior, reduced stress hormones, and neurosteroid supersensitivity in mice lacking protein kinase Cepsilon. , 2002, The Journal of clinical investigation.

[1939]  Heinz Bönisch,et al.  Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3 , 2002, British journal of pharmacology.

[1940]  T. Bolwig,et al.  Extracellular levels of NPY in the dorsal hippocampus of freely moving rats are markedly elevated following a single electroconvulsive stimulation, irrespective of anticonvulsive Y1 receptor blockade , 2002, Neuropeptides.

[1941]  J. Hirschhorn,et al.  A comprehensive review of genetic association studies , 2002, Genetics in Medicine.

[1942]  H. Milman,et al.  Neurologic, Psychological, and Aggressive Disturbances with Sildenafil , 2002, The Annals of pharmacotherapy.

[1943]  G. Koob,et al.  Urocortin shares the memory modulating effects of corticotropin-releasing factor (CRF): mediation by CRF1 receptors , 2002, Brain Research.

[1944]  M. Millan,et al.  Stereospecific blockade of marble-burying behaviour in mice by selective, non-peptidergic neurokinin1 (NK1) receptor antagonists , 2002, Neuropharmacology.

[1945]  C. Pifl,et al.  Organic cation transporter mRNA and function in the rat superior cervical ganglion , 2002, The Journal of physiology.

[1946]  Q. Greba,et al.  Ventral tegmental area dopamine neurons mediate the shock sensitization of acoustic startle: a potential site of action for benzodiazepine anxiolytics. , 2002, Behavioral neuroscience.

[1947]  R. Ursin.  Serotonin and sleep. , 2002, Sleep medicine reviews.

[1948]  W. Burke,et al.  Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients. , 2002, The Journal of clinical psychiatry.

[1949]  Victoria Arango,et al.  Altered Editing of Serotonin 2C Receptor Pre-mRNA in the Prefrontal Cortex of Depressed Suicide Victims , 2002, Neuron.

[1950]  M. Opp,et al.  Role of corticotropin-releasing hormone in stressor-induced alterations of sleep in rat. , 2002, American journal of physiology. Regulatory, integrative and comparative physiology.

[1951]  B. Westerink,et al.  Can antipsychotic drugs be classified by their effects on a particular group of dopamine neurons in the brain? , 2002, European journal of pharmacology.

[1952]  G. Alexopoulos,et al.  Executive dysfunction in geriatric depression. , 2002, The American journal of psychiatry.

[1953]  B. Bjorvatn,et al.  Effects of sleep deprivation on extracellular serotonin in hippocampus and frontal cortex of the rat , 2002, Neuroscience.

[1954]  S. Marumoto,et al.  Design and synthesis of dual inhibitors of acetylcholinesterase and serotonin transporter targeting potential agents for Alzheimer's disease. , 2002, Organic letters.

[1955]  E. Ginns,et al.  Vasopressin V1b receptor knockout reduces aggressive behavior in male mice , 2002, Molecular Psychiatry.

[1956]  K. Otani,et al.  Relationship Between Plasma Concentrations of Trazodone and Its Active Metabolite, m-Chlorophenylpiperazine, and Its Clinical Effect in Depressed Patients , 2002, Therapeutic drug monitoring.

[1957]  O. Stiedl,et al.  Pharmacology and biology of corticotropin-releasing factor (CRF) receptors. , 2002, Receptors & channels.

[1958]  Jeffrey G. Tasker,et al.  Local circuit regulation of paraventricular nucleus stress integration Glutamate–GABA connections , 2002, Pharmacology Biochemistry and Behavior.

[1959]  M. Millan,et al.  Antibody capture assay reveals bell-shaped concentration-response isotherms for h5-HT(1A) receptor-mediated Galpha(i3) activation: conformational selection by high-efficacy agonists, and relationship to trafficking of receptor signaling. , 2002, Molecular pharmacology.

[1960]  M. Raiteri,et al.  Coexistence and function of different neurotransmitter transporters in the plasma membrane of CNS neurons , 2002, Progress in Neurobiology.

[1961]  S. Qvitzau,et al.  Treatment strategies in patients with major depression not responding to first-line sertraline treatment , 2002, Psychopharmacology.

[1962]  J. Montoya,et al.  Small world patterns in food webs. , 2002, Journal of theoretical biology.

[1963]  Optimizing antidepressant treatment: efficacy and tolerability , 2002, International clinical psychopharmacology.

[1964]  Koen Schruers,et al.  Comorbidity of obsessive-compulsive disorder and depression: prevalence, symptom severity, and treatment effect. , 2002, The Journal of clinical psychiatry.

[1965]  E. Giacobini,et al.  Inhibition of acetyl- and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefit , 2002, Journal of Neural Transmission.

[1966]  M. Millan,et al.  Differential Actions of Antiparkinson Agents at Multiple Classes of Monoaminergic Receptor. III. Agonist and Antagonist Properties at Serotonin, 5-HT1 and 5-HT2, Receptor Subtypes , 2002, Journal of Pharmacology and Experimental Therapeutics.

[1967]  S. Salerno,et al.  The effect of antidepressant treatment on chronic back pain: a meta-analysis. , 2002, Archives of internal medicine.

[1968]  E. Hirsch,et al.  Levodopa but not ropinirole induces an internalization of D1 dopamine receptors in parkinsonian rats , 2002, Movement disorders : official journal of the Movement Disorder Society.

[1969]  Chern-Sing Goh,et al.  Co-evolutionary analysis reveals insights into protein-protein interactions. , 2002, Journal of molecular biology.

[1970]  G. Griebel,et al.  Characterization of (2S,4R)-1-[5-chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a selective and orally active vasopressin V1b receptor antagonist. , 2002, The Journal of pharmacology and experimental therapeutics.

[1971]  A. Merighi.  Costorage and coexistence of neuropeptides in the mammalian CNS , 2002, Progress in Neurobiology.

[1972]  V. Neugebauer.  Metabotropic glutamate receptors – important modulators of nociception and pain behavior , 2002, Pain.

[1973]  A. Christopoulos,et al.  Modulation of cannabinoid agonist binding by 5‐HT in the rat cerebellum , 2002, Journal of neurochemistry.

[1974]  H. Manji,et al.  Timing is everything: does the robust upregulation of noradrenergically regulated plasticity genes underlie the rapid antidepressant effects of sleep deprivation? , 2002, Biological Psychiatry.

[1975]  Z. Nahas,et al.  Novel treatments of mood disorders based on brain circuitry (ECT, MST, TMS, VNS, DBS). , 2002, Seminars in clinical neuropsychiatry.

[1976]  E. Paykel,et al.  The role of noradrenaline and selective noradrenaline reuptake inhibition in depression , 2002, European Neuropsychopharmacology.

[1977]  K. Davis,et al.  Developing novel treatments for mood disorders: accelerating discovery , 2002, Biological Psychiatry.

[1978]  J. Krasuski,et al.  Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for major depression: preliminary results of a randomized trial , 2002, Biological Psychiatry.

[1979]  D. Sheehan,et al.  Nicotinic acetylcholine receptors as targets for antidepressants , 2002, Molecular Psychiatry.

[1980]  A. Zapata,et al.  D3 receptor ligands modulate extracellular dopamine clearance in the nucleus accumbens , 2002, Journal of neurochemistry.

[1981]  D. Cussac,et al.  The novel antidepressant, S35966, is a mixed serotonin and noradrenaline reuptake inhibitor and an antagonist at α2-adrenoceptors , 2002, European Neuropsychopharmacology.

[1982]  B. Lerer,et al.  Pharmacogenetics of antidepressant and mood-stabilizing drugs: a review of candidate-gene studies and future research directions. , 2002, The international journal of neuropsychopharmacology.

[1983]  R. Morris,et al.  Chronic Treatment with the Antidepressant Amitriptyline Prevents Impairments in Water Maze Learning in Aging Rats , 2002, The Journal of Neuroscience.

[1984]  D. Sheehan,et al.  Neuronal nicotinic receptor inhibition for treating mood disorders preliminary controlled evidence with mecamylamine , 2002, Depression and anxiety.

[1985]  C. Colwell,et al.  Excitatory mechanisms in the suprachiasmatic nucleus: the role of AMPA/KA glutamate receptors. , 2002, Journal of neurophysiology.

[1986]  K. Itoh,et al.  Monoamine oxidase: A gene polymorphism, tryptophan hydroxylase gene polymorphism and antidepressant response to fluvoxamine in Japanese patients with major depressive disorder , 2002, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[1987]  M. Fava,et al.  A survey of prescribing practices in the treatment of depression , 2002, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[1988]  V. Watts.  Molecular mechanisms for heterologous sensitization of adenylate cyclase. , 2002, The Journal of pharmacology and experimental therapeutics.

[1989]  R. Leadbetter,et al.  Prevalence of sexual dysfunction among newer antidepressants. , 2002, The Journal of clinical psychiatry.

[1990]  R. Verkes,et al.  Neurosteroids in depression: a review , 2002, Psychopharmacology.

[1991]  M. Fava,et al.  The Pharmacologic Management of SSRI-Induced Side Effects: A Survey of Psychiatrists , 2002 .

[1992]  R. Wise,et al.  Dopamine Uptake through the Norepinephrine Transporter in Brain Regions with Low Levels of the Dopamine Transporter: Evidence from Knock-Out Mouse Lines , 2002, The Journal of Neuroscience.

[1993]  R. Kerwin,et al.  Developments in the pharmacological treatment of schizophrenia , 2002, Expert opinion on investigational drugs.

[1994]  D. Small,et al.  Cholinergic abnormalities in Alzheimer's disease: are there new targets for drug development? , 2002 .

[1995]  Jesse Brodkin,et al.  Anxiolytic-like activity of the mGluR5 antagonist MPEP A comparison with diazepam and buspirone , 2002, Pharmacology Biochemistry and Behavior.

[1996]  J. Pin,et al.  The metabotropic glutamate receptors: structure, activation mechanism and pharmacology. , 2002, Current drug targets. CNS and neurological disorders.

[1997]  P. Driggers,et al.  Estrogen action and cytoplasmic signaling cascades. Part I: membrane-associated signaling complexes , 2002, Trends in Endocrinology & Metabolism.

[1998]  S. Datta,et al.  Sleep-wake effects of meta-chlorophenyl piperazine and mianserin in the behaviorally depressed rat. , 2002, European journal of pharmacology.

[1999]  F. Naftolin,et al.  Phytoestrogens: are they really estrogen mimics? , 2002, Fertility and sterility.

[2000]  P. Sachdev,et al.  Effects of different frequencies of transcranial magnetic stimulation (TMS) on the forced swim test model of depression in rats , 2002, Biological Psychiatry.

[2001]  H. Bönisch,et al.  Direct inhibition by cannabinoids of human 5‐HT3A receptors: probable involvement of an allosteric modulatory site , 2002, British journal of pharmacology.

[2002]  C. DeVane,et al.  Pharmacology of antidepressants: focus on nefazodone. , 2002, The Journal of clinical psychiatry.

[2003]  U. Bonnet.  Moclobemide: evolution, pharmacodynamic, and pharmacokinetic properties. , 2006, CNS drug reviews.

[2004]  J. Seibyl,et al.  Do dopamine agonists or levodopa modify Parkinson's disease progression? , 2002, European journal of neurology.

[2005]  R. Seifert,et al.  Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors , 2002, Naunyn-Schmiedeberg's Archives of Pharmacology.

[2006]  M. Guttman,et al.  Dopamine agonist monotherapy in Parkinson's disease , 2002, The Lancet.

[2007]  J. Wess,et al.  M1 muscarinic receptor signaling in mouse hippocampus and cortex , 2002, Brain Research.

[2008]  R. Hen,et al.  Involvement of 5-HT1A Receptors in Homeostatic and Stress-Induced Adaptive Regulations of Paradoxical Sleep: Studies in 5-HT1A Knock-Out Mice , 2002, The Journal of Neuroscience.

[2009]  A. Nieoullon.  Dopamine and the regulation of cognition and attention , 2002, Progress in Neurobiology.

[2010]  The current status of the diagnostic validity and treatment of generalized anxiety disorder , 2002 .

[2011]  A. Young,et al.  Elevation of the cortisol-dehydroepiandrosterone ratio in drug-free depressed patients. , 2002, The American journal of psychiatry.

[2012]  K. Perry,et al.  R-fluoxetine Increases Extracellular DA, NE, As Well As 5-HT in Rat Prefrontal Cortex and Hypothalamus: An in vivo Microdialysis and Receptor Binding Study , 2002, Neuropsychopharmacology.

[2013]  Alex Matter,et al.  Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug , 2002, Nature Reviews Drug Discovery.

[2014]  M. Zhuo,et al.  Activation of brainstem metabotropic glutamate receptors inhibits spinal nociception in adult rats , 2002, Pharmacology Biochemistry and Behavior.

[2015]  Koji Hyodo,et al.  Transcranial magnetic stimulation induces increases in extracellular levels of dopamine and glutamate in the nucleus accumbens , 2002, Neuroreport.

[2016]  J. Adrien.  Neurobiological bases for the relation between sleep and depression. , 2002, Sleep medicine reviews.

[2017]  H. Geerts,et al.  Nicotinic cholinergic modulation: galantamine as a prototype. , 2006, CNS drug reviews.

[2018]  C. Cunha,et al.  Evaluation of the face validity of reserpine administration as an animal model of depression–Parkinson's disease association , 2002, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[2019]  F. Colpaert,et al.  Effects of acute and subchronic administration of dexefaroxan, an alpha(2)-adrenoceptor antagonist, on memory performance in young adult and aged rodents. , 2002, Journal of Pharmacology and Experimental Therapeutics.

[2020]  M. Keck,et al.  Vasopressin in CSF and plasma in depressed suicide attempters: preliminary results , 2002, European Neuropsychopharmacology.

[2021]  H. Westenberg,et al.  Quetiapine addition to serotonin reuptake inhibitor treatment in patients with treatment-refractory obsessive-compulsive disorder: an open-label study. , 2002, The Journal of clinical psychiatry.

[2022]  J. Markowitz,et al.  Clinical Pharmacokinetics of Sertraline , 2002, Clinical pharmacokinetics.

[2023]  M. Popoli,et al.  Modulation of synaptic plasticity by stress and antidepressants. , 2002, Bipolar disorders.

[2024]  K. Krobert,et al.  The human 5‐HT7 serotonin receptor splice variants: constitutive activity and inverse agonist effects , 2002, British journal of pharmacology.

[2025]  S Kasper,et al.  A meta-analysis of randomized controlled trials of tianeptine versus SSRI in the short-term treatment of depression , 2002, European Psychiatry.

[2026]  P. Greengard,et al.  Involvement of striatal and extrastriatal DARPP-32 in biochemical and behavioral effects of fluoxetine (Prozac) , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[2027]  N. Gay,et al.  Neurokinin NK1- and NK3-immunoreactive neurons in serotonergic cell groups in the rat brain , 2002, Neuroscience Letters.

[2028]  J. Krystal,et al.  Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors. , 2002, The American journal of psychiatry.

[2029]  A. Ottani,et al.  Influence of sildenafil on central dopamine-mediated behaviour in male rats. , 2002, Life sciences.

[2030]  L. A. Fetsko,et al.  Dopamine D2L receptor knockout mice display deficits in positive and negative reinforcing properties of morphine and in avoidance learning , 2002, Neuroscience.

[2031]  Z. Nahas,et al.  Vagus nerve stimulation (VNS) synchronized BOLD fMRI suggests that VNS in depressed adults has frequency/dose dependent effects. , 2002, Journal of psychiatric research.

[2032]  J. Frahm,et al.  Substance P receptor antagonist and clomipramine prevent stress-induced alterations in cerebral metabolites, cytogenesis in the dentate gyrus and hippocampal volume , 2002, Molecular Psychiatry.

[2033]  T. Dinan,et al.  Vasopressin as a target for antidepressant development: an assessment of the available evidence. , 2002, Journal of affective disorders.

[2034]  P. Strange.  Mechanisms of inverse agonism at G-protein-coupled receptors. , 2002, Trends in pharmacological sciences.

[2035]  D. Finn,et al.  Reinforcing effects of the neurosteroid allopregnanolone in rats , 2002, Pharmacology Biochemistry and Behavior.

[2036]  H. Manji,et al.  Modulators of the glutamatergic system: implications for the development of improved therapeutics in mood disorders. , 2002, Psychopharmacology bulletin.

[2037]  R. Leak,et al.  Suprachiasmatic nucleus organization , 2002, Cell and Tissue Research.

[2038]  I. Lucki,et al.  Simultaneous analyses of the neurochemical and behavioral effects of the norepinephrine reuptake inhibitor reboxetine in a rat model of antidepressant action , 2002, Psychopharmacology.

[2039]  P. Lestage,et al.  Cognition enhancing or neuroprotective compounds for the treatment of cognitive disorders: why? when? which? , 2003, Experimental Gerontology.

[2040]  Olga V. Demler,et al.  The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). , 2003, JAMA.

[2041]  J. Duan,et al.  Mammalian Mutation Pressure, Synonymous Codon Choice, and mRNA Degradation , 2003, Journal of Molecular Evolution.

[2042]  Markus Kosel,et al.  Magnetic Seizure Therapy Improves Mood in Refractory Major Depression , 2003, Neuropsychopharmacology.

[2043]  Andrew H. Miller,et al.  When Not Enough Is Too Much: The Role of Insufficient Glucocorticoid Signaling in the Pathophysiology of Stress-Related Disorders , 2003 .

[2044]  B. Pollock,et al.  Persistence of cognitive impairment in geriatric patients following antidepressant treatment: a randomized, double-blind clinical trial with nortriptyline and paroxetine. , 2003, Journal of psychiatric research.

[2045]  C. Sánchez,et al.  Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities , 2003, Psychopharmacology.

[2046]  T. Branchek,et al.  Trace amine receptors as targets for novel therapeutics: legend, myth and fact. , 2003, Current opinion in pharmacology.

[2047]  A. Rodrigues,et al.  Melatonin exerts an antidepressant-like effect in the tail suspension test in mice: evidence for involvement of N-methyl-d-aspartate receptors and the l-arginine-nitric oxide pathway , 2003, Neuroscience Letters.

[2048]  K. Ikeda,et al.  Inhibition of G protein‐activated inwardly rectifying K+ channels by fluoxetine (Prozac) , 2003, British journal of pharmacology.

[2049]  A. Janowsky,et al.  Transporter-mediated actions of R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane. , 2003, European journal of pharmacology.

[2050]  B. O'dowd,et al.  Homo- and hetero-oligomerization of G protein-coupled receptors. , 2003, Life sciences.

[2051]  G. Griebel,et al.  Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders. , 2003, Trends in pharmacological sciences.

[2052]  D. Jourdan,et al.  Evidence for a monoamine mediated, opioid-independent, antihyperalgesic effect of venlafaxine, a non-tricyclic antidepressant, in a neurogenic pain model in rats , 2003, Pain.

[2053]  S. Kish.  Biochemistry of Parkinson's disease: is a brain serotonergic deficiency a characteristic of idiopathic Parkinson's disease? , 2003, Advances in neurology.

[2054]  Craig Mallinckrodt,et al.  Duloxetine in treatment of anxiety symptoms associated with depression , 2003, Depression and anxiety.

[2055]  M. Bakker,et al.  Synthesis of 3a,4-dihydro-3H-[1]benzopyrano[4,3-c]isoxazoles, displaying combined 5-HT uptake inhibiting and alpha(2)-adrenoceptor antagonistic activities: a novel series of potential antidepressants. , 2003, Bioorganic & medicinal chemistry letters.

[2056]  Eugene V Koonin,et al.  Evolution of alternative splicing: deletions, insertions and origin of functional parts of proteins from intron sequences. , 2003, Trends in genetics : TIG.

[2057]  V. Gribkoff,et al.  An Assessment of the Effects of Serotonin 6 (5-HT6) Receptor Antagonists in Rodent Models of Learning , 2003, Journal of Pharmacology and Experimental Therapeutics.

[2058]  P. Brambilla,et al.  GABAergic dysfunction in mood disorders , 2003, Molecular Psychiatry.

[2059]  Hiroshi Baba,et al.  The Role of N-Methyl-d-Aspartate (NMDA) Receptors in Pain: A Review , 2003, Anesthesia and analgesia.

[2060]  Chiara Ruini,et al.  Treatment of Recurrent Depression , 2003, CNS drugs.

[2061]  A. Wagner.  How the global structure of protein interaction networks evolves , 2002, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[2062]  P. Kelly,et al.  Antidepressant and anxiolytic‐like effects in mice lacking the group III metabotropic glutamate receptor mGluR7 , 2003, The European journal of neuroscience.

[2063]  F. Bymaster,et al.  New approaches to developing antidepressants by enhancing monoaminergic neurotransmission , 2003, Expert opinion on investigational drugs.

[2064]  S. Horschitz,et al.  Functional coupling of serotonin and noradrenaline transporters , 2003, Journal of neurochemistry.

[2065]  S. Tsai,et al.  Association study of a brain‐derived neurotrophic‐factor genetic polymorphism and major depressive disorders, symptomatology, and antidepressant response , 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[2066]  F. Ayala,et al.  Pseudogenes: are they "junk" or functional DNA? , 2003, Annual review of genetics.

[2067]  J. Krystal,et al.  Increased cortical GABA concentrations in depressed patients receiving ECT. , 2003, The American journal of psychiatry.

[2068]  M. Fava,et al.  Serotonin transporter polymorphisms and adverse effects with fluoxetine treatment , 2003, Biological Psychiatry.

[2069]  J. O'Donnell,et al.  Antagonism of the antidepressant-like effects of clenbuterol by central administration of β-adrenergic antagonists in rats , 2003, Psychopharmacology.

[2070]  N. DeMartinis,et al.  Comparative effects of mirtazapine and fluoxetine on sleep physiology measures in patients with major depression and insomnia. , 2003, The Journal of clinical psychiatry.

[2071]  Ronald W. Davis,et al.  Role of duplicate genes in genetic robustness against null mutations , 2003, Nature.

[2072]  R. Holloway,et al.  Burdens and benefits of placebos in antidepressant clinical trials: a decision and cost-effectiveness analysis. , 2003, The American journal of psychiatry.

[2073]  A. Schatzberg.  Efficacy and tolerability of duloxetine, a novel dual reuptake inhibitor, in the treatment of major depressive disorder. , 2003, The Journal of clinical psychiatry.

[2074]  J. Worthington,et al.  Treatment of antidepressant-induced sexual dysfunction. , 2003, Drugs of today.

[2075]  James E Mitchell,et al.  Towards the pharmacotherapy of eating disorders , 2003, Expert opinion on pharmacotherapy.

[2076]  B. Platt,et al.  Glutamate receptor function in learning and memory , 2003, Behavioural Brain Research.

[2077]  Citalopram treatment of fluoxetine-intolerant depressed patients. , 2003, The Journal of clinical psychiatry.

[2078]  M. Millan,et al.  Piribedil Enhances Frontocortical and Hippocampal Release of Acetylcholine in Freely Moving Rats by Blockade of α2A-Adrenoceptors: A Dialysis Comparison to Talipexole and Quinelorane in the Absence of Acetylcholinesterase Inhibitors , 2003, Journal of Pharmacology and Experimental Therapeutics.

[2079]  C. Wilson,et al.  Total sleep deprivation increases extracellular serotonin in the rat hippocampus , 2003, Neuroscience.

[2080]  Glenda M MacQueen,et al.  Course of illness, hippocampal function, and hippocampal volume in major depression , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[2081]  Andreas Wagner,et al.  Convergent evolution of gene circuits , 2003, Nature Genetics.

[2082]  D. Min,et al.  Fluoxetine blocks cloned neuronal A-type K+ channels Kv1.4 , 2003, Neuroreport.

[2083]  D. Daniels,et al.  Hypothalamic co-localization of substance P receptor and transneuronal tracer from the lordosis-relevant lumbar epaxial muscles in the female rat , 2003, Neuroscience Letters.

[2084]  H. Birnbaum,et al.  The economic burden of depression with painful symptoms. , 2003, The Journal of clinical psychiatry.

[2085]  N. Pitsikas,et al.  The 5-HT1A receptor antagonist WAY 100635 improves rats performance in different models of amnesia evaluated by the object recognition task , 2003, Brain Research.

[2086]  S. Doggrell,et al.  Treatment of dementia with neurotransmission modulation , 2003, Expert opinion on investigational drugs.

[2087]  Alcino J. Silva,et al.  Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice , 2003, Nature Neuroscience.

[2088]  Ricard V Solé,et al.  Adaptive walks in a gene network model of morphogenesis: insights into the Cambrian explosion. , 2003, The International journal of developmental biology.

[2089]  Haiyun Xu,et al.  Dose-Related Effects of Chronic Antidepressants on Neuroprotective Proteins BDNF, Bcl-2 and Cu/Zn-SOD in Rat Hippocampus , 2003, Neuropsychopharmacology.

[2090]  A. Tingström,et al.  Electroconvulsive seizures induce proliferation of NG2-expressing glial cells in adult rat hippocampus , 2003, Biological Psychiatry.

[2091]  M. Papp,et al.  Effect of Agomelatine in the Chronic Mild Stress Model of Depression in the Rat , 2003, Neuropsychopharmacology.

[2092]  S. Sesack,et al.  Anatomical Substrates for Glutamate‐Dopamine Interactions , 2003 .

[2093]  U. Tural,et al.  Faster response in depressive patients treated with fluoxetine alone than in combination with buspirone. , 2003, Journal of affective disorders.

[2094]  C. Sánchez,et al.  The R-enantiomer of citalopram counteracts escitalopram-induced increase in extracellular 5-HT in the frontal cortex of freely moving rats , 2003, Neuropharmacology.

[2095]  S. Awata,et al.  Electroconvulsive shock increases serotonin transporter in the rat frontal cortex , 2003, Neuroscience Letters.

[2096]  C. Wahlestedt,et al.  Behavioural analysis of melanin-concentrating hormone in rats: evidence for orexigenic and anxiolytic properties , 2003, Regulatory Peptides.

[2097]  V. Chapman,et al.  Effects of spinal administration of muscimol on C- and A-fibre evoked neuronal responses of spinal dorsal horn neurones in control and nerve injured rats , 2003, Brain Research.

[2098]  Christopher J. Lee,et al.  Alternative splicing in the nervous system: an emerging source of diversity and regulation , 2003, Biological Psychiatry.

[2099]  K. Hugdahl,et al.  Attention profile in schizophrenia compared with depression: differential effects of processing speed, selective attention and vigilance , 2003, Acta psychiatrica Scandinavica.

[2100]  R. Shelton.  The combination of olanzapine and fluoxetine in mood disorders , 2003, Expert opinion on pharmacotherapy.

[2101]  S. Archer,et al.  Paroxetine-Induced Increase in Metabolic End Products of Nitric Oxide , 2003, Journal of clinical psychopharmacology.

[2102]  Teruo Hayashi,et al.  σ-1 Receptors (σ1 Binding Sites) Form Raft-Like Microdomains and Target Lipid Droplets on the Endoplasmic Reticulum: Roles in Endoplasmic Reticulum Lipid Compartmentalization and Export , 2003, Journal of Pharmacology and Experimental Therapeutics.

[2103]  G. Skuza.  Potential antidepressant activity of sigma ligands. , 2003, Polish journal of pharmacology.

[2104]  R. Oosting,et al.  5-HT1A receptor knockout mice and mice overexpressing corticotropin-releasing hormone in models of anxiety. , 2003, European journal of pharmacology.

[2105]  R. Gannon,et al.  Serotonergic serotonin1A mixed agonists/antagonists elicit large-magnitude phase shifts in hamster circadian wheel-running rhythms , 2003, Neuroscience.

[2106]  C. J. Davis,et al.  REM sleep deprivation-induced deficits in the latency-to-peak induction and maintenance of long-term potentiation within the CA1 region of the hippocampus , 2003, Brain Research.

[2107]  C. Mallinckrodt,et al.  Duloxetine in the long-term treatment of major depressive disorder. , 2003, The Journal of clinical psychiatry.

[2108]  A. Kocabas,et al.  Glycosyl Modification Facilitates Homo- and Hetero-oligomerization of the Serotonin Transporter , 2003, Journal of Biological Chemistry.

[2109]  P. Bork,et al.  Genome evolution reveals biochemical networks and functional modules , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[2110]  R. Hen,et al.  5-HT1A/1B Receptor-Mediated Effects of the Selective Serotonin Reuptake Inhibitor, Citalopram, on Sleep: Studies in 5-HT1A and 5-HT1B Knockout Mice , 2003, Neuropsychopharmacology.

[2111]  M. Kim,et al.  Differential distribution of GABA(B1) and GABA(B2) receptor mRNAs in the rat brain. , 2003, Molecules and cells.

[2112]  R. Gainetdinov,et al.  Plasma membrane monoamine transporters: structure, regulation and function , 2003, Nature Reviews Neuroscience.

[2113]  S. Kennedy,et al.  Recent developments in the psychobiology and pharmacotherapy of depression: optimising existing treatments and novel approaches for the future , 2003, Expert opinion on investigational drugs.

[2114]  R. Schreiber,et al.  AR-R 17779 improves social recognition in rats by activation of nicotinic α7 receptors , 2004, Psychopharmacology.

[2115]  T. Laughren.  Comorbid mood disorders and medical illness: a Food and Drug Administration perspective , 2003, Biological Psychiatry.

[2116]  A. Schatzberg,et al.  A Prospective Trial of Bupropion SR Augmentation of Partial and Non-Responders to Serotonergic Antidepressants , 2003, Journal of clinical psychopharmacology.

[2117]  A. Schatzberg,et al.  Pharmacogenetics of antidepressant medication intolerance. , 2003, The American journal of psychiatry.

[2118]  Z N Oltvai,et al.  Evolutionary conservation of motif constituents in the yeast protein interaction network , 2003, Nature Genetics.

[2119]  A. Gołębiowski,et al.  Lead compounds discovered from libraries: part 2. , 2003, Current opinion in chemical biology.

[2120]  A. Yamatodani,et al.  Modafinil increases histamine release in the anterior hypothalamus of rats , 2003, Neuroscience Letters.

[2121]  F. Holsboer,et al.  Effect of Chronic Administration of Selective Glucocorticoid Receptor Antagonists on the Rat Hypothalamic–Pituitary–Adrenocortical Axis , 2003, Neuropsychopharmacology.

[2122]  M. Popoli,et al.  Selective regulation of presynaptic Calcium/Calmodulin-Dependent protein kinase II by psychotropic drugs , 2003, Biological Psychiatry.

[2123]  M. Briley.  New hope in the treatment of painful symptoms in depression. , 2003, Current opinion in investigational drugs.

[2124]  S. Stern.  The evolution of comets in the Oort cloud and Kuiper belt , 2003, Nature.

[2125]  Wilhelm Kirch,et al.  Effects of sertraline on autonomic and cognitive functions in healthy volunteers , 2003, Psychopharmacology.

[2126]  H. Croft,et al.  Antidepressant-related erectile dysfunction: management via avoidance, switching antidepressants, antidotes, and adaptation. , 2003, The Journal of clinical psychiatry.

[2127]  M. Rasenick,et al.  G protein signaling and the molecular basis of antidepressant action. , 2003, Life sciences.

[2128]  J. Hagan,et al.  Selective Antagonism at Dopamine D3 Receptors Enhances Monoaminergic and Cholinergic Neurotransmission in the Rat Anterior Cingulate Cortex , 2003, Neuropsychopharmacology.

[2129]  Stephen M Stahl,et al.  Brain circuits determine destiny in depression: a novel approach to the psychopharmacology of wakefulness, fatigue, and executive dysfunction in major depressive disorder. , 2003, The Journal of clinical psychiatry.

[2130]  Paul Antoine Salin,et al.  A role of melanin-concentrating hormone producing neurons in the central regulation of paradoxical sleep , 2003, BMC Neuroscience.

[2131]  T. Sharp,et al.  Evidence that central 5‐HT2A and 5‐HT2B/C receptors regulate 5‐HT cell firing in the dorsal raphe nucleus of the anaesthetised rat , 2003, British journal of pharmacology.

[2132]  A. Fernández-Guasti,et al.  Antidepressant-Like Effect of Different Estrogenic Compounds in the Forced Swimming Test , 2003, Neuropsychopharmacology.

[2133]  N. Ling,et al.  Mechanism of corticotropin-releasing factor type I receptor regulation by nonpeptide antagonists. , 2003, Molecular Pharmacology.

[2134]  C. Wichems,et al.  Brain region‐specific alterations of 5‐HT2A and 5‐HT2C receptors in serotonin transporter knockout mice , 2003, Journal of neurochemistry.

[2135]  E. H. Goulding,et al.  Hyperactivity and reduced energy cost of physical activity in serotonin 5-HT(2C) receptor mutant mice. , 2003, Diabetes.

[2136]  Jiunn H. Lin,et al.  Role of P-Glycoprotein in Pharmacokinetics , 2003, Clinical pharmacokinetics.

[2137]  V. Arolt,et al.  Neurotrophic Effects of Electroconvulsive Therapy: A Proton Magnetic Resonance Study of the Left Amygdalar Region in Patients with Treatment-Resistant Depression , 2003, Neuropsychopharmacology.

[2138]  J. Davidson,et al.  Current and potential pharmacological treatments for obsessive-compulsive disorder , 2003, Expert opinion on investigational drugs.

[2139]  K. Inui,et al.  Intestinal absorption of drugs mediated by drug transporters: mechanisms and regulation. , 2003, Drug metabolism and pharmacokinetics.

[2140]  E. sanders-Bush,et al.  Agonist-induced Phosphorylation of the Serotonin 5-HT2C Receptor Regulates Its Interaction with Multiple PDZ Protein 1* , 2003, Journal of Biological Chemistry.

[2141]  Peter Sheridan Dodds,et al.  Information exchange and the robustness of organizational networks , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[2142]  N. Schneiderman,et al.  Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. , 2003, JAMA.

[2143]  Mark Gerstein,et al.  Millions of years of evolution preserved: a comprehensive catalog of the processed pseudogenes in the human genome. , 2003, Genome research.

[2144]  P. Fletcher,et al.  Serotonin and drug reward: focus on 5-HT2C receptors. , 2003, European journal of pharmacology.

[2145]  J. Deuchars,et al.  GABAB receptor subunit expression in glia , 2003, Molecular and Cellular Neuroscience.

[2146]  G. Kennett,et al.  Oral administration of the 5-HT2C receptor agonist, mCPP, reduces body weight gain in rats over 28 days as a result of maintained hypophagia , 2003, Psychopharmacology.

[2147]  J. Kostis,et al.  Overview of phosphodiesterase 5 inhibition in erectile dysfunction. , 2003, The American journal of cardiology.

[2148]  B. Hahn,et al.  Involvement of the prefrontal cortex but not the dorsal hippocampus in the attention-enhancing effects of nicotine in rats , 2003, Psychopharmacology.

[2149]  F. Vollenweider,et al.  Effects of the 5-HT2A Agonist Psilocybin on Mismatch Negativity Generation and AX-Continuous Performance Task: Implications for the Neuropharmacology of Cognitive Deficits in Schizophrenia , 2003, Neuropsychopharmacology.

[2150]  M. Millan,et al.  The CRF1 receptor antagonist, DMP695, abolishes activation of locus coeruleus noradrenergic neurones by CRF in anesthetized rats. , 2003, European journal of pharmacology.

[2151]  S. Palmer,et al.  Use of cognitive therapy for relapse prevention in chronic depression , 2003, British Journal of Psychiatry.

[2152]  P Jeffrey Conn,et al.  A family of highly selective allosteric modulators of the metabotropic glutamate receptor subtype 5. , 2003, Molecular pharmacology.

[2153]  M. Bauer,et al.  Hypothalamic-pituitary-thyroid system activity during lithium augmentation therapy in patients with unipolar major depression. , 2003, Journal of psychiatry & neuroscience : JPN.

[2154]  Abraham Weizman,et al.  Brain neurosteroid changes after paroxetine administration in mice , 2003, European Neuropsychopharmacology.

[2155]  Kevin Pang,et al.  The further evolution of biotech , 2003, Nature Reviews Drug Discovery.

[2156]  A. Cohen,et al.  REM Sleep Effects as a Biomarker for the Effects of Antidepressants in Healthy Volunteers , 2003, Journal of psychopharmacology.

[2157]  A. Argiolas,et al.  Extra‐cellular dopamine increases in the paraventricular nucleus of male rats during sexual activity , 2003, The European journal of neuroscience.

[2158]  J. Lehár,et al.  Systematic discovery of multicomponent therapeutics , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[2159]  Hui-chen Liu,et al.  Stereoselectivity in trans-tramadol metabolism and trans-O-demethyltramadol formation in rat liver microsomes. , 2003, Acta pharmacologica Sinica.

[2160]  J. Spiess,et al.  The corticotropin-releasing factor receptor 1 antagonist CP-154,526 reverses stress-induced learning deficits in mice , 2003, Behavioural Brain Research.

[2161]  J. Finberg,et al.  L-DOPA increases noradrenaline turnover in central and peripheral nervous systems , 2003, Neuropharmacology.

[2162]  B. Sahakian,et al.  Paroxetine does not improve symptoms and impairs cognition in frontotemporal dementia: a double-blind randomized controlled trial , 2004, Psychopharmacology.

[2163]  S. Marumoto,et al.  Pharmacological characterization of RS-1259, an orally active dual inhibitor of acetylcholinesterase and serotonin transporter, in rodents: possible treatment of Alzheimer's disease. , 2003, Journal of pharmacological sciences.

[2164]  D. Butterfield,et al.  The Glutamatergic System and Alzheimer’s Disease , 2003, CNS drugs.

[2165]  J. Leysen,et al.  5-HT2A and 5-HT2C receptors and their atypical regulation properties. , 2003, Life sciences.

[2166]  A. Janowsky,et al.  "Broad spectrum" antidepressants: is more better for the treatment of depression? , 2003, Life sciences.

[2167]  Ramon Pouplana,et al.  QSAR study of dual cyclooxygenase and 5-lipoxygenase inhibitors 2,6-di-tert-butylphenol derivatives. , 2003, Bioorganic & medicinal chemistry.

[2168]  A. Cardno,et al.  Antidepressants for the treatment of depression in people with schizophrenia: a systematic review , 2003, Psychological Medicine.

[2169]  Matthew W. Hahn,et al.  Molecular Evolution in Large Genetic Networks: Does Connectivity Equal Constraint? , 2004, Journal of Molecular Evolution.

[2170]  M. Dubocovich,et al.  Molecular pharmacology, regulation and function of mammalian melatonin receptors. , 2003, Frontiers in bioscience : a journal and virtual library.

[2171]  R. Coggeshall,et al.  N-methyl-d-aspartate-induced excitation and sensitization of normal and inflamed nociceptors , 2003, Neuroscience.

[2172]  F. Leslie,et al.  Co-expression of α7 and β2 nicotinic acetylcholine receptor subunit mRNAs within rat brain cholinergic neurons , 2003, Neuroscience.

[2173]  P. Blier.  The pharmacology of putative early-onset antidepressant strategies , 2003, European Neuropsychopharmacology.

[2174]  J. A. Boer,et al.  Mood regulation in seasonal affective disorder patients and healthy controls studied in forced desynchrony , 2003, Psychiatry Research.

[2175]  J Kirchheiner,et al.  Individualized medicine - implementation of pharmacogenetic diagnostics in antidepressant drug treatment of major depressive disorders. , 2003, Pharmacopsychiatry.

[2176]  M. Youdim,et al.  A novel cholinesterase and brain-selective monoamine oxidase inhibitor for the treatment of dementia comorbid with depression and Parkinson's disease , 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[2177]  H. V. Tol,et al.  The dopamine D4 receptors and mechanisms of antipsychotic atypicality , 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[2178]  I. Hickie,et al.  Vascular Risk to Late-Life Depression: Evidence from a Longitudinal Community Study , 2003, The Australian and New Zealand journal of psychiatry.

[2179]  Marc G Caron,et al.  Monoamine transporters: from genes to behavior. , 2003, Annual review of pharmacology and toxicology.

[2180]  A. Stunkard,et al.  Depression and obesity , 2003, Biological Psychiatry.

[2181]  Pierre Payoux,et al.  Limitations of current Parkinson's disease therapy , 2003, Annals of neurology.

[2182]  Todd M Sanger,et al.  Long-term antidepressant efficacy and safety of olanzapine/fluoxetine combination: a 76-week open-label study. , 2003, The Journal of clinical psychiatry.

[2183]  R. Richmond,et al.  Review of bupropion for smoking cessation. , 2003, Drug and alcohol review.

[2184]  Dan V Iosifescu,et al.  The impact of medical comorbidity on acute treatment in major depressive disorder. , 2003, The American journal of psychiatry.

[2185]  M. Bourin,et al.  Antidepressant- and anxiolytic-like effects of selective neuronal NOS inhibitor 1-(2-trifluoromethylphenyl)-imidazole in mice , 2003, Behavioural Brain Research.

[2186]  R. Fieve,et al.  Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: a preliminary double-blind, placebo-controlled study. , 2003, The Journal of clinical psychiatry.

[2187]  H. Westenberg,et al.  A Double Blind Comparison of Venlafaxine and Paroxetine in Obsessive-Compulsive Disorder , 2003, Journal of clinical psychopharmacology.

[2188]  Paul F. Smith.  Therapeutic N-methyl-D-aspartate receptor antagonists: will reality meet expectation? , 2003, Current opinion in investigational drugs.

[2189]  K. Lesch,et al.  Organic cation transporter capable of transporting serotonin is up‐regulated in serotonin transporter‐deficient mice , 2003, Journal of neuroscience research.

[2190]  F. Bymaster,et al.  Duloxetine Increases Serotonin and Norepinephrine Availability in Healthy Subjects: A Double-Blind, Controlled Study , 2003, Neuropsychopharmacology.

[2191]  B. Stoffel‐Wagner.  Neurosteroid Biosynthesis in the Human Brain and Its Clinical Implications , 2003, Annals of the New York Academy of Sciences.

[2192]  C. Parsons,et al.  a2-Adrenoreceptor activation inhibits LTP and LTD in the basolateral amygdala: involvement of Gi/o-protein-mediated modulation of Ca2þ-channels and inwardly rectifying Kþ-channels in LTD , 2003 .

[2193]  B. Gorzalka,et al.  Corticosterone attenuates the antidepressant-like effects elicited by melatonin in the forced swim test in both male and female rats , 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[2194]  M. Inazu,et al.  Expression and functional characterization of the extraneuronal monoamine transporter in normal human astrocytes , 2002, Journal of neurochemistry.

[2195]  R. Hen,et al.  Requirement of Hippocampal Neurogenesis for the Behavioral Effects of Antidepressants , 2003, Science.

[2196]  A. Massey,et al.  EEG effects of buspirone and pindolol: a method of examining 5-HT1A receptor function in humans , 2003, Psychopharmacology.

[2197]  K. Lesch,et al.  Sex hormone‐dependent desensitization of 5‐HT1A autoreceptors in knockout mice deficient in the 5‐HT transporter , 2003, The European journal of neuroscience.

[2198]  R. Carney,et al.  Pathways linking depression, adiposity, and inflammatory markers in healthy young adults , 2003, Brain, Behavior, and Immunity.

[2199]  W. Katon,et al.  Depression and pain comorbidity: a literature review. , 2003, Archives of internal medicine.

[2200]  Claude Nahmias,et al.  Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL‐PET study , 2003, Annals of neurology.

[2201]  Jeffrey C Magee,et al.  Sleep Deprivation Causes Behavioral, Synaptic, and Membrane Excitability Alterations in Hippocampal Neurons , 2003, The Journal of Neuroscience.

[2202]  H. Mayberg.  Positron emission tomography imaging in depression: a neural systems perspective. , 2003, Neuroimaging clinics of North America.

[2203]  Charles E Samuel,et al.  RNA Editing Minireview Series* , 2003, The Journal of Biological Chemistry.

[2204]  F. Hsu,et al.  Effects of a single dose of cortisol on the neural correlates of episodic memory and error processing in healthy volunteers , 2003, Psychopharmacology.

[2205]  H. Simon,et al.  Combined treatment with galanthaminium bromide, a new cholinesterase inhibitor, and RS 67333, a partial agonist of 5-HT4 receptors, enhances place and object recognition in young adult and old rats , 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[2206]  Elyssa B. Margolis,et al.  κ-Opioid Agonists Directly Inhibit Midbrain Dopaminergic Neurons , 2003, The Journal of Neuroscience.

[2207]  T. Sharp,et al.  Antidepressant drug treatment induces Arc gene expression in the rat brain , 2003, Neuroscience.

[2208]  M. Suyama,et al.  A genome-wide survey of human pseudogenes. , 2003, Genome research.

[2209]  P. Pévet,et al.  MT1 melatonin receptor mRNA tissular localization by PCR amplification. , 2003, Neuro endocrinology letters.

[2210]  O. Rampin,et al.  Proerectile effects of apomorphine in mice. , 2003, Life sciences.

[2211]  S. Grant,et al.  Systems biology in neuroscience: bridging genes to cognition , 2003, Current Opinion in Neurobiology.

[2212]  Markus Kosel,et al.  Efficacy of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Affective Disorders , 2003, Neuropsychopharmacology.

[2213]  P. Emson,et al.  GABAB receptor subunits, R1 and R2, in brainstem catecholamine and serotonin neurons , 2003, Brain Research.

[2214]  N. Newberry,et al.  Inhibition of human α7 nicotinic acetylcholine receptors by open channel blockers of N‐methyl‐D‐aspartate receptors , 2003 .

[2215]  B. Bontempi,et al.  Cognitive Enhancing Properties and Tolerability of Cholinergic Agents in Mice: A Comparative Study of Nicotine, Donepezil, and SIB-1553A, a Subtype-Selective Ligand for Nicotinic Acetylcholine Receptors , 2003, Neuropsychopharmacology.

[2216]  A. Steiger,et al.  Clinical and Neurobiological Effects of Tianeptine and Paroxetine in Major Depression , 2003, Journal of clinical psychopharmacology.

[2217]  G. Nagel,et al.  Different affinities of inhibitors to the outwardly and inwardly directed substrate binding site of organic cation transporter 2. , 2003, Molecular pharmacology.

[2218]  P. Dannon,et al.  A randomized controlled comparison of electroconvulsive therapy and repetitive transcranial magnetic stimulation in severe and resistant nonpsychotic major depression , 2003, Biological Psychiatry.

[2219]  C. Lyketsos,et al.  Diagnosis and Treatment of Depression in Alzheimer’s Disease , 2003, Dementia and Geriatric Cognitive Disorders.

[2220]  J. Sasse,et al.  Lithium augmentation in treatment-resistant depression: clinical evidence, serotonergic and endocrine mechanisms. , 2003, Pharmacopsychiatry.

[2221]  J. Buccafusco,et al.  Potential cognitive actions of (n-propargly-(3r)-aminoindan-5-yl)-ethyl, methyl carbamate (tv3326), a novel neuroprotective agent, as assessed in old rhesus monkeys in their performance of versions of a delayed matching task , 2003, Neuroscience.

[2222]  D. Charney,et al.  Mood disorders and medical illness: a major public health problem , 2003, Biological Psychiatry.

[2223]  H. Manji,et al.  Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for Difficult-to-Treat depression , 2003, Biological Psychiatry.

[2224]  P. Linkowski.  Neuroendocrine profiles in mood disorders. , 2003, The international journal of neuropsychopharmacology.

[2225]  L. Dinardo,et al.  Midbrain Raphe Modulation of Nonphotic Circadian Clock Resetting and 5-HT Release in the Mammalian Suprachiasmatic Nucleus , 2003, The Journal of Neuroscience.

[2226]  R. Lenox,et al.  Molecular basis of lithium action: integration of lithium-responsive signaling and gene expression networks , 2003, Molecular Psychiatry.

[2227]  Y. Hurd,et al.  Neurokinin 1 receptor and relative abundance of the short and long isoforms in the human brain , 2003, The European journal of neuroscience.

[2228]  C. Chavkin,et al.  κ Opioid Receptor Antagonism and Prodynorphin Gene Disruption Block Stress-Induced Behavioral Responses , 2003, The Journal of Neuroscience.

[2229]  Ruoyan Chen,et al.  Effects of electroconvulsive seizures and antidepressant drugs on brain-derived neurotrophic factor protein in rat brain , 2003, Biological Psychiatry.

[2230]  M. Caron,et al.  Oligomerization and Trafficking of the Human Dopamine Transporter , 2003, The Journal of Biological Chemistry.

[2231]  Björn Wahlund,et al.  ECT of Major Depressed Patients in Relation to Biological and Clinical Variables: A Brief Overview , 2003, Neuropsychopharmacology.

[2232]  H. Marín,et al.  Residual symptoms in depression: can treatment be symptom-specific? , 2003, The Journal of clinical psychiatry.

[2233]  Is there a future for 'speculative' gene patents in Europe? , 2003, Nature Reviews Drug Discovery.

[2234]  Peer Bork,et al.  Alternative splicing and evolution. , 2003, BioEssays : news and reviews in molecular, cellular and developmental biology.

[2235]  J. Greden.  Physical symptoms of depression: unmet needs. , 2003, The Journal of clinical psychiatry.

[2236]  G. Wörtwein,et al.  Associative and nonassociative learning after chronic imipramine in rats , 2003, Pharmacology Biochemistry and Behavior.

[2237]  E. Tirelli,et al.  Facilitatory effect of the dopamine D4 receptor agonist PD168,077 on memory consolidation of an inhibitory avoidance learned response in C57BL/6J mice , 2003, Behavioural Brain Research.

[2238]  L. Bristow,et al.  Pharmacological characterization and identification of amino acids involved in the positive modulation of metabotropic glutamate receptor subtype 2. , 2003, Molecular pharmacology.

[2239]  Philip S. Portoghese,et al.  Antidepressant-Like Effects of κ-Opioid Receptor Antagonists in the Forced Swim Test in Rats , 2003, Journal of Pharmacology and Experimental Therapeutics.

[2240]  H. Sitte,et al.  Oligomer formation by Na+-Cl--coupled neurotransmitter transporters. , 2003, European journal of pharmacology.

[2241]  C. S. Gal,et al.  The vasopressin V1b receptor as a therapeutic target in stress-related disorders. , 2003, Current drug targets. CNS and neurological disorders.

[2242]  Mark Washburn,et al.  3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-pyridine: a potent and highly selective metabotropic glutamate subtype 5 receptor antagonist with anxiolytic activity. , 2003, Journal of medicinal chemistry.

[2243]  A. Sands,et al.  Knockouts model the 100 best-selling drugs—will they model the next 100? , 2003, Nature Reviews Drug Discovery.

[2244]  I. Lucki,et al.  Corticotropin-releasing factor in the dorsal raphe nucleus regulates activity of lateral septal neurons , 2003, Brain Research.

[2245]  M. Bergeron,et al.  Chronic AMPA receptor potentiator (LY451646) treatment increases cell proliferation in adult rat hippocampus , 2003, Neuropharmacology.

[2246]  G. Simon.  Social and economic burden of mood disorders , 2003, Biological Psychiatry.

[2247]  E. Jutkiewicz,et al.  Effects of the delta-opioid receptor agonist SNC80 on learning relative to its antidepressant-like effects in rats , 2003, Behavioural pharmacology.

[2248]  F. Holsboer.  Corticotropin-releasing hormone modulators and depression. , 2003, Current opinion in investigational drugs.

[2249]  H. Kamiya,et al.  Roles of substance P and NK(1) receptor in the brainstem in the development of emesis. , 2003, Journal of pharmacological sciences.

[2250]  C. Nemeroff,et al.  Epidemiology of comorbid coronary artery disease and depression , 2003, Biological Psychiatry.

[2251]  K. Brady,et al.  Current review of the comorbidity of affective, anxiety, and substance use disorders , 2003 .

[2252]  H. Koepsell,et al.  Organic cation transporters. , 2003, Reviews of physiology, biochemistry and pharmacology.

[2253]  Ronald S Duman,et al.  Cell Proliferation in Adult Hippocampus is Decreased by Inescapable Stress: Reversal by Fluoxetine Treatment , 2003, Neuropsychopharmacology.

[2254]  James R. Knight,et al.  A Protein Interaction Map of Drosophila melanogaster , 2003, Science.

[2255]  J. Cryan,et al.  Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat , 2003, Psychopharmacology.

[2256]  Diane Boivin,et al.  Seasonal Affective Disorder: An Overview , 2003, Chronobiology international.

[2257]  P. Mallorga,et al.  Pharmacology and expression analysis of glycine transporter GlyT1 with [3H]-(N-[3-(4′-fluorophenyl)-3-(4′phenylphenoxy)propyl])sarcosine , 2003, Neuropharmacology.

[2258]  H. Sackeim,et al.  Vagus nerve stimulation (VNS): utility in neuropsychiatric disorders. , 2003, The international journal of neuropsychopharmacology.

[2259]  D. Peters,et al.  Xanomeline and the antipsychotic potential of muscarinic receptor subtype selective agonists. , 2006, CNS drug reviews.

[2260]  A. Nierenberg,et al.  Prevention of relapse and recurrence in depression: the role of long-term pharmacotherapy and psychotherapy. , 2003, The Journal of clinical psychiatry.

[2261]  David Morganstein,et al.  Cost of lost productive work time among US workers with depression. , 2003, JAMA.

[2262]  W. Haefeli,et al.  Inhibition of P-Glycoprotein by Newer Antidepressants , 2003, Journal of Pharmacology and Experimental Therapeutics.

[2263]  C. Sánchez,et al.  P.1.101 R-citalopram decreases the association of [3H]-S-citalopram with the human serotonin transporter by an allosteric mechanism , 2003, European Neuropsychopharmacology.

[2264]  M. Sarter,et al.  Attentional functions of cortical cholinergic inputs: What does it mean for learning and memory? , 2003, Neurobiology of Learning and Memory.

[2265]  I. Módy,et al.  Neuroactive steroids reduce neuronal excitability by selectively enhancing tonic inhibition mediated by δ subunit-containing GABAA receptors , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[2266]  S. Mangan,et al.  The coherent feedforward loop serves as a sign-sensitive delay element in transcription networks. , 2003, Journal of molecular biology.

[2267]  W. May,et al.  Elevated agonist binding to α2-adrenoceptors in the locus coeruleus in major depression , 2003, Biological Psychiatry.

[2268]  M. Saji,et al.  Antisense knockdown of spinal-mGluR1 reduces the sustained phase of formalin-induced nociceptive responses , 2003, Brain Research.

[2269]  D. Kupfer,et al.  Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review , 2003, The Lancet.

[2270]  N. Moore,et al.  Animal models of depression: are there any? , 2003, Human psychopharmacology.

[2271]  C. Quéva,et al.  Effects of GABA agonists on body temperature regulation in GABAB(1)−/− mice , 2003, British journal of pharmacology.

[2272]  D. Januel,et al.  Multicenter double-blind randomized parallel-group clinical trial of efficacy of the combination clomipramine (150 mg/day) plus lithium carbonate (750 mg/day) versus clomipramine (150 mg/day) plus placebo in the treatment of unipolar major depression. , 2003 .

[2273]  D. Murphy,et al.  Abnormal anxiety‐related behavior in serotonin transporter null mutant mice: the influence of genetic background , 2003, Genes, brain, and behavior.

[2274]  Gary B Willars,et al.  Mechanisms of cross-talk between G-protein-coupled receptors resulting in enhanced release of intracellular Ca2+. , 2003, The Biochemical journal.

[2275]  T. Shors,et al.  Estrogen-mediated effects on depression and memory formation in females. , 2003, Journal of affective disorders.

[2276]  M. Millan,et al.  The neurobiology and control of anxious states , 2003, Progress in Neurobiology.

[2277]  M. Millan,et al.  Discriminative stimulus properties of antidepressant agents: a review , 2003, Behavioural pharmacology.

[2278]  M. Meaney,et al.  Long-term effects of BIBN-99, a selective muscarinic M2 receptor antagonist, on improving spatial memory performance in aged cognitively impaired rats , 2003, Behavioural Brain Research.

[2279]  Kazuya Iwamoto,et al.  RNA editing of serotonin 2C receptor in human postmortem brains of major mental disorders , 2003, Neuroscience Letters.

[2280]  R. Glennon,et al.  Behavioral and biochemical investigations of bupropion metabolites. , 2003, European journal of pharmacology.

[2281]  J. Markowitz,et al.  The effects of psychotherapy, nefazodone, and their combination on subjective assessment of disturbed sleep in chronic depression. , 2003, Sleep.

[2282]  S. Hunt,et al.  Increased neurogenesis and brain‐derived neurotrophic factor in neurokinin‐1 receptor gene knockout mice , 2003, The European journal of neuroscience.

[2283]  P. Jeffrey Conn,et al.  N-desmethylclozapine, an allosteric agonist at muscarinic 1 receptor, potentiates N-methyl-d-aspartate receptor activity , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[2284]  P. G. Clifton,et al.  Serotonergic and histaminergic mechanisms involved in intralipid drinking? , 2003, Pharmacology Biochemistry and Behavior.

[2285]  Antagonists at the neurokinin receptors--recent patent literature. , 2003, IDrugs : the investigational drugs journal.

[2286]  Thomas Pollmächer,et al.  Epidemiology, implications and mechanisms underlying drug-induced weight gain in psychiatric patients. , 2003, Journal of psychiatric research.

[2287]  J. Wess,et al.  Dysregulated hippocampal acetylcholine neurotransmission and impaired cognition in M2, M4 and M2/M4 muscarinic receptor knockout mice , 2003, Molecular Psychiatry.

[2288]  M. Millan,et al.  The role of dopamine D3 compared with D2 receptors in the control of locomotor activity: a combined behavioural and neurochemical analysis with novel, selective antagonists in rats , 2004, Psychopharmacology.

[2289]  V. M. Kumar,et al.  Role of noradrenergic fibers of the preoptic area in regulating sleep , 2003, Journal of Chemical Neuroanatomy.

[2290]  H. Pan,et al.  Spinal GABAB receptors mediate antinociceptive actions of cholinergic agents in normal and diabetic rats , 2003, Brain Research.

[2291]  P. Fitzgerald,et al.  Transcranial magnetic stimulation in the treatment of depression: a double-blind, placebo-controlled trial. , 2003, Archives of general psychiatry.

[2292]  J. Hensler,et al.  Regulation of 5-HT1A receptor function in brain following agonist or antidepressant administration. , 2003, Life sciences.

[2293]  J. Krystal,et al.  Clinical Studies Implementing Glutamate Neurotransmission in Mood Disorders , 2003, Annals of the New York Academy of Sciences.

[2294]  T. Jay.  Dopamine: a potential substrate for synaptic plasticity and memory mechanisms , 2003, Progress in Neurobiology.

[2295]  P. Popik,et al.  Nicotine and nicotinic receptor antagonists potentiate the antidepressant‐like effects of imipramine and citalopram , 2003, British journal of pharmacology.

[2296]  A. Halpern,et al.  Treatment of obesity: an update on anti‐obesity medications , 2003, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[2297]  M. Rogawski,et al.  The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease. , 2006, CNS drug reviews.

[2298]  S. Maier,et al.  Corticotropin Releasing Hormone Type 2 Receptors in the Dorsal Raphe Nucleus Mediate the Behavioral Consequences of Uncontrollable Stress , 2003, The Journal of Neuroscience.

[2299]  S. Amara,et al.  Dynamic regulation of the dopamine transporter. , 2003, European journal of pharmacology.

[2300]  G. Wegener,et al.  Augmentation of the NO-cGMP cascade induces anxiogenic-like effect in mice. , 2003, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[2301]  A. Harwood,et al.  Search for a common mechanism of mood stabilizers. , 2003, Biochemical pharmacology.

[2302]  W. Willis,et al.  Postsynaptic dorsal column neurons express NK1 receptors following colon inflammation , 2003, Neuroscience.

[2303]  L. McWilliams,et al.  Mood and anxiety disorders associated with chronic pain: an examination in a nationally representative sample , 2003, Pain.

[2304]  A. Cavalli,et al.  3-(4-[[Benzyl(methyl)amino]methyl]phenyl)-6,7-dimethoxy-2H-2-chromenone (AP2238) inhibits both acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation: a dual function lead for Alzheimer's disease therapy. , 2003, Journal of medicinal chemistry.

[2305]  P. Riederer,et al.  Dopamine receptor agonists in the therapy of Parkinson’s disease , 2004, Journal of Neural Transmission.

[2306]  J. DeFelipe,et al.  Lack of thyroid hormone receptor α1 is associated with selective alterations in behavior and hippocampal circuits , 2003, Molecular Psychiatry.

[2307]  J. Tignol,et al.  The ELIXIR study: evaluation of sexual dysfunction in 4557 depressed patients in France. , 2003, Current medical research and opinion.

[2308]  I. Goldstein,et al.  Female sexual dysfunction. , 2001, International journal of impotence research.

[2309]  B. Sorg,et al.  Manipulation of dopamine d1-like receptor activation in the rat medial prefrontal cortex alters stress- and cocaine-induced reinstatement of conditioned place preference behavior , 2003, Neuroscience.

[2310]  G. Sperk,et al.  Reduced anxiety and improved stress coping ability in mice lacking NPY‐Y2 receptors , 2003, The European journal of neuroscience.

[2311]  K. Kendrick,et al.  Biphasic role of dopamine on female sexual behaviour via D2 receptors in the mediobasal hypothalamus , 2003, Neuropharmacology.

[2312]  B. Williams-Jones,et al.  Rhetoric and Hype , 2003, American journal of pharmacogenomics : genomics-related research in drug development and clinical practice.

[2313]  M. Scheinin,et al.  Constitutive precoupling to Gi and increased agonist potency in the α2B-adrenoceptor , 2003 .

[2314]  S. Chiechio,et al.  Prediction of the response to citalopram and reboxetine in post-stroke depressed patients , 2004, Psychopharmacology.

[2315]  Christopher J. Lee,et al.  Alternative splicing in the human, mouse and rat genomes is associated with an increased frequency of exon creation and/or loss , 2003, Nature Genetics.

[2316]  M. Alreja,et al.  Acetylcholinesterase Inhibitors Activate Septohippocampal GABAergic Neurons via Muscarinic but Not Nicotinic Receptors , 2003, Journal of Pharmacology and Experimental Therapeutics.

[2317]  G. Friehs,et al.  Cervical vagus nerve stimulation for treatment-resistant depression. , 2003, Neurosurgery clinics of North America.

[2318]  M. Zarrindast,et al.  Adrenoceptor mechanisms underlying imipramine-induced memory deficits in rats , 2003, Journal of psychopharmacology.

[2319]  Pramipexole in Routine Clinical Practice , 2003, CNS drugs.

[2320]  M. Fava,et al.  Lithium Augmentation of Nortriptyline for Subjects Resistant to Multiple Antidepressants , 2003, Journal of clinical psychopharmacology.

[2321]  J. Martínez-Raga,et al.  Treatment of nicotine dependence with bupropion SR: review of its efficacy, safety and pharmacological profile , 2003, Addiction biology.

[2322]  Alberto Granato,et al.  Analgesia and hyperalgesia from GABA-mediated modulation of the cerebral cortex , 2003, Nature.

[2323]  A. Janowsky,et al.  Antidepressant-like actions of DOV 21,947: a "triple" reuptake inhibitor. , 2003, European journal of pharmacology.

[2324]  Antonio Damasio,et al.  Feelings of Emotion and the Self , 2003, Annals of the New York Academy of Sciences.

[2325]  P. Kalivas,et al.  Prefrontal Group II Metabotropic Glutamate Receptor Activation Decreases Performance on a Working Memory Task , 2003, Annals of the New York Academy of Sciences.

[2326]  J. Hagan,et al.  SB‐656104‐A, a novel selective 5‐HT7 receptor antagonist, modulates REM sleep in rats , 2003, British journal of pharmacology.

[2327]  K. Sung,et al.  Mechanism of block by fluoxetine of 5-hydroxytryptamine3 (5-HT3)-mediated currents in NCB-20 neuroblastoma cells. , 2003, Biochemical pharmacology.

[2328]  F. Yasuno,et al.  Inhibitory effect of hippocampal 5-HT1A receptors on human explicit memory. , 2003, The American journal of psychiatry.

[2329]  Alan I Green,et al.  Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). , 2003, Archives of general psychiatry.

[2330]  M. Pérez,et al.  Increased susceptibility to LTP generation and changes in NMDA-NR1 and -NR2B subunits mRNA expression in rat hippocampus after MCH administration , 2003, Peptides.

[2331]  A. Heinz,et al.  Neurotransmitter changes by interferon-alpha and therapeutic implications. , 2003, Pharmacopsychiatry.

[2332]  B. Maher,et al.  Genome‐wide linkage survey for genetic loci that influence the development of depressive disorders in families with recurrent, early‐onset, major depression , 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[2333]  N. Toschi,et al.  Reduction of Hypothalamic Vasopressinergic Hyperdrive Contributes to Clinically Relevant Behavioral and Neuroendocrine Effects of Chronic Paroxetine Treatment in a Psychopathological Rat Model , 2003, Neuropsychopharmacology.

[2334]  Direct activation by dopamine of recombinant human 5‐HT1A receptors: Comparison with human 5‐HT2C and 5‐HT3 receptors , 2003, Synapse.

[2335]  L. Jasmin,et al.  Is noradrenaline a significant factor in the analgesic effect of antidepressants? , 2003, Pain.

[2336]  A. Stoessl,et al.  Effects of oligonucleotide antisense to dopamine D3 receptor mRNA in a rodent model of behavioural sensitization to levodopa , 2003, Neuroscience.

[2337]  Maureen R. Prather,et al.  The efficacy of nefazodone augmentation for treatment‐resistant depression with anxiety symptoms or anxiety disorder , 2003, Depression and anxiety.

[2338]  A. Zwinderman,et al.  Antidepressants and Ejaculation: A Double-Blind, Randomized, Fixed-Dose Study With Mirtazapine and Paroxetine , 2003, Journal of clinical psychopharmacology.

[2339]  Richard J. Porter,et al.  Neurocognitive impairment in drug-free patients with major depressive disorder , 2003, British Journal of Psychiatry.

[2340]  Richard De La Garza,et al.  Involvement of 5-HT1A receptors in animal tests of anxiety and depression: evidence from genetic models. , 2003, Stress.

[2341]  H. Kubinyi.  Drug research: myths, hype and reality , 2003, Nature Reviews Drug Discovery.

[2342]  D. M. Krylov,et al.  Gene loss, protein sequence divergence, gene dispensability, expression level, and interactivity are correlated in eukaryotic evolution. , 2003, Genome research.

[2343]  T. Robbins,et al.  Cognitive Impairments in Early Parkinson's Disease Are Accompanied by Reductions in Activity in Frontostriatal Neural Circuitry , 2003, The Journal of Neuroscience.

[2344]  Craig E. Nelson,et al.  Managing treatment-resistant major depression. , 2003, The Journal of clinical psychiatry.

[2345]  A. Wirz-Justice,et al.  Role of Melatonin in the Regulation of Human Circadian Rhythms and Sleep , 2003, Journal of neuroendocrinology.

[2346]  L-DOPA biotransformation: correlations of dosage, erythrocyte catechol O-methyltransferase and platelet SULT1A3 activities with metabolic pathways in Parkinsonian patients , 2003, Journal of Neural Transmission.

[2347]  G. Barceló-Coblijn,et al.  Short-term administration of omega 3 fatty acids from fish oil results in increased transthyretin transcription in old rat hippocampus , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[2348]  E. Giller,et al.  Frequency of Positive Studies Among Fixed and Flexible Dose Antidepressant Clinical Trials: An Analysis of the Food and Drug Administraton Summary Basis of Approval Reports , 2003, Neuropsychopharmacology.

[2349]  C. Forray.  The MCH receptor family: feeding brain disorders? , 2003, Current opinion in pharmacology.

[2350]  M. Raiteri,et al.  Pharmacological heterogeneity of release-regulating presynaptic AMPA/kainate receptors in the rat brain: study with receptor antagonists , 2003, Neurochemistry International.

[2351]  Jiangbei Cao,et al.  Antidepressant-like effect of agmatine and its possible mechanism. , 2003, European journal of pharmacology.

[2352]  J. Loeffler,et al.  Neuroendocrinology of Neurodegenerative Diseases , 2003, Neuroendocrinology.

[2353]  M. Fava,et al.  Treatment of antidepressant-associated sexual dysfunction with sildenafil: a randomized controlled trial. , 2003, JAMA.

[2354]  J. Knauber,et al.  Anseculin improves passive avoidance learning of aged mice. , 2003, Pharmacological research.

[2355]  G. Mengod,et al.  GABAB receptor mRNA in the raphe nuclei: co‐expression with serotonin transporter and glutamic acid decarboxylase , 2003, Journal of neurochemistry.

[2356]  C. Clarke,et al.  Systematic review of antidepressant therapies in Parkinson's disease. , 2003, Parkinsonism & related disorders.

[2357]  Michael J. Anderle,et al.  The neural substrates of affective processing in depressed patients treated with venlafaxine. , 2003, The American journal of psychiatry.

[2358]  G. Wegener,et al.  Local, but not systemic, administration of serotonergic antidepressants decreases hippocampal nitric oxide synthase activity , 2003, Brain Research.

[2359]  A. Fernández-Guasti,et al.  Interaction between estrogens and antidepressants in the forced swimming test in rats , 2004, Psychopharmacology.

[2360]  W. Riedel,et al.  Monoamine depletion in psychiatric and healthy populations: review , 2003, Molecular Psychiatry.

[2361]  J. O'Donnell,et al.  Antidepressant-Induced Increase in High-Affinity Rolipram Binding Sites in Rat Brain: Dependence on Noradrenergic and Serotonergic Function , 2003, Journal of Pharmacology and Experimental Therapeutics.

[2362]  V. Chapman,et al.  Inhibitory effects of spinal baclofen on spinal dorsal horn neurones in inflamed and neuropathic rats in vivo , 2003, Brain Research.

[2363]  Jeffrey A Lieberman,et al.  Recent advances in the neurobiology of schizophrenia. , 2003, Molecular interventions.

[2364]  C. Nemeroff,et al.  The Effects of Chronic Treatment with the Mood Stabilizers Valproic Acid and Lithium on Corticotropin-Releasing Factor Neuronal Systems , 2003, Journal of Pharmacology and Experimental Therapeutics.

[2365]  B. Roth,et al.  A Direct Interaction of PSD-95 with 5-HT2A Serotonin Receptors Regulates Receptor Trafficking and Signal Transduction* , 2003, Journal of Biological Chemistry.

[2366]  M. B. Gatch.  Discriminative stimulus effects of m-chlorophenylpiperazine as a model of the role of serotonin receptors in anxiety. , 2003, Life sciences.

[2367]  B. O'dowd,et al.  Attenuation of sucrose reinforcement in dopamine D1 receptor deficient mice , 2003, The European journal of neuroscience.

[2368]  A. Eschalier,et al.  Evidence for an antihyperalgesic effect of venlafaxine in vincristine-induced neuropathy in rat , 2003, Brain Research.

[2369]  Jianzhi Zhang.  Evolution by gene duplication: an update , 2003 .

[2370]  A. Fletcher,et al.  Effects of single and repeated electroconvulsive shock on the social and agonistic behaviour of resident rats , 2003, Neuropharmacology.

[2371]  M. Atmaca,et al.  Switching to tianeptine in patients with antidepressant‐induced sexual dysfunction , 2003, Human psychopharmacology.

[2372]  D. Searls.  Pharmacophylogenomics: genes, evolution and drug targets , 2003, Nature Reviews Drug Discovery.

[2373]  S. File,et al.  Modafinil affects mood, but not cognitive function, in healthy young volunteers , 2003, Human psychopharmacology.

[2374]  A. Sartorius,et al.  Choline rise in the rat hippocampus induced by electroconvulsive shock treatment , 2003, Biological Psychiatry.

[2375]  Dopamine D1 receptor agonists induce penile erections in rats. , 2003, European journal of pharmacology.

[2376]  A. Faden,et al.  Modulation of metabotropic glutamate receptors as potential treatment for acute and chronic neurodegenerative disorders. , 2003, Drug news & perspectives.

[2377]  T. Dohi,et al.  Norepinephrine transporter splice variants and their interaction with substrates and blockers. , 2003, European journal of pharmacology.

[2378]  C. Hawkey,et al.  COX‐LOX INHIBITION: CURRENT EVIDENCE FOR AN EMERGING NEW THERAPY , 2003, International journal of clinical practice.

[2379]  M. Romanelli,et al.  Cholinergic nicotinic receptors: Competitive ligands, allosteric modulators, and their potential applications , 2003, Medicinal research reviews.

[2380]  S. Firbank,et al.  Functional interactions between native Gs-coupled 5-HT receptors in HEK-293 cells and the heterologously expressed serotonin transporter. , 2003, Cellular signalling.

[2381]  N. Masumori,et al.  Direct evidence of facilitative actions of dopamine in the medial preoptic area on reflexive and noncontact erections in male rats. , 2003, The Journal of urology.

[2382]  G. Rudnick,et al.  Functional consequences of homo‐ but not hetero‐oligomerization between transporters for the biogenic amine neurotransmitters , 2003, Journal of neurochemistry.

[2383]  R. Jope.  Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes. , 2003, Trends in pharmacological sciences.

[2384]  Christel A. S. Bergström,et al.  Absorption classification of oral drugs based on molecular surface properties. , 2003, Journal of medicinal chemistry.

[2385]  A. Caspi,et al.  Influence of Life Stress on Depression: Moderation by a Polymorphism in the 5-HTT Gene , 2003, Science.

[2386]  Maurice M Ohayon,et al.  Using chronic pain to predict depressive morbidity in the general population. , 2003, Archives of general psychiatry.

[2387]  S. Biello,et al.  Neuropeptide y, gaba and circadian phase shifts to photic stimuli , 2003, Neuroscience.

[2388]  M. Picciotto,et al.  Neuroprotection by Nicotine in Mouse Primary Cortical Cultures Involves Activation of Calcineurin and L-Type Calcium Channel Inactivation , 2003, The Journal of Neuroscience.

[2389]  C. Chapman,et al.  GABAB Receptor‐ and Metabotropic Glutamate Receptor‐Dependent Cooperative Long‐Term Potentiation of Rat Hippocampal GABAA Synaptic Transmission , 2003, The Journal of physiology.

[2390]  J. Forn,et al.  Effect of α2-adrenoceptor blockade on lithium action in the rat brain , 2003, Brain Research.

[2391]  J. Bolós.  Current strategies for the development of novel antipsychotic drugs. , 2003, Mini reviews in medicinal chemistry.

[2392]  Abraham Weizman,et al.  Amantadine as augmentation therapy in the management of treatment-resistant depression , 2003, International clinical psychopharmacology.

[2393]  P. E. Gold.  Acetylcholine modulation of neural systems involved in learning and memory , 2003, Neurobiology of Learning and Memory.

[2394]  S. Kanba,et al.  Clinical efficacy of tandospirone augmentation in patients with major depressive disorder: A randomized controlled trial , 2003, Psychiatry and clinical neurosciences.

[2395]  T. Svensson.  α-Adrenoceptor modulation hypothesis of antipsychotic atypicality , 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[2396]  P. Joyce,et al.  Age-dependent antidepressant pharmacogenomics: polymorphisms of the serotonin transporter and G protein beta3 subunit as predictors of response to fluoxetine and nortriptyline. , 2003, The international journal of neuropsychopharmacology.

[2397]  J. Gorman.  Treating generalized anxiety disorder. , 2003, The Journal of clinical psychiatry.

[2398]  J. Stamford,et al.  Different α2 adrenoceptor subtypes control noradrenaline release and cell firing in the locus coeruleus of wildtype and monoamine oxidase‐A knockout mice , 2003, The European journal of neuroscience.

[2399]  M. Berk,et al.  A double-blind, randomized, placebo-controlled trial of augmentation with lamotrigine or placebo in patients concomitantly treated with fluoxetine for resistant major depressive episodes. , 2003, The Journal of clinical psychiatry.

[2400]  D. Sheehan,et al.  Paroxetine treatment of generalized anxiety disorder: a double-blind, placebo-controlled study. , 2003, The American journal of psychiatry.

[2401]  P. Skolnick,et al.  Glutamate and Depression , 2003 .

[2402]  R. Hirschfeld.  Long-term side effects of SSRIs: sexual dysfunction and weight gain. , 2003, The Journal of clinical psychiatry.

[2403]  C. McBain,et al.  GABAB receptor modulation of excitatory and inhibitory synaptic transmission onto rat CA3 hippocampal interneurons , 2003, The Journal of physiology.

[2404]  F. Dauphin,et al.  BIMU 1 and RS 67333, two 5-HT4 receptor agonists, modulate spontaneous alternation deficits induced by scopolamine in the mouse , 2003, Naunyn-Schmiedeberg's Archives of Pharmacology.

[2405]  Daniela Popa,et al.  Behavioral, neurochemical, and electrophysiological characterization of a genetic mouse model of depression , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[2406]  Dick F Swaab,et al.  Melatonin rhythmicity: effect of age and Alzheimer's disease , 2003, Experimental Gerontology.

[2407]  E. Castrén,et al.  Activation of the TrkB Neurotrophin Receptor Is Induced by Antidepressant Drugs and Is Required for Antidepressant-Induced Behavioral Effects , 2003, The Journal of Neuroscience.

[2408]  G. Debonnel,et al.  Neurochemical and Psychotropic Effects of Bupropion in Healthy Male Subjects , 2003, Journal of clinical psychopharmacology.

[2409]  A. Chagraoui,et al.  Agomelatine(S 20098) antagonizes the penile erections induced by the stimulation of 5-HT2C receptors in Wistar rats , 2003, Psychopharmacology.

[2410]  D. Kennaway,et al.  Activation of 5-HT2C receptors acutely induces Per gene expression in the rat suprachiasmatic nucleus at night. , 2003, Brain research. Molecular brain research.

[2411]  A. Chocyk,et al.  Serotonin 5-HT1A receptors might control the output of cortical glutamatergic neurons in rat cingulate cortex , 2003, Brain Research.

[2412]  F. Bymaster,et al.  Dual Monoamine Modulation for Improved Treatment of Major Depressive Disorder , 2003, Journal of clinical psychopharmacology.

[2413]  J. Kehne,et al.  Chapter 2. Neuropeptide receptor antagonists for CNS disorders , 2003 .

[2414]  M. Zimmerman,et al.  Generalized anxiety disorder in patients with major depression: is DSM-IV's hierarchy correct? , 2003, The American journal of psychiatry.

[2415]  G. Lynch,et al.  Chronic Elevation of Brain-Derived Neurotrophic Factor by Ampakines , 2003, Journal of Pharmacology and Experimental Therapeutics.

[2416]  I. Gottesman,et al.  The endophenotype concept in psychiatry: etymology and strategic intentions. , 2003, The American journal of psychiatry.

[2417]  P. Cuevas,et al.  Vardenafil reverses erectile dysfunction induced by paroxetine in rats , 2003, International Journal of Impotence Research.

[2418]  D. Gründemann,et al.  Agmatine Is Efficiently Transported by Non-Neuronal Monoamine Transporters Extraneuronal Monoamine Transporter (EMT) and Organic Cation Transporter 2 (OCT2) , 2003, Journal of Pharmacology and Experimental Therapeutics.

[2419]  P. Leeson,et al.  A comparison of physiochemical property profiles of development and marketed oral drugs. , 2003, Journal of medicinal chemistry.

[2420]  Hui Zhang,et al.  Glutamate Spillover in the Striatum Depresses Dopaminergic Transmission by Activating Group I Metabotropic Glutamate Receptors , 2003, The Journal of Neuroscience.

[2421]  W. McCall,et al.  Cognitive deficits are associated with functional impairment in severely depressed patients , 2003, Psychiatry Research.

[2422]  J. Quillfeldt,et al.  Role of hippocampal M1 and M4 muscarinic receptor subtypes in memory consolidation in the rat , 2003, Pharmacology Biochemistry and Behavior.

[2423]  G. E. Pickard,et al.  Response of the Mouse Circadian System to Serotonin 1A/2/7 Agonists in vivo: Surprisingly Little , 2003, Journal of biological rhythms.

[2424]  P. Sönksen,et al.  Psychological effects of withdrawal of growth hormone therapy from adults with growth hormone deficiency , 2003, Clinical endocrinology.

[2425]  M. Aldana.  Boolean dynamics of networks with scale-free topology , 2003 .

[2426]  G. Wegener,et al.  Increased extracellular serotonin level in rat hippocampus induced by chronic citalopram is augmented by subchronic lithium: neurochemical and behavioural studies in the rat , 2003, Psychopharmacology.

[2427]  P. Jenner.  Dopamine agonists, receptor selectivity and dyskinesia induction in Parkinson's disease , 2003, Current opinion in neurology.

[2428]  P. Nguyen,et al.  Regulation of hippocampal synaptic plasticity by cyclic AMP-dependent protein kinases , 2003, Progress in Neurobiology.

[2429]  M. Trivedi.  Treatment-Resistant Depression: New Therapies on the Horizon , 2003, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

[2430]  S. Tsai,et al.  Pharmacogenetics of Selective Serotonin Reuptake Inhibitor Response in Major Depression , 2003 .

[2431]  H. Sei,et al.  Six-hour selective REM sleep deprivation increases the expression of the galanin gene in the hypothalamus of rats. , 2003, Brain research. Molecular brain research.

[2432]  P. Joyce,et al.  Thyroid Indices and Response to Fluoxetine and Nortriptyline in Major Depression , 2003, Journal of psychopharmacology.

[2433]  P. Pompei,et al.  Safety of antidepressants in the elderly , 2003, Expert opinion on drug safety.

[2434]  P. Blier,et al.  Is there a role for 5-HT1A agonists in the treatment of depression? , 2003, Biological Psychiatry.

[2435]  T. Bolwig.  Putative Common Pathways in Therapeutic Brain Stimulation for Affective Disorders , 2003, CNS Spectrums.

[2436]  E. Fuchs,et al.  α2A and α2C‐adrenoceptor regulation in the brain: α2A changes persist after chronic stress , 2003 .

[2437]  C. Flachskamm,et al.  Effect of sleep and sleep deprivation on serotonergic neurotransmission in the hippocampus: a combined in vivo microdialysis/EEG study in rats , 2003, The European journal of neuroscience.

[2438]  A. Gershon,et al.  Transcranial magnetic stimulation in the treatment of depression. , 2003, The American journal of psychiatry.

[2439]  J‐Bloom Corey.  GALANTAMINE: A REVIEW OF ITS USE IN ALZHEIMER'S DISEASE AND VASCULAR DEMENTIA , 2003, International journal of clinical practice.

[2440]  J. Buccafusco,et al.  The Cholinergic Hypothesis of Age and Alzheimer's Disease-Related Cognitive Deficits: Recent Challenges and Their Implications for Novel Drug Development , 2003, Journal of Pharmacology and Experimental Therapeutics.

[2441]  G. Skuza,et al.  Effects of combined treatment with imipramine and metyrapone in the forced swimming test in rats. Behavioral and pharmacokinetic studies. , 2003, Polish journal of pharmacology.

[2442]  R. Palmiter,et al.  Dopamine controls the firing pattern of dopamine neurons via a network feedback mechanism , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[2443]  S Boyce,et al.  P-Glycoprotein efflux reduces the brain concentration of the substance P (NK1 receptor) antagonists SR140333 and GR205171: a comparative study using mdr1a−/− and mdr1a+/+ mice , 2003, Behavioural pharmacology.

[2444]  W. Drevets,et al.  Glucocorticoid regulation of diverse cognitive functions in normal and pathological emotional states , 2003, Neuroscience & Biobehavioral Reviews.

[2445]  B. Fiebich,et al.  Valproic acid inhibits substance P‐induced activation of protein kinase C epsilon and expression of the substance P receptor , 2003, Journal of neurochemistry.

[2446]  F. Holsboer,et al.  Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor , 2003, Molecular Psychiatry.

[2447]  E. Loetscher,et al.  alpha2C-Adrenoceptor blockade by clozapine and other antipsychotic drugs. , 2003, European journal of pharmacology.

[2448]  J. Kelly,et al.  Serotonergic mediation of the antidepressant-like effects of nitric oxide synthase inhibitors , 2003, Neuropharmacology.

[2449]  R. Dantzer,et al.  Chronic treatment with the antidepressant tianeptine attenuates lipopolysaccharide-induced Fos expression in the rat paraventricular nucleus and HPA axis activation , 2003, Psychoneuroendocrinology.

[2450]  R. Blakely,et al.  A Regulated Interaction of Syntaxin 1A with the Antidepressant-Sensitive Norepinephrine Transporter Establishes Catecholamine Clearance Capacity , 2003, The Journal of Neuroscience.

[2451]  C. Broeckhoven,et al.  Genetics of personality: are we making progress? , 2003, Molecular Psychiatry.

[2452]  A. Levey,et al.  Vesicular Localization and Activity-Dependent Trafficking of Presynaptic Choline Transporters , 2003, The Journal of Neuroscience.

[2453]  Sildenafil for Selective Serotonin Reuptake Inhibitor-Induced Erectile Dysfunction in Elderly Male Depressed Patients , 2003, Journal of sex & marital therapy.

[2454]  P. Celada,et al.  Modulation of Serotonergic Function in Rat Brain by VN2222, a Serotonin Reuptake Inhibitor and 5-HT1A Receptor Agonist , 2003, Neuropsychopharmacology.

[2455]  SLV-308. Solvay. , 2003, Current opinion in investigational drugs.

[2456]  S. Hjorth,et al.  Effects of selective serotonin and serotonin/noradrenaline reuptake inhibitors on extracellular serotonin in rat diencephalon and frontal cortex , 2003, Naunyn-Schmiedeberg's Archives of Pharmacology.

[2457]  D. Barch,et al.  Working memory and prefrontal cortex dysfunction: specificity to schizophrenia compared with major depression , 2003, Biological Psychiatry.

[2458]  D. Dinh,et al.  Positive allosteric modulator of the human 5-HT2C receptor. , 2003, Molecular pharmacology.

[2459]  R. Quirion,et al.  Neuropeptide Y (NPY) Y2 receptors mediate behaviour in two animal models of anxiety: evidence from Y2 receptor knockout mice , 2003, Behavioural Brain Research.

[2460]  Michael Bader,et al.  Synthesis of Serotonin by a Second Tryptophan Hydroxylase Isoform , 2003, Science.

[2461]  M. Detke,et al.  Duloxetine: A New Treatment for the Emotional and Physical Symptoms of Depression. , 2003, Primary care companion to the Journal of clinical psychiatry.

[2462]  E. Susser,et al.  The concept of population prevention: application to schizophrenia. , 2003, Schizophrenia bulletin.

[2463]  K. Doghramji.  Treatment strategies for sleep disturbance in patients with depression. , 2003, The Journal of clinical psychiatry.

[2464]  S. Biello,et al.  Attenuation of circadian light induced phase advances and delays by neuropeptide y and a neuropeptide y y1/y5 receptor agonist , 2003, Neuroscience.

[2465]  F. Bymaster,et al.  Comparison of effects of dual transporter inhibitors on monoamine transporters and extracellular levels in rats , 2003, Neuropharmacology.

[2466]  C. Reynolds,et al.  Combined treatment with methylphenidate and citalopram for accelerated response in the elderly: an open trial. , 2003, The Journal of clinical psychiatry.

[2467]  Marcin Siwek,et al.  Effect of zinc supplementation on antidepressant therapy in unipolar depression: a preliminary placebo-controlled study. , 2003, Polish journal of pharmacology.

[2468]  Distinct effects of diazepam and NK1 receptor antagonists in two conflict procedures in rats , 2003, Behavioural pharmacology.

[2469]  Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 1. , 2003 .

[2470]  J. Fisher,et al.  Fluoxetine Increases GABAA Receptor Activity through a Novel Modulatory Site , 2003, Journal of Pharmacology and Experimental Therapeutics.

[2471]  B. Lerer,et al.  Algorithm-based treatment of major depression in an outpatient clinic: clinical correlates of response to a specific serotonin reuptake inhibitor and to triiodothyronine augmentation. , 2003, The international journal of neuropsychopharmacology.

[2472]  W. Fleischhacker,et al.  The safety of clozapine in the treatment of first- and multiple-episode patients with treatment-resistant schizophrenia. , 2003, The international journal of neuropsychopharmacology.

[2473]  J. Jankovic,et al.  Dopamine agonists in Parkinson’s disease , 2003, Expert opinion on investigational drugs.

[2474]  M. Youdim,et al.  Anti-apoptotic action of anti-Alzheimer drug, TV3326 [(N-propargyl)-(3R)-aminoindan-5-yl]-ethyl methyl carbamate, a novel cholinesterase-monoamine oxidase inhibitor , 2003, Neuroscience Letters.

[2475]  T. Schlaepfer,et al.  Beyond the Treatment of Epilepsy: New Applications of Vagus Nerve Stimulation in Psychiatry , 2003, CNS Spectrums.

[2476]  M. Millan,et al.  The Novel Melatonin Agonist Agomelatine (S20098) Is an Antagonist at 5-Hydroxytryptamine2C Receptors, Blockade of Which Enhances the Activity of Frontocortical Dopaminergic and Adrenergic Pathways , 2003, Journal of Pharmacology and Experimental Therapeutics.

[2477]  Mary T Johnson,et al.  Autoradiographic evaluation of electromagnetic field effects on serotonin (5HT1A) receptors in rat brain. , 2003, Biomedical sciences instrumentation.

[2478]  G. Milligan.  Principles: extending the utility of [35S]GTP gamma S binding assays. , 2003, Trends in pharmacological sciences.

[2479]  H. Randeva,et al.  Article Title: Corticotropin-releasing Factor Receptors Couple to Multiple G-proteins to Activate Diverse Intracellular Signaling Pathways in Mouse Hippocampus: Role in Neuronal Excitability and Associative Learning Corticotropin-releasing Factor Receptors Couple to Multiple G-proteins to Activate D , 2022 .

[2480]  M. Bouvier,et al.  Role of palmitoylation/depalmitoylation reactions in G-protein-coupled receptor function. , 2003, Pharmacology & therapeutics.

[2481]  R. Ravid,et al.  Molecular changes underlying reduced pineal melatonin levels in Alzheimer disease: alterations in preclinical and clinical stages. , 2003, The Journal of clinical endocrinology and metabolism.

[2482]  L. Balant,et al.  Time course of clinical response to venlafaxine: relevance of plasma level and chirality , 2004, European Journal of Clinical Pharmacology.

[2483]  R. Solé,et al.  Evolving protein interaction networks through gene duplication. , 2003, Journal of theoretical biology.

[2484]  I. Sora,et al.  Experimental gene interaction studies with SERT mutant mice as models for human polygenic and epistatic traits and disorders , 2003, Genes, brain, and behavior.

[2485]  M. J. Jarzynka,et al.  Melatonin receptors and their regulation: biochemical and structural mechanisms. , 2003, Life sciences.

[2486]  M. Quick.  Regulating the Conducting States of a Mammalian Serotonin Transporter , 2003, Neuron.

[2487]  T. Hébert,et al.  Protein complexes involved in heptahelical receptor-mediated signal transduction. , 2003, Receptors & channels.

[2488]  M. Millan,et al.  Blockade of serotonin 5-HT1B and 5-HT2A receptors suppresses the induction of locomotor activity by 5-HT reuptake inhibitors, citalopram and fluvoxamine, in NMRI mice exposed to a novel environment: a comparison to other 5-HT receptor subtypes , 2003, Psychopharmacology.

[2489]  J. Gugten,et al.  5-HT1A receptor and 5-HT1B receptor knockout mice in stress and anxiety paradigms. , 2003, Behavioural pharmacology.

[2490]  J. Korf,et al.  Nerve Growth Factor and Brain-Derived Neurotrophic Factor in Schizophrenia and Depression: Findings in Humans, and Animal Models , 2003 .

[2491]  J. Monti,et al.  Differential effects of the 5-HT1A receptor agonist flesinoxan given locally or systemically on REM sleep in the rat. , 2003, European journal of pharmacology.

[2492]  P. Tyrer,et al.  Separation of anxiety and depressive disorders: blind alley in psychopharmacology and classification of disease , 2003, BMJ : British Medical Journal.

[2493]  B. Banerjee,et al.  Modulation of stress-induced neurobehavioral changes by nitric oxide in rats. , 2003, European journal of pharmacology.

[2494]  Yasuhiro Kaneda,et al.  Serotonin receptors : their key role in drugs to treat schizophrenia , 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[2495]  C. Flachskamm,et al.  Altered Serotonergic Neurotransmission but Normal Hypothalamic–Pituitary–Adrenocortical Axis Activity in Mice Chronically Treated with the Corticotropin-Releasing Hormone Receptor Type 1 Antagonist NBI 30775 , 2003, Neuropsychopharmacology.

[2496]  Bryan L. Roth,et al.  Serotonin receptors represent highly favorable molecular targets for cognitive enhancement in schizophrenia and other disorders , 2004, Psychopharmacology.

[2497]  D. Nebert,et al.  Pharmacogenomics and “Individualized Drug Therapy” , 2003 .

[2498]  P. Gressens,et al.  Neuroprotective properties of tianeptine: interactions with cytokines , 2003, Neuropharmacology.

[2499]  Maurizio Fava,et al.  Diagnosis and definition of treatment-resistant depression , 2003, Biological Psychiatry.

[2500]  R. Blakely,et al.  Calcium-Dependent Inhibition of Synaptosomal Serotonin Transport by the α2-Adrenoceptor Agonist 5-Bromo-N-[4,5-dihydro-1H-imidazol-2-yl]-6-quinoxalinamine (UK14304) , 2003, Journal of Pharmacology and Experimental Therapeutics.

[2501]  J. Zajecka.  Treating depression to remission. , 2003, The Journal of clinical psychiatry.

[2502]  Serotonin Control of Dopaminergic Neurotransmission: Focus on 5-HT2 Receptors , 2003 .

[2503]  G. Stoltenburg‐Didinger,et al.  Thyroid hormones in the rat amygdala as common targets for antidepressant drugs, mood stabilizers, and sleep deprivation , 2003, Biological Psychiatry.

[2504]  M. Millan,et al.  Potent activation of dopamine D3/D2 heterodimers by the antiparkinsonian agents, S32504, pramipexole and ropinirole , 2003, Journal of neurochemistry.

[2505]  F. Martel,et al.  An update on the extraneuronal monoamine transporter (EMT): characteristics, distribution and regulation. , 2003, Current drug metabolism.

[2506]  A. Dellarole,et al.  Acquisition, retention, and recall of memory after injection of RS67333, a 5-HT(4) receptor agonist, into the nucleus basalis magnocellularis of the rat. , 2003, Learning & memory.

[2507]  S. Kelley,et al.  Targeted gene deletion of the 5-HT3A receptor subunit produces an anxiolytic phenotype in mice. , 2003, European journal of pharmacology.

[2508]  M. Corsi,et al.  Effects of antidepressant drugs and GR 205171, an neurokinin-1 (NK1) receptor antagonist, on the response in the forced swim test and on monoamine extracellular levels in the frontal cortex of the mouse , 2003, Neuroscience Letters.

[2509]  J. Javitch,et al.  The Human Dopamine Transporter Forms a Tetramer in the Plasma Membrane , 2003, Journal of Biological Chemistry.

[2510]  G. Skuza,et al.  Sigma1 receptor antagonists attenuate antidepressant-like effect induced by co-administration of 1,3 di-o-tolylguanidine (DTG) and memantine in the forced swimming test in rats. , 2003, Polish journal of pharmacology.

[2511]  S. Ueno.  Genetic polymorphisms of serotonin and dopamine transporters in mental disorders. , 2003, The journal of medical investigation : JMI.

[2512]  P. Moberg,et al.  Neuropsychological deficits among patients with late-onset minor and major depression. , 2003, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[2513]  Ronald C Kessler,et al.  The economic burden of depression in the United States: how did it change between 1990 and 2000? , 2003, The Journal of clinical psychiatry.

[2514]  U. Kang,et al.  Biphasic changes in the Ser-9 phosphorylation of glycogen synthase kinase-3β after electroconvulsive shock in the rat brain , 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[2515]  F. Holsboer,et al.  Reduced attention in mice overproducing corticotropin-releasing hormone , 2003, Behavioural Brain Research.

[2516]  H. Scharfman,et al.  Neuropeptide Y is neuroproliferative for post‐natal hippocampal precursor cells , 2003, Journal of neurochemistry.

[2517]  Shigeru Okuyama,et al.  Anxiolytic-Like and Antidepressant-Like Activities of MCL0129 (1-[(S)-2-(4-Fluorophenyl)-2-(4-isopropylpiperadin-1-yl)ethyl]-4-[4-(2-methoxynaphthalen-1-yl)butyl]piperazine), a Novel and Potent Nonpeptide Antagonist of the Melanocortin-4 Receptor , 2003, Journal of Pharmacology and Experimental Therapeutics.

[2518]  H. Giedke,et al.  Direct comparison of total sleep deprivation and late partial sleep deprivation in the treatment of major depression. , 2003, Journal of affective disorders.

[2519]  R. Koeppe,et al.  Regulation of human affective responses by anterior cingulate and limbic mu-opioid neurotransmission. , 2003, Archives of general psychiatry.

[2520]  C. Lindley,et al.  Aprepitant – a novel NK1-receptor antagonist , 2003, Expert opinion on pharmacotherapy.

[2521]  Alexander Rich,et al.  A-to-I RNA Editing: Recent News and Residual Mysteries* , 2003, The Journal of Biological Chemistry.

[2522]  V. Arolt,et al.  Metabolic changes within the left dorsolateral prefrontal cortex occurring with electroconvulsive therapy in patients with treatment resistant unipolar depression , 2003, Psychological Medicine.

[2523]  Su-Jane Wang,et al.  Fluoxetine depresses glutamate exocytosis in the rat cerebrocortical nerve terminals (synaptosomes) via inhibition of P/Q‐type Ca2+ channels , 2003, Synapse.

[2524]  C. Correll,et al.  Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials. , 2003, The American journal of psychiatry.

[2525]  R. Reenan,et al.  Nervous System Targets of RNA Editing Identified by Comparative Genomics , 2003, Science.

[2526]  J. Cassel,et al.  Neurotransmitter release and its presynaptic modulation in the rat hippocampus after selective damage to cholinergic or/and serotonergic afferents , 2003, Brain Research Bulletin.

[2527]  C. McDougle,et al.  Synergistic Action of 5-HT2A Antagonists and Selective Serotonin Reuptake Inhibitors in Neuropsychiatric Disorders , 2003, Neuropsychopharmacology.

[2528]  Eugenia Migliavacca.  Applied introduction to multivariate methods used in drug discovery. , 2003, Mini reviews in medicinal chemistry.

[2529]  Martin Radina,et al.  Galantamine Is an Allosterically Potentiating Ligand of Neuronal Nicotinic but Not of Muscarinic Acetylcholine Receptors , 2003, Journal of Pharmacology and Experimental Therapeutics.

[2530]  John R. Geddes,et al.  Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis , 2003, The Lancet.

[2531]  S. Shibata,et al.  Facilitation of α‐amino‐3‐hydroxy‐5‐methylisoxazole‐4‐propionate receptor transmission in the suprachiasmatic nucleus by aniracetam enhances photic responses of the biological clock in rodents , 2003, Journal of neurochemistry.

[2532]  C. O'connor,et al.  Depression and cardiovascular disease: mechanisms of interaction , 2003, Biological Psychiatry.

[2533]  M. Millan,et al.  Neuroprotective effects of the novel D3/D2 receptor agonist and antiparkinson agent, S32504, in vitro against 1-methyl-4-phenylpyridinium (MPP+) and in vivo against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a comparison to ropinirole , 2003, Experimental Neurology.

[2534]  G. Milligan.  Constitutive activity and inverse agonists of G protein-coupled receptors: a current perspective. , 2003, Molecular pharmacology.

[2535]  S. Ögren,et al.  Selective 5-HT1A Antagonists WAY 100635 and NAD-299 Attenuate the Impairment of Passive Avoidance Caused by Scopolamine in the Rat , 2003, Neuropsychopharmacology.

[2536]  J. Turgeon,et al.  Role of CYP2D6 in the stereoselective disposition of venlafaxine in humans. , 2003, Pharmacogenetics.

[2537]  J. Vázquez-Prado,et al.  G protein-coupled receptor cross-talk: pivotal roles of protein phosphorylation and protein-protein interactions. , 2003, Cellular signalling.

[2538]  C. Adler,et al.  Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease , 2003, Movement disorders : official journal of the Movement Disorder Society.

[2539]  K. Krishnan,et al.  Effect of bupropion SR on specific symptom clusters of depression: analysis of the 31-item Hamilton Rating Scale for depression. , 2003, Psychopharmacology bulletin.

[2540]  M. Wood.  Therapeutic potential of 5-HT2C receptor antagonists in the treatment of anxiety disorders. , 2003, Current drug targets. CNS and neurological disorders.

[2541]  Robert B. Innis,et al.  Dopamine mediation of positive reinforcing effects of amphetamine in stimulant naı̈ve healthy volunteers: results from a large cohort , 2003, European Neuropsychopharmacology.

[2542]  Donald F. Smith,et al.  [N-methyl-11C]Mirtazapine for positron emission tomography neuroimaging of antidepressant actions in humans , 2004, Psychopharmacology.

[2543]  Anne W. Schmidt,et al.  The pharmacology of CP-154,526, a non-peptide antagonist of the CRH1 receptor: a review. , 2003, CNS drug reviews.

[2544]  Paul Ernsberger,et al.  H1-Histamine Receptor Affinity Predicts Short-Term Weight Gain for Typical and Atypical Antipsychotic Drugs , 2003, Neuropsychopharmacology.

[2545]  H. Kazazian.  Mobile Elements: Drivers of Genome Evolution , 2004, Science.

[2546]  E. Wolters,et al.  Cognitive dysfunction and dementia in Parkinson’s disease , 2004, Journal of Neural Transmission.

[2547]  M. Filip,et al.  Opioid and monoamine systems mediate the discriminative stimulus of tramadol in rats. , 2004, European journal of pharmacology.

[2548]  A. Scott,et al.  Electroconvulsive therapy in depressive illness that has not responded to drug treatment. , 2004, Journal of affective disorders.

[2549]  P. Strange,et al.  Mechanisms of Agonist Action at D2 Dopamine Receptors , 2004, Molecular Pharmacology.

[2550]  B. Grahn,et al.  Quality of life and pain in Parkinson's disease: a controlled cross-sectional study. , 2004, Parkinsonism & related disorders.

[2551]  T. Mashimo,et al.  In vitro inhibition of recombinant ligand-gated ion channels by high concentrations of milnacipran , 2004, Psychopharmacology.

[2552]  A. Young,et al.  Effect of chronic lithium treatment on glucocorticoid and 5-HT1A receptor messenger RNA in hippocampal and dorsal raphe nucleus regions of the rat brain , 2004, Journal of psychopharmacology.

[2553]  P. Boyce,et al.  The relationship between interpersonal sensitivity, anxiety disorders and major depression. , 2004, Journal of affective disorders.

[2554]  S. Stahl,et al.  A critical review of atypical antipsychotic utilization: comparing monotherapy with polypharmacy and augmentation. , 2004, Current medicinal chemistry.

[2555]  R. Goodwin,et al.  Depression and anxiety associated with three pain conditions: results from a nationally representative sample , 2004, Pain.

[2556]  J. Siuciak,et al.  The activity of pramipexole in the mouse forced swim test is mediated by D2 rather than D3 receptors , 2004, Psychopharmacology.

[2557]  L. Fitzgerald,et al.  Melatonin Agonists for the Treatment of Sleep Disorders and Major Depression , 2004 .

[2558]  G. Adler,et al.  Six-month course of mild cognitive impairment and affective symptoms in late-life depression , 2004, European Psychiatry.

[2559]  D. Rasmusson,et al.  Cortical acetylcholine release and electroencephalogram activation evoked by ionotropic glutamate receptor agonists in the rat basal forebrain , 2004, Neuroscience.

[2560]  K. Gamble,et al.  Neuropeptide y and n-methyl-d-aspartic acid interact within the suprachiasmatic nuclei to alter circadian phase , 2004, Neuroscience.

[2561]  Andrew H. Miller,et al.  Cytokines and psychopathology: Lessons from interferon-α , 2004, Biological Psychiatry.

[2562]  S. Montgomery,et al.  Venlafaxine versus placebo in the preventive treatment of recurrent major depression. , 2004, The Journal of clinical psychiatry.

[2563]  P. Celada,et al.  The therapeutic role of 5-HT1A and 5-HT2A receptors in depression. , 2004, Journal of psychiatry & neuroscience : JPN.

[2564]  T. Jay,et al.  Acute stress-induced changes in hippocampal/prefrontal circuits in rats: effects of antidepressants. , 2004, Cerebral cortex.

[2565]  E. Syková,et al.  Glia and volume transmission during physiological and pathological states , 2004, Journal of Neural Transmission.

[2566]  Impact of gene polymorphisms on depression and its treatment. , 2004, IDrugs : the investigational drugs journal.

[2567]  S. Genedani,et al.  Influence of mirtazapine on the sexual behavior of male rats , 2004, Psychopharmacology.

[2568]  J. Hughes,et al.  Review of the validity and significance of cannabis withdrawal syndrome. , 2004, The American journal of psychiatry.

[2569]  J Licinio,et al.  Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response , 2004, Molecular Psychiatry.

[2570]  Shock factor shed by microbe , 2004, Nature Medicine.

[2571]  S. Maier,et al.  Microinjection of urocortin 2 into the dorsal raphe nucleus activates serotonergic neurons and increases extracellular serotonin in the basolateral amygdala , 2004, Neuroscience.

[2572]  A. Walf,et al.  Antidepressant effects of ERβ-selective estrogen receptor modulators in the forced swim test , 2004, Pharmacology Biochemistry and Behavior.

[2573]  G. Gessa,et al.  Mirtazapine-induced corelease of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex. , 2004, European journal of pharmacology.

[2574]  H. Sitte,et al.  Identification of an Additional Interaction Domain in Transmembrane Domains 11 and 12 That Supports Oligomer Formation in the Human Serotonin Transporter* , 2004, Journal of Biological Chemistry.

[2575]  R. Jaffard,et al.  The Serotonin1A Receptor Partial Agonist S15535 [4-(Benzodioxan-5-yl)1-(indan-2-yl)piperazine] Enhances Cholinergic Transmission and Cognitive Function in Rodents: A Combined Neurochemical and Behavioral Analysis , 2004, Journal of Pharmacology and Experimental Therapeutics.

[2576]  G. Bartoszyk,et al.  The highly selective 5‐hydroxytryptamine (5‐HT)2A receptor antagonist, EMD 281014, significantly increases swimming and decreases immobility in male congenital learned helpless rats in the forced swim test , 2004, Synapse.

[2577]  J. Seamans,et al.  The principal features and mechanisms of dopamine modulation in the prefrontal cortex , 2004, Progress in Neurobiology.

[2578]  M. Doretto,et al.  Involvement of prolactin, vasopressin and opioids in post-ictal antinociception induced by electroshock in rats , 2004, Brain Research.

[2579]  G. Fox,et al.  Perspectives on cognitive domains, H3 receptor ligands and neurological disease , 2004, Expert opinion on investigational drugs.

[2580]  G. Tunnicliff,et al.  Central GABAergic Systems and Depressive Illness , 2003, Neurochemical Research.

[2581]  M. Breeding,et al.  Sertraline-induced desensitization of the serotonin 5HT-2 receptor transmembrane signaling system , 2004, Psychopharmacology.

[2582]  A. Eschalier,et al.  Blockade of supraspinal 5-HT1A receptors potentiates the inhibitory effect of venlafaxine on wind-up activity in mononeuropathic rats , 2004, Brain Research.

[2583]  M. Chee,et al.  Functional Imaging of Working Memory after 24 Hr of Total Sleep Deprivation , 2004, The Journal of Neuroscience.

[2584]  P. Calabresi,et al.  Therapeutic doses of L-dopa reverse hypersensitivity of corticostriatal D2-dopamine receptors and glutamatergic overactivity in experimental parkinsonism. , 2004, Brain : a journal of neurology.

[2585]  J. Aubry,et al.  Valproic acid inhibits corticotropin-releasing factor synthesis and release from the rat hypothalamus in vitro: evidence for the involvement of GABAergic neurotransmission. , 2004, Journal of psychiatry & neuroscience : JPN.

[2586]  M. Gerstein,et al.  Genomic analysis of essentiality within protein networks. , 2004, Trends in genetics : TIG.

[2587]  Michael F. Green,et al.  Approaching a consensus cognitive battery for clinical trials in schizophrenia: The NIMH-MATRICS conference to select cognitive domains and test criteria , 2004, Biological Psychiatry.

[2588]  C. Montigny,et al.  Long-term 5-HT reuptake blockade, but not monoamine oxidase inhibition, decreases the function of terminal 5-HT autoreceptors: an electrophysiological study in the rat brain , 1988, Naunyn-Schmiedeberg's Archives of Pharmacology.

[2589]  J. Hughes,et al.  A taxa–area relationship for bacteria , 2004, Nature.

[2590]  P. Sham,et al.  The future of association studies: gene-based analysis and replication. , 2004, American journal of human genetics.

[2591]  Erich Bornberg-Bauer,et al.  Convergent evolution of gene networks by single‐gene duplications in higher eukaryotes , 2004, EMBO reports.

[2592]  C. Halldin,et al.  Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain , 2004, Human brain mapping.

[2593]  M. Millan,et al.  Selective blockade of D3 dopamine receptors enhances the anti-parkinsonian properties of ropinirole and levodopa in the MPTP-lesioned primate , 2004, Experimental Neurology.

[2594]  H. Sitte,et al.  Sodium-dependent neurotransmitter transporters: oligomerization as a determinant of transporter function and trafficking. , 2004, Molecular interventions.

[2595]  M. Wiegand,et al.  Nefazodone in primary insomnia: an open pilot study , 2004, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[2596]  B. Czéh,et al.  Examining novel concepts of the pathophysiology of depression in the chronic psychosocial stress paradigm in tree shrews , 2004, Behavioural pharmacology.

[2597]  Wim E Crusio.  Flanking gene and genetic background problems in genetically manipulated mice , 2004, Biological Psychiatry.

[2598]  S. Kulkarni,et al.  GABA-mediated modification of despair behavior in mice , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

[2599]  L. Lanfumey,et al.  Differential effects of the novel antidepressant agomelatine (S 20098) versus fluoxetine on 5-HT1A receptors in the rat brain , 2004, Neuropharmacology.

[2600]  T. Bártfai,et al.  Galmic, a nonpeptide galanin receptor agonist, affects behaviors in seizure, pain, and forced-swim tests. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[2601]  Behavioural effects of rapid intravenous administration of meta-chlorophenylpiperazine in patients with panic disorder and controls , 2004, European Neuropsychopharmacology.

[2602]  Venkata S Mattay,et al.  Imaging genetic influences in human brain function , 2004, Current Opinion in Neurobiology.

[2603]  S. Sands,et al.  Effect of antidepressants on GABAB receptor function and subunit expression in rat hippocampus , 2004 .

[2604]  S. Wright,et al.  Molecular and cellular physiology of renal organic cation and anion transport. , 2004, Physiological reviews.

[2605]  M. D. Lindner,et al.  Effects of CRF1 receptor antagonists and benzodiazepines in the Morris water maze and delayed non-matching to position tests , 2005, Psychopharmacology.

[2606]  Joanne Wang,et al.  Identification and Characterization of a Novel Monoamine Transporter in the Human Brain* , 2004, Journal of Biological Chemistry.

[2607]  T. Gilliam,et al.  Molecular triangulation: bridging linkage and molecular-network information for identifying candidate genes in Alzheimer's disease. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[2608]  D. Paré.  Presynaptic induction and expression of NMDA-dependent LTP , 2004, Trends in Neurosciences.

[2609]  J. O'Donnell,et al.  Antidepressant effects of inhibitors of cAMP phosphodiesterase (PDE4). , 2004, Trends in pharmacological sciences.

[2610]  M. Raiteri,et al.  Chronic nicotine causes functional upregulation of ionotropic glutamate receptors mediating hippocampal noradrenaline and striatal dopamine release , 2004, Neurochemistry International.

[2611]  H. Xu,et al.  Recovery of hippocampal cell proliferation and BDNF levels, both of which are reduced by repeated restraint stress, is accelerated by chronic venlafaxine , 2004, The Pharmacogenomics Journal.

[2612]  J. Morrison,et al.  Adult male rat hippocampus synthesizes estradiol from pregnenolone by cytochromes P45017alpha and P450 aromatase localized in neurons. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[2613]  John Suckling,et al.  Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. , 2004, Archives of general psychiatry.

[2614]  R. Milo,et al.  Network motifs in integrated cellular networks of transcription-regulation and protein-protein interaction. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[2615]  M. López-Rodríguez,et al.  Benzimidazole derivatives. Part 5: design and synthesis of new benzimidazole-arylpiperazine derivatives acting as mixed 5-HT1A/5-HT3 ligands. , 2004, Bioorganic & medicinal chemistry.

[2616]  C. Dourish,et al.  Serotonin receptor ligands and the treatment of obesity. , 2004, Current opinion in investigational drugs.

[2617]  M. Gershon.  Review article: serotonin receptors and transporters — roles in normal and abnormal gastrointestinal motility , 2004, Alimentary pharmacology & therapeutics.

[2618]  S. Tufik,et al.  Effects of pre- or post-training paradoxical sleep deprivation on two animal models of learning and memory in mice , 2004, Neurobiology of Learning and Memory.

[2619]  J. Malberg.  CRSN Symposium : Focus on Depression , Part I Symposium du CRSN : le point sur la dépression , première partie Implications of adult hippocampal neurogenesis in antidepressant action , 2004 .

[2620]  R. Shelton.  The dual-action hypothesis: does pharmacology matter? , 2004, The Journal of clinical psychiatry.

[2621]  P. Newhouse,et al.  Effects of nicotinic stimulation on cognitive performance. , 2004, Current opinion in pharmacology.

[2622]  Mark D. McBriar,et al.  Therapeutic potential of melanin-concentrating hormone-1 receptor antagonists for the treatment of obesity , 2004, Expert opinion on investigational drugs.

[2623]  M. Ishiguro.  Ligand‐Binding Modes in Cationic Biogenic Amine Receptors , 2004, Chembiochem : a European journal of chemical biology.

[2624]  A. Lawrence,et al.  Chronic Antidepressant Treatment Causes a Selective Reduction of μ-Opioid Receptor Binding and Functional Coupling to G Proteins in the Amygdala of Fawn-Hooded Rats , 2004, Journal of Pharmacology and Experimental Therapeutics.

[2625]  J. Dekker,et al.  Psychotherapy alone and combined with pharmacotherapy in the treatment of depression , 2004, British Journal of Psychiatry.

[2626]  E. Navratilova,et al.  Agonist-specific regulation of the δ-opioid receptor , 2004 .

[2627]  B. Ferger,et al.  The biogenic trace amine tyramine induces a pronounced hydroxyl radical production via a monoamine oxidase dependent mechanism: an in vivo microdialysis study in mouse striatum , 2004, Brain Research.

[2628]  S. Iyengar,et al.  Efficacy of Duloxetine, a Potent and Balanced Serotonin-Norepinephrine Reuptake Inhibitor in Persistent Pain Models in Rats , 2004, Journal of Pharmacology and Experimental Therapeutics.

[2629]  Alan Frazer,et al.  Onset and Early Behavioral Effects of Pharmacologically Different Antidepressants and Placebo in Depression , 2004, Neuropsychopharmacology.

[2630]  R. Bartzatt.  Evaluation of pyridine-3-carboxylic acid as a drug carrier by utilizing multivariate methods, structure property correlations, and pattern recognition techniques. , 2004, Receptors & channels.

[2631]  P. Moleman,et al.  A double-blind randomized study comparing imipramine with fluvoxamine in depressed inpatients , 2004, Psychopharmacology.

[2632]  J. Bonfield,et al.  Finishing the euchromatic sequence of the human genome , 2004, Nature.

[2633]  H. Robertson,et al.  Induction of neurogenesis in the adult rat subventricular zone and neostriatum following dopamine D3 receptor stimulation , 2004, The European journal of neuroscience.

[2634]  M. Munafo,et al.  Meta-analysis of genetic association studies. , 2004, Trends in genetics : TIG.

[2635]  Martin Knapp,et al.  Cost-effectiveness of computerised cognitive-behavioural therapy for anxiety and depression in primary care: Randomised controlled trial , 2004, British Journal of Psychiatry.

[2636]  M. Lynch,et al.  The altered evolutionary trajectories of gene duplicates. , 2004, Trends in genetics : TIG.

[2637]  F. Pralong,et al.  The neuropeptide Y Y1 receptor mediates NPY‐induced inhibition of the gonadotrope axis under poor metabolic conditions , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[2638]  Pal Pacher,et al.  Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns? , 2004, Current pharmaceutical design.

[2639]  S. Nakanishi,et al.  Pharmacological manipulation of mGlu2 receptors influences cognitive performance in the rodent , 2004, Neuropharmacology.

[2640]  T. Pedrazzini.  Importance of NPY Y1 receptor-mediated pathways: assessment using NPY Y1 receptor knockouts , 2004, Neuropeptides.

[2641]  R. Chambers,et al.  Regulation of affect by the lateral septum: implications for neuropsychiatry , 2004, Brain Research Reviews.

[2642]  J. Shih.  Cloning, after cloning, knock-out mice, and physiological functions of MAO A and B. , 2004, Neurotoxicology.

[2643]  M. Papp,et al.  S32504, a Novel Naphtoxazine Agonist at Dopamine D3/D2 Receptors: III. Actions in Models of Potential Antidepressive and Anxiolytic Activity in Comparison with Ropinirole , 2004, Journal of Pharmacology and Experimental Therapeutics.

[2644]  S. Archer,et al.  Decreased platelet nitric oxide synthase activity and plasma nitric oxide metabolites in major depressive disorder , 2004, Biological Psychiatry.

[2645]  S. Darvesh,et al.  Butyrylcholinesterase-Mediated Enhancement of the Enzymatic Activity of Trypsin , 2001, Cellular and Molecular Neurobiology.

[2646]  G. Tortora,et al.  Strategies for Multiple Signalling Inhibition , 2004, Journal of chemotherapy.

[2647]  Willem Soudijn,et al.  Allosteric modulation of G protein-coupled receptors: perspectives and recent developments. , 2004, Drug discovery today.

[2648]  Xingbao Li,et al.  Acute left prefrontal transcranial magnetic stimulation in depressed patients is associated with immediately increased activity in prefrontal cortical as well as subcortical regions , 2004, Biological Psychiatry.

[2649]  D. Ho,et al.  Retraction of an Interpretation , 2004, Science.

[2650]  P. Mulder,et al.  Effect of Antidepressant Medication Resistance on Short-term Response to Electroconvulsive Therapy , 2004, Journal of clinical psychopharmacology.

[2651]  D. Charney,et al.  Addition of the α2-Antagonist Yohimbine to Fluoxetine: Effects on Rate of Antidepressant Response , 2004, Neuropsychopharmacology.

[2652]  Anand R. Kumar,et al.  The Clinical Neuroscience of Post Stroke Depression , 2004 .

[2653]  D. Gründemann,et al.  The localisation of the extraneuronal monoamine transporter (EMT) in rat brain , 2003, Journal of neurochemistry.

[2654]  C. Bowden,et al.  A multivantaged behavioural method for measuring onset and sequence of the clinical actions of antidepressants. , 2004, The international journal of neuropsychopharmacology.

[2655]  D. Javitt,et al.  Glutamate as a therapeutic target in psychiatric disorders , 2004, Molecular Psychiatry.

[2656]  P. Micevych,et al.  Estrogen-Induced μ-Opioid Receptor Internalization in the Medial Preoptic Nucleus Is Mediated via Neuropeptide Y-Y1 Receptor Activation in the Arcuate Nucleus of Female Rats , 2004, The Journal of Neuroscience.

[2657]  B. Moghaddam,et al.  Functional Interaction Between NMDA and mGlu5 Receptors: Effects on Working Memory, Instrumental Learning, Motor Behaviors, and Dopamine Release , 2004, Neuropsychopharmacology.

[2658]  Anabella Villalobos,et al.  Pharmacology of selective acetylcholinesterase inhibitors: implications for use in Alzheimer's disease. , 2004, European journal of pharmacology.

[2659]  G. Sanger.  Neurokinin NK1 and NK3 receptors as targets for drugs to treat gastrointestinal motility disorders and pain , 2004, British journal of pharmacology.

[2660]  Sabina Frascarelli,et al.  3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone , 2004, Nature Medicine.

[2661]  Anton J. Enright,et al.  Detection of functional modules from protein interaction networks , 2003, Proteins.

[2662]  J. Kamei,et al.  Potential anxiolytic and antidepressant-like activities of SNC80, a selective delta-opioid agonist, in behavioral models in rodents. , 2004, Journal of pharmacological sciences.

[2663]  P. Mulholland,et al.  (−)-nicotine ameliorates corticosterone's potentiation of N-methyl-d-aspartate receptor-mediated cornu ammonis 1 toxicity , 2004, Neuroscience.

[2664]  M. Roh,et al.  In Vivo Regulation of Glycogen Synthase Kinase-3β (GSK3β) by Serotonergic Activity in Mouse Brain , 2004, Neuropsychopharmacology.

[2665]  Identification and characterization of a novel allosteric modulator (SoRI‐6238) of the serotonin transporter , 2004, Synapse.

[2666]  D. Swaab.  Neuropeptides in hypothalamic neuronal disorders. , 2004, International review of cytology.

[2667]  P. Cuijpers,et al.  Cannabis use and the risk of later schizophrenia: a review. , 2004, Addiction.

[2668]  M. Villarroya,et al.  New classes of AChE inhibitors with additional pharmacological effects of interest for the treatment of Alzheimer's disease. , 2004, Current pharmaceutical design.

[2669]  Maurice M Ohayon,et al.  Specific characteristics of the pain/depression association in the general population. , 2004, The Journal of clinical psychiatry.

[2670]  B. Ravnkilde,et al.  Hippocampal volume and depression: a meta-analysis of MRI studies. , 2004, The American journal of psychiatry.

[2671]  G. Bernardi,et al.  Inhibitory effects of trace amines on rat midbrain dopaminergic neurons , 2004, Neuropharmacology.

[2672]  A. Blokland,et al.  Dissociable effects of acetylcholinesterase inhibitors and phosphodiesterase type 5 inhibitors on object recognition memory: acquisition versus consolidation , 2004, Psychopharmacology.

[2673]  A. Heagerty,et al.  The risk factors for depression in first myocardial infarction patients , 2004, Psychological Medicine.

[2674]  M. Lader,et al.  Does tolerance develop to the sedative and amnesic effects of antidepressants? , 2004, European Journal of Clinical Pharmacology.

[2675]  S. Kalra,et al.  NPY—an endearing journey in search of a neurochemical on/off switch for appetite, sex and reproduction , 2004, Peptides.

[2676]  M. Hamon,et al.  Melatonin MT1/2 receptor stimulation reduces cortical overflow of cholecystokinin-like material in a model of anticipation of social defeat in the rat , 2004, Neuropharmacology.

[2677]  G. Kennett,et al.  Reduced hypophagic effects of d-fenfluramine and the 5-HT2C receptor agonist mCPP in 5-HT1B receptor knockout mice , 2004, Psychopharmacology.

[2678]  R. DeRubeis,et al.  Response to tryptophan depletion in major depression treated with either cognitive therapy or selective serotonin reuptake inhibitor antidepressants , 2004, Biological Psychiatry.

[2679]  A. Guidotti,et al.  Fluoxetine and norfluoxetine stereospecifically facilitate pentobarbital sedation by increasing neurosteroids. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[2680]  Histamine-selective H3 receptor ligands and cognitive functions: an overview. , 2004, IDrugs : the investigational drugs journal.

[2681]  G. Baker,et al.  Nitric oxide: a key player in the relation between cardiovascular disease and major depressive disorder? , 2004, Journal of psychiatry & neuroscience : JPN.

[2682]  The role of neuropeptides in sleep modulation. , 2004, Drug news & perspectives.

[2683]  M. Bouvier,et al.  Roles of G‐protein‐coupled receptor dimerization , 2004, EMBO reports.

[2684]  Robert B. Innis,et al.  Brain serotonin transporter availability predicts treatment response to selective serotonin reuptake inhibitors , 2004, Biological Psychiatry.

[2685]  C. Nemeroff,et al.  Are mood disorders and obesity related? A review for the mental health professional. , 2004, The Journal of clinical psychiatry.

[2686]  M. Bouvier,et al.  Hetero-oligomerization between β2- and β3-Adrenergic Receptors Generates a β-Adrenergic Signaling Unit with Distinct Functional Properties* , 2004, Journal of Biological Chemistry.

[2687]  Roded Sharan,et al.  Revealing modularity and organization in the yeast molecular network by integrated analysis of highly heterogeneous genomewide data. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[2688]  D. Nebert,et al.  Advances in pharmacogenomics and individualized drug therapy: exciting challenges that lie ahead. , 2004, European journal of pharmacology.

[2689]  G. Juckel,et al.  Differential effects of reboxetine and citalopram on hand-motor function in patients suffering from major depression , 2005, Psychopharmacology.

[2690]  M. Keck,et al.  Repetitive Transcranial Magnetic Stimulation Increases the Release of Dopamine in the Nucleus Accumbens Shell of Morphine-Sensitized Rats During Abstinence , 2004, Neuropsychopharmacology.

[2691]  J. Hagan,et al.  5-HT7 receptors. , 2004, Current drug targets. CNS and neurological disorders.

[2692]  H. Möller,et al.  Single nucleotide polymorphism and haplotype analysis of a novel tryptophan hydroxylase Isoform (TPH2) gene in suicide victims , 2004, Biological Psychiatry.

[2693]  T. Dinan,et al.  Cytokines: abnormalities in major depression and implications for pharmacological treatment , 2004, Human psychopharmacology.

[2694]  M. Fromm,et al.  Clinical aspects of the MDR1 (ABCB1) gene polymorphism. , 2004, Therapeutic drug monitoring.

[2695]  Sati Mazumdar,et al.  Serotonin 1A Receptor Binding and Treatment Response in Late-Life Depression , 2004, Neuropsychopharmacology.

[2696]  Intravenous administration of the neuropeptide galanin has fast antidepressant efficacy and affects the sleep EEG , 2004, Psychoneuroendocrinology.

[2697]  S. Sands,et al.  Relationship between the antinociceptive response to desipramine and changes in GABAB receptor function and subunit expression in the dorsal horn of the rat spinal cord. , 2004, Biochemical pharmacology.

[2698]  Peter Herscovitch,et al.  Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls. , 2004, Archives of general psychiatry.

[2699]  W. Goodman.  Selecting pharmacotherapy for generalized anxiety disorder. , 2004, The Journal of clinical psychiatry.

[2700]  B. Roth,et al.  Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia , 2004, Nature Reviews Drug Discovery.

[2701]  Graeme Eisenhofer,et al.  Catecholamine Metabolism: A Contemporary View with Implications for Physiology and Medicine , 2004, Pharmacological Reviews.

[2702]  J. S. Simon,et al.  Extended-release venlafaxine in relapse prevention for patients with major depressive disorder. , 2004, Journal of psychiatric research.

[2703]  T. Bonhoeffer,et al.  Bidirectional Activity-Dependent Morphological Plasticity in Hippocampal Neurons , 2004, Neuron.

[2704]  A. Sleight,et al.  5-HT6 receptor antagonists reverse delay-dependent deficits in novel object discrimination by enhancing consolidation—an effect sensitive to NMDA receptor antagonism , 2004, Neuropharmacology.

[2705]  A. Gemignani,et al.  Pramipexole in treatment‐resistant depression: An extended follow‐up , 2004, Depression and anxiety.

[2706]  M. Minami,et al.  Molecular pharmacology of the opioid receptors. , 1995, Pharmacology & therapeutics.

[2707]  Sheng Kang,et al.  A systematic review and meta-analysis of the efficacy and safety of a fixed, low-dose perindopril-indapamide combination as first-line treatment of hypertension. , 2004, Clinical therapeutics.

[2708]  U. Kang,et al.  Activation of protein kinase B (Akt) signaling after electroconvulsive shock in the rat hippocampus , 2004, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[2709]  L. Egede.  Diabetes, major depression, and functional disability among U.S. adults. , 2004, Diabetes care.

[2710]  F. Mazzi,et al.  Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project , 2004, Acta psychiatrica Scandinavica. Supplementum.

[2711]  B. Martin,et al.  Prevalence, trends, and factors associated with antipsychotic polypharmacy among Medicaid-eligible schizophrenia patients, 1998-2000. , 2004, The Journal of clinical psychiatry.

[2712]  L. Provinciali,et al.  Motivational Symptoms of Depression Mask Preclinical Alzheimer’s Disease in Elderly Subjects , 2004, Dementia and Geriatric Cognitive Disorders.

[2713]  J. Cryan,et al.  In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice , 2004, Molecular Psychiatry.

[2714]  Teruo Hayashi,et al.  σ-1 Receptor Ligands , 2004 .

[2715]  J. Friedman,et al.  Sleep and fatigue in Parkinson's disease. , 2004, Parkinsonism & related disorders.

[2716]  Ozgur Yorbik,et al.  Clinical characteristics of depressive symptoms in children and adolescents with major depressive disorder. , 2004, The Journal of clinical psychiatry.

[2717]  D. Liley,et al.  Selective effects of simultaneous monoamine depletion on mood and emotional responsiveness. , 2004, The international journal of neuropsychopharmacology.

[2718]  J. Hensler,et al.  Autoreceptor‐mediated inhibition of norepinephrine release in rat medial prefrontal cortex is maintained after chronic desipramine treatment , 2004, Journal of neurochemistry.

[2719]  I. Yalcin,et al.  Dual effects of nitric oxide in the mouse forced swimming test: possible contribution of nitric oxide-mediated serotonin release and potassium channel modulation , 2004, Pharmacology Biochemistry and Behavior.

[2720]  B. Roth,et al.  The highly efficacious actions of N-desmethylclozapine at muscarinic receptors are unique and not a common property of either typical or atypical antipsychotic drugs: is M1 agonism a pre-requisite for mimicking clozapine’s actions? , 2005, Psychopharmacology.

[2721]  D. Weinberger,et al.  Depletion and restoration of endogenous monoamines affects beta-CIT binding to serotonin but not dopamine transporters in non-human primates. , 2004, Journal of neural transmission. Supplementum.

[2722]  Stephen J. Smith,et al.  Neural activity and the dynamics of central nervous system development , 2004, Nature Neuroscience.

[2723]  J. Storm-Mathisen,et al.  GABAergic synapses in hippocampus exocytose aspartate on to NMDA receptors: quantitative immunogold evidence for co-transmission , 2004, Molecular and Cellular Neuroscience.

[2724]  S. Woods,et al.  Pharmaceutical approaches to the treatment of obesity. , 2004, Drug discovery today.

[2725]  C. Supuran,et al.  COX-2 selective inhibitors, carbonic anhydrase inhibition and anticancer properties of sulfonamides belonging to this class of pharmacological agents. , 2004, Mini reviews in medicinal chemistry.

[2726]  W. Drevets,et al.  Discovering Endophenotypes for Major Depression , 2004, Neuropsychopharmacology.

[2727]  B. Grant,et al.  Prevalence and Co-Occurrence of Substance Use Disorders and Independent Mood and Anxiety Disorders , 2004, Archives of general psychiatry.

[2728]  S. Faraone,et al.  Heterogeneity of schizophrenia: a study of individual neuropsychological profiles , 2004, Schizophrenia Research.

[2729]  Stephen C. Heinrichs,et al.  Corticotropin-Releasing Factor in Brain: A Role in Activation, Arousal, and Affect Regulation , 2004, Journal of Pharmacology and Experimental Therapeutics.

[2730]  Jie Hu,et al.  Technological Advances in High-Throughput Screening , 2004, American journal of pharmacogenomics : genomics-related research in drug development and clinical practice.

[2731]  P. Platania,et al.  Novel neuronal targets for the acetylcholinesterase inhibitor donepezil , 2004, Neuropharmacology.

[2732]  P. Navarra,et al.  Mirtazapine acutely inhibits basal and K+-stimulated release of corticotropin-releasing hormone from the rat hypothalamus via a non-genomic mechanism , 2005, Psychopharmacology.

[2733]  Nora D. Volkow,et al.  The reality of comorbidity: Depression and drug abuse , 2004, Biological Psychiatry.

[2734]  R. Drucker-Colín,et al.  Neurogenesis in the subventricular zone following transcranial magnetic field stimulation and nigrostriatal lesions , 2004, Journal of neuroscience research.

[2735]  P. Francis,et al.  Cholinesterase Inhibitors Used in the Treatment of Alzheimer’s Disease , 2004, Drugs & aging.

[2736]  P.1.062 Reboxetine added to SSRI accelerates the improvement in depressed patients who failed to respond to SSRI alone , 2004, European Neuropsychopharmacology.

[2737]  M. Rubio,et al.  Acute and chronic effects of lithium chloride on GABA-ergic function in the rat corpus striatum and frontal cerebral cortex , 1986, Naunyn-Schmiedeberg's Archives of Pharmacology.

[2738]  I. Laszlovszky,et al.  Dopamine D3 receptor antagonists improve the learning performance in memory-impaired rats , 2005, Psychopharmacology.

[2739]  T. Müller.  Mood disorders in early Parkinson's disease , 2004 .

[2740]  J. Landeira-Fernández,et al.  Anxiogenic effects in the rat elevated plus-maze of 5-HT2C agonists into ventral but not dorsal hippocampus , 2004, Behavioural pharmacology.

[2741]  Philippe A. Chouinard,et al.  Mechanisms of Action Underlying the Effect of Repetitive Transcranial Magnetic Stimulation on Mood: Behavioral and Brain Imaging Studies , 2004, Neuropsychopharmacology.

[2742]  S. Watson,et al.  The δ-Opioid Receptor Agonist (+)BW373U86 Regulates BDNF mRNA Expression in Rats , 2004, Neuropsychopharmacology.

[2743]  A. Walf,et al.  Progesterone enhances motor, anxiolytic, analgesic, and antidepressive behavior of wild-type mice, but not those deficient in type 1 5α-reductase , 2004, Brain Research.

[2744]  Gal Yadid,et al.  The serotonin–dopamine interaction is critical for fast-onset action of antidepressant treatment: in vivo studies in an animal model of depression , 2004, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[2745]  K. Nishikura,et al.  Altered RNA editing of serotonin 5-HT2C receptor induced by interferon: implications for depression associated with cytokine therapy. , 2004, Brain research. Molecular brain research.

[2746]  P. Nieto,et al.  Tachykinins and tachykinin receptors: structure and activity relationships. , 2004, Current medicinal chemistry.

[2747]  M. Detke,et al.  Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial , 2004, European Neuropsychopharmacology.

[2748]  J. Vry,et al.  5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat , 2004, European Neuropsychopharmacology.

[2749]  T. George,et al.  Current pharmacological treatments for nicotine dependence. , 2004, Trends in pharmacological sciences.

[2750]  Panos Macheras,et al.  Multivariate Statistics of Disposition Pharmacokinetic Parameters for Structurally Unrelated Drugs Used in Therapeutics , 2002, Pharmaceutical Research.

[2751]  Thomas Meitinger,et al.  Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment , 2004, Nature Genetics.

[2752]  J. Sutcliffe,et al.  Functional, molecular and pharmacological advances in 5-HT7 receptor research. , 2004, Trends in pharmacological sciences.

[2753]  H. Manji,et al.  Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers , 2004, Molecular Psychiatry.

[2754]  J. Leysen,et al.  Functional role of 5-HT2 receptors in the regulation of sleep and wakefulness in the rat , 2004, Psychopharmacology.

[2755]  Marc G Caron,et al.  Desensitization of G protein-coupled receptors and neuronal functions. , 2004, Annual review of neuroscience.

[2756]  A. Bianchi,et al.  Effects of Reboxetine on Sleep and Nocturnal Cardiac Autonomic Activity in Patients with Dysthymia , 2004, Journal of psychopharmacology.

[2757]  B. Bondy,et al.  Regional mRNA expression of a second tryptophan hydroxylase isoform in postmortem tissue samples of two human brains , 2004, European Neuropsychopharmacology.

[2758]  G. Kennett,et al.  Tonic regulation of satiety by 5‐HT1B receptors in the mouse: converging evidence from behavioural and c‐fos immunoreactivity studies? , 2004, The European journal of neuroscience.

[2759]  T. Coleman,et al.  Novel aryloxy-8-azabicyclo[3.2.1]oct-3-enes with 5-HT transporter and 5-HT1A affinity. , 2004, Bioorganic & medicinal chemistry letters.

[2760]  X. Langlois,et al.  Anxiolytic- and antidepressant-like profile of a new CRF1 receptor antagonist, R278995/CRA0450. , 2004, European journal of pharmacology.

[2761]  T. Robbins,et al.  Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates , 2004, Neuroscience & Biobehavioral Reviews.

[2762]  K. Nakayama,et al.  Mirtazapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation , 2004, Brain Research Bulletin.

[2763]  M. Baxter,et al.  Central blockade of muscarinic cholinergic receptors disrupts affective and attentional set‐shifting , 2004, The European journal of neuroscience.

[2764]  R. Neve,et al.  Effects of cyclic adenosine monophosphate response element binding protein overexpression in the basolateral amygdala on behavioral models of depression and anxiety , 2004, Biological Psychiatry.

[2765]  Seppo Kähkönen,et al.  Transcranial Magnetic Stimulation: Applications for Neuropsychopharmacology , 2004, Journal of psychopharmacology.

[2766]  H. Manji,et al.  Focus on CaMKII: a molecular switch in the pathophysiology and treatment of mood and anxiety disorders. , 2004, The international journal of neuropsychopharmacology.

[2767]  E. Janke,et al.  Depression increases onset of tension-type headache following laboratory stress , 2004, Pain.

[2768]  M. Millan,et al.  Quantification and pharmacological characterization of dialysate levels of noradrenaline in the striatum of freely-moving rats: release from adrenergic terminals and modulation by α2-autoreceptors , 2004, Journal of Neuroscience Methods.

[2769]  M. Giovannini,et al.  S 18986, a positive modulator of AMPA receptors with cognition-enhancing properties, increases ACh release in the hippocampus of young and aged rat , 2004, Neuroscience Letters.

[2770]  T. Bártfai.  Pharmacogenomics in drug development: societal and technical aspects , 2004, The Pharmacogenomics Journal.

[2771]  K. Lesch,et al.  GABAB receptors in 5‐HT transporter‐ and 5‐HT1A receptor‐knock‐out mice: further evidence of a transduction pathway shared with 5‐HT1A receptors , 2004 .

[2772]  J. Bockaert,et al.  Modulation of memory processes and cellular excitability in the dentate gyrus of freely moving rats by a 5-HT4 receptors partial agonist, and an antagonist , 2004, Neuropharmacology.

[2773]  M. Kuśmider,et al.  Long-term exposure of rats to tramadol alters brain dopamine and alpha 1-adrenoceptor function that may be related to antidepressant potency. , 2004, European journal of pharmacology.

[2774]  J. Sacher,et al.  Therapy of Treatment Resistant Depression: Focus on the Management of TRD with Atypical Antipsychotics , 2004, CNS Spectrums.

[2775]  A. Russo-Neustadt,et al.  Hippocampal Brain-Derived Neurotrophic Factor Expression Following Treatment with Reboxetine, Citalopram, and Physical Exercise , 2004, Neuropsychopharmacology.

[2776]  M. Meyer,et al.  Mechanism of action of A-85380 in an animal model of depression , 2004, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[2777]  Yaakov Stern,et al.  Identification and differential vulnerability of a neural network in sleep deprivation. , 2004, Cerebral cortex.

[2778]  Yukio Mano,et al.  Effects of acute repetitive transcranial magnetic stimulation on dopamine release in the rat dorsolateral striatum , 2004, Journal of the Neurological Sciences.

[2779]  Antidepressant research in the era of functional genomics: Farewell to the monoamine hypothesis , 2004 .

[2780]  C. Swanson,et al.  The mGlu2/3 receptor agonist, LY354740, blocks immobilization‐induced increases in noradrenaline and dopamine release in the rat medial prefrontal cortex , 2003, Journal of neurochemistry.

[2781]  K. Wilson,et al.  A comparison of side effects of selective serotonin reuptake inhibitors and tricyclic antidepressants in older depressed patients: a meta‐analysis , 2004, International journal of geriatric psychiatry.

[2782]  J. Cryan,et al.  Altered response to benzodiazepine anxiolytics in mice lacking GABA B(1) receptors. , 2004, European journal of pharmacology.

[2783]  M. Lader,et al.  Antidepressants and human memory: an investigation of four drugs with different sedative and anticholinergic profiles , 2004, Psychopharmacology.

[2784]  J. Johanson.  Options for patients with irritable bowel syndrome: contrasting traditional and novel serotonergic therapies , 2004, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[2785]  J. Kew,et al.  GABAergic modulation of 5-HT7 receptor-mediated effects on 5-HT efflux in the guinea-pig dorsal raphe nucleus , 2004, Neuropharmacology.

[2786]  M. Long,et al.  Origin of New Genes: Evidence from Experimental and Computational Analyses , 2003, Genetica.

[2787]  G. Chiara,et al.  Noradrenaline transporter blockers raise extracellular dopamine in medial prefrontal but not parietal and occipital cortex: differences with mianserin and clozapine , 2004, Journal of neurochemistry.

[2788]  H. Kashima,et al.  Revising polypharmacy to a single antipsychotic regimen for patients with chronic schizophrenia. , 2004, The international journal of neuropsychopharmacology.

[2789]  D. Jezova,et al.  Modulation of Neuroendocrine Response and Non-Verbal Behavior during Psychosocial Stress in Healthy Volunteers by the Glutamate Release-Inhibiting Drug Lamotrigine , 2004, Neuroendocrinology.

[2790]  M. Heilig.  The NPY system in stress, anxiety and depression , 2004, Neuropeptides.

[2791]  Kenneth M. Johnson,et al.  Piperidine-based nocaine/modafinil hybrid ligands as highly potent monoamine transporter inhibitors: efficient drug discovery by rational lead hybridization. , 2004, Journal of medicinal chemistry.

[2792]  S. Nakanishi,et al.  Pharmacological and genetic evidence indicates that combined inhibition of NR2A and NR2B subunit containing NMDA receptors is required to disrupt prepulse inhibition , 2004, Psychopharmacology.

[2793]  Victoria Arango,et al.  Volumetric Analysis of the Prefrontal Cortex, Amygdala, and Hippocampus in Major Depression , 2004, Neuropsychopharmacology.

[2794]  A. Schatzberg,et al.  Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression. , 2004, Archives of general psychiatry.

[2795]  J. A. Boer,et al.  Future Antidepressants , 2004, CNS drugs.

[2796]  P. Kelly,et al.  Behavioral Characterization of the Novel GABAB Receptor-Positive Modulator GS39783 (N,N′-Dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): Anxiolytic-Like Activity without Side Effects Associated with Baclofen or Benzodiazepines , 2004, Journal of Pharmacology and Experimental Therapeutics.

[2797]  Masanori Arita.  The metabolic world of Escherichia coli is not small. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[2798]  J. Amsterdam,et al.  Pindolol does not augment cortisol and prolactin responses to paroxetine in healthy subjects , 2004, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[2799]  M. Zarrindast,et al.  The effect of electroconvulsive shock seizures on behaviour induced by dopaminergic agonists and on immobility in the Porsolt test , 2004, European Neuropsychopharmacology.

[2800]  E. Uhlenhuth,et al.  Long‐term effectiveness of cognitive therapy in major depressive disorder , 2004, Depression and anxiety.

[2801]  M. Millan,et al.  Involvement of dopamine D2/D3 receptors and BDNF in the neuroprotective effects of S32504 and pramipexole against 1-methyl-4-phenylpyridinium in terminally differentiated SH-SY5Y cells , 2004, Experimental Neurology.

[2802]  J. Wess,et al.  Muscarinic acetylcholine receptor knockout mice: novel phenotypes and clinical implications. , 2004, Annual review of pharmacology and toxicology.

[2803]  M. Millan,et al.  S32504, a Novel Naphtoxazine Agonist at Dopamine D3/D2 Receptors: II. Actions in Rodent, Primate, and Cellular Models of Antiparkinsonian Activity in Comparison to Ropinirole , 2004, Journal of Pharmacology and Experimental Therapeutics.

[2804]  B. Kupelnick,et al.  Combined pharmacotherapy and psychological treatment for depression: a systematic review. , 2004, Archives of general psychiatry.

[2805]  Jerry J. Buccafusco,et al.  Selective serotonin 5-HT2A receptor antagonist EMD 281014 improves delayed matching performance in young and aged rhesus monkeys , 2005, Psychopharmacology.

[2806]  B. Rounsaville.  Treatment of cocaine dependence and depression , 2004, Biological Psychiatry.

[2807]  A. Beck‐Sickinger,et al.  Novel modified and radiolabelled neuropeptide Y analogues to study Y-receptor subtypes , 2004, Neuropeptides.

[2808]  B. McEwen,et al.  Chronic restraint stress up-regulates GLT-1 mRNA and protein expression in the rat hippocampus: Reversal by tianeptine , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[2809]  S. Mitchell,et al.  The role of the 5-HT1D receptor as a presynaptic autoreceptor in the guinea pig. , 2004, European journal of pharmacology.

[2810]  P A Sargent,et al.  Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635 , 2004, Molecular Psychiatry.

[2811]  E. Hull,et al.  Dopamine and serotonin: influences on male sexual behavior , 2004, Physiology & Behavior.

[2812]  P. Cannistraro,et al.  Clinical correlates of recurrent major depression in obsessive–compulsive disorder , 2004, Depression and anxiety.

[2813]  A. Dhillon,et al.  Lamina-specific differences in GABAB autoreceptor-mediated regulation of spontaneous GABA release in rat entorhinal cortex , 2004, Neuropharmacology.

[2814]  N. Ling,et al.  Ligand affinity for amino-terminal and juxtamembrane domains of the corticotropin releasing factor type I receptor: regulation by G-protein and nonpeptide antagonists. , 2004, Biochemistry.

[2815]  R. Kessler,et al.  12‐Month comorbidity patterns and associated factors in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project , 2004, Acta psychiatrica Scandinavica. Supplementum.

[2816]  Alicja Lerner,et al.  Serotonin transporter: gene, genetic disorders, and pharmacogenetics. , 2004, Molecular interventions.

[2817]  A. Argiolas,et al.  The role of oxytocin and the paraventricular nucleus in the sexual behaviour of male mammals , 2004, Physiology & Behavior.

[2818]  Charles Shelton.  Long-term management of major depressive disorder: are differences among antidepressant treatments meaningful? , 2004, The Journal of clinical psychiatry.

[2819]  H. Kalant,et al.  Adverse effects of cannabis on health: an update of the literature since 1996 , 2004, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[2820]  T. Robinson,et al.  The Rate of Cocaine Administration Alters Gene Regulation and Behavioral Plasticity: Implications for Addiction , 2004, The Journal of Neuroscience.

[2821]  A. Goldberger,et al.  Emergence of complex dynamics in a simple model of signaling networks. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[2822]  S. Avissar,et al.  Beta-arrestin-1 levels: reduced in leukocytes of patients with depression and elevated by antidepressants in rat brain. , 2004, The American journal of psychiatry.

[2823]  M. Fava,et al.  Ziprasidone augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant major depressive disorder. , 2004, The Journal of clinical psychiatry.

[2824]  Anil K Malhotra,et al.  Pharmacogenetics of psychotropic drug response. , 2004, The American journal of psychiatry.

[2825]  M. Bourin,et al.  Antidepressant-like activity of S 20098 (agomelatine) in the forced swimming test in rodents: involvement of melatonin and serotonin receptors. , 2004, Journal of psychiatry & neuroscience : JPN.

[2826]  W. Oechel,et al.  Biodiversity, Distributions and Adaptations of Arctic Species in the Context of Environmental Change , 2004, Ambio.

[2827]  S. Nakanishi,et al.  MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity , 2004, Neuropharmacology.

[2828]  K. Hashimoto,et al.  Critical role of brain-derived neurotrophic factor in mood disorders , 2004, Brain Research Reviews.

[2829]  L. Devi,et al.  INTERACTIONS BETWEEN δ OPIOID RECEPTORS AND α2A‐ADRENOCEPTORS , 2004, Clinical and experimental pharmacology & physiology.

[2830]  H. Anisman,et al.  Dysregulation in the Suicide Brain: mRNA Expression of Corticotropin-Releasing Hormone Receptors and GABAA Receptor Subunits in Frontal Cortical Brain Region , 2004, The Journal of Neuroscience.

[2831]  K. Lesch,et al.  CRSN Symposium : Focus on Depression , Part I Symposium du CRSN : le point sur la dépression , première partie Gene – environment interaction and the genetics of depression , 2004 .

[2832]  C. Sánchez,et al.  Comparison of the Effects of Antidepressants and Their Metabolites on Reuptake of Biogenic Amines and on Receptor Binding , 1999, Cellular and Molecular Neurobiology.

[2833]  I. Lucki,et al.  Distinguishing roles for norepinephrine and serotonin in the behavioral effects of antidepressant drugs. , 2004, The Journal of clinical psychiatry.

[2834]  G. Lynch.  AMPA receptor modulators as cognitive enhancers. , 2004, Current opinion in pharmacology.

[2835]  Richard Morphy,et al.  From magic bullets to designed multiple ligands. , 2004, Drug discovery today.

[2836]  Daisuke Mochizucki.  Serotonin and noradrenaline reuptake inhibitors in animal models of pain , 2004, Human psychopharmacology.

[2837]  B. Aouizerate,et al.  Pathophysiology of obsessive–compulsive disorder A necessary link between phenomenology, neuropsychology, imagery and physiology , 2004, Progress in Neurobiology.

[2838]  S. Krahl,et al.  Vagus nerve stimulation (VNS) is effective in a rat model of antidepressant action. , 2004, Journal of psychiatric research.

[2839]  A. Kemp,et al.  Simultaneous Depletion of Serotonin and Catecholamines Impairs Sustained Attention in Healthy Female Subjects without Affecting Learning and Memory , 2004, Journal of psychopharmacology.

[2840]  J. Lépine,et al.  The European Study of the Epidemiology of Mental Disorders (ESEMeD) project: an epidemiological basis for informing mental health policies in Europe , 2004, Acta psychiatrica Scandinavica. Supplementum.

[2841]  S. Russek,et al.  cAMP Response Element-Binding Protein, Activating Transcription Factor-4, and Upstream Stimulatory Factor Differentially Control Hippocampal GABABR1a and GABABR1b Subunit Gene Expression through Alternative Promoters , 2004, The Journal of Neuroscience.

[2842]  E. Koonin,et al.  Conservation and coevolution in the scale-free human gene coexpression network. , 2004, Molecular biology and evolution.

[2843]  R. Kessler,et al.  Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. , 2004, JAMA.

[2844]  Jingyu Chang,et al.  Brain Stimulation for Neurological and Psychiatric Disorders, Current Status and Future Direction , 2004, Journal of Pharmacology and Experimental Therapeutics.

[2845]  M. Bakker,et al.  Synthesis of 3a,4-dihydro-3H-[1]benzopyrano[4,3-c]isoxazoles, displaying combined 5-HT uptake inhibiting and alpha2-adrenoceptor antagonistic activities. Part 2: Further exploration on the cinnamyl moiety. , 2004, Bioorganic & medicinal chemistry letters.

[2846]  M. Meaney,et al.  A comparison of the effects of diazepam versus several typical and atypical anti-depressant drugs in an animal model of anxiety , 2004, Psychopharmacology.

[2847]  C. Sánchez,et al.  Different roles of 5-HT2A and 5-HT2C receptors in regulation of female rat paced mating behaviour , 2004, Behavioural Brain Research.

[2848]  A. Serretti,et al.  From molecular biology to pharmacogenetics: a review of the literature on antidepressant treatment and suggestions of possible candidate genes , 2004, Psychopharmacology.

[2849]  P. Brambilla,et al.  Stress and hippocampal abnormalities in psychiatric disorders , 2004, European Neuropsychopharmacology.

[2850]  M. Díaz-Ricart,et al.  Decrease of the platelet 5‐HT2A receptor function by long‐term imipramine treatment in endogenous depression , 2004, Human psychopharmacology.

[2851]  R. Watts,et al.  Treatment of depression in Parkinson's disease. , 2004, Parkinsonism & related disorders.

[2852]  A. Shekhar,et al.  Interactions between NPY and CRF in the amygdala to regulate emotionality , 2004, Neuropeptides.

[2853]  GABAergic system and imipramine-induced impairment of memory retention in rats , 2004, European Neuropsychopharmacology.

[2854]  R. Jakus,et al.  Increased wakefulness, motor activity and decreased theta activity after blockade of the 5‐HT2B receptor by the subtype‐selective antagonist SB‐215505 , 2004, British journal of pharmacology.

[2855]  S. Beyenburg,et al.  "Dopamine-dependent" side effects of selective serotonin reuptake inhibitors: a clinical review. , 2004, The Journal of clinical psychiatry.

[2856]  Daniel J Buysse,et al.  The treatment of chronic insomnia: drug indications, chronic use and abuse liability. Summary of a 2001 New Clinical Drug Evaluation Unit meeting symposium. , 2004, Sleep medicine reviews.

[2857]  R. Duman.  Depression: a case of neuronal life and death? , 2004, Biological Psychiatry.

[2858]  H. Tanila,et al.  In vivo regulation of dopamine and noradrenaline release by alpha2A‐adrenoceptors in the mouse nucleus accumbens , 2004, Journal of neurochemistry.

[2859]  A. Schinkel,et al.  Pharmacological and Physiological Functions of the Polyspecific Organic Cation Transporters: OCT1, 2, and 3 (SLC22A1-3) , 2004, Journal of Pharmacology and Experimental Therapeutics.

[2860]  S. Thomas,et al.  A Distinct Role for Norepinephrine in Memory Retrieval , 2004, Cell.

[2861]  J. Zajecka,et al.  SNRIs in the management of acute major depressive disorder. , 2004, The Journal of clinical psychiatry.

[2862]  L. Tecott,et al.  Contributions of 5-HT(2C) receptors to multiple actions of central serotonin systems. , 2004, European journal of pharmacology.

[2863]  K. Fink,et al.  Stimulation of serotonin release in the rat brain cortex by activation of ionotropic glutamate receptors and its modulation via α2-heteroreceptors , 1995, Naunyn-Schmiedeberg's Archives of Pharmacology.

[2864]  J. Sprouse,et al.  8-OH-DPAT as a 5-HT7 agonist: phase shifts of the circadian biological clock through increases in cAMP production , 2004, Neuropharmacology.

[2865]  Klaas Enno Stephan,et al.  On the role of general system theory for functional neuroimaging , 2004, Journal of anatomy.

[2866]  A. Serretti,et al.  New antipsychotics and schizophrenia: a review on efficacy and side effects. , 2004, Current medicinal chemistry.

[2867]  P. Csermely.  Strong links are important, but weak links stabilize them. , 2004, Trends in biochemical sciences.

[2868]  P. Cowen,et al.  Preferential 5-HT1A Autoreceptor Occupancy by Pindolol is Attenuated in Depressed Patients: Effect of Treatment or an Endophenotype of Depression? , 2004, Neuropsychopharmacology.

[2869]  David Eidelberg,et al.  Effects of Serotonin Transporter Promoter Polymorphisms on Serotonin Function , 2004, Neuropsychopharmacology.

[2870]  R. Quirion,et al.  Aged neuropeptide Y transgenic rats are resistant to acute stress but maintain spatial and non-spatial learning , 2004, Behavioural Brain Research.

[2871]  R. Bielski,et al.  A double-blind comparison of escitalopram and venlafaxine extended release in the treatment of major depressive disorder. , 2004, The Journal of clinical psychiatry.

[2872]  F. Guimarães,et al.  Antidepressant-like effects of NMDA-receptor antagonist injected into the dorsal hippocampus of rats , 2004, Pharmacology Biochemistry and Behavior.

[2873]  Effect of metyrapone supplementation on imipramine therapy in patients with treatment-resistant unipolar depression. , 2004, Polish journal of pharmacology.

[2874]  T. Kenakin.  Principles: receptor theory in pharmacology. , 2004, Trends in pharmacological sciences.

[2875]  C. Eastman,et al.  Bright Light Therapy for Winter Depression—Is Phase Advancing Beneficial? , 2004, Chronobiology international.

[2876]  C. Pariante,et al.  Psychopharmacological Treatment of Depression, Anxiety, Irritability and Insomnia in Patients Receiving Interferon-α: a Prospective Case Series and a Discussion of Biological Mechanisms , 2004 .

[2877]  M. Scarselli,et al.  The Paired Activation of the Two Components of the Muscarinic M3 Receptor Dimer Is Required for Induction of ERK1/2 Phosphorylation* , 2004, Journal of Biological Chemistry.

[2878]  J. O'Donnell,et al.  Inhibition of the Phosphodiesterase 4 (PDE4) Enzyme Reverses Memory Deficits Produced by Infusion of the MEK Inhibitor U0126 into the CA1 Subregion of the Rat Hippocampus , 2004, Neuropsychopharmacology.

[2879]  M. Millan,et al.  The novel monoamine reuptake inhibitor and potential antidepressant, S33005, induces Arc gene expression in cerebral cortex. , 2004, European journal of pharmacology.

[2880]  C. Lüscher,et al.  Bi-directional effects of GABAB receptor agonists on the mesolimbic dopamine system , 2004, Nature Neuroscience.

[2881]  N. Schork,et al.  Candidate genes, pathways and mechanisms for bipolar (manic–depressive) and related disorders: an expanded convergent functional genomics approach , 2004, Molecular Psychiatry.

[2882]  P. Grasby,et al.  Occupancy of Agonist Drugs at the 5-HT1A Receptor , 2004, Neuropsychopharmacology.

[2883]  Huan Liu,et al.  Substance P promotes sleep in the ventrolateral preoptic area of rats , 2004, Brain Research.

[2884]  Tyrosine depletion does not cause depressive relapse in antidepressant-treated patients , 2004, Psychopharmacology.

[2885]  Dan J Stein,et al.  Escitalopram in the treatment of social anxiety disorder: Analysis of efficacy for different clinical subgroups and symptom dimensions , 2004, Depression and anxiety.

[2886]  J. Zentner,et al.  Characterization of nicotinic receptors inducing noradrenaline release and absence of nicotinic autoreceptors in human neocortex , 2004, Brain Research Bulletin.

[2887]  Steffen Moritz,et al.  Late-Onset Depression with Mild Cognitive Deficits: Electrophysiological Evidences for a Preclinical Dementia Syndrome , 2004, Dementia and Geriatric Cognitive Disorders.

[2888]  Dong-Hwan Kim,et al.  Syntaxin 1A and Receptor for Activated C Kinase Interact with the N-Terminal Region of Human Dopamine Transporter , 2004, Neurochemical Research.

[2889]  Jordi Serrats,et al.  Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex. , 2004, Cerebral cortex.

[2890]  E. Weiller,et al.  A comparative study of milnacipran and paroxetine in outpatients with major depression. , 2004, Journal of affective disorders.

[2891]  M. Farlow.  NMDA receptor antagonists. A new therapeutic approach for Alzheimer's disease. , 2004, Geriatrics.

[2892]  the Spanish Milnacipran/Imipramine Study Group,et al.  A comparative study of milnacipran and imipramine in the treatment of major depressive disorder , 2004, Current medical research and opinion.

[2893]  T. Snutch,et al.  Mammalian Voltage-Gated Calcium Channels Are Potently Blocked by the Pyrethroid Insecticide Allethrin , 2004, Journal of Pharmacology and Experimental Therapeutics.

[2894]  D. Gehlert.  Introduction to the reviews on neuropeptide Y , 2004, Neuropeptides.

[2895]  B. McEwen,et al.  Stress-induced structural remodeling in hippocampus: prevention by lithium treatment. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[2896]  Anthony R. McIntosh,et al.  Limbic–frontal circuitry in major depression: a path modeling metanalysis , 2004, NeuroImage.

[2897]  P. Baumann,et al.  Therapeutic Monitoring of Antidepressants in the Era of Pharmacogenetics Studies , 2004, Therapeutic drug monitoring.

[2898]  J. Palha,et al.  Transthyretin is involved in depression‐like behaviour and exploratory activity , 2004, Journal of neurochemistry.

[2899]  E. Mayer,et al.  Electrophysiological characterization of N-methyl-d-aspartate receptors in rat dorsal root ganglia neurons , 2004, Pain.

[2900]  R. Lukas,et al.  Electrophysiological, Pharmacological, and Molecular Evidence for α7-Nicotinic Acetylcholine Receptors in Rat Midbrain Dopamine Neurons , 2004, Journal of Pharmacology and Experimental Therapeutics.

[2901]  Yoshikazu Ugawa,et al.  Endogenous dopamine release induced by repetitive transcranial magnetic stimulation over the primary motor cortex: an [11C]raclopride positron emission tomography study in anesthetized macaque monkeys , 2004, Biological Psychiatry.

[2902]  W. Pan,et al.  The supramammillary area: its organization, functions and relationship to the hippocampus , 2004, Progress in Neurobiology.

[2903]  M. Reith,et al.  Synaptic uptake and beyond: the sodium- and chloride-dependent neurotransmitter transporter family SLC6 , 2004, Pflügers Archiv.

[2904]  K. Perry,et al.  Brain region and dose effects of an olanzapine/fluoxetine combination on extracellular monoamine concentrations in the rat , 2004, Neuropharmacology.

[2905]  Mark A. Davis,et al.  Priority actions to improve the care of persons with co-occurring substance abuse and other mental disorders: A call to action , 2004, Biological Psychiatry.

[2906]  R. Kahn,et al.  Hippocampal changes and white matter lesions in early-onset depression , 2004, Biological Psychiatry.

[2907]  R. Paredes,et al.  Has dopamine a physiological role in the control of sexual behavior? A critical review of the evidence , 2004, Progress in Neurobiology.

[2908]  S. Nair,et al.  Activation of 5‐HT2 receptors enhances the release of acetylcholine in the prefrontal cortex and hippocampus of the rat , 2004, Synapse.

[2909]  K. Bogeso,et al.  Escitalopram versus citalopram: the surprising role of the R-enantiomer , 2004, Psychopharmacology.

[2910]  M. Åsberg,et al.  Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with preproNPY gene polymorphism. , 2004, Journal of psychiatric research.

[2911]  M. Millan,et al.  Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: role of 5-HT2C receptor blockade , 2005, Psychopharmacology.

[2912]  Karrie E Grear,et al.  Aging and SB-269970-A, a selective 5-HT7 receptor antagonist, attenuate circadian phase advances induced by microinjections of serotonergic drugs in the hamster dorsal raphe nucleus , 2004, Brain Research.

[2913]  S.13.05 Peptide approaches in the treatment of major depression — lack of efficacy of the substance P (neurokinin1 receptor) antagonist aprepitant , 2004, European Neuropsychopharmacology.

[2914]  M. Black.  Therapeutic potential of positive AMPA modulators and their relationship to AMPA receptor subunits. A review of preclinical data , 2005, Psychopharmacology.

[2915]  H. Manji,et al.  AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test. , 2004, The international journal of neuropsychopharmacology.

[2916]  Ralitza Gueorguieva,et al.  The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis , 2004, Neuropsychopharmacology.

[2917]  B. Costall,et al.  5-HT3 receptors. , 2004, Current drug targets. CNS and neurological disorders.

[2918]  M. Brandão,et al.  Neurokinin-1 receptor antagonism by SR140333: enhanced in vivo ACh in the hippocampus and promnestic post-trial effects , 2004, Peptides.

[2919]  U. Breyer‐Pfaff.  The Metabolic Fate of Amitriptyline, Nortriptyline and Amitriptylinoxide in Man , 2004, Drug metabolism reviews.

[2920]  C. Geula,et al.  Butyrylcholinesterase, cholinergic neurotransmission and the pathology of Alzheimer's disease. , 2004, Drugs of today.

[2921]  P. Luppi,et al.  Effect of the wake-promoting agent modafinil on sleep-promoting neurons from the ventrolateral preoptic nucleus: an in vitro pharmacologic study. , 2004, Sleep.

[2922]  J. Mooney,et al.  Toward a rapidly acting antidepressant: the normetanephrine and extraneuronal monoamine transporter (uptake 2) hypothesis. , 2004, The American journal of psychiatry.

[2923]  L. Limbird.  The receptor concept: a continuing evolution. , 2004, Molecular interventions.

[2924]  H. Schoemaker,et al.  Differences in presynaptic α-blockade, noradrenaline uptake inhibition, and potential antidepressant activity between (+)- and (-)mianserin , 2004, Psychopharmacology.

[2925]  A. Tobin,et al.  G-protein-coupled receptor phosphorylation and palmitoylation. , 2004, Methods in molecular biology.

[2926]  G. Mengod,et al.  5‐ht5B Receptor mRNA in the raphe nuclei: Coexpression with serotonin transporter , 2004, Synapse.

[2927]  M. Blandina.  The Neuronal Histaminergic System in Cognition , 2004 .

[2928]  R. Blakely,et al.  Adenosine receptor, protein kinase G, and p38 mitogen-activated protein kinase-dependent up-regulation of serotonin transporters involves both transporter trafficking and activation. , 2004, Molecular pharmacology.

[2929]  Enrico Smeraldi,et al.  Neural network analysis in pharmacogenetics of mood disorders , 2004, BMC Medical Genetics.

[2930]  S. Shen-Orr,et al.  Superfamilies of Evolved and Designed Networks , 2004, Science.

[2931]  U. Heilbronner,et al.  The Alpha-2B Adrenoceptor in the Paraventricular Thalamic Nucleus is Persistently Upregulated by Chronic Psychosocial Stress , 2004, Cellular and Molecular Neurobiology.

[2932]  L. Culpepper.  Identifying and treating panic disorder in primary care. , 2004, The Journal of clinical psychiatry.

[2933]  H. Westenberg,et al.  Glutamate and anxiety , 2004, European Neuropsychopharmacology.

[2934]  C. S. Patil,et al.  Phosphodiesterase 5 enzyme and its inhibitors: update on pharmacological and therapeutical aspects. , 2004, Methods and findings in experimental and clinical pharmacology.

[2935]  J. Corbin,et al.  Mechanisms of action of PDE5 inhibition in erectile dysfunction , 2004, International Journal of Impotence Research.

[2936]  A. Adell.  Antidepressant properties of substance P antagonists: relationship to monoaminergic mechanisms? , 2004, Current drug targets. CNS and neurological disorders.

[2937]  F. M. Nilsson.  Psychiatric and cognitive disorders in Parkinson's disease , 2003 .

[2938]  L. Prézeau,et al.  The Heptahelical Domain of GABAB2 Is Activated Directly by CGP7930, a Positive Allosteric Modulator of the GABAB Receptor* , 2004, Journal of Biological Chemistry.

[2939]  V. Burt.  Plotting the course to remission: the search for better outcomes in the treatment of depression. , 2004, The Journal of clinical psychiatry.

[2940]  D. Pfaff,et al.  Estrogens and non-reproductive behaviors related to activity and fear , 2004, Neuroscience & Biobehavioral Reviews.

[2941]  C. McDougle,et al.  Cerebrospinal Fluid Corticotropin-Releasing Factor and Perceived Early-Life Stress in Depressed Patients and Healthy Control Subjects , 2004, Neuropsychopharmacology.

[2942]  D. Morilak,et al.  Antidepressants and brain monoaminergic systems: a dimensional approach to understanding their behavioural effects in depression and anxiety disorders. , 2004, The international journal of neuropsychopharmacology.

[2943]  E. Ringdahl,et al.  Treatment of primary insomnia. , 2004, The Journal of the American Board of Family Practice.

[2944]  David J. Goldstein,et al.  Duloxetine in the Treatment of Depression: A Double-Blind Placebo-Controlled Comparison With Paroxetine , 2004 .

[2945]  A. Farmer,et al.  Atypical depression in growth hormone deficient adults, and the beneficial effects of growth hormone treatment on depression and quality of life. , 2004, European journal of endocrinology.

[2946]  Jonathan Silvertown,et al.  Plant coexistence and the niche , 2004 .

[2947]  F. Marini,et al.  Expression analysis of brain-derived neurotrophic factor (BDNF) mRNA isoforms after chronic and acute antidepressant treatment , 2004, Brain Research.

[2948]  Mitchel S. Berger,et al.  Unique astrocyte ribbon in adult human brain contains neural stem cells but lacks chain migration , 2004, Nature.

[2949]  F. Holsboer,et al.  Alterations in Central Neuropeptide Expression, Release, and Receptor Binding in Rats Bred for High Anxiety: Critical Role of Vasopressin , 2004, Neuropsychopharmacology.

[2950]  S. Stahl.  Focus on antipsychotic polypharmacy: evidence-based prescribing or prescribing-based evidence? , 2004, The international journal of neuropsychopharmacology.

[2951]  B. Dean,et al.  Antipsychotic drugs: evolving mechanisms of action with improved therapeutic benefits. , 2004, Current drug targets. CNS and neurological disorders.

[2952]  R. Lukas,et al.  Enantioselective Effects of Hydroxy Metabolites of Bupropion on Behavior and on Function of Monoamine Transporters and Nicotinic Receptors , 2004, Molecular Pharmacology.

[2953]  M. Barrot,et al.  Essential role of brain-derived neurotrophic factor in adult hippocampal function. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[2954]  C. Léránth,et al.  Group I metabotropic glutamate receptor activation produces a direct excitation of identified septohippocampal cholinergic neurons. , 2004, Journal of neurophysiology.

[2955]  V. Giannetti.  Adherence with antidepressant medication. , 2004, Managed care.

[2956]  Takeshi Inoue,et al.  Effect of co-administration of lithium and reboxetine on extracellular monoamine concentrations in rats. , 2004, European journal of pharmacology.

[2957]  D. Cyril D’Souza,et al.  Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects , 2005, Psychopharmacology.

[2958]  D. Murphy,et al.  Oestrogens, brain function and neuropsychiatric disorders , 2004 .

[2959]  L. Bendtsen,et al.  Analgesic effect of amitriptyline in chronic tension-type headache is not directly related to serotonin reuptake inhibition , 2004, Pain.

[2960]  P. Riederer,et al.  Clinical applications of MAO-inhibitors. , 2004, Current medicinal chemistry.

[2961]  J. Micó,et al.  Non-selective opioid receptor antagonism of the antidepressant-like effect of venlafaxine in the forced swimming test in mice , 2004, Neuroscience Letters.

[2962]  G. Griebel,et al.  Blockade of CRF1 or V1b receptors reverses stress-induced suppression of neurogenesis in a mouse model of depression , 2004, Molecular Psychiatry.

[2963]  J. Sprouse,et al.  Serotonin‐induced phase advances of SCN neuronal firing in vitro: A possible role for 5‐HT5A receptors? , 2004, Synapse.

[2964]  Mu-ming Poo,et al.  Reversal and consolidation of activity-induced synaptic modifications , 2004, Trends in Neurosciences.

[2965]  S. Dickerson,et al.  Uncoupling of social zeitgebers and diurnal cortisol secretion in clinical depression , 2004, Psychoneuroendocrinology.

[2966]  L. Callado,et al.  Effectiveness of pindolol plus serotonin uptake inhibitors in depression: a meta-analysis of early and late outcomes from randomised controlled trials. , 2004, Journal of affective disorders.

[2967]  Laurent Descarries,et al.  Acute Treatment with the Antidepressant Fluoxetine Internalizes 5-HT1A Autoreceptors and Reduces the In Vivo Binding of the PET Radioligand [18F]MPPF in the Nucleus Raphe Dorsalis of Rat , 2004, The Journal of Neuroscience.

[2968]  M. Fava.  Daytime sleepiness and insomnia as correlates of depression. , 2004, The Journal of clinical psychiatry.

[2969]  Bita Moghaddam,et al.  Targeting metabotropic glutamate receptors for treatment of the cognitive symptoms of schizophrenia , 2004, Psychopharmacology.

[2970]  Leroy Hood,et al.  The impact of systems approaches on biological problems in drug discovery , 2004, Nature Biotechnology.

[2971]  T. Sotnikova,et al.  Dopamine transporter‐dependent and ‐independent actions of trace amine β‐phenylethylamine , 2004, Journal of neurochemistry.

[2972]  C. Grillon,et al.  Adaptive and maladaptive psychobiological responses to severe psychological stress: implications for the discovery of novel pharmacotherapy , 2004, Neuroscience & Biobehavioral Reviews.

[2973]  M. Höfler,et al.  What characteristics of primary anxiety disorders predict subsequent major depressive disorder? , 2004, The Journal of clinical psychiatry.

[2974]  F. Henn,et al.  New insights into the mechanisms of antidepressant therapy. , 2004, Pharmacology & therapeutics.

[2975]  M. Pedrazzoli,et al.  Rapid eye movement sleep deprivation-induced down-regulation of beta-adrenergic receptors in the rat brainstem and hippocampus , 2004, Pharmacology Biochemistry and Behavior.

[2976]  G. Mengod,et al.  An autoradiographic study of the influence of pindolol upon [35S]GTPgammaS binding in rat, guinea pig and human brain. , 2004, The international journal of neuropsychopharmacology.

[2977]  J. Kelly,et al.  Nitric oxide synthase inhibitors augment the effects of serotonin re-uptake inhibitors in the forced swimming test , 2004, European Neuropsychopharmacology.

[2978]  J. Kehr,et al.  The Role of α1- and α2-Adrenoreceptors on Venlafaxineinduced Elevation of Extracellular Serotonin, Noradrenaline and Dopamine Levels in the Rat Prefrontal Cortex and Hippocampus , 2004 .

[2979]  P. Silverstone.  Qualitative review of SNRIs in anxiety. , 2004, The Journal of clinical psychiatry.

[2980]  M. Kuśmider,et al.  Effects of tramadol on α2-adrenergic receptors in the rat brain , 2004, Brain Research.

[2981]  P. Gaspar,et al.  Localization of VGLUT3, the vesicular glutamate transporter type 3, in the rat brain , 2004, Neuroscience.

[2982]  R. Spengler,et al.  Brain-Derived Tumor Necrosis Factor-α and Its Involvement in Noradrenergic Neuron Functioning Involved in the Mechanism of Action of an Antidepressant , 2004, Journal of Pharmacology and Experimental Therapeutics.

[2983]  Eric Vermetten,et al.  Hippocampal volume, memory, and cortisol status in major depressive disorder: effects of treatment , 2004, Biological Psychiatry.

[2984]  P. Moleman,et al.  Comparison of two-phase treatment with imipramine or fluvoxamine, both followed by lithium addition, in inpatients with major depressive disorder. , 2004, The American journal of psychiatry.

[2985]  R. Krysiak,et al.  Does neuropeptide Y (NPY) mediate the effects of psychotropic drugs? , 2004, Neuroscience & Biobehavioral Reviews.

[2986]  M. Detke,et al.  The efficacy of duloxetine: A comprehensive summary of results from MMRM and LOCF_ANCOVA in eight clinical trials , 2004, BMC psychiatry.

[2987]  L. Uphouse,et al.  WAY100635 and female rat lordosis behavior , 2004, Brain Research.

[2988]  D. Murphy,et al.  Comparative anxiogenic, neuroendocrine, and other physiologic effects of m-chlorophenylpiperazine given intravenously or orally to healthy volunteers , 2004, Psychopharmacology.

[2989]  José L Torres-Escalante,et al.  5‐HT1A, 5‐HT2, and GABAB receptors interact to modulate neurotransmitter release probability in layer 2/3 somatosensory rat cortex as evaluated by the paired pulse protocol , 2004, Journal of neuroscience research.

[2990]  J. Leysen,et al.  5-HT2 receptors. , 2004, Current drug targets. CNS and neurological disorders.

[2991]  J. Micó,et al.  Antidepressant-Like Effect of tramadol and its Enantiomers in Reserpinized Mice: Comparativestudy with Desipramine, Fluvoxamine, Venlafaxine and Opiates , 2004, Journal of psychopharmacology.

[2992]  Margaret E Balfour,et al.  Sexual Behavior and Sex-Associated Environmental Cues Activate the Mesolimbic System in Male Rats , 2004, Neuropsychopharmacology.

[2993]  G. Alexopoulos,et al.  Executive Dysfunction, Heart Disease Burden, and Remission of Geriatric Depression , 2004, Neuropsychopharmacology.

[2994]  R. Vaughan.  Phosphorylation and Regulation of Psychostimulant-Sensitive Neurotransmitter Transporters , 2004, Journal of Pharmacology and Experimental Therapeutics.

[2995]  X. Codony,et al.  Sigma receptors: biology and therapeutic potential , 2004, Psychopharmacology.

[2996]  A. Pietrobelli,et al.  Mood disorders and obesity , 2004 .

[2997]  T. Vos,et al.  The burden of major depression avoidable by longer-term treatment strategies. , 2004, Archives of general psychiatry.

[2998]  S. Vicini,et al.  Genetic manipulations of GABAA receptor in mice make inhibition exciting. , 2004, Pharmacology & therapeutics.

[2999]  A. López‐Avila,et al.  Dopamine and NMDA systems modulate long-term nociception in the rat anterior cingulate cortex , 2004, Pain.

[3000]  D. Raju,et al.  Hetero-oligomerization between GABAA and GABAB Receptors Regulates GABAB Receptor Trafficking* , 2004, Journal of Biological Chemistry.

[3001]  R. Poland,et al.  Total Sleep Deprivation Decreases Immobility In The Forced-Swim Test , 2004, Neuropsychopharmacology.

[3002]  P. Zhong,et al.  Chronic antidepressant treatment alters serotonergic regulation of GABA transmission in prefrontal cortical pyramidal neurons , 2004, Neuroscience.

[3003]  S. Arndt,et al.  Repetitive transcranial magnetic stimulation as treatment of poststroke depression: a preliminary study , 2004, Biological Psychiatry.

[3004]  John Sharkey,et al.  Nicotine Improves Sustained Attention in Mice: Evidence for Involvement of the α7 Nicotinic Acetylcholine Receptor , 2004, Neuropsychopharmacology.

[3005]  D. Nutt,et al.  Tryptophan depletion reverses the therapeutic effect of selective serotonin reuptake inhibitors in social anxiety disorder , 2004, Biological Psychiatry.

[3006]  B. Pollock,et al.  Meta-analysis of serotonin transporter polymorphisms and affective disorders , 2004, Psychiatric genetics.

[3007]  K. Dev,et al.  Making protein interactions druggable: targeting PDZ domains , 2004, Nature Reviews Drug Discovery.

[3008]  A. Barabasi,et al.  Network biology: understanding the cell's functional organization , 2004, Nature Reviews Genetics.

[3009]  Darci M. Nielsen,et al.  Antidepressant-like activity of corticotropin-releasing factor type-1 receptor antagonists in mice. , 2004, European journal of pharmacology.

[3010]  John H Krystal,et al.  Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. , 2004, Archives of general psychiatry.

[3011]  H. Bönisch,et al.  Functional importance of the C‐terminus of the human norepinephrine transporter , 2004, Journal of neurochemistry.

[3012]  Mark D. Berry,et al.  Mammalian central nervous system trace amines. Pharmacologic amphetamines, physiologic neuromodulators , 2004, Journal of neurochemistry.

[3013]  Magnus Ingelman-Sundberg,et al.  Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future. , 2004, Trends in pharmacological sciences.

[3014]  P. Ninan,et al.  Adjunctive modafinil at initiation of treatment with a selective serotonin reuptake inhibitor enhances the degree and onset of therapeutic effects in patients with major depressive disorder and fatigue. , 2004, The Journal of clinical psychiatry.

[3015]  D. Morilak,et al.  Regulation of the norepinephrine transporter by chronic administration of antidepressants , 2004, Biological Psychiatry.

[3016]  S. Chaki,et al.  Increased cell proliferation in the adult mouse hippocampus following chronic administration of group II metabotropic glutamate receptor antagonist, MGS0039. , 2004, Biochemical and biophysical research communications.

[3017]  R. Duman,et al.  Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat , 2004, Biological Psychiatry.

[3018]  G. Debonnel,et al.  Effects of the Potential Antidepressant OPC-14523 [1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2-quinolinone Monomethanesulfonate] a Combined σ and 5-HT1A Ligand: Modulation of Neuronal Activity in the Dorsal Raphe Nucleus , 2004, Journal of Pharmacology and Experimental Therapeutics.

[3019]  D. Goff,et al.  Focus on polypharmacy in schizophrenia: does anyone truly benefit? , 2004, The international journal of neuropsychopharmacology.

[3020]  E. Nisenbaum,et al.  AMPA receptor potentiators for the treatment of CNS disorders. , 2004, Current drug targets. CNS and neurological disorders.

[3021]  M. Serra,et al.  Neurosteroids and neuroactive drugs in mental disorders. , 2004, Life sciences.

[3022]  J. Montgomery,et al.  Discrete synaptic states define a major mechanism of synapse plasticity , 2004, Trends in Neurosciences.

[3023]  F. Mazzi,et al.  Disability and quality of life impact of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project , 2004, Acta psychiatrica Scandinavica. Supplementum.

[3024]  E. Vizi,et al.  Inhibitory effect of nitric oxide on dopamine transporters: interneuronal communication without receptors , 2004, Neurochemistry International.

[3025]  G. MacQueen,et al.  Special issues in the management of depression in women. , 2004, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[3026]  R. Milo,et al.  Topological generalizations of network motifs. , 2003, Physical review. E, Statistical, nonlinear, and soft matter physics.

[3027]  F. Guimarães,et al.  Benzodiazepine receptor and serotonin 2A receptor modulate the aversive-like effects of nitric oxide in the dorsolateral periaqueductal gray of rats , 2004, Psychopharmacology.

[3028]  M. Kano,et al.  Ca2+ activity at GABAB receptors constitutively promotes metabotropic glutamate signaling in the absence of GABA. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[3029]  E. Wong,et al.  The selective norepinephrine reuptake inhibitor antidepressant reboxetine: pharmacological and clinical profile. , 2006, CNS drug reviews.

[3030]  Z. Boldogköi,et al.  Gene Network Polymorphism Is the Raw Material of Natural Selection: The Selfish Gene Network Hypothesis , 2004, Journal of Molecular Evolution.

[3031]  J Christian Gillin, 1938–2003 , 2004, Neuropsychopharmacology.

[3032]  Depressive Symptoms Increase the Likelihood of Cognitive Impairment in Elderly People with Subclinical Alzheimer Pathology , 2004, Dementia and Geriatric Cognitive Disorders.

[3033]  R. Dantzer,et al.  Chronic administration of tianeptine balances lipopolysaccharide-induced expression of cytokines in the spleen and hypothalamus of rats , 2004, Psychoneuroendocrinology.

[3034]  C. Marmar,et al.  Depression and 24-hour urinary cortisol in medical outpatients with coronary heart disease: The Heart and Soul Study , 2004, Biological Psychiatry.

[3035]  R. Tallarida,et al.  Isobolographic Analysis for Combinations of a Full and Partial Agonist: Curved Isoboles , 2004, Journal of Pharmacology and Experimental Therapeutics.

[3036]  B. Vollmayr,et al.  Neurogenesis and depression: etiology or epiphenomenon? , 2004, Biological Psychiatry.

[3037]  R. Poland,et al.  Effect of treatment with bupropion on EEG sleep: relationship to antidepressant response. , 2004, The international journal of neuropsychopharmacology.

[3038]  W. Sierralta,et al.  α2-Adrenoceptor modulation of long-term potentiation elicited in vivo in rat occipital cortex , 2004, Brain Research.

[3039]  B. Greenberg,et al.  Repetitive transcranial magnetic stimulation: a putative add-on treatment for major depression in elderly patients , 2004, Psychiatry Research.

[3040]  U. Ziemann.  TMS Induced Plasticity in Human Cortex , 2004, Reviews in the neurosciences.

[3041]  M. Molina-hernandez,et al.  Synergistic interaction between ketoconazole and several antidepressant drugs with allopregnanolone treatments in ovariectomized Wistar rats forced to swim , 2004, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[3042]  M. Detke,et al.  Effects of duloxetine on painful physical symptoms associated with depression. , 2004, Psychosomatics.

[3043]  S. Kauffman,et al.  Genetic networks with canalyzing Boolean rules are always stable. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[3044]  M. Valenstein,et al.  Benzodiazepine use among depressed patients treated in mental health settings. , 2004, The American journal of psychiatry.

[3045]  M. Millan.  The role of monoamines in the actions of established and "novel" antidepressant agents: a critical review. , 2004, European journal of pharmacology.

[3046]  E. Giacobini.  Cholinesterases: New Roles in Brain Function and in Alzheimer's Disease , 2003, Neurochemical Research.

[3047]  D. McManus,et al.  Effects of age and of chronic antidepressant treatment on [3H]tryptamine and [3H]dihydroalprenolol binding to rat cortical membranes , 1993, Cellular and Molecular Neurobiology.

[3048]  L. Sanford,et al.  A serotonergic (5-HT2) receptor mechanism in the laterodorsal tegmental nucleus participates in regulating the pattern of rapid-eye-movement sleep occurrence in the rat , 2004, Brain Research.

[3049]  L. Bryan-Lluka,et al.  Nitric oxide donors inhibit 5‐hydroxytryptamine (5‐HT) uptake by the human 5‐HT transporter (SERT) , 2004, British journal of pharmacology.

[3050]  H. Bönisch,et al.  Expression of the extraneuronal monoamine transporter (uptake2) in human glioma cells , 1996, Naunyn-Schmiedeberg's Archives of Pharmacology.

[3051]  J. Beavo,et al.  Specific localized expression of cGMP PDEs in Purkinje neurons and macrophages , 2004, Neurochemistry International.

[3052]  Michel Goedert,et al.  GSK3 inhibitors: development and therapeutic potential , 2004, Nature Reviews Drug Discovery.

[3053]  S. Grant,et al.  Proteomics in postgenomic neuroscience: the end of the beginning , 2004, Nature Neuroscience.

[3054]  J. Stachowicz,et al.  Genetic diversity enhances the resistance of a seagrass ecosystem to disturbance , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[3055]  P. De Deurwaerdère,et al.  Constitutive Activity of the Serotonin2C Receptor Inhibits In Vivo Dopamine Release in the Rat Striatum and Nucleus Accumbens , 2004, The Journal of Neuroscience.

[3056]  G. Tsujimoto,et al.  The vasopressin V1b receptor critically regulates hypothalamic-pituitary-adrenal axis activity under both stress and resting conditions. , 2004, The Journal of clinical investigation.

[3057]  I. Lucki,et al.  Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[3058]  Yi Xing,et al.  The multiassembly problem: reconstructing multiple transcript isoforms from EST fragment mixtures. , 2004, Genome research.

[3059]  A. Deutch,et al.  Effects of Antipsychotic Drugs on Neurogenesis in the Forebrain of the Adult Rat , 2004, Neuropsychopharmacology.

[3060]  T. Sharp,et al.  Glutamate receptor activation is involved in 5-HT2 agonist-induced Arc gene expression in the rat cortex , 2004, Neuropharmacology.

[3061]  D. Overstreet,et al.  Antidepressant-like effects of CRF1 receptor antagonist SSR125543 in an animal model of depression. , 2004, European journal of pharmacology.

[3062]  D. Schoepp,et al.  Anxiolytic Activity of the MGLU2/3 Receptor Agonist LY354740 on the Elevated Plus Maze is Associated with the Suppression of Stress-Induced c-Fos in the Hippocampus and Increases in c-Fos Induction in Several Other Stress-Sensitive Brain Regions , 2004, Neuropsychopharmacology.

[3063]  C. Schwarzer,et al.  Y1 receptors regulate aggressive behavior by modulating serotonin pathways. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[3064]  H. Westenberg,et al.  Synergistic dopamine increase in the rat prefrontal cortex with the combination of quetiapine and fluvoxamine , 2004, Psychopharmacology.

[3065]  M. Carreiras,et al.  Recent approaches to novel anti-Alzheimer therapy. , 2004, Current pharmaceutical design.

[3066]  J. Boutin,et al.  Preparation of 4-azaindole and 7-azaindole dimers with a bisalkoxyalkyl spacer in order to preferentially target melatonin MT1 receptors over melatonin MT2 receptors. , 2004, European journal of medicinal chemistry.

[3067]  A. Hughes,et al.  Recent Mammalian Gene Duplications: Robust Search for Functionally Divergent Gene Pairs , 2004, Journal of Molecular Evolution.

[3068]  Koh-ich Tanaka,et al.  Facilitative effect of a novel AVP fragment analog, NC-1900, on memory retention and recall in mice , 2004, Peptides.

[3069]  W. McCall,et al.  Quality of life and function after electroconvulsive therapy , 2004, British Journal of Psychiatry.

[3070]  P. Illés,et al.  D1 but not D2 dopamine receptors or adrenoceptors mediate dopamine-induced potentiation of N-methyl-d-aspartate currents in the rat prefrontal cortex , 2004, Neuroscience Letters.

[3071]  C. Montigny,et al.  Effect of acute and prolonged tianeptine administration on the 5-HT transporter: electrophysiological, biochemical and radioligand binding studies in the rat brain , 1995, Naunyn-Schmiedeberg's Archives of Pharmacology.

[3072]  Assessment of excessive sleepiness and insomnia as they relate to circadian rhythm sleep disorders. , 2004, The Journal of clinical psychiatry.

[3073]  P. Delagrange,et al.  Preferential Formation of MT1/MT2 Melatonin Receptor Heterodimers with Distinct Ligand Interaction Properties Compared with MT2 Homodimers , 2004, Molecular Pharmacology.

[3074]  Tudor I. Oprea,et al.  Pursuing the leadlikeness concept in pharmaceutical research. , 2004, Current opinion in chemical biology.

[3075]  R. Duman,et al.  Activation of cAMP Signaling Facilitates the Morphological Maturation of Newborn Neurons in Adult Hippocampus , 2004, The Journal of Neuroscience.

[3076]  G. Tsujimoto,et al.  V1a receptor knockout mice exhibit impairment of spatial memory in an eight-arm radial maze , 2004, Neuroscience Letters.

[3077]  M. Scheinin,et al.  Loss of amitriptyline analgesia in α2A-adrenoceptor deficient mice , 2004 .

[3078]  Y. Taché,et al.  Corticotropin releasing factor receptor antagonists: potential future therapy in gastroenterology? , 2004, Gut.

[3079]  L. Trudeau.  Glutamate co-transmission as an emerging concept in monoamine neuron function. , 2004, Journal of psychiatry & neuroscience : JPN.

[3080]  M. Pangalos,et al.  Phosphorylation and Chronic Agonist Treatment Atypically Modulate GABAB Receptor Cell Surface Stability* , 2004, Journal of Biological Chemistry.

[3081]  P. Escribá,et al.  Increased mRNA Expression of α2A-Adrenoceptors, Serotonin Receptors and μ-Opioid Receptors in the Brains of Suicide Victims , 2004, Neuropsychopharmacology.

[3082]  Graeme Milligan,et al.  G Protein-Coupled Receptor Dimerization: Function and Ligand Pharmacology , 2004, Molecular Pharmacology.

[3083]  J. Ott,et al.  Estimating rates of alternative splicing in mammals and invertebrates , 2004, Nature Genetics.

[3084]  E. Tatarczyńska,et al.  Effects of a selective 5-HT1B receptor agonist and antagonists in animal models of anxiety and depression , 2004, Behavioural pharmacology.

[3085]  J. D. McGaugh,et al.  The Basolateral Amygdala Interacts with the Medial Prefrontal Cortex in Regulating Glucocorticoid Effects on Working Memory Impairment , 2004, The Journal of Neuroscience.

[3086]  R. Kessler,et al.  Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project , 2004, Acta psychiatrica Scandinavica. Supplementum.

[3087]  A. E. Hirsh,et al.  Coevolution of gene expression among interacting proteins , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[3088]  M. O'Neill,et al.  Fluoxetine-induced change in rat brain expression of brain-derived neurotrophic factor varies depending on length of treatment , 2004, Neuroscience.

[3089]  Alan A. Wilson,et al.  Tryptophan depletion and serotonin loss in selective serotonin reuptake inhibitor–treated depression: An [18F] MPPF positron emission tomography study , 2004, Biological Psychiatry.

[3090]  M. Posternak,et al.  Which factors influence psychiatrists' selection of antidepressants? , 2004, The American journal of psychiatry.

[3091]  Larry J Young,et al.  Profound Impairment in Social Recognition and Reduction in Anxiety-Like Behavior in Vasopressin V1a Receptor Knockout Mice , 2004, Neuropsychopharmacology.

[3092]  C. Guilleminault,et al.  The effects of trazodone on sleep in patients treated with stimulant antidepressants. , 2004, Sleep medicine.

[3093]  P. Matthews,et al.  Increased brain GABA concentrations following acute administration of a selective serotonin reuptake inhibitor. , 2004, The American journal of psychiatry.

[3094]  I. Hers,et al.  PKC-interacting proteins: from function to pharmacology. , 2004, Trends in pharmacological sciences.

[3095]  Xiaojie Shi,et al.  Studies toward the discovery of the next generation of antidepressants. 3. Dual 5-HT1A and serotonin transporter affinity within a class of N-aryloxyethylindolylalkylamines. , 2004, Journal of medicinal chemistry.

[3096]  T. Insel,et al.  Neuroendocrine basis of social recognition , 2004, Current Opinion in Neurobiology.

[3097]  Alan J. Thomas,et al.  Depression and vascular disease: what is the relationship? , 2004, Journal of affective disorders.

[3098]  Dual acting antihistaminergic agents. , 2004, Mini reviews in medicinal chemistry.

[3099]  Silvio Garattini,et al.  Role of presynaptic α2-adrenoceptors in antidepressant action: recent findings from microdialysis studies , 2004, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[3100]  U. Moens,et al.  What turns CREB on? , 2004, Cellular signalling.

[3101]  H. Knobler,et al.  Suicidality and second generation anytipsychotics in schizophrenia patients: a case-controlled retrospective study during a 5-year period , 2003, Psychopharmacology.

[3102]  K. Nisijima,et al.  Perospirone, a novel atypical antipsychotic drug, potentiates fluoxetine-induced increases in dopamine levels via multireceptor actions in the rat medial prefrontal cortex , 2004, Neuroscience Letters.

[3103]  W. Mendelson,et al.  The use of trazodone as a hypnotic: a critical review. , 2004, The Journal of clinical psychiatry.

[3104]  C. Wermuth.  Selective optimization of side activities: another way for drug discovery. , 2004, Journal of medicinal chemistry.

[3105]  M. Gassmann,et al.  Molecular Structure and Physiological Functions of GABAB Receptors , 2004 .

[3106]  Andrés Martin,et al.  Is the party over? Cannabis and juvenile psychiatric disorder: the past 10 years. , 2004, Journal of the American Academy of Child and Adolescent Psychiatry.

[3107]  Kjell Någren,et al.  Effects of fluoxetine on dopamine D2 receptors in the human brain: a positron emission tomography study with [11C]raclopride. , 2004, The international journal of neuropsychopharmacology.

[3108]  L. Tecott,et al.  Inactivation of 5-HT2C Receptors Potentiates Consequences of Serotonin Reuptake Blockade , 2004, Neuropsychopharmacology.

[3109]  Christopher T. Walsh,et al.  Drugs as materials: valuing physical form in drug discovery , 2004, Nature Reviews Drug Discovery.

[3110]  G. Chrousos,et al.  Nonpeptide Corticotropin-Releasing Hormone Receptor Type 1 Antagonists and Their Applications in Psychosomatic Disorders , 2004, Neuroendocrinology.

[3111]  M. Rowbotham,et al.  Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study , 2004, Pain.

[3112]  Dante R. Chialvo,et al.  Chronic pain patients are impaired on an emotional decision-making task , 2004, Pain.

[3113]  Curtis Keith,et al.  Multi-target lead discovery for networked systems , 2004 .

[3114]  T. Sotnikova,et al.  Tryptophan Hydroxylase-2 Controls Brain Serotonin Synthesis , 2004, Science.

[3115]  H. Koepsell.  Polyspecific organic cation transporters: their functions and interactions with drugs. , 2004, Trends in pharmacological sciences.

[3116]  A. Marini,et al.  AMPA protects cultured neurons against glutamate excitotoxicity through a phosphatidylinositol 3‐kinase‐dependent activation in extracellular signal‐regulated kinase to upregulate BDNF gene expression , 2004, Journal of neurochemistry.

[3117]  J. Monti,et al.  Effects of the 5-HT1A receptor ligands flesinoxan and WAY 100635 given systemically or microinjected into the laterodorsal tegmental nucleus on REM sleep in the rat , 2004, Behavioural Brain Research.

[3118]  P. Skolnick,et al.  Enhancement of Antidepressant Potency by a Potentiator of AMPA Receptors , 2003, Cellular and Molecular Neurobiology.

[3119]  C. Ghelardini,et al.  Alpha-2 agonist-induced memory impairment is mediated by the alpha-2A-adrenoceptor subtype , 2004, Behavioural Brain Research.

[3120]  J. Kleinman,et al.  Reduced glucocorticoid and estrogen receptor alpha messenger ribonucleic acid levels in the amygdala of patients with major mental illness , 2004, Biological Psychiatry.

[3121]  B. Szewczyk,et al.  Group III mGlu receptor agonists produce anxiolytic- and antidepressant-like effects after central administration in rats , 2004, Neuropharmacology.

[3122]  S. Hunt,et al.  Blockade of substance P (neurokinin 1) receptors enhances extracellular serotonin when combined with a selective serotonin reuptake inhibitor: an in vivo microdialysis study in mice , 2004, Journal of neurochemistry.

[3123]  J. Feldon,et al.  Mesolimbic dopaminergic pathways in fear conditioning , 2004, Progress in Neurobiology.

[3124]  Daniel P. F. Sturdy,et al.  The connectivity of the brain: multi-level quantitative analysis , 1995, Biological Cybernetics.

[3125]  M. Caron,et al.  RNA Editing Induces Variation in Desensitization and Trafficking of 5-Hydroxytryptamine 2c Receptor Isoforms* , 2004, Journal of Biological Chemistry.

[3126]  T. George,et al.  Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders , 2004, Journal of psychopharmacology.

[3127]  D. Nutt,et al.  Using sleep to evaluate comparative serotonergic effects of paroxetine and citalopram , 2004, European Neuropsychopharmacology.

[3128]  C. Marsden,et al.  5-ht6 receptors. , 2004, Current drug targets. CNS and neurological disorders.

[3129]  A. Grace,et al.  Corticotropin-Releasing Hormone Directly Activates Noradrenergic Neurons of the Locus Ceruleus Recorded In Vitro , 2004, The Journal of Neuroscience.

[3130]  S. Yamada,et al.  Involvement of dopamine receptors in the anti-immobility effects of dopamine re-uptake inhibitors in the forced swimming test. , 2004, European journal of pharmacology.

[3131]  F Peter Guengerich,et al.  Cytochrome P450: What Have We Learned and What Are the Future Issues? , 2004, Drug metabolism reviews.

[3132]  James C. Overholser,et al.  Cellular changes in the postmortem hippocampus in major depression , 2004, Biological Psychiatry.

[3133]  C. Shayo,et al.  Mepyramine, a Histamine H1 Receptor Inverse Agonist, Binds Preferentially to a G Protein-coupled Form of the Receptor and Sequesters G Protein* , 2004, Journal of Biological Chemistry.

[3134]  S. Schiffmann,et al.  Dopamine D3 receptor stimulation promotes the proliferation of cells derived from the post‐natal subventricular zone , 2004, Journal of neurochemistry.

[3135]  L. Price,et al.  Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients , 2004, Biological Psychiatry.

[3136]  R. Navari.  Role of Neurokinin-1 Receptor Antagonists in Chemotherapy-Induced Emesis: Summary of Clinical Trials , 2004, Cancer investigation.

[3137]  M. Briley.  Clinical experience with dual action antidepressants in different chronic pain syndromes , 2004, Human psychopharmacology.

[3138]  Sylvain Crochet,et al.  The histamine H3 receptor as a novel therapeutic target for cognitive and sleep disorders. , 2004, Trends in pharmacological sciences.

[3139]  A. Meneses,et al.  Involvement of 5-HT2A/2B/2C Receptors on Memory Formation: Simple Agonism, Antagonism, or Inverse Agonism? , 2002, Cellular and Molecular Neurobiology.

[3140]  R. Blakely,et al.  Stimulation of serotonin transport by the cyclic GMP phosphodiesterase-5 inhibitor sildenafil. , 2004, European journal of pharmacology.

[3141]  J. Velázquez-Moctezuma,et al.  Antidepressant-like effects of the acute and chronic administration of nicotine in the rat forced swimming test and its interaction with flouxetine , 2004, Pharmacology Biochemistry and Behavior.

[3142]  T. Heinrich,et al.  Dual 5-HT1A agonists and 5-HT re-uptake inhibitors by combination of indole-butyl-amine and chromenonyl-piperazine structural elements in a single molecular entity. , 2004, Bioorganic & medicinal chemistry.

[3143]  Jia Zhou.  Norepinephrine transporter inhibitors and their therapeutic potential. , 2004, Drugs of the future.

[3144]  A. Serretti,et al.  The pharmacogenomics of selective serotonin reuptake inhibitors , 2004, The Pharmacogenomics Journal.

[3145]  K. Resing,et al.  Applying proteomics to signaling networks. , 2004, Current opinion in genetics & development.

[3146]  J. Abramowitz.  Treatment of obsessive-compulsive disorder in patients who have comorbid major depression. , 2004, Journal of clinical psychology.

[3147]  Marc G Caron,et al.  Uptake and Release of Norepinephrine by Serotonergic Terminals in Norepinephrine Transporter Knock-Out Mice: Implications for the Action of Selective Serotonin Reuptake Inhibitors , 2004, The Journal of Neuroscience.

[3148]  S. Lipton.  Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders. , 2005, Journal of Alzheimer's disease : JAD.

[3149]  René Hen,et al.  Impact of substance P receptor antagonism on the serotonin and norepinephrine systems: relevance to the antidepressant/anxiolytic response. , 2004, Journal of psychiatry & neuroscience : JPN.

[3150]  D. Nelson,et al.  5-HT5 receptors. , 2004, Current drug targets. CNS and neurological disorders.

[3151]  Laurenz Wiskott,et al.  Functional significance of adult neurogenesis , 2004, Current Opinion in Neurobiology.

[3152]  W. Pan,et al.  Neurochemical interaction between dopaminergic and noradrenergic neurons in the medial prefrontal cortex , 2004, Synapse.

[3153]  R. Vandenberg,et al.  Allosteric modulation of neurotransmitter transporters at excitatory synapses. , 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[3154]  H. Praag,et al.  Can stress cause depression? , 2004, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[3155]  J. Buccafusco.  Cognitive Enhancing Drugs , 2012, Milestones in Drug Therapy MDT.

[3156]  J. Wess,et al.  M2 Muscarinic Acetylcholine Receptor Knock-Out Mice Show Deficits in Behavioral Flexibility, Working Memory, and Hippocampal Plasticity , 2004, The Journal of Neuroscience.

[3157]  A. Anand,et al.  Pindolol augmentation in depressed patients resistant to selective serotonin reuptake inhibitors: a double-blind, randomized, controlled trial. , 2004, The Journal of clinical psychiatry.

[3158]  Pal Pacher,et al.  Trends in the development of new antidepressants. Is there a light at the end of the tunnel? , 2004, Current medicinal chemistry.

[3159]  Stuart Maudsley,et al.  BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders , 2004, Trends in Neurosciences.

[3160]  Masaaki Iwata,et al.  Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism produces antidepressant‐like effects , 2004, Journal of neurochemistry.

[3161]  H. Solvason,et al.  A Prospective Trial of Modafinil as an Adjunctive Treatment of Major Depression , 2004, Journal of clinical psychopharmacology.

[3162]  D. Donnelly-roberts,et al.  Central Mechanisms Regulating Penile Erection in Conscious Rats: The Dopaminergic Systems Related to the Proerectile Effect of Apomorphine , 2004, Journal of Pharmacology and Experimental Therapeutics.

[3163]  D. Donnelly-roberts,et al.  Activation of dopamine D4 receptors by ABT-724 induces penile erection in rats. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[3164]  U. Engelmann,et al.  Future Options for Combination Therapy in the Management of Erectile Dysfunction in Older Men , 2004, Drugs & aging.

[3165]  R. Shamir,et al.  How prevalent is functional alternative splicing in the human genome? , 2004, Trends in genetics : TIG.

[3166]  F. Buntinx,et al.  Is depression related to subsequent diabetes mellitus? , 2004, Acta psychiatrica Scandinavica.

[3167]  C. Gallen,et al.  Effectiveness of the selective D4 antagonist sonepiprazole in schizophrenia: a placebo-controlled trial , 2004, Biological Psychiatry.

[3168]  A. Macdermott,et al.  Presynaptic ionotropic receptors and control of transmitter release , 2004, Nature Reviews Neuroscience.

[3169]  J. Friedman,et al.  Cholinergic targets for cognitive enhancement in schizophrenia: focus on cholinesterase inhibitors and muscarinic agonists , 2004, Psychopharmacology.

[3170]  A. Beekman,et al.  Depression in older persons with versus without vascular disease in the open population: similar depressive symptom patterns, more disability. , 2004, Journal of affective disorders.

[3171]  G. Gessa,et al.  Alpha2‐adrenoceptor mediated co‐release of dopamine and noradrenaline from noradrenergic neurons in the cerebral cortex , 2004, Journal of neurochemistry.

[3172]  A. Nierenberg,et al.  Placebo-Controlled Continuation Treatment with Mirtazapine: Acute Pattern of Response Predicts Relapse , 2004, Neuropsychopharmacology.

[3173]  B. Mulsant,et al.  Geriatric depression treatment in nonresponders to selective serotonin reuptake inhibitors. , 2004, The Journal of clinical psychiatry.

[3174]  A. Malhotra,et al.  Pharmacogenetics of antipsychotic-induced weight gain , 2004, Psychopharmacology.

[3175]  J. Buccafusco.  The cholinergic hypothesis — past and present , 2004 .

[3176]  J. Swanson,et al.  Dopamine in drug abuse and addiction: results from imaging studies and treatment implications , 2004, Molecular Psychiatry.

[3177]  J. Gilmore,et al.  Novel selective and potent 5-HT reuptake inhibitors with 5-HT1D antagonist activity: chemistry and pharmacological evaluation of a series of thienopyran derivatives. , 2004, Bioorganic & medicinal chemistry.

[3178]  David J. Daniels,et al.  A Bivalent Ligand (KDN-21) Reveals Spinal δ and κ Opioid Receptors Are Organized as Heterodimers That Give Rise to δ1 and κ2 Phenotypes. Selective Targeting of δ−κ Heterodimers , 2004 .

[3179]  H. Nakanishi,et al.  Sibutramine induces potential-dependent exocytotic release but not carrier-mediated release of dopamine and 5-hydroxytryptamine. , 2004, European journal of pharmacology.

[3180]  Janos P. Kiss,et al.  Nonsynaptic communication in the central nervous system , 2004, Neurochemistry International.

[3181]  E. Nofzinger.  What can neuroimaging findings tell us about sleep disorders? , 2004, Sleep medicine.

[3182]  C. Eap,et al.  Combination therapy with venlafaxine and carbamazepine in depressive patients not responding to venlafaxine: pharmacokinetic and clinical aspects , 2004, Journal of psychopharmacology.

[3183]  M. Picciotto,et al.  Alteration of hippocampal cell proliferation in mice lacking the β2 subunit of the neuronal nicotinic acetylcholine receptor , 2004, Synapse.

[3184]  N. Cosford,et al.  The Behavioral Profile of the Potent and Selective mGlu5 Receptor Antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP) in Rodent Models of Anxiety , 2004, Neuropsychopharmacology.

[3185]  M. Frye,et al.  Peripheral thyroid hormones and response to selective serotonin reuptake inhibitors. , 2004, Journal of psychiatry & neuroscience : JPN.

[3186]  G. Lahoste,et al.  Sleep deprivation impairs hippocampus‐mediated contextual learning but not amygdala‐mediated cued learning in rats , 2004, The European journal of neuroscience.

[3187]  P. Patel,et al.  Robust and tissue-specific expression of TPH2 versus TPH1 in rat raphe and pineal gland , 2004, Biological Psychiatry.

[3188]  C. Mazure,et al.  Combining norepinephrine and serotonin reuptake inhibition mechanisms for treatment of depression: a double-blind, randomized study , 2003, Biological Psychiatry.

[3189]  Atsuro Nakazato,et al.  The MC4 receptor as a therapeutic target , 2004 .

[3190]  T. Itoh,et al.  Effects of rolipram, a phosphodiesterase 4 inhibitor, in combination with imipramine on depressive behavior, CRE-binding activity and BDNF level in learned helplessness rats. , 2004, European journal of pharmacology.

[3191]  J. Bockaert,et al.  5-HT4 Receptors , 2012 .

[3192]  J. Solich,et al.  The effect of combined treatment with imipramine and amantadine on the behavioral reactivity of central &agr;1-adrenergic system in rats , 2004, Behavioural pharmacology.

[3193]  S. Kennedy,et al.  Absence of discontinuation symptoms with agomelatine and occurrence of discontinuation symptoms with paroxetine: a randomized, double-blind, placebo-controlled discontinuation study , 2004, International clinical psychopharmacology.

[3194]  C. Nemeroff,et al.  Prediction of Antidepressant Response to Milnacipran by Norepinephrine Transporter Gene Polymorphisms , 2004 .

[3195]  T. Hökfelt,et al.  Neuropeptide expression in rats exposed to chronic mild stresses , 2005, Psychopharmacology.

[3196]  A. Mørk,et al.  The effect of escitalopram, desipramine, electroconvulsive seizures and lithium on brain-derived neurotrophic factor mRNA and protein expression in the rat brain and the correlation to 5-HT and 5-HIAA levels , 2004, Brain Research.

[3197]  E. Demet,et al.  Once-daily high-dose pindolol for SSRI-refractory depression , 2004, Psychiatry Research.

[3198]  R. Hellweg,et al.  State of the art of the neurotrophin hypothesis in psychiatric disorders: implications and limitations , 2004, Journal of Neural Transmission.

[3199]  Mark Lau,et al.  Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy. , 2004, Archives of general psychiatry.

[3200]  D. Baldwin.  Sexual dysfunction associated with antidepressant drugs , 2004, Expert opinion on drug safety.

[3201]  M. Oquendo,et al.  Antidepressants and suicide risk in the United States, 1985-1999. , 2004, The Journal of clinical psychiatry.

[3202]  S. Preskorn,et al.  Demonstration of the Efficacy and Safety of a Novel Substance P (NK1) Receptor Antagonist in Major Depression , 2004, Neuropsychopharmacology.

[3203]  D. Sibley,et al.  Reduction in Acetylcholine Release in the Hippocampus of Dopamine D5 Receptor-Deficient Mice , 2004, Neuropsychopharmacology.

[3204]  M. Hongo,et al.  Decreased histamine H1 receptor binding in the brain of depressed patients , 2004, The European journal of neuroscience.

[3205]  A. Neumeister,et al.  Implications of genetic research on the role of the serotonin in depression: emphasis on the serotonin type 1A receptor and the serotonin transporter , 2004, Psychopharmacology.

[3206]  T. Bolwig,et al.  Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation , 2004, Journal of neuroscience research.

[3207]  Y. Ueta,et al.  The Inhibitory Effects of Tramadol on 5-Hydroxytryptamine Type 2C Receptors Expressed in Xenopus Oocytes , 2004, Anesthesia and analgesia.

[3208]  Abraham Weizman,et al.  Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on β-catenin in mouse hippocampus , 2004, Biological Psychiatry.

[3209]  E. Watkins,et al.  Brief psychotherapies for depression: current status , 2004 .

[3210]  Brenton R Graveley,et al.  The origins and implications of Aluternative splicing. , 2004, Trends in genetics : TIG.

[3211]  E. Carboni,et al.  Dopamine reuptake by norepinephrine neurons: exception or rule? , 2004, Critical reviews in neurobiology.

[3212]  M. Héry,et al.  Serotonin-Induced Increases in Adult Cell Proliferation and Neurogenesis are Mediated Through Different and Common 5-HT Receptor Subtypes in the Dentate Gyrus and the Subventricular Zone , 2004, Neuropsychopharmacology.

[3213]  N. Bowery,et al.  GABA(B) receptor alterations as indicators of physiological and pharmacological function. , 2004, Biochemical pharmacology.

[3214]  T. Imanishi,et al.  Chronic treatment with fluvoxamine desensitizes 5-HT2C receptor-mediated hypolocomotion in rats , 2004, Pharmacology Biochemistry and Behavior.

[3215]  E. Schlatter,et al.  Regulation of organic cation transport , 2005, Pflügers Archiv.

[3216]  K. Ikeda,et al.  Inhibition of G Protein-Activated Inwardly Rectifying K+ Channels by Various Antidepressant Drugs , 2004, Neuropsychopharmacology.

[3217]  M. Gallagher,et al.  SGS742: the first GABA(B) receptor antagonist in clinical trials. , 2004, Biochemical pharmacology.

[3218]  Julio Licinio,et al.  From monoamines to genomic targets: a paradigm shift for drug discovery in depression , 2004, Nature Reviews Drug Discovery.

[3219]  R. Sapolsky.  Is impaired neurogenesis relevant to the affective symptoms of depression? , 2004, Biological Psychiatry.

[3220]  B. Harvey,et al.  Recent advances in drug action and therapeutics: relevance of novel concepts in G-protein-coupled receptor and signal transduction pharmacology. , 2004, British journal of clinical pharmacology.

[3221]  D. Malone,et al.  Mirtazapine is associated with less anxiolytic use among elderly depressed patients in long-term care facilities. , 2004, Journal of the American Medical Directors Association.

[3222]  Michael E. May,et al.  Possible role for the 5-HT1A receptor in the behavioral effects of REM sleep deprivation on free-operant avoidance responding in rat , 2004, Psychopharmacology.

[3223]  Xiqun Chen,et al.  Chronic Nicotine Treatment Leads to Induction of Tyrosine Hydroxylase in Locus Ceruleus Neurons: The Role of Transcriptional Activation , 2004, Molecular Pharmacology.

[3224]  A. Young,et al.  Improvements in Neurocognitive Function and Mood Following Adjunctive Treatment with Mifepristone (RU-486) in Bipolar Disorder , 2004, Neuropsychopharmacology.

[3225]  L. Lanfumey,et al.  Early desensitization of somato-dendritic 5-HT1A autoreceptors in rats treated with fluoxetine or paroxetine , 1995, Naunyn-Schmiedeberg's Archives of Pharmacology.

[3226]  K. Reid,et al.  Circadian rhythm sleep disorders. , 2004, The Medical clinics of North America.

[3227]  Paul A Clemons,et al.  Complex phenotypic assays in high-throughput screening. , 2004, Current opinion in chemical biology.

[3228]  Y. Sari.  Serotonin1B receptors: from protein to physiological function and behavior , 2004, Neuroscience & Biobehavioral Reviews.

[3229]  M. V. Regenmortel,et al.  Reductionism and complexity in molecular biology , 2004, HIV/AIDS: Immunochemistry, Reductionism and Vaccine Design.

[3230]  W. Fenton,et al.  Measurement and Treatment Research to Improve Cognition in Schizophrenia: NIMH MATRICS initiative to support the development of agents for improving cognition in schizophrenia , 2004, Schizophrenia Research.

[3231]  M. Yamada,et al.  Clinical pharmacology of MAO inhibitors: safety and future. , 2004, Neurotoxicology.

[3232]  P. Illés,et al.  Depression by neuropeptide Y of noradrenergic inhibitory postsynaptic potentials of locus coeruleus neurones , 1992, Naunyn-Schmiedeberg's Archives of Pharmacology.

[3233]  M. Stein,et al.  Well-being and life satisfaction in generalized anxiety disorder: comparison to major depressive disorder in a community sample. , 2004, Journal of affective disorders.

[3234]  M. Picciotto,et al.  High-affinity nicotinic acetylcholine receptors are required for antidepressant effects of amitriptyline on behavior and hippocampal cell proliferation , 2004, Biological Psychiatry.

[3235]  J. Mazurkiewicz,et al.  Biochemical and biophysical characterization of serotonin 5-HT2C receptor homodimers on the plasma membrane of living cells. , 2004, Biochemistry.

[3236]  R. Bagby,et al.  The Hamilton Depression Rating Scale: has the gold standard become a lead weight? , 2004, The American journal of psychiatry.

[3237]  M. Graham,et al.  Tyrosine hydroxylase phosphorylation: regulation and consequences , 2004, Journal of neurochemistry.

[3238]  A. S. Elhwuegi.  Central monoamines and their role in major depression , 2004, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[3239]  K. Pacak,et al.  Disprocynium24, a novel inhibitor of the extraneuronal monoamine transporter, has potent effects on the inactivation of circulating noradrenaline and adrenaline in conscious rat , 1996, Naunyn-Schmiedeberg's Archives of Pharmacology.

[3240]  R. Rosmond.  Obesity and depression: same disease, different names? , 2004, Medical hypotheses.

[3241]  Shagufta Ahmad,et al.  Effects of combined lamotrigine and valproate on basal and stimulated extracellular amino acids and monoamines in the hippocampus of freely moving rats , 2005, Naunyn-Schmiedeberg's Archives of Pharmacology.

[3242]  R. Dantzer,et al.  Modulation of social memory in male rats by neurohypophyseal peptides , 1987, Psychopharmacology.

[3243]  J. Forn,et al.  Effect of chronic lithium treatment on the turnover of α2-adrenoceptors after chemical inactivation in rats , 2004, European Neuropsychopharmacology.

[3244]  B. Grant,et al.  Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. , 2004, Archives of general psychiatry.

[3245]  P. Nelemans,et al.  Influence of SERTPR and STin2 in the serotonin transporter gene on the effect of selective serotonin reuptake inhibitors in depression: a systematic review , 2004, Molecular Psychiatry.

[3246]  C. Epstein,et al.  Brain Blood‐flow Alterations Induced by Therapeutic Vagus Nerve Stimulation in Partial Epilepsy: II. Prolonged Effects at High and Low Levels of Stimulation , 2004, Epilepsia.

[3247]  Effect of repeated treatment with olanzapine or olanzapine plus fluoxetine on tyrosine hydroxylase in the rat locus coeruleus. , 2004, The international journal of neuropsychopharmacology.

[3248]  J. Cryan,et al.  Genetic and Pharmacological Evidence of a Role for GABAB Receptors in the Modulation of Anxiety- and Antidepressant-Like Behavior , 2004, Neuropsychopharmacology.

[3249]  S. Hunt,et al.  Mechanisms of action of the antidepressants fluoxetine and the substance P antagonist L-000760735 are associated with altered neurofilaments and synaptic remodeling , 2004, Brain Research.

[3250]  S. Arneric,et al.  Anxiolytic-Like Effects of the Corticotropin-Releasing Factor1 (CRF1) Antagonist DMP904 [4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1,5-a]-pyrimidine] Administered Acutely or Chronically at Doses Occupying Central CRF1 Receptors in Rats , 2004, Journal of Pharmacology and Experimental Therapeutics.

[3251]  Marcus Teo,et al.  Management of hepatitis C. , 2004, British medical bulletin.

[3252]  D. Richter,et al.  The 5-Hydroxytryptamine(1A) Receptor Is Stably Palmitoylated, and Acylation Is Critical for Communication of Receptor with Gi Protein* , 2004, Journal of Biological Chemistry.

[3253]  M. Thase.  Therapeutic Alternatives for Difficult-to-Treat Depression: A Narrative Review of the State of the Evidence , 2004, CNS Spectrums.

[3254]  Y. Taché,et al.  CRF1 receptor signaling pathways are involved in stress‐related alterations of colonic function and viscerosensitivity: implications for irritable bowel syndrome , 2004, British journal of pharmacology.

[3255]  O. Kukula,et al.  Effect of sildenafil on anxiety in the plus-maze test in mice. , 2004, Polish journal of pharmacology.

[3256]  Andrew Lemire,et al.  Electroconvulsive Seizures Regulate Gene Expression of Distinct Neurotrophic Signaling Pathways , 2004, The Journal of Neuroscience.

[3257]  R. Califf,et al.  Prognostic Value of Anxiety and Depression in Patients With Chronic Heart Failure , 2004, Circulation.

[3258]  P. Illés,et al.  Neuropeptide Y potentiates via Y2-receptors the inhibitory effect of noradrenaline in rat locus coeruleus neurones , 1993, Naunyn-Schmiedeberg's Archives of Pharmacology.

[3259]  J. Boulenger,et al.  Prevalence of DSM ^ IV psychiatric disorder in the French elderly population , 2022 .

[3260]  K. Kendrick,et al.  The effects of nitric oxide on striatal serotoninergic transmission involve multiple targets: an in vivo microdialysis study in the awake rat , 2004, Brain Research.

[3261]  P. Strange,et al.  Investigation of the mechanism of agonist and inverse agonist action at D2 dopamine receptors. , 2004, Biochemical pharmacology.

[3262]  M. V. van Duijn,et al.  A 3-month, follow-up, randomized, placebo-controlled study of repetitive transcranial magnetic stimulation in depression. , 2004, The Journal of clinical psychiatry.

[3263]  B. O'dowd,et al.  Minireview: Diversity and complexity of signaling through peptidergic G protein-coupled receptors. , 2004, Endocrinology.

[3264]  R. Huganir,et al.  MAPK cascade signalling and synaptic plasticity , 2004, Nature Reviews Neuroscience.

[3265]  M. Tohen,et al.  A Double-Blind, Randomized Study of Olanzapine and Olanzapine/Fluoxetine Combination for Major Depression With Psychotic Features , 2004, Journal of clinical psychopharmacology.

[3266]  A. Schatzberg,et al.  HPA axis activation in major depression and response to fluoxetine: a pilot study , 2004, Psychoneuroendocrinology.

[3267]  J. Tijssen,et al.  Triiodothyronine addition to paroxetine in the treatment of major depressive disorder. , 2004, The Journal of clinical endocrinology and metabolism.

[3268]  B. Su,et al.  Recent origin of a hominoid-specific splice form of neuropsin, a gene involved in learning and memory. , 2004, Molecular biology and evolution.

[3269]  Y. Humeau,et al.  Redistribution of GABAB(1) Protein and Atypical GABAB Responses in GABAB(2)-Deficient Mice , 2004, The Journal of Neuroscience.

[3270]  B. Czéh,et al.  Antidepressant treatment with tianeptine reduces apoptosis in the hippocampal dentate gyrus and temporal cortex , 2004, Biological Psychiatry.

[3271]  R. Athanazio,et al.  Histaminergic H1 and H2 receptors located within the ventromedial hypothalamus regulate food and water intake in rats , 2004, Pharmacology Biochemistry and Behavior.

[3272]  P. Greengard,et al.  Pharmacological inhibitors of glycogen synthase kinase 3. , 2004, Trends in pharmacological sciences.

[3273]  F. Kiefer,et al.  Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial. , 2004, Archives of general psychiatry.

[3274]  B. Giros,et al.  Organic Cation Transporter 3 (Slc22a3) Is Implicated in Salt-Intake Regulation , 2004, The Journal of Neuroscience.

[3275]  M. Tuszynski,et al.  Anatomical evidence for transsynaptic influences of estrogen on brain‐derived neurotrophic factor expression , 2004, The Journal of comparative neurology.

[3276]  D. Stein,et al.  Stress–restress evokes sustained iNOS activity and altered GABA levels and NMDA receptors in rat hippocampus , 2003, Psychopharmacology.

[3277]  M. Stein,et al.  Efficacy of low and higher dose extended-release venlafaxine in generalized social anxiety disorder: a 6-month randomized controlled trial , 2004, Psychopharmacology.

[3278]  S. Volpi,et al.  Regulation of Vasopressin V1b Receptors and Stress Adaptation , 2004, Annals of the New York Academy of Sciences.

[3279]  M. Mesulam.  The cholinergic lesion of Alzheimer's disease: pivotal factor or side show? , 2004, Learning & memory.

[3280]  T. Roth,et al.  Ramelteon (TAK-375), a selective MT1/MT2-receptor agonist, reduces latency to persistent sleep in a model of transient insomnia related to a novel sleep environment. , 2005, Sleep.

[3281]  K. Tsiganis,et al.  Origin of the orbital architecture of the giant planets of the Solar System , 2005, Nature.

[3282]  P. Cowen,et al.  The effects of paroxetine and nefazodone on sleep: a placebo controlled trial , 1996, Psychopharmacology.

[3283]  D. Sibley,et al.  Dopamine D5 receptor modulates male and female sexual behavior in mice , 2005, Psychopharmacology.

[3284]  M Pope,et al.  Duration of relapse prevention after cognitive therapy in residual depression: follow-up of controlled trial , 2005, Psychological Medicine.

[3285]  Jerry J Buccafusco,et al.  Multi-functional drugs for various CNS targets in the treatment of neurodegenerative disorders. , 2005, Trends in pharmacological sciences.

[3286]  H. Scharfman,et al.  Similarities between actions of estrogen and BDNF in the hippocampus: coincidence or clue? , 2005, Trends in Neurosciences.

[3287]  R. Kessler,et al.  Failure and delay in initial treatment contact after first onset of mental disorders in the National Comorbidity Survey Replication. , 2005, Archives of general psychiatry.

[3288]  Ravi Iyengar,et al.  Postsynaptic signaling networks: Cellular cogwheels underlying long-term plasticity , 2005, Biological Psychiatry.

[3289]  M. Sykes,et al.  Climate change threats to plant diversity in Europe. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[3290]  Guy Woodward,et al.  Body size in ecological networks. , 2005, Trends in ecology & evolution.

[3291]  Carsten Wiuf,et al.  Subnets of scale-free networks are not scale-free: sampling properties of networks. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[3292]  M. Fava,et al.  A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness. , 2005, The Journal of clinical psychiatry.

[3293]  H. Hermann,et al.  Coexpression of the cannabinoid receptor type 1 with the corticotropin-releasing hormone receptor type 1 in distinct regions of the adult mouse forebrain , 2005, Neuroscience Letters.

[3294]  Richard W. Hass,et al.  Selective and nonselective serotonin antagonists block the aversive stimulus properties of MK212 and m-chlorophenylpiperazine (mCPP) in mice , 2005, Neuropharmacology.

[3295]  G. Griebel,et al.  AVP V1b selective antagonist SSR149415 blocks aggressive behaviors in hamsters , 2005, Pharmacology Biochemistry and Behavior.

[3296]  L. Devi,et al.  Mechanisms of action of antidepressants: from neurotransmitter systems to signaling pathways. , 2005, Cellular signalling.

[3297]  J. Cryan,et al.  Don't worry 'B' happy!: a role for GABA(B) receptors in anxiety and depression. , 2005, Trends in pharmacological sciences.

[3298]  David A. Schwartz,et al.  Loss-of-Function Mutation in Tryptophan Hydroxylase-2 Identified in Unipolar Major Depression , 2005, Neuron.

[3299]  W. Haefely,et al.  Effects of repeated mild stress and two antidepressant treatments on the behavioral response to 5HT1C receptor activation in rats , 2005, Psychopharmacology.

[3300]  J. Tiihonen,et al.  Serotonergic modulation of striatal D2 dopamine receptor binding in humans measured with positron emission tomography , 1996, Psychopharmacology.

[3301]  H. Fibiger,et al.  Effects of chronic electroconvulsive shock on interstitial concentrations of dopamine in the nucleus accumbens , 2005, Psychopharmacology.

[3302]  Jae S. Choi,et al.  Trophic Cascades in a Formerly Cod-Dominated Ecosystem , 2005, Science.

[3303]  Andrew J Duncan,et al.  Nitric oxide and neurological disorders. , 2005, Molecular aspects of medicine.

[3304]  P. Donnelly,et al.  Comparison of Fine-Scale Recombination Rates in Humans and Chimpanzees , 2005, Science.

[3305]  R. Sorek,et al.  Is abundant A-to-I RNA editing primate-specific? , 2004, Trends in genetics : TIG.

[3306]  Michel Bouvier,et al.  Emerging role of homo- and heterodimerization in G-protein-coupled receptor biosynthesis and maturation. , 2005, Trends in pharmacological sciences.

[3307]  R. Duman,et al.  Electroconvulsive Seizures Increase the Expression of MAP Kinase Phosphatases in Limbic Regions of Rat Brain , 2005, Neuropsychopharmacology.

[3308]  Stephen M Stahl,et al.  The many faces of fatigue in major depressive disorder. , 2005, The international journal of neuropsychopharmacology.

[3309]  L. Judd,et al.  Tachyphylaxis in unipolar major depressive disorder. , 2005, The Journal of clinical psychiatry.

[3310]  D. Pal,et al.  Role of alpha and beta adrenoceptors in locus coeruleus stimulation-induced reduction in rapid eye movement sleep in freely moving rats , 2005, Behavioural Brain Research.

[3311]  P. Riederer,et al.  Organization of the human serotonin transporter gene , 2005, Journal of Neural Transmission / General Section JNT.

[3312]  A. Magnússon,et al.  The Diagnosis, Symptomatology, and Epidemiology of Seasonal Affective Disorder , 2005, CNS Spectrums.

[3313]  R. Toyoshima,et al.  Trazodone and its active metabolite m-chlorophenylpiperazine as partial agonists at 5-HT1A receptors assessed by [35S]GTPγS binding , 2005, Journal of psychopharmacology.

[3314]  Robert W. Williams,et al.  Complex trait analysis of gene expression uncovers polygenic and pleiotropic networks that modulate nervous system function , 2005, Nature Genetics.

[3315]  S. Ögren,et al.  Analysis of the role of 5-HT1A receptors in spatial and aversive learning in the rat , 2005, Neuropharmacology.

[3316]  D. Manahan‐Vaughan,et al.  The metabotropic glutamate receptor, mGluR5, is a key determinant of good and bad spatial learning performance and hippocampal synaptic plasticity. , 2005, Cerebral cortex.

[3317]  Stimulation cérébrale profonde du striatum ventral dans le traitement du trouble obsessionnel-compulsif avec dépression majeure , 2005 .

[3318]  Charles Auffray,et al.  'The 39 steps' in gene expression profiling: critical issues and proposed best practices for microarray experiments. , 2005, Drug discovery today.

[3319]  J. Lambert,et al.  Neurosteroids: endogenous regulators of the GABAA receptor , 2005, Nature Reviews Neuroscience.

[3320]  Boris Worm,et al.  Ecosystem recovery after climatic extremes enhanced by genotypic diversity. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[3321]  M. Detke,et al.  Duloxetine vs. placebo in patients with painful diabetic neuropathy , 2005, Pain.

[3322]  A. Tozzi,et al.  Trace Amines Depress GABAB Response in Dopaminergic Neurons by Inhibiting G-βγ-Gated Inwardly Rectifying Potassium Channels , 2005, Molecular Pharmacology.

[3323]  H. Berendsen,et al.  Attenuation of 5-HT1A and 5-HT2 but not 5-HT1C receptor mediated behaviour in rats following chronic treatment with 5-HT receptor agonists, antagonists or antidepressants , 2005, Psychopharmacology.

[3324]  M. Bakker,et al.  Discovery of a new series of centrally active tricyclic isoxazoles combining serotonin (5-HT) reuptake inhibition with alpha2-adrenoceptor blocking activity. , 2005, Journal of medicinal chemistry.

[3325]  M. Lowe,et al.  Antidepressant Effect on Connectivity of the Mood-Regulating Circuit: An fMRI Study , 2005, Neuropsychopharmacology.

[3326]  M. Serafin,et al.  Opposite effects of noradrenaline and acetylcholine upon hypocretin/orexin versus melanin concentrating hormone neurons in rat hypothalamic slices , 2005, Neuroscience.

[3327]  Martin Sarter,et al.  Choline transporters, cholinergic transmission and cognition , 2005, Nature Reviews Neuroscience.

[3328]  A. Baba,et al.  Sulpiride in Combination with Fluvoxamine Increases in vivo Dopamine Release Selectively in Rat Prefrontal Cortex , 2005, Neuropsychopharmacology.

[3329]  J. Mikkelsen,et al.  Antinociceptive effects of the antidepressants amitriptyline, duloxetine, mirtazapine and citalopram in animal models of acute, persistent and neuropathic pain , 2005, Neuropharmacology.

[3330]  A. Chistyakov,et al.  Antidepressant effects of different schedules of repetitive transcranial magnetic stimulation vs. clomipramine in patients with major depression: relationship to changes in cortical excitability. , 2005, The international journal of neuropsychopharmacology.

[3331]  K. Gysling,et al.  Acute morphine administration increases extracellular DA levels in the rat lateral septum by decreasing the GABAergic inhibitory tone in the ventral tegmental area , 2005, Journal of neuroscience research.

[3332]  J. Buccafusco,et al.  Long-lasting cognitive improvement with nicotinic receptor agonists: mechanisms of pharmacokinetic-pharmacodynamic discordance. , 2005, Trends in pharmacological sciences.

[3333]  R. Lam,et al.  Update on the Biology of Seasonal Affective Disorder , 2005, CNS Spectrums.

[3334]  B. Pollock,et al.  Candidate genes for antidepressant response to selective serotonin reuptake inhibitors , 2005, Neuropsychiatric disease and treatment.

[3335]  T. Svensson,et al.  The combination of nicotine with the D2 antagonist raclopride or the weak D4 antagonist L-745,870 generates a clozapine-like facilitation of NMDA receptor-mediated neurotransmission in pyramidal cells of the rat medial prefrontal cortex. , 2005, The international journal of neuropsychopharmacology.

[3336]  N. Richard,et al.  Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trials. , 2005, The Journal of clinical psychiatry.

[3337]  A. Blokland,et al.  The selective PDE5 inhibitor, sildenafil, improves object memory in Swiss mice and increases cGMP Levels in hippocampal slices , 2005, Behavioural Brain Research.

[3338]  Evidence-based pharmacotherapy of panic disorder. , 2005 .

[3339]  Treatmentof Alzheimer's dementia treatment of attention deficit hyperactivity disorder GABAB receptor antagonist , 2005 .

[3340]  P. Morgane,et al.  A review of systems and networks of the limbic forebrain/limbic midbrain , 2005, Progress in Neurobiology.

[3341]  C. Surowy,et al.  Different nicotinic acetylcholine receptor subtypes mediating striatal and prefrontal cortical [3H]dopamine release , 2005, Neuropharmacology.

[3342]  M. Fava,et al.  An open study of triiodothyronine augmentation of selective serotonin reuptake inhibitors in treatment-resistant major depressive disorder. , 2005, The Journal of clinical psychiatry.

[3343]  M. Knapp,et al.  Evidence of cost-effective treatments for depression: a systematic review. , 2005, Journal of affective disorders.

[3344]  Philip B. Ward,et al.  Reduced hippocampal volumes and memory loss in patients with early- and late-onset depression , 2005, British Journal of Psychiatry.

[3345]  K. Brady,et al.  Co-occurring mental and substance use disorders: the neurobiological effects of chronic stress. , 2005, The American journal of psychiatry.

[3346]  Brent C. Emerson,et al.  Species diversity can drive speciation , 2005, Nature.

[3347]  H. Zangrossi,et al.  Panicolytic-like effect induced by the stimulation of GABAA and GABAB receptors in the dorsal periaqueductal grey of rats. , 2005, European journal of pharmacology.

[3348]  John J. Foxe,et al.  The case for feedforward multisensory convergence during early cortical processing , 2005, Neuroreport.

[3349]  S. Kasper,et al.  Pharmacotherapy of Seasonal Affective Disorder , 2005, CNS Spectrums.

[3350]  M. Olianas,et al.  Allosteric modulation of GABAB receptor function in human frontal cortex , 2005, Neurochemistry International.

[3351]  N. Subhedar,et al.  Interaction between neuropeptide Y and alpha-melanocyte stimulating hormone in amygdala regulates anxiety in rats , 2005, Brain Research.

[3352]  A. Lansner,et al.  The cortex as a central pattern generator , 2005, Nature Reviews Neuroscience.

[3353]  R. DeRubeis,et al.  Prevention of relapse following cognitive therapy vs medications in moderate to severe depression. , 2005, Archives of general psychiatry.

[3354]  B. Green,et al.  Cost-effectiveness of evidence-based pharmacotherapy or cognitive behavior therapy compared with community referral for major depression in predominantly low-income minority women. , 2005, Archives of general psychiatry.

[3355]  K. Grove,et al.  Melanin concentrating hormone (MCH): A novel neural pathway for regulation of GnRH neurons , 2005, Brain Research.

[3356]  L. Jacobson,et al.  Chronic treatment with the monoamine oxidase inhibitor phenelzine increases hypothalamic-pituitary-adrenocortical activity in male C57BL/6 mice: relevance to atypical depression. , 2005, Endocrinology.

[3357]  E. Davidson,et al.  Gene regulatory networks. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[3358]  M. Liebowitz,et al.  Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder. , 2005, Archives of general psychiatry.

[3359]  B. Gutiérrez,et al.  Evidence for a combined genetic effect of the 5-HT1A receptor and serotonin transporter genes in the clinical outcome of major depressive patients treated with citalopram , 2005, Journal of psychopharmacology.

[3360]  A. Fernández-Guasti,et al.  Role of presynaptic serotonergic receptors on the mechanism of action of 5-HT1A and 5-HT1B agonists on masculine sexual behaviour: physiological and pharmacological implications , 2005, Journal of Neural Transmission / General Section JNT.

[3361]  R. Shelton,et al.  Signal transduction abnormalities in melancholic depression. , 2005, The international journal of neuropsychopharmacology.

[3362]  N. Volkow,et al.  The slow and long-lasting blockade of dopamine transporters in human brain induced by the new antidepressant drug radafaxine predict poor reinforcing effects , 2005, Biological Psychiatry.

[3363]  Manfred Gessler,et al.  Transposable elements as a source of genetic innovation: expression and evolution of a family of retrotransposon-derived neogenes in mammals. , 2005, Gene.

[3364]  Eugene S. Paykel,et al.  Size and burden of depressive disorders in Europe , 2005, European Neuropsychopharmacology.

[3365]  Sergio P. Rigonatti,et al.  Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: A double-blind placebo-controlled study , 2005, Biological Psychiatry.

[3366]  E. Castrén,et al.  Is mood chemistry? , 2005, Nature Reviews Neuroscience.

[3367]  Aaron Kershenbaum,et al.  Lasting impressions: motifs in protein-protein maps may provide footprints of evolutionary events. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[3368]  M. Raiteri,et al.  Chronic Antidepressants Reduce Depolarization-Evoked Glutamate Release and Protein Interactions Favoring Formation of SNARE Complex in Hippocampus , 2005, The Journal of Neuroscience.

[3369]  M. Posternak,et al.  Is it time to replace the Hamilton Depression Rating Scale as the primary outcome measure in treatment studies of depression? , 2005, Journal of clinical psychopharmacology.

[3370]  P. Nathan,et al.  Pindolol augmentation of selective serotonin reuptake inhibitors: Accounting for the variability of results of placebo‐controlled double‐blind studies in patients with major depression , 2005, Human psychopharmacology.

[3371]  B. Dubrovsky.  Steroids, neuroactive steroids and neurosteroids in psychopathology , 2005, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[3372]  P. Renshaw,et al.  Antidepressant-like effects of cranial stimulation within a low-energy magnetic field in rats , 2005, Biological Psychiatry.

[3373]  Huanming Yang,et al.  Origin and evolution of new exons in rodents. , 2005, Genome research.

[3374]  T. Bártfai,et al.  A role for galanin in antidepressant actions with a focus on the dorsal raphe nucleus. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[3375]  W. Maier,et al.  Treatment of chronic depression with sulpiride: evidence of efficacy in placebo-controlled single case studies , 1994, Psychopharmacology.

[3376]  P. M. S. Hacker,et al.  Emotion and cortical-subcortical function: conceptual developments , 2005, Progress in Neurobiology.

[3377]  S. Hunt,et al.  A comparison of neurokinin 1 receptor knock-out (NK1−/−) and wildtype mice: exploratory behaviour and extracellular noradrenaline concentration in the cerebral cortex of anaesthetised subjects , 2005, Neuropharmacology.

[3378]  E. Tatarczyńska,et al.  Antidepressant-like effect of the selective 5-HT1B receptor agonist CP 94253: a possible mechanism of action. , 2005, European journal of pharmacology.

[3379]  A. Vergoni,et al.  Chronic administration ofl-sulpiride at non-neuroleptic doses reduces the duration of immobility in experimental models of “depression-like” behavior , 1995, Psychopharmacology.

[3380]  Assessing combination treatments in acute stroke: Preclinical experiences , 2005, Behavioural Brain Research.

[3381]  Jon T. Willie,et al.  Modafinil more effectively induces wakefulness in orexin-null mice than in wild-type littermates , 2005, Neuroscience.

[3382]  M. Reith,et al.  Pharmacological profile of radioligand binding to the norepinephrine transporter: instances of poor indication of functional activity , 2005, Journal of Neuroscience Methods.

[3383]  M. Millan.  N-Methyl-d-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives , 2005, Psychopharmacology.

[3384]  B. Stockwell,et al.  Multicomponent therapeutics for networked systems , 2005, Nature Reviews Drug Discovery.

[3385]  N. Toda,et al.  Nitric oxide and penile erectile function. , 2005, Pharmacology & therapeutics.

[3386]  M. Gallagher,et al.  GABAB receptor antagonist SGS742 improves spatial memory and reduces protein binding to the cAMP response element (CRE) in the hippocampus , 2005, Neuropharmacology.

[3387]  M. Millan,et al.  The selective tachykinin neurokinin 1 (NK1) receptor antagonist, GR 205,171, stereospecifically inhibits light-induced phase advances of hamster circadian activity rhythms. , 2005, European journal of pharmacology.

[3388]  Robert M Sears,et al.  The Hypothalamic Neuropeptide Melanin-Concentrating Hormone Acts in the Nucleus Accumbens to Modulate Feeding Behavior and Forced-Swim Performance , 2005, The Journal of Neuroscience.

[3389]  I. Reid,et al.  Regulation of corticosteroid receptors in the rat brain: the role of serotonin and stress , 2005, The European journal of neuroscience.

[3390]  F. Sams-Dodd.  Target-based drug discovery: is something wrong? , 2005, Drug discovery today.

[3391]  A. Meyer-Lindenberg,et al.  5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression , 2005, Nature Neuroscience.

[3392]  A. Schnitzler,et al.  Normal and pathological oscillatory communication in the brain , 2005, Nature Reviews Neuroscience.

[3393]  Su-Jane Wang.  Potential antidepressant LY 367265 presynaptically inhibits the release of glutamate in rat cerebral cortex , 2005, Synapse.

[3394]  B. McEwen,et al.  Neurobiology of mood, anxiety, and emotions as revealed by studies of a unique antidepressant: tianeptine , 2005, Molecular Psychiatry.

[3395]  D. Manahan‐Vaughan,et al.  Pharmacological antagonism of metabotropic glutamate receptor 1 regulates long‐term potentiation and spatial reference memory in the dentate gyrus of freely moving rats via N‐methyl‐d‐aspartate and metabotropic glutamate receptor‐dependent mechanisms , 2005, The European journal of neuroscience.

[3396]  V. Vanderhorst,et al.  Estrogen receptor‐α and ‐β immunoreactive neurons in the brainstem and spinal cord of male and female mice: Relationships to monoaminergic, cholinergic, and spinal projection systems , 2005, The Journal of comparative neurology.

[3397]  D. Bellwood,et al.  New paradigms for supporting the resilience of marine ecosystems. , 2005, Trends in ecology & evolution.

[3398]  F. Montorsi,et al.  Peripheral relaxant activity of apomorphine and of a D1 selective receptor agonist on human corpus cavernosum strips , 2005, International Journal of Impotence Research.

[3399]  Meharvan Singh,et al.  PKC modulation of GABAA receptor endocytosis and function is inhibited by mutation of a dileucine motif within the receptor β2 subunit , 2005, Neuropharmacology.

[3400]  G. Griebel,et al.  An overview of SSR149415, a selective nonpeptide vasopressin V(1b) receptor antagonist for the treatment of stress-related disorders. , 2006, CNS drug reviews.

[3401]  Robert L. Phillips,et al.  Regulation of Gene Expression by Lithium and Depletion of Inositol in Slices of Adult Rat Cortex , 2005, Neuron.

[3402]  Sean P David,et al.  A Functional Genetic Variation of the Serotonin (5-HT) Transporter Affects 5-HT1A Receptor Binding in Humans , 2005, The Journal of Neuroscience.

[3403]  M. Palkovits,et al.  Molecular neurobiology and pharmacology of the Vasopressin/Oxytocin receptor family , 1995, Cellular and Molecular Neurobiology.

[3404]  M. Seager,et al.  Chronic coadministration of olanzapine and fluoxetine activates locus coeruleus neurons in rats: implications for bipolar disorder , 2005, Psychopharmacology.

[3405]  W. Lennarz,et al.  Unraveling the Mechanism of Protein N-Glycosylation* , 2005, Journal of Biological Chemistry.

[3406]  Nicolas Loeuille,et al.  Evolutionary emergence of size-structured food webs. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[3407]  Jianzhi Zhang,et al.  Rapid Subfunctionalization Accompanied by Prolonged and Substantial Neofunctionalization in Duplicate Gene Evolution , 2005, Genetics.

[3408]  Patrick R Hof,et al.  Mice lacking dopamine D2 and D3 receptors exhibit differential activation of prefrontal cortical neurons during tasks requiring attention. , 2005, Cerebral cortex.

[3409]  P. Celada,et al.  Modulation of the activity of pyramidal neurons in rat prefrontal cortex by raphe stimulation in vivo: involvement of serotonin and GABA. , 2004, Cerebral cortex.

[3410]  G. Maksay,et al.  Allosteric modulation of 5-HT3 serotonin receptors. , 2005, European journal of pharmacology.

[3411]  D. Abrous,et al.  Adult Neurogenesis : From Precursors to Network and Physiology , 2005 .

[3412]  P. Bottoni,et al.  Nitric oxide donor drugs: an update on pathophysiology and therapeutic potential , 2005, Expert opinion on investigational drugs.

[3413]  J. Koolhaas,et al.  Anxiolytic-like action of the antidepressant agomelatine (S 20098) after a social defeat requires the integrity of the SCN , 2005, European Neuropsychopharmacology.

[3414]  M. Menziani,et al.  Further studies on the interaction of the 5-hydroxytryptamine3 (5-HT3) receptor with arylpiperazine ligands. development of a new 5-HT3 receptor ligand showing potent acetylcholinesterase inhibitory properties. , 2005, Journal of medicinal chemistry.

[3415]  E. Stip,et al.  On the trail of a cognitive enhancer for the treatment of schizophrenia , 2005, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[3416]  R Kohnen,et al.  The catechol-O-methyltransferase Val108/158Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depression , 2005, The Pharmacogenomics Journal.

[3417]  Patricia Vickers-Rich,et al.  Independent Origins of Middle Ear Bones in Monotremes and Therians , 2005, Science.

[3418]  R. Blakely,et al.  Evidence for Biphasic Effects of Protein Kinase C on Serotonin Transporter Function, Endocytosis, and Phosphorylation , 2005, Molecular Pharmacology.

[3419]  E. Fuchs,et al.  Behavioural, neural and cardiovascular adaptations in mice lacking the NPY Y1 receptor , 2005, Neuroscience & Biobehavioral Reviews.

[3420]  P. Tyrer,et al.  Managing mood disorders and comorbid personality disorders , 2005, Current opinion in psychiatry.

[3421]  S. Arnold,et al.  A preclinical view of cholinesterase inhibitors in neuroprotection: do they provide more than symptomatic benefits in Alzheimer's disease? , 2005, Trends in pharmacological sciences.

[3422]  N. Martin,et al.  The relationship between stressful life events, the serotonin transporter (5-HTTLPR) genotype and major depression , 2005, Psychological Medicine.

[3423]  K. Ryan,et al.  Intracellular signalling and cancer: complex pathways lead to multiple targets. , 2005, European journal of cancer.

[3424]  R. Nussbaum,et al.  Midbrain dopamine and prefrontal function in humans: interaction and modulation by COMT genotype , 2005, Nature Neuroscience.

[3425]  R. Baldessarini,et al.  Effects of desipramine treatment on tyrosine hydroxylase gene expression in cultured neuroblastoma cells and rat brain tissue. , 2005, Brain research. Molecular brain research.

[3426]  M. Detke,et al.  Onset of action for duloxetine 60 mg once daily: double-blind, placebo-controlled studies. , 2005, Journal of psychiatric research.

[3427]  I. Anderson,et al.  Effect of acute tryptophan depletion on the response to controllable and uncontrollable noise stress , 2005, Biological Psychiatry.

[3428]  D. Mayleben,et al.  The efficacy and safety of the melatonin agonist beta-methyl-6-chloromelatonin in primary insomnia: a randomized, placebo-controlled, crossover clinical trial. , 2005, The Journal of clinical psychiatry.

[3429]  M. Youdim,et al.  Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases , 2005, Mechanisms of Ageing and Development.

[3430]  Y. Khazaal,et al.  Escitalopram/reboxetine combination in depressed patients with substance use disorder , 2005, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[3431]  S. Faraone,et al.  Meta‐analysis of the association between two polymorphisms in the serotonin transporter gene and affective disorders , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[3432]  J. Reul,et al.  The Selective Glucocorticoid Receptor Antagonist ORG 34116 Decreases Immobility Time in the Forced Swim Test and Affects cAMP-Responsive Element-Binding Protein Phosphorylation in Rat Brain , 2005, Neuroendocrinology.

[3433]  Mikko Sairanen,et al.  Brain-Derived Neurotrophic Factor and Antidepressant Drugs Have Different But Coordinated Effects on Neuronal Turnover, Proliferation, and Survival in the Adult Dentate Gyrus , 2005, The Journal of Neuroscience.

[3434]  Matthew M. Burg,et al.  Effects of Antidepressant Medication on Morbidity and Mortality in Depressed Patients After Myocardial Infarction , 2005 .

[3435]  H. Mishima,et al.  Role of C-terminal region in the functional regulation of rat serotonin transporter (SERT) , 2005, Neurochemistry International.

[3436]  J. Monti,et al.  A study of the brain structures involved in the acute effects of fluoxetine on REM sleep in the rat. , 2005, The international journal of neuropsychopharmacology.

[3437]  T. Yeh,et al.  Heterodimerization of opioid receptor‐like 1 and µ‐opioid receptors impairs the potency of µ receptor agonist , 2005, Journal of neurochemistry.

[3438]  M. Dziedzicka-Wasylewska,et al.  The effect of prolonged treatment with imipramine and electroconvulsive shock on the levels of endogenous enkephalins in the nucleus accumbens and the ventral tegmentum of the rat , 2005, Journal of Neural Transmission / General Section JNT.

[3439]  P. Uetz,et al.  From protein networks to biological systems , 2005, FEBS letters.

[3440]  C. Debattista,et al.  A placebo-controlled, randomized, double-blind study of adjunctive bupropion sustained release in the treatment of SSRI-induced sexual dysfunction. , 2005, The Journal of clinical psychiatry.

[3441]  C. Surowy,et al.  Nicotinic Acetylcholine Receptor-Mediated [3H]Dopamine Release from Hippocampus , 2005, Journal of Pharmacology and Experimental Therapeutics.

[3442]  Jamie Fong,et al.  A heterodimer-selective agonist shows in vivo relevance of G protein-coupled receptor dimers. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[3443]  R. M. Eglen,et al.  Ondansetron improves cognitive performance in the Morris water maze spatial navigation task , 1995, Psychopharmacology.

[3444]  J. Micó,et al.  Role of 5-HT1A and 5-HT1B receptors in the antinociceptive effect of tramadol. , 2005, European journal of pharmacology.

[3445]  M. Hoener,et al.  A renaissance in trace amines inspired by a novel GPCR family. , 2005, Trends in pharmacological sciences.

[3446]  A. Maelicke,et al.  Memantine Blocks α7* Nicotinic Acetylcholine Receptors More Potently Than N-Methyl-D-aspartate Receptors in Rat Hippocampal Neurons , 2005, Journal of Pharmacology and Experimental Therapeutics.

[3447]  Y. Uezono,et al.  The Effects of the Tramadol Metabolite O-Desmethyl Tramadol on Muscarinic Receptor-Induced Responses in Xenopus Oocytes Expressing Cloned M1 or M3 Receptors , 2005, Anesthesia and analgesia.

[3448]  Benjamin Audit,et al.  An exponential core in the heart of the yeast protein interaction network. , 2005, Molecular biology and evolution.

[3449]  M. Berk,et al.  Antidepressants and the placebo response , 2005, Human psychopharmacology.

[3450]  K. Miczek,et al.  Prolonged Effects of Repeated Social Defeat Stress on mRNA Expression and Function of μ-Opioid Receptors in the Ventral Tegmental Area of Rats , 2005, Neuropsychopharmacology.

[3451]  M. Barrot,et al.  Frontocortical 5-HT4 receptors exert positive feedback on serotonergic activity: Viral transfections, subacute and chronic treatments with 5-HT4 agonists , 2005, Biological Psychiatry.

[3452]  W. Riedel,et al.  Specific serotonergic reuptake inhibition impairs vigilance performance acutely and after subchronic treatment , 2005, Journal of psychopharmacology.

[3453]  C. Nemeroff,et al.  Depression during pegylated interferon-alpha plus ribavirin therapy: prevalence and prediction. , 2005, The Journal of clinical psychiatry.

[3454]  Igor Timofeev,et al.  Modulation of synaptic transmission in neocortex by network activities , 2005, The European journal of neuroscience.

[3455]  M. Detke,et al.  Sexual functioning assessed in 4 double-blind placebo- and paroxetine-controlled trials of duloxetine for major depressive disorder. , 2005, The Journal of clinical psychiatry.

[3456]  D. Nutt,et al.  Regional neurotransmitter responses after acute and chronic electroconvulsive shock , 2005, Psychopharmacology.

[3457]  K. Krishnan,et al.  Comparing the Effects of Antidepressants: Consensus Guidelines for Evaluating Quantitative Reviews of Antidepressant Efficacy , 2005, Neuropsychopharmacology.

[3458]  J. Kemp,et al.  Ionotropic and metabotropic glutamate receptor structure and pharmacology , 2005, Psychopharmacology.

[3459]  P. Popik,et al.  Nicotine produces antidepressant-like actions: Behavioral and neurochemical evidence. , 2005, European journal of pharmacology.

[3460]  M. Molina-hernandez,et al.  Antidepressant-like actions of intra-accumbens infusions of allopregnanolone in ovariectomized Wistar rats , 2005, Pharmacology Biochemistry and Behavior.

[3461]  A. Frasch,et al.  Chronic Stress, Depression and Antidepressants: Effects on Gene Transcription in the Hippocampus , 2005, Reviews in the neurosciences.

[3462]  M. Thase,et al.  Cardiovascular Profile of Duloxetine, a Dual Reuptake Inhibitor of Serotonin and Norepinephrine , 2005, Journal of clinical psychopharmacology.

[3463]  S. Faraone,et al.  Identification of the phenotype in psychiatric genetics , 2005, European Archives of Psychiatry and Clinical Neuroscience.

[3464]  Yogesh K. Dwivedi,et al.  Focus on protein kinase A and protein kinase C, critical components of signal transduction system, in mood disorders and suicide. , 2005, The international journal of neuropsychopharmacology.

[3465]  I. Utsunomiya,et al.  Effects of β-Phenylethylamine on Dopaminergic Neurons of the Ventral Tegmental Area in the Rat: A Combined Electrophysiological and Microdialysis Study , 2005, Journal of Pharmacology and Experimental Therapeutics.

[3466]  T. Robinson,et al.  Why does the rapid delivery of drugs to the brain promote addiction? , 2005, Trends in pharmacological sciences.

[3467]  W. Goodman,et al.  Treatment of generalized anxiety disorder with escitalopram: pooled results from double-blind, placebo-controlled trials. , 2005, Journal of affective disorders.

[3468]  George Sugihara,et al.  Distinguishing random environmental fluctuations from ecological catastrophes for the North Pacific Ocean , 2005, Nature.

[3469]  G. Parker,et al.  Structural and functional models of depression: from sub‐types to substrates , 2005, Acta psychiatrica Scandinavica.

[3470]  G. Gerhardt,et al.  Transport mechanisms governing serotonin clearance in vivo revealed by high-speed chronoamperometry , 2005, Journal of Neuroscience Methods.

[3471]  Ruoyan Chen,et al.  In vitro profile of the antidepressant candidate OPC-14523 at rat and human 5-HT1A receptors. , 2005, European journal of pharmacology.

[3472]  J. Elmquist,et al.  Body weight is regulated by the brain: a link between feeding and emotion , 2005, Molecular Psychiatry.

[3473]  Peter B. Jones,et al.  The Subjective and Cognitive Effects of Acute Phenylalanine and Tyrosine Depletion in Patients Recovered from Depression , 2005, Neuropsychopharmacology.

[3474]  M. Terman,et al.  Light Therapy for Seasonal and Nonseasonal Depression: Efficacy, Protocol, Safety, and Side Effects , 2005, CNS Spectrums.

[3475]  Christian Büchel,et al.  Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter , 2005, Nature Neuroscience.

[3476]  Olga V. Demler,et al.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. , 2005, Archives of general psychiatry.

[3477]  Andon Hestiantoro,et al.  Colocalization of corticotropin-releasing hormone and oestrogen receptor-alpha in the paraventricular nucleus of the hypothalamus in mood disorders. , 2005, Brain : a journal of neurology.

[3478]  M. Youdim,et al.  Rasagiline: Neurodegeneration, neuroprotection, and mitochondrial permeability transition , 2005, Journal of neuroscience research.

[3479]  J. Vry.  5-HT1A receptor agonists: recent developments and controversial issues , 1995, Psychopharmacology.

[3480]  S. Ögren,et al.  5-HT1A receptor mRNA and immunoreactivity in the rat medial septum/diagonal band of Broca—relationships to GABAergic and cholinergic neurons , 2005, Journal of Chemical Neuroanatomy.

[3481]  M. Posternak,et al.  Dual reuptake inhibitors incur lower rates of tachyphylaxis than selective serotonin reuptake inhibitors: a retrospective study. , 2005, The Journal of clinical psychiatry.

[3482]  Faith M. Gunning-Dixon,et al.  Executive Dysfunction and the Course of Geriatric Depression , 2005, Biological Psychiatry.

[3483]  R. McNally,et al.  Acute tryptophan depletion as a model of depressive relapse: behavioural specificity and ethical considerations. , 2005, The British journal of psychiatry : the journal of mental science.

[3484]  G. Gessa,et al.  Stimulation of the locus coeruleus elicits noradrenaline and dopamine release in the medial prefrontal and parietal cortex , 2005, Journal of neurochemistry.

[3485]  P. Whiting,et al.  Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression , 2005, Neuropharmacology.

[3486]  H. Meltzer,et al.  Lithium differs from anticonvulsant mood stabilizers in prefrontal cortical and accumbal dopamine release: Role of 5-HT1A receptor agonism , 2005, Brain Research.

[3487]  F. Nicoletti,et al.  Metabotropic glutamate receptors and neuroadaptation to antidepressants: imipramine‐induced down‐regulation of β‐adrenergic receptors in mice treated with metabotropic glutamate 2/3 receptor ligands , 2005, Journal of neurochemistry.

[3488]  G. Glazko,et al.  Eighty percent of proteins are different between humans and chimpanzees. , 2005, Gene.

[3489]  T. Nikolskaya,et al.  Biological networks and analysis of experimental data in drug discovery. , 2005, Drug discovery today.

[3490]  G. Debonnel,et al.  The role of sigma receptors in depression. , 2005, Journal of pharmacological sciences.

[3491]  David J. Daniels,et al.  A bivalent ligand (KDAN-18) containing delta-antagonist and kappa-agonist pharmacophores bridges delta2 and kappa1 opioid receptor phenotypes. , 2004, Journal of medicinal chemistry.

[3492]  F. Angelucci,et al.  BDNF in schizophrenia, depression and corresponding animal models , 2005, Molecular Psychiatry.

[3493]  Hong Yang,et al.  Primate Trace Amine Receptor 1 Modulation by the Dopamine Transporter , 2005, Journal of Pharmacology and Experimental Therapeutics.

[3494]  V. Brown,et al.  Recordings from the rat locus coeruleus during acute vagal nerve stimulation in the anaesthetised rat , 2005, Neuroscience Letters.

[3495]  R. Blakely,et al.  Single Nucleotide Polymorphisms in the Human Norepinephrine Transporter Gene Affect Expression, Trafficking, Antidepressant Interaction, and Protein Kinase C Regulation , 2005, Molecular Pharmacology.

[3496]  J. Tijssen,et al.  Thyroid and adrenal axis in major depression: a controlled study in outpatients. , 2005, European journal of endocrinology.

[3497]  S. Childers,et al.  Effects of long-term biogenic amine transporter blockade on receptor/G-protein coupling in rat brain , 2005, Neuropharmacology.

[3498]  Vincenza Andrisano,et al.  Rational approach to discover multipotent anti-Alzheimer drugs. , 2005, Journal of medicinal chemistry.

[3499]  Humberto Nicolini,et al.  A Patient with a Resistant Major Depression Disorder Treated with Deep Brain Stimulation in the Inferior Thalamic Peduncle , 2005, Neurosurgery.

[3500]  D. Rubinow,et al.  Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression. , 2005, Archives of general psychiatry.

[3501]  G. Di Chiara,et al.  Selective serotonin reuptake blockade increases extracellular dopamine in noradrenaline‐rich isocortical but not prefrontal areas: dependence on serotonin‐1A receptors and independence from noradrenergic innervation , 2005, Journal of neurochemistry.

[3502]  F. Quitkin,et al.  Defining the boundaries of atypical depression: evidence from the HPA axis supports course of illness distinctions. , 2005, Journal of affective disorders.

[3503]  B. Czéh,et al.  Chronic psychosocial stress in tree shrews: effect of the substance P (NK1 receptor) antagonist L-760735 and clomipramine on endocrine and behavioral parameters , 2005, Psychopharmacology.

[3504]  J. C. Winter,et al.  Serotonergic/glutamatergic interactions: Potentiation of phencyclidine-induced stimulus control by citalopram , 2005, Pharmacology Biochemistry and Behavior.

[3505]  A. Adamantidis,et al.  Disrupting the melanin‐concentrating hormone receptor 1 in mice leads to cognitive deficits and alterations of NMDA receptor function , 2005, The European journal of neuroscience.

[3506]  H. Meltzer,et al.  Effect of pindolol on hormone secretion and body temperature: Partial agonist effects , 2005, Journal of Neural Transmission.

[3507]  Mercedes Pascual,et al.  Criticality and disturbance in spatial ecological systems. , 2005, Trends in ecology & evolution.

[3508]  Maurizio Corbetta,et al.  The human brain is intrinsically organized into dynamic, anticorrelated functional networks. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[3509]  D. Lorrain,et al.  Comparison of the effects of diazepam, the CRF1 antagonist CP-154,526 and the group II mGlu receptor agonist LY379268 on stress-evoked extracellular norepinephrine levels , 2005, Neuropharmacology.

[3510]  M. Millan,et al.  Serotonin 5-HT2C receptors as a target for the treatment of depressive and anxious states: focus on novel therapeutic strategies. , 2005, Therapie.

[3511]  H. Wetzel,et al.  Roxindole, a dopamine autoreceptor agonist, in the treatment of major depression , 2005, Psychopharmacology.

[3512]  C. Marsden,et al.  Increased 5-HT2C receptor responsiveness occurs on rearing rats in social isolation , 1996, Psychopharmacology.

[3513]  Alan A. Wilson,et al.  Distinct effects of sleep deprivation on binding to norepinephrine and serotonin transporters in rat brain , 2005, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[3514]  M. Danhof,et al.  Towards a mechanism-based analysis of pharmacodynamic drug-drug interactions in vivo. , 2005, Pharmacology & therapeutics.

[3515]  J. T. Coull,et al.  Theα2 antagonist idazoxan remediates certain attentional and executive dysfunction in patients with dementia of frontal type , 1996, Psychopharmacology.

[3516]  K. Fuxe,et al.  How receptor mosaics decode transmitter signals. Possible relevance of cooperativity. , 2005, Trends in biochemical sciences.

[3517]  M. Rietschel,et al.  Association between COMT (Val158Met) functional polymorphism and early onset in patients with major depressive disorder in a European multicenter genetic association study , 2005, Molecular Psychiatry.

[3518]  R. Blakely,et al.  p38 MAPK Activation Elevates Serotonin Transport Activity via a Trafficking-independent, Protein Phosphatase 2A-dependent Process* , 2005, Journal of Biological Chemistry.

[3519]  Hirohisa Kishino,et al.  Divergence pattern of duplicate genes in protein-protein interactions follows the power law. , 2005, Molecular biology and evolution.

[3520]  R. Hagan,et al.  The anxiolytic-like activity of GR159897, a non-peptide NK2 receptor antagonist, in rodent and primate models of anxiety , 1995, Psychopharmacology.

[3521]  J. Markowitz,et al.  Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not. , 2005, Archives of general psychiatry.

[3522]  R. Invernizzi,et al.  Chronic Reboxetine Desensitizes Terminal but not Somatodendritic α2-Adrenoceptors Controlling Noradrenaline Release in the Rat Dorsal Hippocampus , 2005, Neuropsychopharmacology.

[3523]  R. Britten.  The majority of human genes have regions repeated in other human genes. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[3524]  R. Hamer,et al.  The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. , 2005, The American journal of psychiatry.

[3525]  M. Hautzinger,et al.  A Meta-analytic Review of the Efficacy of Drug Treatment in Generalized Anxiety Disorder , 2005, Journal of clinical psychopharmacology.

[3526]  Yogesh K. Dwivedi,et al.  Differential regulation of serotonin (5HT)2A receptor mRNA and protein levels after single and repeated stress in rat brain: role in learned helplessness behavior , 2005, Neuropharmacology.

[3527]  A. Hughes,et al.  Gene duplication and the origin of novel proteins. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[3528]  M. Rietschel,et al.  The power of sample size and homogenous sampling: Association between the 5-HTTLPR serotonin transporter polymorphism and major depressive disorder , 2005, Biological Psychiatry.

[3529]  Myung-Suk Kim,et al.  Fluoxetine inhibits ATP-induced [Ca2+]i increase in PC12 cells by inhibiting both extracellular Ca2+ influx and Ca2+ release from intracellular stores , 2005, Neuropharmacology.

[3530]  S. Hunt,et al.  Changes in signaling pathways regulating neuroplasticity induced by neurokinin 1 receptor knockout , 2005, The European journal of neuroscience.

[3531]  Takeshi Inoue,et al.  Effect of milnacipran on extracellular monoamine concentrations in the medial prefrontal cortex of rats pre-treated with lithium. , 2005, European journal of pharmacology.

[3532]  Ove Wiborg,et al.  The S-enantiomer of R,S-citalopram, increases inhibitor binding to the human serotonin transporter by an allosteric mechanism. Comparison with other serotonin transporter inhibitors , 2003, European Neuropsychopharmacology.

[3533]  Shigeru Okuyama,et al.  Anxiolytic- and Antidepressant-Like Profile of ATC0065 and ATC0175: Nonpeptidic and Orally Active Melanin-Concentrating Hormone Receptor 1 Antagonists , 2005, Journal of Pharmacology and Experimental Therapeutics.

[3534]  H. Shannon,et al.  Efficacy of Duloxetine, a Potent and Balanced Serotonergic and Noradrenergic Reuptake Inhibitor, in Inflammatory and Acute Pain Models in Rodents , 2005, Journal of Pharmacology and Experimental Therapeutics.

[3535]  Fenghua Chen,et al.  Characterization of an allosteric citalopram‐binding site at the serotonin transporter , 2005, Journal of neurochemistry.

[3536]  W. Abraham,et al.  Memory retention – the synaptic stability versus plasticity dilemma , 2005, Trends in Neurosciences.

[3537]  G. Juhász,et al.  Subthreshold depression is linked to the functional polymorphism of the 5HT transporter gene. , 2005, Journal of affective disorders.

[3538]  S. Gershon,et al.  Dopamine and depression , 2005, Journal of Neural Transmission / General Section JNT.

[3539]  S. Chaki,et al.  Neuropharmacological profiles of antagonists of group II metabotropic glutamate receptors , 2005, Neuroscience Letters.

[3540]  J. Daniel,et al.  Role of hippocampal M2 muscarinic receptors in the estrogen-induced enhancement of working memory , 2005, Neuroscience.

[3541]  S. Chaki,et al.  AMPA receptor stimulation mediates the antidepressant-like effect of a group II metabotropic glutamate receptor antagonist , 2005, Brain Research.

[3542]  N. Bhat,et al.  A Role for p38 Mitogen-Activated Protein Kinase in the Regulation of the Serotonin Transporter: Evidence for Distinct Cellular Mechanisms Involved in Transporter Surface Expression , 2005, The Journal of Neuroscience.

[3543]  G. Knudsen,et al.  α7 nicotinic receptor subunit is present on serotonin neurons projecting to hippocampus and septum , 2005 .

[3544]  Modulation of working, short- and long-term memory by nicotinic receptors in the basolateral amygdala in rats , 2005, Neurobiology of Learning and Memory.

[3545]  G. Drummond,et al.  Selective effects of clonidine and temazepam on attention and memory , 2005, Journal of psychopharmacology.

[3546]  Ronald S Duman,et al.  Electroconvulsive Seizure Treatment Increases Cell Proliferation in Rat Frontal Cortex , 2005, Neuropsychopharmacology.

[3547]  J. Pineda,et al.  α2-Adrenoceptor involvement in the in vitro inhibitory effect of citalopram on a subpopulation of rat locus coeruleus neurons , 2005 .

[3548]  A. Leuchter,et al.  Estrogen augmentation of antidepressants in perimenopausal depression: a pilot study. , 2005, The Journal of clinical psychiatry.

[3549]  F. Taylor,et al.  A retrospective chart review of the effects of modafinil on depression as monotherapy and as adjunctive therapy , 2005, Depression and anxiety.

[3550]  F. Giorgi,et al.  Paired Activation of Two Components within Muscarinic M3 Receptor Dimers Is Required for Recruitment of β-Arrestin-1 to the Plasma Membrane* , 2005, Journal of Biological Chemistry.

[3551]  Dinesh Gautam,et al.  Acetylcholine modulates cortical synaptic transmission via different muscarinic receptors, as studied with receptor knockout mice , 2005, The Journal of physiology.

[3552]  P. Popik,et al.  A comparison of the predictive therapeutic and undesired side-effects of the NMDA receptor antagonist, memantine, in mice , 2005, Behavioural pharmacology.

[3553]  E. Tzavara,et al.  Mesolimbic Dopamine Super-Sensitivity in Melanin-Concentrating Hormone-1 Receptor-Deficient Mice , 2005, The Journal of Neuroscience.

[3554]  J. Haavik,et al.  Different properties of the central and peripheral forms of human tryptophan hydroxylase , 2005, Journal of neurochemistry.

[3555]  B. Czéh,et al.  Chronic Stress Decreases the Number of Parvalbumin-Immunoreactive Interneurons in the Hippocampus: Prevention by Treatment with a Substance P Receptor (NK1) Antagonist , 2005, Neuropsychopharmacology.

[3556]  M. Raiteri,et al.  Chronic nicotine differentially affects the function of nicotinic receptor subtypes regulating neurotransmitter release , 2005, Journal of neurochemistry.

[3557]  Recent Advances in Melatonin Receptor Ligands , 2005, Archiv der Pharmazie.

[3558]  S. Henriksen,et al.  5-HT7 Receptor Inhibition and Inactivation Induce Antidepressantlike Behavior and Sleep Pattern , 2005, Biological Psychiatry.

[3559]  N. Mirza,et al.  Lamotrigine has an anxiolytic-like profile in the rat conditioned emotional response test of anxiety: a potential role for sodium channels? , 2005, Psychopharmacology.

[3560]  T. L. Thompson,et al.  Estrogen mediated inhibition of dopamine transport in the striatum: Regulation by Gαi/o , 2005 .

[3561]  M. Millan,et al.  Acute administration of the novel serotonin and noradrenaline reuptake inhibitor, S33005, markedly modifies sleep–wake cycle architecture in the rat , 2005, Psychopharmacology.

[3562]  Juha O. Rinne,et al.  Cortical 6-[18F]fluoro-l-dopa uptake and frontal cognitive functions in early Parkinson's disease , 2005, Neurobiology of Aging.

[3563]  Risto J. Ilmoniemi,et al.  Prefrontal TMS produces smaller EEG responses than motor-cortex TMS: implications for rTMS treatment in depression , 2005, Psychopharmacology.

[3564]  M. Millan,et al.  Dopamine D3 receptor antagonists as therapeutic agents. , 2005, Drug discovery today.

[3565]  Mark Zimmerman,et al.  Is there a delay in the antidepressant effect? A meta-analysis. , 2005, The Journal of clinical psychiatry.

[3566]  J. Barrett,et al.  Lecozotan (SRA-333): A Selective Serotonin 1A Receptor Antagonist That Enhances the Stimulated Release of Glutamate and Acetylcholine in the Hippocampus and Possesses Cognitive-Enhancing Properties , 2005, Journal of Pharmacology and Experimental Therapeutics.

[3567]  Barbara E. Jones,et al.  Basic Mechanisms of Sleep-Wake States , 2005 .

[3568]  A. Cools,et al.  Effects of chronic selective serotonin reuptake inhibitors on 8-OH-DPAT-induced facilitation of ejaculation in rats: comparison of fluvoxamine and paroxetine , 2005, Psychopharmacology.

[3569]  A. Lozano,et al.  Deep Brain Stimulation for Treatment-Resistant Depression , 2005, Neuron.

[3570]  W. Danysz,et al.  Anxiolytic-like effects of mGlu1 and mGlu5 receptor antagonists in rats. , 2005, European journal of pharmacology.

[3571]  S. Dewhurst,et al.  Opposite effects of lithium and valproic acid on trophic factor deprivation-induced glycogen synthase kinase-3 activation, c-Jun expression and neuronal cell death , 2005, Neuropharmacology.

[3572]  K. Miller.  Serotonin 5-ht2c receptor agonists: potential for the treatment of obesity. , 2005, Molecular interventions.

[3573]  H. Fukuzako,et al.  Repetitive transcranial magnetic stimulation induces kf-1 expression in the rat brain. , 2005, Life sciences.

[3574]  H. Manji,et al.  Glycogen Synthase Kinase-3: a Putative Molecular Target for Lithium Mimetic Drugs , 2005, Neuropsychopharmacology.

[3575]  D. Overstreet,et al.  Hyperfunctionality of serotonin-2C receptor-mediated inhibition of accumbal dopamine release in an animal model of depression is reversed by antidepressant treatment , 2005, Neuropharmacology.

[3576]  D. Ware,et al.  Bottom-Up Ecosystem Trophic Dynamics Determine Fish Production in the Northeast Pacific , 2005, Science.

[3577]  T. Jensen,et al.  Antidepressants in the treatment of neuropathic pain. , 2005, Basic & clinical pharmacology & toxicology.

[3578]  Kristine Yaffe,et al.  Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. , 2005, JAMA.

[3579]  K. Fuxe,et al.  Modafinil enhances the increase of extracellular serotonin levels induced by the antidepressant drugs fluoxetine and imipramine: A dual probe microdialysis study in awake rat , 2005, Synapse.

[3580]  B. Gillain,et al.  Effects of sertraline on depressive symptoms and attentional and executive functions in major depression , 2005, Depression and anxiety.

[3581]  G. Trendler,et al.  Schizophrenia and depression: Challenging the paradigm of two separate diseases—A controlled study of schizophrenia, depression and healthy controls , 2005, Schizophrenia Research.

[3582]  M. Biasi,et al.  Corelease of Dopamine and Serotonin from Striatal Dopamine Terminals , 2005, Neuron.

[3583]  J. Herbert,et al.  Serotonin Modulates the Suppressive Effects of Corticosterone on Proliferating Progenitor Cells in the Dentate Gyrus of the Hippocampus in the Adult Rat , 2005, Neuropsychopharmacology.

[3584]  M. Liebowitz,et al.  A randomized controlled trial of venlafaxine extended release in generalized social anxiety disorder. , 2005, The Journal of clinical psychiatry.

[3585]  Marc W Kirschner,et al.  The Meaning of Systems Biology , 2005, Cell.

[3586]  E. Sher,et al.  GABAB receptor modulators potentiate baclofen‐induced depression of dopamine neuron activity in the rat ventral tegmental area , 2005 .

[3587]  P. Willner,et al.  Dopaminergic mechanism of antidepressant action in depressed patients. , 2005, Journal of affective disorders.

[3588]  W. Sierralta,et al.  Mild prenatal protein malnutrition increases α2C‐adrenoceptor density in the cerebral cortex during postnatal life and impairs neocortical long‐term potentiation and visuo‐spatial performance in rats , 2005, Journal of neurochemistry.

[3589]  S. Cummings,et al.  Effect of raloxifene on prevention of dementia and cognitive impairment in older women: the Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trial. , 2005, The American journal of psychiatry.

[3590]  C. Léránth,et al.  Short‐term treatment with the antidepressant fluoxetine triggers pyramidal dendritic spine synapse formation in rat hippocampus , 2005, The European journal of neuroscience.

[3591]  B. Roth,et al.  Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2C receptor , 1996, Psychopharmacology.

[3592]  Eric A. Stone and David Quartermain.  The Brain Epinephrine-α1-Adrenoceptor System in Behavioral Activation and Depression , 2005 .

[3593]  M. Detke,et al.  Time course of depression‐symptom improvement during treatment with duloxetine , 2005, Depression and anxiety.

[3594]  Punita Bhansali,et al.  How Stress and Fluoxetine Modulate Serotonin 2C Receptor Pre-mRNA Editing , 2005, The Journal of Neuroscience.

[3595]  K. Bogeso,et al.  The pharmacological effect of citalopram resides in the (S)-(+)-enantiomer , 2005, Journal of Neural Transmission / General Section JNT.

[3596]  C. Eap,et al.  Neuropeptide Y and corticotropin-releasing hormone in CSF mark response to antidepressive treatment with citalopram. , 2005, The international journal of neuropsychopharmacology.

[3597]  M. Suyama,et al.  Complex genomic rearrangements lead to novel primate gene function. , 2005, Genome research.

[3598]  K. Lesch,et al.  Loss of brain‐derived neurotrophic factor gene allele exacerbates brain monoamine deficiencies and increases stress abnormalities of serotonin transporter knockout mice , 2005, Journal of neuroscience research.

[3599]  A. Argiolas,et al.  PD-168077, a selective dopamine D4 receptor agonist, induces penile erection when injected into the paraventricular nucleus of male rats , 2005, Neuroscience Letters.

[3600]  K. Lieb,et al.  Substance P Receptor Antagonists in Psychiatry , 2005, CNS drugs.

[3601]  P. Riederer,et al.  Animal models of Parkinson's disease: An empirical comparison with the phenomenology of the disease in man , 2005, Journal of Neural Transmission.

[3602]  E. van Cauter,et al.  Phase‐shifts of 24‐h rhythms of hormonal release and body temperature following early evening administration of the melatonin agonist agomelatine in healthy older men , 2005, Clinical endocrinology.

[3603]  V. Brown,et al.  Vagal nerve stimulation: a review of its applications and potential mechanisms that mediate its clinical effects , 2005, Neuroscience & Biobehavioral Reviews.

[3604]  G. Dawson,et al.  Different GABAA receptor subtypes mediate the anxiolytic, abuse-related, and motor effects of benzodiazepine-like drugs in primates. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[3605]  Martin Ebeling,et al.  Trace amine-associated receptors form structurally and functionally distinct subfamilies of novel G protein-coupled receptors. , 2005, Genomics.

[3606]  K. Larsson,et al.  Clozapine acts as a 5-HT2 antagonist by attenuating DOI-induced inhibition of male rat sexual behaviour , 1995, Psychopharmacology.

[3607]  Jordi Bascompte,et al.  Interaction strength combinations and the overfishing of a marine food web. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[3608]  Péter Csermely,et al.  The efficiency of multi-target drugs: the network approach might help drug design. , 2004, Trends in pharmacological sciences.

[3609]  D. Kajdasz,et al.  Safety and tolerability of duloxetine in the treatment of major depressive disorder: analysis of pooled data from eight placebo‐controlled clinical trials , 2005, Human psychopharmacology.

[3610]  P. Blier,et al.  Effect of neurokinin-1 receptor antagonists on serotoninergic, noradrenergic and hippocampal neurons: Comparison with antidepressant drugs , 2005, Peptides.

[3611]  M. Fava,et al.  Obesity among outpatients with major depressive disorder. , 2005, The international journal of neuropsychopharmacology.

[3612]  C. Hague,et al.  Heterodimerization with β2-Adrenergic Receptors Promotes Surface Expression and Functional Activity of α1D-Adrenergic Receptors , 2005, Journal of Pharmacology and Experimental Therapeutics.

[3613]  Janet A. Clark,et al.  Differential hormonal regulation of tryptophan hydroxylase-2 mRNA in the murine dorsal raphe nucleus , 2005, Biological Psychiatry.

[3614]  K. Sluka,et al.  Acetazolamide, a Carbonic Anhydrase Inhibitor, Reverses Inflammation-Induced Thermal Hyperalgesia in Rats , 2005, Journal of Pharmacology and Experimental Therapeutics.

[3615]  E. Ziv,et al.  Inferring network mechanisms: the Drosophila melanogaster protein interaction network. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[3616]  C. Gambarana,et al.  Study of mirtazapine antidepressant effects in rats. , 2005, The international journal of neuropsychopharmacology.

[3617]  L. Porrino,et al.  Time-Dependent Changes in Receptor/G-Protein Coupling in Rat Brain following Chronic Monoamine Transporter Blockade , 2005, Journal of Pharmacology and Experimental Therapeutics.

[3618]  S. Urwyler,et al.  Mechanisms of allosteric modulation at GABAB receptors by CGP7930 and GS39783: effects on affinities and efficacies of orthosteric ligands with distinct intrinsic properties , 2005, Neuropharmacology.

[3619]  F. Hofmann,et al.  Function of cGMP-dependent Protein Kinases in the Nervous System , 2005, Reviews in the neurosciences.

[3620]  C. Langmead,et al.  Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone. , 2005, European journal of pharmacology.

[3621]  J. Claverie.  Fewer Genes, More Noncoding RNA , 2005, Science.

[3622]  J. Rochford,et al.  Antidepressant-like effects of neurokinin receptor antagonists in the forced swim test in the rat. , 2005, European journal of pharmacology.

[3623]  I. Lucki,et al.  Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test , 2005, Neuroscience & Biobehavioral Reviews.

[3624]  J. Wisor,et al.  Dopaminergic—adrenergic interactions in the wake promoting mechanism of modafinil , 2005, Neuroscience.

[3625]  D. Monaghan,et al.  An Antisense Oligonucleotide to the N-Methyl-d-aspartate (NMDA) Subunit NMDAR1 Attenuates NMDA-Induced Nociception, Hyperalgesia, and Morphine Tolerance , 2005, Journal of Pharmacology and Experimental Therapeutics.

[3626]  H. Berendsen,et al.  Involvement of 5-HT1C-receptors in drug-induced penile erections in rats , 2005, Psychopharmacology.

[3627]  A. Rush,et al.  Relief of expressed suicidal intent by ECT: a consortium for research in ECT study. , 2005, The American journal of psychiatry.

[3628]  H. Wittchen,et al.  Cost of affective disorders in Europe , 2005, European journal of neurology.

[3629]  M. Thase,et al.  Incidence of sexual side effects in refractory depression during treatment with citalopram or paroxetine. , 2005, The Journal of clinical psychiatry.

[3630]  S. Stahl.  Antidepressant Treatment of Psychotic Major Depression: Potential Role of the σ Receptor , 2005, CNS Spectrums.

[3631]  P. Celada,et al.  Strategies for producing faster acting antidepressants. , 2005, Drug discovery today.

[3632]  J. Stock,et al.  Circadian Rhythm Phenotype of 5-HT₇ Receptor Knockout Mice: 5-HT and 8-OH-DPAT-Induced Phase Advances of SCN Neuronal Firing , 2005, Journal of biological rhythms.

[3633]  R Todd Constable,et al.  Beyond affect: a role for genetic variation of the serotonin transporter in neural activation during a cognitive attention task. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[3634]  F. Bosetti,et al.  Microarray analysis of rat brain gene expression after chronic administration of sodium valproate , 2005, Brain Research Bulletin.

[3635]  N. Rifai,et al.  Truncal adiposity, relative growth hormone deficiency, and cardiovascular risk. , 2005, The Journal of clinical endocrinology and metabolism.

[3636]  B. Waeber.  What can be learned from the experience with the fixed low-dose combination of perindopril/indapamide in the treatment of hypertension? , 2005, Expert opinion on pharmacotherapy.

[3637]  A. Rush,et al.  Escitalopram in clinical practice: Results of an open‐label trial in a naturalistic setting , 2005, Depression and anxiety.

[3638]  G. Chiara,et al.  Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential? , 1994, Psychopharmacology.

[3639]  M. L. Saux,et al.  Changes in 5-HT1A receptor binding and G-protein activation in the rat brain after estrogen treatment: comparison with tamoxifen and raloxifene. , 2005 .

[3640]  K. H. Wolfe,et al.  Changes in alternative splicing of human and mouse genes are accompanied by faster evolution of constitutive exons. , 2005, Molecular biology and evolution.

[3641]  R. Bertorelli,et al.  The antinociceptive and anxiolytic-like effects of the metabotropic glutamate receptor 5 (mGluR5) antagonists, MPEP and MTEP, and the mGluR1 antagonist, LY456236, in rodents: a comparison of efficacy and side-effect profiles , 2005, Psychopharmacology.

[3642]  Min Zhang,et al.  Pharmacological Properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological Characterization and Broad Preclinical Efficacy in Cognition and Schizophrenia of a Potent and Selective Histamine H3 Receptor Antagonist , 2005, Journal of Pharmacology and Experimental Therapeutics.

[3643]  J. Cryan,et al.  Altered anxiety and depression-related behaviour in mice lacking GABAB(2) receptor subunits , 2005, Neuroreport.

[3644]  J. Jefferson.  Lamotrigine in Psychiatry: Pharmacology and Therapeutics , 2005, CNS Spectrums.

[3645]  S. L. Parker,et al.  Lithium inhibits internalization and endosomal processing of both neuropeptide Y (NPY) Y1 and transferrin receptors , 2005, Neuroscience Letters.

[3646]  Anat Sakov,et al.  Genotype-environment interactions in mouse behavior: a way out of the problem. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[3647]  Prahlad T. Ram,et al.  Formation of Regulatory Patterns During Signal Propagation in a Mammalian Cellular Network , 2005, Science.

[3648]  D. Shapiro,et al.  The effectiveness of psychological treatments for treatment‐resistant depression: a systematic review , 2005, Acta psychiatrica Scandinavica.

[3649]  K. Hsu,et al.  Behavioral Stress Enhances Hippocampal CA1 Long-Term Depression through the Blockade of the Glutamate Uptake , 2005, The Journal of Neuroscience.

[3650]  S. Stamm,et al.  Function of Alternative Splicing , 2004 .

[3651]  Phillip Gribbon,et al.  High-throughput drug discovery: what can we expect from HTS? , 2005, Drug discovery today.

[3652]  Nora Turjanski,et al.  Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system. , 2005, Brain : a journal of neurology.

[3653]  Peter S Whitton,et al.  Effects of amantadine and budipine on antidepressant drug‐evoked changes in extracellular 5‐HT in the frontal cortex of freely moving rats , 2005, British journal of pharmacology.

[3654]  Tyson A. Clark,et al.  Nova regulates brain-specific splicing to shape the synapse , 2005, Nature Genetics.

[3655]  I. Weiner,et al.  Modulators of the glycine site on NMDA receptors, d-serine and ALX 5407, display similar beneficial effects to clozapine in mouse models of schizophrenia , 2005, Psychopharmacology.

[3656]  J. Tsien,et al.  Acquired deficit of forebrain glucocorticoid receptor produces depression-like changes in adrenal axis regulation and behavior. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[3657]  D. Slattery,et al.  GABAB Receptor Antagonist-Mediated Antidepressant-Like Behavior Is Serotonin-Dependent , 2005, Journal of Pharmacology and Experimental Therapeutics.

[3658]  Michael E. Hasselmo,et al.  Unraveling the attentional functions of cortical cholinergic inputs: interactions between signal-driven and cognitive modulation of signal detection , 2005, Brain Research Reviews.

[3659]  M. Bednarek,et al.  Antiobesity effect of a melanin-concentrating hormone 1 receptor antagonist in diet-induced obese mice. , 2005, Endocrinology.

[3660]  A. Shekhar,et al.  Stress and central Urocortin increase anxiety-like behavior in the social interaction test via the CRF1 receptor. , 2005, European journal of pharmacology.

[3661]  R. Valentino,et al.  Peptides that fine-tune the serotonin system , 2005, Neuropeptides.

[3662]  J. Hietala,et al.  Serotonin 5-HT2C receptor-mediated phosphoinositide hydrolysis in rat choroid plexus after fluoxetine and citalopram treatments. , 2005, Pharmacological research.

[3663]  J. Redman,et al.  Dose dependent effects of S-20098, a melatonin agonist, on direction of re-entrainment of rat circadian activity rhythms , 1995, Psychopharmacology.

[3664]  P. Micevych,et al.  Neurobiological Effects of Sex Steroid Hormones , 2005 .

[3665]  G. Griebel,et al.  Evidence that the Lateral Septum is Involved in the Antidepressant-Like Effects of the Vasopressin V1b Receptor Antagonist, SSR149415 , 2005, Neuropsychopharmacology.

[3666]  A. Pizzimenti,et al.  Randomized double‐blind comparison of serotonergic (Citalopram) versus noradrenergic (Reboxetine) reuptake inhibitors in outpatients with somatoform, DSM‐IV‐TR pain disorder , 2005, European journal of pain.

[3667]  J. Herman,et al.  Organization and regulation of paraventricular nucleus glutamate signaling systems: N‐methyl‐D‐aspartate receptors , 2005, The Journal of comparative neurology.

[3668]  C. Katona,et al.  Association between pain and depression among older adults in Europe: results from the Aged in Home Care (AdHOC) project: a cross-sectional study. , 2005, The Journal of clinical psychiatry.

[3669]  Circadian control during the day and night: Role of neuropeptide Y Y5 receptors in the suprachiasmatic nucleus , 2005, Brain Research Bulletin.

[3670]  M. Millan,et al.  Serotonin1A autoreceptor activation by S 15535 enhances circadian activity rhythms in hamsters: Evaluation of potential interactions with serotonin2A and serotonin2C receptors , 2006, Neuroscience.

[3671]  B. Harrison,et al.  Muscarinic and nicotinic receptors synergistically modulate working memory and attention in humans. , 2005, The international journal of neuropsychopharmacology.

[3672]  Y. Hurd,et al.  Electroconvulsive shock increases dopamine D1 and D2 receptor mRNA in the nucleus accumbens of the rat , 1995, Psychopharmacology.

[3673]  D. McKinzie,et al.  Melanin-Concentrating Hormone-1 Receptor Modulates Neuroendocrine, Behavioral, and Corticolimbic Neurochemical Stress Responses in Mice , 2006, Neuropsychopharmacology.

[3674]  Bryan L Roth,et al.  Evidence for the Preferential Involvement of 5-HT2A Serotonin Receptors in Stress- and Drug-Induced Dopamine Release in the Rat Medial Prefrontal Cortex , 2006, Neuropsychopharmacology.

[3675]  H. Terrace,et al.  Randomized controlled trial of the cognitive side-effects of magnetic seizure therapy (MST) and electroconvulsive shock (ECS). , 2005, The international journal of neuropsychopharmacology.

[3676]  M. Trivedi,et al.  Treatment-resistant depression. , 2006, The Journal of clinical psychiatry.

[3677]  H. Baribault,et al.  Genetic Inactivation of Melanin-Concentrating Hormone Receptor Subtype 1 (MCHR1) in Mice Exerts Anxiolytic-Like Behavioral Effects , 2006, Neuropsychopharmacology.

[3678]  Tramadol for neuropathic pain. , 2006, The Cochrane database of systematic reviews.

[3679]  M. Weller,et al.  Signaling from cAMP/PKA to MAPK and synaptic plasticity , 2003, Molecular Neurobiology.

[3680]  M. Tokuda,et al.  Regulation of neuronal plasticity in the central nervous system by phosphorylation and dephosphorylation , 2007, Molecular Neurobiology.

[3681]  Larry S. Goldman,et al.  Awareness, diagnosis, and treatment of depression , 1999, Journal of General Internal Medicine.

[3682]  H. Sei,et al.  Short-term sleep disturbance enhances brain-derived neurotrophic factor gene expression in rat hippocampus by acting as internal stressor , 2007, Journal of Molecular Neuroscience.

[3683]  R. Quirion,et al.  Characterization of neuropeptide Y, Y2 receptor knockout mice in two animal models of learning and memory processing , 2007, Journal of Molecular Neuroscience.

[3684]  A. Fisher,et al.  M1 muscarinic agonists can modulate some of the hallmarks in Alzheimer’s disease , 2007, Journal of Molecular Neuroscience.

[3685]  V. Gribkoff,et al.  The augementation hypothesis for improvement of antidepressant therapy , 2000, Molecular Neurobiology.

[3686]  J. Blendy,et al.  Regulation of antidepressant activity by cAMP response element binding proteins , 2004, Molecular Neurobiology.

[3687]  Richard E. White,et al.  Rapid Suppression of Plasma Testosterone Levels and Tumor Growth in the Dunning Rat Model Treated with Degarelix, a New Gonadotropin-Releasing Hormone Antagonist , 2007, Journal of Pharmacology and Experimental Therapeutics.

[3688]  F. Marshall.  Is the GABAB heterodimer a good drug target? , 2007, Journal of Molecular Neuroscience.

[3689]  C. Sommer.  Serotonin in pain and analgesia , 2004, Molecular Neurobiology.

[3690]  Zhen Yan.  Regulation of GABAergic inhibition by serotonin signaling in prefrontal cortex , 2002, Molecular Neurobiology.

[3691]  S. Schreiber,et al.  Venlafaxine and mirtazapine , 2002, Journal of Molecular Neuroscience.

[3692]  K. Fuxe,et al.  Existence and theoretical aspects of homomeric and heteromeric dopamine receptor complexes and their relevance for neurological diseases , 2007, NeuroMolecular Medicine.